
<html lang="en"     class="pb-page"  data-request-id="36bde26e-8647-4d4b-b661-0c3f6f48a799"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;issue:issue:10.1021/jmcmar.2013.56.issue-13;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/jm400556w;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Discovery of Potent and Selective Benzothiazole Hydrazone Inhibitors of Bcl-XL" /></meta><meta name="dc.Creator" content="Brad E.  Sleebs" /></meta><meta name="dc.Creator" content="Wilhemus J. A.  Kersten" /></meta><meta name="dc.Creator" content="Sanji  Kulasegaram" /></meta><meta name="dc.Creator" content="George  Nikolakopoulos" /></meta><meta name="dc.Creator" content="Effie  Hatzis" /></meta><meta name="dc.Creator" content="Rebecca M.  Moss" /></meta><meta name="dc.Creator" content="John P.  Parisot" /></meta><meta name="dc.Creator" content="Hong  Yang" /></meta><meta name="dc.Creator" content="Peter E.  Czabotar" /></meta><meta name="dc.Creator" content="W. Douglas  Fairlie" /></meta><meta name="dc.Creator" content="Erinna F.  Lee" /></meta><meta name="dc.Creator" content="Jerry M.  Adams" /></meta><meta name="dc.Creator" content="Lin  Chen" /></meta><meta name="dc.Creator" content="Mark F.  van Delft" /></meta><meta name="dc.Creator" content="Kym N.  Lowes" /></meta><meta name="dc.Creator" content="Andrew  Wei" /></meta><meta name="dc.Creator" content="David C.S.  Huang" /></meta><meta name="dc.Creator" content="Peter M.  Colman" /></meta><meta name="dc.Creator" content="Ian P.  Street" /></meta><meta name="dc.Creator" content="Jonathan B.  Baell" /></meta><meta name="dc.Creator" content="Keith  Watson" /></meta><meta name="dc.Creator" content="Guillaume  Lessene" /></meta><meta name="dc.Description" content="Developing potent molecules that inhibit Bcl-2 family mediated apoptosis affords opportunities to treat cancers via reactivation of the cell death machinery. We describe the hit-to-lead development..." /></meta><meta name="Description" content="Developing potent molecules that inhibit Bcl-2 family mediated apoptosis affords opportunities to treat cancers via reactivation of the cell death machinery. We describe the hit-to-lead development..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="June 26, 2013" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm400556w" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2013 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm400556w" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm400556w" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm400556w" /></link>
        
    
    

<title>Discovery of Potent and Selective Benzothiazole Hydrazone Inhibitors of Bcl-XL | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm400556w" /></meta><meta property="og:title" content="Discovery of Potent and Selective Benzothiazole Hydrazone Inhibitors of Bcl-XL" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-13/jm400556w/production/images/large/jm-2013-00556w_0027.jpeg" /></meta><meta property="og:description" content="Developing potent molecules that inhibit Bcl-2 family mediated apoptosis affords opportunities to treat cancers via reactivation of the cell death machinery. We describe the hit-to-lead development of selective Bcl-XL inhibitors originating from a high-throughput screening campaign. Small structural changes to the hit compound increased binding affinity more than 300-fold (to IC50 &lt; 20 nM). This molecular series exhibits drug-like characteristics, low molecular weights (Mw &lt; 450), and unprecedented selectivity for Bcl-XL. Surface plasmon resonance experiments afford strong evidence of binding affinity within the hydrophobic groove of Bcl-XL. Biological experiments using engineered Mcl-1 deficient mouse embryonic fibroblasts (MEFs, reliant only on Bcl-XL for survival) and Bax/Bak deficient MEFs (insensitive to selective activation of Bcl-2-driven apoptosis) support a mechanism-based induction of apoptosis. This manuscript describes the first series of selective small-molecule inhibitors of Bcl-XL and provides promising leads for the development of efficacious therapeutics against solid tumors and chemoresistant cancer cell lines." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm400556w"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm400556w">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm400556w&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm400556w&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm400556w&amp;href=/doi/10.1021/jm400556w" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2013</span><span class="cit-fg-volume">, 56</span><span class="cit-fg-issue">, 13</span><span class="cit-fg-pageRange">, 5514-5540</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/56/13" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm4005219" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm400560z" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of Potent and Selective Benzothiazole Hydrazone Inhibitors of Bcl-X<sub>L</sub></span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Brad+E.++Sleebs">Brad E. Sleebs</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Wilhemus+J.+A.++Kersten">Wilhemus J. A. Kersten</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sanji++Kulasegaram">Sanji Kulasegaram</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=George++Nikolakopoulos">George Nikolakopoulos</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Effie++Hatzis">Effie Hatzis</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Rebecca+M.++Moss">Rebecca M. Moss</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John+P.++Parisot">John P. Parisot</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hong++Yang">Hong Yang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Peter+E.++Czabotar">Peter E. Czabotar</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=W.+Douglas++Fairlie">W. Douglas Fairlie</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Erinna+F.++Lee">Erinna F. Lee</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jerry+M.++Adams">Jerry M. Adams</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lin++Chen">Lin Chen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mark+F.++van+Delft">Mark F. van Delft</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kym+N.++Lowes">Kym N. Lowes</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Andrew++Wei">Andrew Wei</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=David+C.S.++Huang">David C.S. Huang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Peter+M.++Colman">Peter M. Colman</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ian+P.++Street">Ian P. Street</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jonathan+B.++Baell">Jonathan B. Baell</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Keith++Watson">Keith Watson</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Guillaume++Lessene">Guillaume Lessene</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">The Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville VIC-3052, Australia</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Department of Medical Biology, The University of Melbourne, Parkville VIC-3010, Australia</span></div><div class="corresp-info"><strong>*</strong>Phone: +613-9345-2103. Fax: +613-9345-2211. E-mail: <a href="/cdn-cgi/l/email-protection#553239302626303b301522303d3c7b3031207b3420"><span class="__cf_email__" data-cfemail="e3848f869090868d86a394868b8acd868796cd8296">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm400556w&amp;href=/doi/10.1021%2Fjm400556w" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2013</span></span><span class="cit-volume">, 56</span><span class="cit-issue">, 13</span><span class="cit-pageRange">, 5514–5540</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">June 14, 2013</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>16 April 2013</li><li><span class="item_label"><b>Published</b> online</span>26 June 2013</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 11 July 2013</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm400556w" title="DOI URL">https://doi.org/10.1021/jm400556w</a></div><div class="article_header-article-copyright"><strong>Copyright © 2013 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D5514%26pageCount%3D27%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DBrad%2BE.%2BSleebs%252C%2BWilhemus%2BJ.%2BA.%2BKersten%252C%2BSanji%2BKulasegaram%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D56%26issueNum%3D13%26contentID%3Djm400556w%26title%3DDiscovery%2Bof%2BPotent%2Band%2BSelective%2BBenzothiazole%2BHydrazone%2BInhibitors%2Bof%2BBcl-XL%26numPages%3D27%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D5540%26publicationDate%3DJuly%2B2013">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm400556w"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2794</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">45</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm400556w" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of Potent and Selective Benzothiazole Hydrazone Inhibitors of Bcl-XL&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Brad&quot;,&quot;last_name&quot;:&quot;E. Sleebs&quot;},{&quot;first_name&quot;:&quot;Wilhemus&quot;,&quot;last_name&quot;:&quot;J. A. Kersten&quot;},{&quot;first_name&quot;:&quot;Sanji&quot;,&quot;last_name&quot;:&quot;Kulasegaram&quot;},{&quot;first_name&quot;:&quot;George&quot;,&quot;last_name&quot;:&quot;Nikolakopoulos&quot;},{&quot;first_name&quot;:&quot;Effie&quot;,&quot;last_name&quot;:&quot;Hatzis&quot;},{&quot;first_name&quot;:&quot;Rebecca&quot;,&quot;last_name&quot;:&quot;M. Moss&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;P. Parisot&quot;},{&quot;first_name&quot;:&quot;Hong&quot;,&quot;last_name&quot;:&quot;Yang&quot;},{&quot;first_name&quot;:&quot;Peter&quot;,&quot;last_name&quot;:&quot;E. Czabotar&quot;},{&quot;first_name&quot;:&quot;W.&quot;,&quot;last_name&quot;:&quot;Douglas Fairlie&quot;},{&quot;first_name&quot;:&quot;Erinna&quot;,&quot;last_name&quot;:&quot;F. Lee&quot;},{&quot;first_name&quot;:&quot;Jerry&quot;,&quot;last_name&quot;:&quot;M. Adams&quot;},{&quot;first_name&quot;:&quot;Lin&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;Mark&quot;,&quot;last_name&quot;:&quot;F. van Delft&quot;},{&quot;first_name&quot;:&quot;Kym&quot;,&quot;last_name&quot;:&quot;N. Lowes&quot;},{&quot;first_name&quot;:&quot;Andrew&quot;,&quot;last_name&quot;:&quot;Wei&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;C.S. Huang&quot;},{&quot;first_name&quot;:&quot;Peter&quot;,&quot;last_name&quot;:&quot;M. Colman&quot;},{&quot;first_name&quot;:&quot;Ian&quot;,&quot;last_name&quot;:&quot;P. Street&quot;},{&quot;first_name&quot;:&quot;Jonathan&quot;,&quot;last_name&quot;:&quot;B. Baell&quot;},{&quot;first_name&quot;:&quot;Keith&quot;,&quot;last_name&quot;:&quot;Watson&quot;},{&quot;first_name&quot;:&quot;Guillaume&quot;,&quot;last_name&quot;:&quot;Lessene&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2013&quot;,&quot;month&quot;:&quot;06&quot;,&quot;day&quot;:&quot;26&quot;,&quot;issue&quot;:&quot;13&quot;,&quot;volume&quot;:&quot;56&quot;,&quot;pages&quot;:&quot;5514-5540&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm400556w&quot;},&quot;abstract&quot;:&quot;Developing potent molecules that inhibit Bcl-2 family mediated apoptosis affords opportunities to treat cancers via reactivation of the cell death machinery. We describe the hit-to-lead development of selective Bcl-XL inhibitors originating from a high-throughput screening campaign. Small structural changes to the hit compound increased binding affinity more than 300-fold (to IC50 &lt; 20 nM). This molecular series exhibits drug-like characteristics, low molecular weights (Mw &lt; 450), and unprecedented selectivity for Bcl-XL. Surface plasmon resonance experiments afford strong evidence of binding affinity within the hydrophobic groove of Bcl-XL. Biological experiments using engineered Mcl-1 deficient mouse embryonic fibroblasts (MEFs, reliant only on Bcl-XL for survival) and Bax/Bak deficient MEFs (insensitive to selective activation of Bcl-2-driven apoptosis) support a mechanism-based induction of apoptosis. This manuscript describes the first series of selective small-molecule inhibitors of Bcl-XL and provides &quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm400556w&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm400556w" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm400556w&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm400556w" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm400556w&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm400556w" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm400556w&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm400556w&amp;href=/doi/10.1021/jm400556w" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm400556w" /></input><a href="/doi/pdf/10.1021/jm400556w" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm400556w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm400556w%26sid%3Dliteratum%253Aachs%26pmid%3D23767404%26genre%3Darticle%26aulast%3DSleebs%26date%3D2013%26atitle%3DDiscovery%2Bof%2BPotent%2Band%2BSelective%2BBenzothiazole%2BHydrazone%2BInhibitors%2Bof%2BBcl-XL%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D56%26issue%3D13%26spage%3D5514%26epage%3D5540%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=291788" title="Reaction products">Reaction products</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291352" title="Screening assays">Screening assays</a>,</li><li><a href="/action/doSearch?ConceptID=291754" title="Molecules">Molecules</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/56/13" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-13/jmcmar.2013.56.issue-13/production/jmcmar.2013.56.issue-13.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_null" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-13/jm400556w/production/images/medium/jm-2013-00556w_0027.gif" alt="" id="_i1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-13/jm400556w/production/images/large/jm-2013-00556w_0027.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400556w&amp;id=f_null"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Developing potent molecules that inhibit Bcl-2 family mediated apoptosis affords opportunities to treat cancers via reactivation of the cell death machinery. We describe the hit-to-lead development of selective Bcl-X<sub>L</sub> inhibitors originating from a high-throughput screening campaign. Small structural changes to the hit compound increased binding affinity more than 300-fold (to IC<sub>50</sub> < 20 nM). This molecular series exhibits drug-like characteristics, low molecular weights (<i>M</i><sub>w</sub> < 450), and unprecedented selectivity for Bcl-X<sub>L</sub>. Surface plasmon resonance experiments afford strong evidence of binding affinity within the hydrophobic groove of Bcl-X<sub>L</sub>. Biological experiments using engineered Mcl-1 deficient mouse embryonic fibroblasts (MEFs, reliant only on Bcl-X<sub>L</sub> for survival) and Bax/Bak deficient MEFs (insensitive to selective activation of Bcl-2-driven apoptosis) support a mechanism-based induction of apoptosis. This manuscript describes the first series of selective small-molecule inhibitors of Bcl-X<sub>L</sub> and provides promising leads for the development of efficacious therapeutics against solid tumors and chemoresistant cancer cell lines.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17533" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17533" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The Bcl-2 family of proteins plays a central role in the regulation of apoptosis.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> The interplay between its members commits cells toward survival or death. It participates in the removal of unwanted cells during embryogenesis and in maintenance of cell homeostasis in mature organisms. The link between the Bcl-2 family of proteins and cancer is now well established and amply documented.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Pro-survival proteins such as Bcl-2, Bcl-X<sub>L</sub>, or Mcl-1, which promote cell survival, are overexpressed in a large number of tumor cell lines, thereby preventing these cells from undergoing natural apoptosis. Failure to remove damaged cells carrying potentially oncogenic DNA damage is a hallmark of cancer evolution.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Inability to respond to apoptotic stimuli has also been linked to metastasis and resistance to currently used cytotoxic agents and targeted therapeutics. Indeed, many such drugs rely on a functional Bcl-2 signaling pathway to exert their anticancer activity.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> This body of evidence has made the pro-survival members of the Bcl-2 family of proteins a novel and promising target for treating cancers. The aim of this strategy is to target the core mechanism controlling cell death and thus re-establish the tumor cell’s sensitivity to death signals.</div><div class="NLM_p">The Bcl-2 family comprises three subfamilies, defined by their biological function (pro- or antiapoptotic) and their structure (presence of some or all the Bcl-2-Homology domains BH1 to BH4). The pro-survival subclass (Bcl-2 itself, Mcl-1, Bcl-X<sub>L</sub>, and Bcl-w) maintains cell survival by keeping in check the pro-apoptotic activity of a second subclass, the pro-apoptotic Bax and Bak proteins. Their activity is focused on the mitochondrial membrane, where Bak is constitutively anchored and Bax converges upon apoptotic activation. A second class of pro-apoptotic proteins, the BH3-only proteins, responds to diverse cellular stress signals including DNA damage and acts as the upstream triggers of the “intrinsic” apoptotic pathway. The precise mechanism of apoptosis induction by the Bcl-2 family of proteins is still debated,<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> but all current models agree that upon pro-apoptotic signaling, BH3-only proteins are released and induce the downstream apoptotic response (cytochrome <i>c</i> release, caspase activation, cellular dismantlement) by indirectly or directly activating Bax/Bak.<a onclick="showRef(event, 'ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref6 ref7">(6, 7)</a> Bax and Bak are therefore essential mediators of apoptosis induced by the BH3-only proteins.<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8, 9)</a></div><div class="NLM_p">Replicating the pro-apoptotic activity of the BH3-only proteins using small molecules targeting the pro-survival subclass of proteins is currently an important goal of anticancer drug discovery. Despite major advances, only four small molecules modulating the activity of Bcl-2 proteins are currently in clinical trials.<a onclick="showRef(event, 'ref10 ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref10 ref11 ref12">(10-12)</a> One of these series of compounds has shown a mechanism-based mode of action, including Bax/Bak dependency: ABT-737, its related orally available analogue ABT-263, and ABT-199 (<b>1</b>, <b>2</b>, and <b>3</b>, respectively in Chart <a class="ref internalNav" href="#cht1" aria-label="1">1</a>).<a onclick="showRef(event, 'ref12 ref13 ref14 ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref12 ref13 ref14 ref15 ref16">(12-16)</a> While <b>3</b> is a selective and potent inhibitor of Bcl-2, <b>1</b> and <b>2</b> are high-affinity ligands of Bcl-2, Bcl-w, and Bcl-X<sub>L</sub>, replicating the binding profile of the BH3-only protein Bad and require the presence of Bax/Bak for cellular activity.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Because neither compound potently binds Mcl-1, their efficacy is limited to tumor cell lines with low levels of Mcl-1, although their spectrum of activity can be increased to a wider range of cancer cell lines when used in combination with drugs that neutralize Mcl-1.<a onclick="showRef(event, 'ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref18 ref19">(18, 19)</a> Their on-target side effects include acute and reversible thrombocytopenia due to interference with Bcl-X<sub>L</sub>’s key role in regulating platelets’ life-span.<a onclick="showRef(event, 'ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref20 ref21">(20, 21)</a> Nevertheless, <b>1</b> has shown positive results in preclinical experiments in multiple blood-related malignancies and a subset of lung cancers.<a onclick="showRef(event, 'ref13 ref22'); return false;" href="javascript:void(0);" class="ref ref13 ref22">(13, 22)</a></div><figure id="cht1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-13/jm400556w/production/images/medium/jm-2013-00556w_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-13/jm400556w/production/images/large/jm-2013-00556w_0002.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Structure of Previously Reported BH3-Mimetics Acylsulfonamide Derivatives <b>1</b>, <b>2</b>, and <b>3</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-13/jm400556w/production/images/large/jm-2013-00556w_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400556w&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The paucity of successful examples of functional mimetics of the BH3-only proteins after two decades of interest in this target emphasizes the difficulty in developing Bcl-2 inhibitors and the need for new compounds, especially with different and/or selective binding profiles. Bcl-X<sub>L</sub> is of particular interest. Although Bcl-2 was first recognized as an oncogene, more recent findings have shown the importance of Bcl-X<sub>L</sub> in carcinogenesis, especially in solid tumors and in the specter of drug resistance.<a onclick="showRef(event, 'ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref23 ref24">(23, 24)</a> It is not yet known how problematic thrombocytopenia due to Bcl-X<sub>L</sub> abatement will be in a clinical setting, but the advantages of a potent inhibitor of Bcl-X<sub>L</sub> might well outweigh the transient platelet reduction derived from targeting this protein.<a onclick="showRef(event, 'ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref21 ref22">(21, 22)</a> In any case, the development of a compound with high affinity and high selectivity for Bcl-X<sub>L</sub> would provide a valuable tool for investigating the role of this pro-survival protein in tumor development.</div><div class="NLM_p last">We have recently described small molecules that potently and selectively inhibit the pro-survival activity of Bcl-X<sub>L</sub>.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Here we present a detailed account of this discovery and early hit-to-lead development of this series. We present an analysis of the mechanism of action of key compounds and show that they indeed act as functional mimetics of the BH3-only proteins. This work, based primarily on classical medicinal chemistry strategies, provides further evidence that the Bcl-2 pro-survival proteins are “druggable”, but drug discovery in this field requires multiple assays and a deep understanding of the biology.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_58184" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_58184" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Hit Identification</h3><div class="NLM_p">Bcl-w-ΔC29 was chosen as the protein target for the initial primary assay due to its favorable solution properties and because its binding profile to BH3 ligands resembles that of Bcl-2 and Bcl-X<sub>L</sub>. Our in-house library of approximately 100000 structurally diverse “hit-like” compounds was screened using an luminescent proximity assay (LPA).<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> This bead-based proximity competition assay was chosen for its robustness and its ability to detect weak binders with a manageable number of false positives. In parallel to the main assay involving Bcl-w, a counter-screen was also employed using beads carrying only GST-Ab to identify the compounds interfering with the assay technology (<a class="ref internalNav" href="#notes-1" aria-label="Supporting Information Figure S1">Supporting Information Figure S1</a>). As references for the binding affinity, we prepared three compounds from a validated series of BH3-mimetics, published by AbbVie, for which binding affinities are known (compounds <b>1</b>, <b>4</b>, and <b>5</b>, Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>).<a onclick="showRef(event, 'ref14 ref27'); return false;" href="javascript:void(0);" class="ref ref14 ref27">(14, 27)</a> Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> summarizes binding assay results for these control compounds against Bcl-X<sub>L</sub>. The data show that the luminescence proximity assay (LPA) technology yields higher IC<sub>50</sub> values compared to the calculated <i>K</i><sub>i</sub> values obtained by fluorescence polarization (FP) assays.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a></div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Binding Affinities for Bcl-X<sub>L</sub>: A Comparison between Published Data and LPA IC<sub>50</sub> Values</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-13/jm400556w/production/images/medium/jm-2013-00556w_0015.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">assay</th><th class="colsep0 rowsep0" align="center" char="."><b>1</b></th><th class="colsep0 rowsep0" align="center" char="."><b>4</b></th><th class="colsep0 rowsep0" align="center" char="."><b>5</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">LPA (IC<sub>50</sub>, μM)<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="char" char=".">0.0005</td><td class="colsep0 rowsep0" align="char" char=".">2.2</td><td class="colsep0 rowsep0" align="char" char=".">0.15</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">FP (<i>K</i><sub>i</sub>, μM)</td><td class="colsep0 rowsep0" align="char" char="."><0.0005<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="char" char=".">0.036<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="char" char="."> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">Average values from multiple separate repeats.</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">From ref <a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">13</a>.</p></div><div class="footnote" id="t1fn3"><sup>c</sup><p class="last">From ref <a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">27</a>. LPA: luminescence proximity assay. FP: fluorescence polarization.</p></div></div></div><div class="NLM_p">The library of compounds was initially tested at 50 μM in a single-point assay, and all the selected hits were characterized with 5 or 11 point titration curves against Bcl-w and in the control counter-screen assay. At this stage, 60 compounds were selected for further analysis (see <a class="ref internalNav" href="#notes-1" aria-label="Figure S1 for full screening cascade, Supporting Information">Figure S1 for full screening cascade, Supporting Information</a>). Where available, new samples were sourced from the original vendors and thus only 46 compounds were obtained as fresh powder samples. These 46 reordered hits were characterized against Bcl-w, Bcl-X<sub>L</sub>, Mcl-1, and in the counter-screen using 11-point titration curves and two distinct screening technologies: LPA and FP assays (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>).<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Only one compound (<b>6</b>) showed binding to Bcl-X<sub>L</sub> in both the LPA and FP assays and lacked activity in the counter-screen assay (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>).<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Other potentially interesting hits obtained during this process were characterized by one or more flaws (e.g., low selectivity compared to counter-screen) and were therefore abandoned. We also encountered a large number of “frequent-hitters”, structures identified as pan-assay interference compounds or “PAINS”,<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> such as rhodanine-like and fused tetrahydroquinoline derivatives.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> Upon examination of the binding affinities across pro-survival proteins, <b>6</b> displayed some selectivity for Bcl-X<sub>L</sub> with an IC<sub>50</sub> below 10 μM, which was of a higher affinity than that measured for Bcl-w (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). At this early stage, compound <b>6</b> also showed distinct selectivity over Mcl-1 and no activity in the counter-screen assay.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Binding Data for the Sole Hit Compound <b>6</b><a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-13/jm400556w/production/images/medium/jm-2013-00556w_0016.gif" alt="" id="fx2" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">Bcl-w</th><th class="rowsep1 colsep0" colspan="3" align="center" char=".">Bcl-X<sub>L</sub></th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">Mcl-1</th><th class="rowsep1 colsep0" align="center" char=".">counter-screen</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd no.</th><th class="colsep0 rowsep0" align="center" char=".">LPA</th><th class="colsep0 rowsep0" align="center" char=".">LPA</th><th class="colsep0 rowsep0" align="center" char=".">LPA</th><th class="colsep0 rowsep0" align="center" char=".">FP<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a> (Bim)</th><th class="colsep0 rowsep0" align="center" char=".">FP<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a> (Bak)</th><th class="colsep0 rowsep0" align="center" char=".">LPA</th><th class="colsep0 rowsep0" align="center" char=".">FP</th><th class="colsep0 rowsep0" align="center" char=".">LPA</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="char" char=".">33</td><td class="colsep0 rowsep0" align="char" char=".">>240</td><td class="colsep0 rowsep0" align="char" char=".">7.7</td><td class="colsep0 rowsep0" align="char" char=".">20</td><td class="colsep0 rowsep0" align="char" char=".">6.8</td><td class="colsep0 rowsep0" align="char" char=".">110</td><td class="colsep0 rowsep0" align="char" char=".">167</td><td class="colsep0 rowsep0" align="char" char=".">249</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">IC<sub>50</sub> values in μM. These values are from the original primary assay. In the remaining part of the text, IC<sub>50</sub> will be reported as average of several experiments and therefore might differ slightly from the ones presented in this table.</p></div><div class="footnote" id="t2fn2"><sup>b</sup><p class="last">Competition assay using the BH3 peptide indicated in bracket. LPA: Luminescence Proximity Assay. FP: Fluorescence Polarization.</p></div></div></div><figure id="fig1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-13/jm400556w/production/images/medium/jm-2013-00556w_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-13/jm400556w/production/images/large/jm-2013-00556w_0003.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Identification of compound <b>6</b>. The final set of 46 reordered compounds was tested against Bcl-w, Bcl-X<sub>L</sub>, and Mcl-1 using the luminescence proximity assay (LPA) and fluorescence polarization (FP) assays together with a counter-screen assay. Hits were compounds showing IC<sub>50</sub> values below 60 μM against any of the three targets.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-13/jm400556w/production/images/large/jm-2013-00556w_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400556w&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Chemistry</h3><div class="NLM_p">The majority of the target compounds prepared for this study are based on a simple generic structure exemplified by compound <b>6</b>: a hydrazone moiety linking a biaryl group to a fused heterocyclic ring system (generally benzothiazole). A simple and obvious retrosynthetic analysis indicated that these compounds could be readily prepared from heteroaromatic hydrazines and biaryl formyl or acetyl precursors (Schemes<a class="ref internalNav" href="#sch1" aria-label="1">1</a>–<a class="ref internalNav" href="#sch3" aria-label="3">3</a>). Several methods could be envisaged to prepare the biaryl moiety. In Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>, the direct precursor of compound <b>6</b> is 3-(5-formyl-2-furyl)-2-methylbenzoic acid <b>9a</b>, which is classically formed using a Meerwein arylation reaction between furaldehyde <b>7a</b> and 2-methyl-3-aminobenzoic acid <b>8a</b>.<a onclick="showRef(event, 'ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref33 ref34">(33, 34)</a> Although this reaction afforded compounds in modest yields, it proved to be versatile and initially applicable to a wide range of substrates containing five-membered heterocyclic rings (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>). Thus, anilines <b>8a</b>–<b>i</b> were treated with sodium nitrite, followed by addition of formyl or acetyl furans, pyrroles, or thiophenes dissolved in acetone in the presence of copper(II) chloride (derivative <b>10j</b> was easily obtained from the reduction of <b>10i</b>). Compounds depicted in Schemes <a class="ref internalNav" href="#sch1" aria-label="1">1</a> and <a class="ref internalNav" href="#sch3" aria-label="3">3</a> were prepared using this method. Reverse biaryl structures, such as <b>34</b>, were also accessible using this protocol (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>). In the final step of the synthesis, a condensation of the aldehyde or ketone with hydrazine derivatives was performed in refluxing ethanol or acetic acid. The desired final products were obtained as precipitates from the reaction mixture and were easily isolated in high purity and reasonable yields.</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-13/jm400556w/production/images/medium/jm-2013-00556w_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-13/jm400556w/production/images/large/jm-2013-00556w_0008.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Furyl-benzothiazole Hydrazone Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-13/jm400556w/production/images/large/jm-2013-00556w_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400556w&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(i) NaNO<sub>2</sub>, HCl, H<sub>2</sub>O, 0 °C; (ii) CuCl<sub>2</sub>, acetone; (iii) ammonium formate, Pd/C, MeOH; (iv) 2-hydrazino-benzothiazole, EtOH or AcOH, 60–80 °C; (v) H<sub>2</sub>SO<sub>4</sub>, MeOH.</p></p></figure><div class="NLM_p">SAR exploration of the benzothiazole section of the molecule required the preparation of derivatives with alternative groups at this position (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>). 2-Hydrazino-benzoxazole and 2-hydrazino-1-methyl-benzimidazole (<b>19a</b>–<b>b</b>) were prepared simply by reacting the corresponding 2-chloro precursors (<b>18a</b>–<b>b</b>) with hydrazine. Substituted 2-hydrazino benzothiazoles <b>21a</b>–<b>f</b> were prepared from known substituted 2-amino-benzothiazole precursors <b>20a</b>–<b>f</b> using an acid-mediated displacement of the amino group in the presence of hydrazine hydrate and hydrazine hydrogen sulfate salt. The corresponding final compounds <b>22a</b>–<b>f</b>, <b>23</b>, and <b>24</b> were prepared according to the general synthesis using a hydrazone formation. Alternatively, commercially available aryl-hydrazine reagents were required to prepare compounds <b>25</b>–<b>27</b>.</div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-13/jm400556w/production/images/medium/jm-2013-00556w_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-13/jm400556w/production/images/large/jm-2013-00556w_0009.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Analogues with Various Replacements of the Benzothiazole Group<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-13/jm400556w/production/images/large/jm-2013-00556w_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400556w&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(i) NH<sub>2</sub>NH<sub>2</sub>, EtOH, 70 °C; (ii) NH<sub>2</sub>NH<sub>2</sub>.H<sub>2</sub>O, NH<sub>2</sub>NH<sub>2</sub>·HCl, ethylene glycol, 140 °C; (iii) Various R-NH-NH<sub>2</sub>, EtOH or AcOH, 60–80 °C.</p></p></figure><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-13/jm400556w/production/images/medium/jm-2013-00556w_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-13/jm400556w/production/images/large/jm-2013-00556w_0010.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Analogues with Various Biarylic Moieties Using the Meerwein Reaction<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-13/jm400556w/production/images/large/jm-2013-00556w_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400556w&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(i) NaNO<sub>2</sub>, HCl, H<sub>2</sub>O, 0 °C; (ii) CuCl<sub>2</sub>, acetone; (iii) 2-hydrazino-benzothiazole, EtOH or AcOH, 60–80 °C.</p></p></figure><div class="NLM_p">As the project progressed, more diversity was required in the biaryl section of the target molecules. Thus, the Suzuki–Miyaura coupling reaction provided another route to these key intermediates with conditions tolerating a wide variety of aryl-, heteroaryl halides and various boronic acids or esters. Schemes <a class="ref internalNav" href="#sch4" aria-label="4">4</a>–<a class="ref internalNav" href="#sch7" aria-label="7">7</a> describe the synthesis of analogues using this method. Specifically, Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a> describes analogues exploring 6/6, 6/5, and 5/6 biaryl systems prepared from commercially available boronic acids and esters <b>35</b> and <b>45</b>.</div><figure id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-13/jm400556w/production/images/medium/jm-2013-00556w_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-13/jm400556w/production/images/large/jm-2013-00556w_0011.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Analogues with Various Biarylic Moieties Using a Suzuki–Miyaura Coupling Reaction<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-13/jm400556w/production/images/large/jm-2013-00556w_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400556w&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(i) TBAB, K<sub>2</sub>CO<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, dioxane/H<sub>2</sub>O, 70 °C, μW; (ii) NaOH, MeOH/THF then HCl; (iii) 2-hydrazino-benzothiazole, EtOH or AcOH, 60–80 °C.</p></p></figure><div class="NLM_p">The synthesis of constrained compounds depicted in Schemes <a class="ref internalNav" href="#sch5" aria-label="5">5</a>, <a class="ref internalNav" href="#sch6" aria-label="6">6</a>, and <a class="ref internalNav" href="#sch7" aria-label="7">7</a> used essentially the same strategy based on a Suzuki–Miyaura coupling, however the cost of the commercially available borylated derivatives of picolinic acid and their extreme instability under classical coupling conditions led us to opt for the preparation of boronic ester derivatives of the arylketone precursors. Thus, the boronic esters <b>53</b> and <b>57a</b>–<b>b</b> were easily prepared from the corresponding commercially available bromoarylketones <b>52</b> and <b>56a</b>–<b>b</b>. Notably, the very efficient transformation described by Han et al. (Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>) provided an excellent alternative to the oil bath heating method.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> This procedure involved microwave irradiation of a mixture of the substrate and bispinacoldiboron in toluene at 150 °C for 5 min in the presence Pd(dppf)Cl<sub>2</sub>, leading to the desired compounds <b>53</b> and <b>57a</b>–<b>b</b> in high yield and good purity. They were then engaged in the coupling/hydrazone formation sequence to furnish constrained derivatives <b>55</b> and <b>59a</b>–<b>b</b>.</div><figure id="sch5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-13/jm400556w/production/images/medium/jm-2013-00556w_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-13/jm400556w/production/images/large/jm-2013-00556w_0012.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of Simple Conformationally Constrained Analogues<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-13/jm400556w/production/images/large/jm-2013-00556w_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400556w&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(i) Bispinacoldiboron, Pd(dppf)Cl<sub>2</sub>, KOAc, toluene, 150 °C, μW; (ii) 6-Bromopicolinic acid, TBAB, K<sub>2</sub>CO<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, dioxane/H<sub>2</sub>O, 70 °C, μW; (iii) 2-hydrazino-benzothiazole, EtOH or AcOH, 60–80 °C.</p></p></figure><figure id="sch6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-13/jm400556w/production/images/medium/jm-2013-00556w_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-13/jm400556w/production/images/large/jm-2013-00556w_0013.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of Constrained Hydrazone Analogues<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-13/jm400556w/production/images/large/jm-2013-00556w_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400556w&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(i) Bispinacoldiboron, Pd(dppf)Cl<sub>2</sub>, KOAc, toluene, 150 °C, μM; (ii) 6-bromopicolinic acid, TBAB, K<sub>2</sub>CO<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, dioxane/H<sub>2</sub>O, 70 °C, μW; (iii) 6-bromopicolinic acid, Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, Na<sub>2</sub>CO<sub>3</sub>, EtOH/DME/H<sub>2</sub>O; (iv) 2-hydrazino-benzothiazole, EtOH or AcOH, 60–80 °C; (v) <i>t</i>-butyl 6-bromo-picolinate, TBAB, K<sub>2</sub>CO<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, dioxane/H<sub>2</sub>O, 70 °C, μW; (vi) <i>n</i> = 1: <i>m</i>-CPBA, CHCl<sub>3</sub>; (vii) <i>n</i> = 2: <i>m</i>-CPBA, CH<sub>2</sub>Cl<sub>2</sub>; (viii) formic acid.</p></p></figure><figure id="sch7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-13/jm400556w/production/images/medium/jm-2013-00556w_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-13/jm400556w/production/images/large/jm-2013-00556w_0014.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Synthesis of Analogues of <b>59b</b> with Alternative Terminal Aryl Rings<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-13/jm400556w/production/images/large/jm-2013-00556w_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400556w&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(i) TBAB, K<sub>2</sub>CO<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, dioxane/H<sub>2</sub>O, 70 °C, μW; (ii) Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, Na<sub>2</sub>CO<sub>3</sub>, EtOH/DME/H<sub>2</sub>O; (iii) LiOH or NaOH, THF/MeOH; (iv) 2-hydrazino-benzothiazole, EtOH or AcOH, 60–80 °C.</p></p></figure><div class="NLM_p">A series of analogues exploring changes to the cyclic structure of the tetralone core (either by introducing heteroatoms or adding substitutions onto the ring) were prepared from the various precursors <b>60a</b>–<b>i</b> (Scheme <a class="ref internalNav" href="#sch6" aria-label="6">6</a>, <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information Scheme S1">Supporting Information Scheme S1</a>).<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> These precursors were then transformed into their respective boronic esters <b>61a</b>–<b>i</b> and reacted with 6-bromopicolinic acid to form biaryls <b>62a</b>–<b>i</b>. The final compounds <b>63a</b>–<b>i</b> were obtained by reacting the biaryl ketone with 2-hydrazinobenzothiazole in the usual manner. As oxidation of the advanced intermediate benzothiopyran-4-one with a free carboxylic <b>62f</b> failed to give the desired sulfone and sulfoxide products, a specific route had to be designed for these two derivatives. First, 6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)thiochroman-4-one <b>61f</b> was coupled to <i>t</i>-butyl-6-bromopicolinate. This protected biaryl acid <b>64</b> was then easily converted into sulfoxide <b>65a</b> using <i>m</i>-CPBA or into sulfone <b>65b</b> using hydrogen peroxide. Usual hydrazone preparation followed by <i>t</i>-butyl ester deprotection in formic acid resulted in the desired compounds <b>67a</b>–<b>b</b>.</div><div class="NLM_p last">The last set of compounds was prepared to explore the SAR of the terminal ring bearing the acid moiety (compounds <b>71a</b>–<b>b</b> and <b>74a</b>–<b>b</b>, Scheme <a class="ref internalNav" href="#sch7" aria-label="7">7</a>). These compounds were prepared using the Suzuki–Miyaura route presented above using known five- and six-membered heterocyclic esters <b>68a</b>–<b>b</b> or acids <b>72a</b>–<b>b</b>. In the case where esters were used as starting material, an additional hydrolysis step was required prior to the preparation of the final compounds <b>71a</b>–<b>b</b>.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Hit-to-Lead Progression</h3><div class="NLM_p">After the identification of compound <b>6</b> as a promising hit with moderate activity against Bcl-X<sub>L</sub>, an initial small set of close analogues was prepared to validate the screening results with indication of early SAR. The binding affinities measured with this set of compounds quickly confirmed the results obtained with <b>6</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). Deletion of the methyl group on the terminal ring (compound <b>11</b>) did not affect the activity while the methylketohydrazone analogue <b>12a</b> and <b>12h</b> exhibited increased potency, bringing the IC<sub>50</sub> values close to 1 μM. In addition to these positive assay results, this series also displayed a reasonable ligand binding efficiency (BE) value of 0.29 for compound <b>12a</b> compared to a BE of 0.21 for compound <b>4</b> at a similar level of potency.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a></div><figure id="fig2" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-13/jm400556w/production/images/medium/jm-2013-00556w_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-13/jm400556w/production/images/large/jm-2013-00556w_0004.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Binding affinities of compound <b>6</b> and its close analogues for Bcl-X<sub>L</sub>. IC<sub>50</sub> values shown with standard deviation if two separate experiments were performed, with standard error indicated with * if three or more.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-13/jm400556w/production/images/large/jm-2013-00556w_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400556w&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The next part of our study was aimed at increasing our understanding of the SAR and at improving the activity of the series. In the absence of structural information, these data would help formulate hypotheses about the binding mode of the molecules. We tried to elucidate the essential pharmacophore of the series by dissecting each section of the target compounds: the acidic moiety, the biaryl unit, the hydrazone linker, and the benzothiazole group. It quickly became evident that most of the elements constituting the core structure were essential for binding to Bcl-X<sub>L</sub>. Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> presents results obtained for compounds where the nature and position of the terminal carboxylic acid are modified and where substituents have been added to the terminal ring.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> While the derivative with the acid moiety in position 6 (<b>12b</b>, see Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a> for terminal ring numbering) had no activity, the analogue <b>12c</b> (carboxylic acid in position 2) retained most of the original binding affinity although its binding affinity was difficult to assess accurately due to its low solubility. Exploration of ring substitutions indicated that position 6 tolerated a large range of substituents (from electron withdrawing to electron donating groups, compounds <b>12e</b> and <b>12i</b>–<b>j</b>, Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). Position 2 tolerates the presence of substituents such as a methyl (<b>6</b> and <b>12h</b>) and chloro (<b>12f</b>) group. Addition of a chlorine atom or a carboxylic acid on the opposite side of the ring (compounds <b>12d</b> and <b>12g</b>, at position 4 and 5, respectively, Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>) did however reduce the affinity for Bcl-X<sub>L</sub>. It can be deduced from these results that positions 2 and 4 of the terminal ring may point away from the target protein, whereas positions 5 and 6 may interact with the protein. The results observed with the orientation of the carboxylic acid on the ring suggest that an important electrostatic interaction is taking place with a residue located on the interacting pocket of Bcl-X<sub>L</sub>. This conclusion was further supported by the lack of activity of compounds <b>16a</b>–<b>b</b> and <b>17a</b>, with nitro, ester, and amide replacements, respectively. Only the homologated compound <b>17b</b> retained activity similar to compound <b>12a</b>.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Influence of Changes the Benzothiazole Group Imparts on Binding Affinity<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-13/jm400556w/production/images/medium/jm-2013-00556w_0017.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-13/jm400556w/production/images/medium/jm-2013-00556w_0018.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>Table a</sup><p class="last">IC<sub>50</sub> values shown with standard deviation if two separate experiments were performed, or with standard error indicated with * if three or more experiments were performed.</p></div></div><div></div></div><div class="NLM_p">The benzothiazole moiety tolerated very little change without completely abrogating binding. Analogues with small substituents on positions 4 and 6 of the benzothiazole nucleus were the only compounds that retained some level of activity (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>, <b>22a</b>–<b>c</b>, <b>22e</b>–<b>f</b>). Conversely, derivative <b>22d</b> bearing a CF<sub>3</sub> group in position 6 of the benzothiazole was totally inactive, suggesting that benzothiazole sits in a relatively narrow pocket. The exquisite match between the benzothiazole unit and the protein was also strikingly demonstrated by the lack of activity of the benzoxazole and methylbenzimidazole derivatives (<b>23</b> and <b>24</b>, respectively). These results indicate that hydrophobicity, as well as steric factors, contribute to the binding of the whole compound. Unsurprisingly, drastic changes to this section of the molecule (quinoline <b>25</b>, 5-phenylthiazole <b>26</b>, and benzoyl <b>27</b>) also led to loss in affinity for Bcl-X<sub>L</sub>.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Influence of Changes on the Benzothiazole Group on the Binding Affinity<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-13/jm400556w/production/images/medium/jm-2013-00556w_0019.gif" alt="" id="fx5" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-13/jm400556w/production/images/medium/jm-2013-00556w_0020.gif" alt="" id="fx6" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>Table a</sup><p class="last">IC<sub>50</sub> values shown with standard deviation if two separate experiments were performed, or with standard error indicated with * if three or more experiments were performed.</p></div></div><div></div></div><div class="NLM_p">In contrast to other parts of the molecule, the biaryl unit was more tolerant to alteration; results presented in Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a> indicate that 6/5, 5/6, and 5/5 biaryl sequences give very similar IC<sub>50</sub> values between 1 and 5 μM (compare <b>12a</b>, <b>34</b>, and <b>51</b>, Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). The nature of the central five-membered heterocycle also seemed less important: thiophene, <i>N</i>-Me pyrrole, and pyrrole can replace the original furan motif without impairing the affinity for Bcl-X<sub>L</sub> (compounds <b>30a</b>–<b>c</b>). Despite this tolerance to changes, none of these analogues imparted significantly better activity to the target molecules: compounds are either of similar or lower affinity. Satisfyingly, however, our exploration of the biaryl moiety led to picolinic acid derivative <b>38</b>, which bound more tightly to Bcl-X<sub>L</sub>, with an IC<sub>50</sub> of 0.12 μM (18 times more potent that compound <b>12a</b>). Importantly, the position of the picolinic acid nitrogen atom is crucial for affinity as a nicotinic acid derivative <b>41</b> reverts activity to micromolar levels. A pyrazinoic acid derivative <b>44</b> also exhibited sharply reduced affinity. Along with the lack of activity of the carboxylic acid replacement derivatives <b>16a</b>–<b>b</b> and <b>17a</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>), these results confirm the importance of the acidic moiety for the overall binding affinity. The putative interaction between this group and a hydrogen bond donor from Bcl-X<sub>L</sub> seems to be enhanced with a picolinic acid motif. Interestingly, with the picolinic acid, the 6/6 biaryl sequence seems to have reached an optimal geometry for efficient binding. While various 5/5, 5/6, and 6/5 biaryl sequences have little impact on the binding affinity (see compounds <b>12a</b>, <b>30a</b>, and <b>34</b>, Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>), they are critical when the terminal ring is a picolinic acid: the thiophene derivative <b>48</b> binds to Bcl-X<sub>L</sub> more weakly than related analogue <b>38</b>. Overall, we were encouraged that the increase in activity observed with compound <b>38</b> was due to a small change on the molecule, thereby indicating that optimization of other portions of the molecule might also lead to significant improvement in binding affinity without increasing the molecular weight.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Biaryl Moiety<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-13/jm400556w/production/images/medium/jm-2013-00556w_0021.gif" alt="" id="fx7" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-13/jm400556w/production/images/medium/jm-2013-00556w_0022.gif" alt="" id="fx8" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>Table a</sup><p class="last">IC<sub>50</sub> values shown with standard deviation if two separate experiments were performed, or with standard error indicated with * if three or more experiments were performed.</p></div></div><div></div></div><div class="NLM_p">The next increase in potency came from a consideration of the binding conformations available to our compounds. We reasoned that the free rotation around the aromatic-hydrazone bond would allow two major conformations maintaining coplanarity with the flanking aromatic rings (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>a). One conformation would result in the molecule adopting an L-shape, whereas the other one would lead to a more linear pharmacophore. Constraining the molecule at this position could therefore potentially increase the binding affinity by locking the compound in its binding conformation. A first set of derivatives based on the indanone core confirmed our hypothesis. One of the conformations, represented by constrained compound <b>55</b>, showed decreased activity while the other constrained compound <b>59a</b> maintained an affinity close to compound <b>38</b> (0.13 vs 0.12 μM, respectively, Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>b). When the tetralone derivative <b>59b</b> was prepared, we observed a further increase in affinity for Bcl-X<sub>L</sub> with an IC<sub>50</sub> value of 23 nM (6-fold more potent than <b>38</b> and 100-fold more potent than <b>12a</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>b). Once again, a significant increase in binding efficiency was achieved with little increase in molecular weight.</div><figure id="fig3" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-13/jm400556w/production/images/medium/jm-2013-00556w_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-13/jm400556w/production/images/large/jm-2013-00556w_0005.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Introduction of constraints to the hydrazone core. IC<sub>50</sub> values shown with standard deviation if two separate experiments were performed, with standard error indicated with * if three or more.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-13/jm400556w/production/images/large/jm-2013-00556w_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400556w&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In an effort to further enhance the binding affinity of the series, we explored derivatives of <b>59b</b> with variation of the saturated section of the tetralone moiety. These targets included constrained structures incorporating heteroatoms and substituted tetralones (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>). In general, this subset of compounds exhibited very good binding affinities for Bcl-X<sub>L</sub> in a similar range compared to <b>59b</b> but with no significant increase in activity. The most potent analogues were the seven-membered ring analogue <b>63b</b> (IC<sub>50</sub> = 10 nM), the β-methyl tetralone <b>63d</b> (IC<sub>50</sub> = 17 nM), and the tetrahydroquinolone derivative <b>63g</b> (IC<sub>50</sub> = 6 nM). Comparison of the five-, six-, and seven-membered ring analogues indicates that the angle induced on the structures by these rings does affect the binding affinity, with optimum binding observed for the seven-membered ring derivative <b>63b</b>. Similar levels of activity compared to <b>59b</b> were observed with chromanone derivative <b>63e</b> (IC<sub>50</sub> = 55 nM) and the thiochromanone derivative <b>63f</b> (IC<sub>50</sub> = 14 nM). Compounds with substitutents at the 4 position of the tetralone or related rings seemed to have decreased activity (see for example compound <b>63a</b> and <b>63i</b>, IC<sub>50</sub> = 47 and 49 nM, respectively). The sulfoxide <b>67a</b> and sulfone <b>67b</b> derivatives of thiochromanone <b>63f</b> were also less potent. Although the β-methyltetralone derivative <b>63d</b> showed good potency, β-dimethylchromanone <b>63h</b> was less potent. Finally the α-methyltetralone <b>63c</b> suffered the largest loss in activity (IC<sub>50</sub> = 260 nM), suggesting that either the methyl group in this position clashes with the protein or that it induces a steric clash with the hydrazone linker, forcing it into a nonbinding conformation.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Constrained Analogues<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-13/jm400556w/production/images/medium/jm-2013-00556w_0023.gif" alt="" id="fx9" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-13/jm400556w/production/images/medium/jm-2013-00556w_0024.gif" alt="" id="fx10" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup>Table a</sup><p class="last">IC<sub>50</sub> values shown with standard deviation if two separate experiments were performed, or with standard error indicated with * if three or more experiments were performed.</p></div></div><div></div></div><div class="NLM_p">In a final exploration of the SAR of our series, we prepared a set of analogues of <b>59b</b> varying the terminal ring bearing a carboxylic acid (Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>). We observed that a thiazole-4-carboxylic acid (compound <b>71a</b>) could efficiently replace the picolinic acid. However, replacement with an oxazole moiety was deleterious to the affinity. Previous results obtained in the nonconstrained series were also confirmed with compound <b>74a</b>–<b>b</b>, where changes from a picolinic acid to a pyrimidinic acid or to the other isomer of picolinic acid also severely decreased the activity. In particular, <b>74b</b> shows that the nitrogen atom on the ring not only modulates the acidity of the carboxylic acid but that its position in the ring is critical for obtaining maximum binding affinity.</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Further Analogues of Compound <b>59b</b><a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-13/jm400556w/production/images/medium/jm-2013-00556w_0025.gif" alt="" id="fx11" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-13/jm400556w/production/images/medium/jm-2013-00556w_0026.gif" alt="" id="fx12" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup>Table a</sup><p class="last">IC<sub>50</sub> values shown with standard deviation if two separate experiments were performed, or with standard error indicated with * if three or more experiments were performed.</p></div></div><div></div></div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Selectivity</h3><div class="NLM_p">Compound <b>6</b> was discovered from a screen using Bcl-w as the target protein. Our interest in Bcl-X<sub>L</sub>, together with the preferential affinity of <b>6</b> for this pro-survival protein (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>), led us to explore the SAR against Bcl-X<sub>L</sub> and develop more potent inhibitors of this pro-survival protein. With this new series of compounds in hand, we were interested in determining how the affinity profile across a panel of other pro-survival proteins had evolved during the hit-to-lead process. We assessed the binding affinity of key compounds of our series (Table <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a>) for Bcl-w, Bcl-2, and Mcl-1 using two different competition assay technologies. Using LPA assays and surface plasmon resonance (SPR), we evaluated the binding of the compounds for Mcl-1 and Bcl-w in addition to Bcl-X<sub>L</sub>.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> SPR also allowed us to assess binding to Bcl-2. We observed that the compounds derived from <b>6</b> rapidly developed a high selectivity for Bcl-X<sub>L</sub>. Compound <b>12a</b>, which differs from <b>6</b> only by two minor changes (methyl groups on terminal aromatic ring and methylketohydazone instead of aldehydehydrazone), was found to have increased its affinity for Bcl-X<sub>L</sub> without concomitantly gaining affinity for Bcl-w. Similarly, <b>12a</b> did not show any relevant activity for Mcl-1 and Bcl-2. The most potent compounds <b>59b</b> and <b>71a</b> exhibited some residual weak activity for Mcl-1, Bcl-2, and Bcl-w (at least 2 orders of magnitude less potent). We suspect that this activity is due to nonselective binding of these hydrophobic and acidic molecules rather than to selective interaction. Regardless of the nature of this binding, such low affinities are unlikely to interfere in the interpretation of biological data. We conclude from this analysis that the most potent compounds are indeed highly selective for Bcl-X<sub>L</sub>.</div><div class="NLM_table-wrap" id="tbl8"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 8. Binding Affinity of a Subset from the Benzothiazole Series against Members of the Bcl-2 Family</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="char" char="." /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">LPA</th><th class="rowsep1 colsep0" colspan="4" align="center">SPR<a class="ref internalNav" href="#t8fn1" aria-label="a">a</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">Bcl-X<sub>L</sub></th><th class="colsep0 rowsep0" align="center">Mcl-1</th><th class="colsep0 rowsep0" align="center">Bcl-X<sub>L</sub></th><th class="colsep0 rowsep0" align="center">Bcl-w</th><th class="colsep0 rowsep0" align="center" char=".">Mcl-1</th><th class="colsep0 rowsep0" align="center">Bcl-2</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="char" char=".">0.0005</td><td class="colsep0 rowsep0" align="center">>1</td><td class="colsep0 rowsep0" align="center">0.014 ± 0.001</td><td class="colsep0 rowsep0" align="center">0.066 ± 0.005</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="center">0.007 ± 0.001</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12a</b></td><td class="colsep0 rowsep0" align="char" char=".">2.2</td><td class="colsep0 rowsep0" align="center">>100</td><td class="colsep0 rowsep0" align="center">∼15</td><td class="colsep0 rowsep0" align="center">>10</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="center">>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>48</b></td><td class="colsep0 rowsep0" align="char" char=".">1.2</td><td class="colsep0 rowsep0" align="center">>100</td><td class="colsep0 rowsep0" align="center">0.75 ± 0.07</td><td class="colsep0 rowsep0" align="center">>10</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="center">>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>74a</b></td><td class="colsep0 rowsep0" align="char" char=".">0.34</td><td class="colsep0 rowsep0" align="center">>100</td><td class="colsep0 rowsep0" align="center">0.077 ± 0.014</td><td class="colsep0 rowsep0" align="center">>10</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="center">>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>74b</b></td><td class="colsep0 rowsep0" align="char" char=".">0.06</td><td class="colsep0 rowsep0" align="center">>100</td><td class="colsep0 rowsep0" align="center">0.041 ± 0.007</td><td class="colsep0 rowsep0" align="center">∼5</td><td class="colsep0 rowsep0" align="char" char=".">∼5</td><td class="colsep0 rowsep0" align="center">∼5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>59b</b></td><td class="colsep0 rowsep0" align="char" char=".">0.023</td><td class="colsep0 rowsep0" align="center">68 ± 4</td><td class="colsep0 rowsep0" align="center">0.02 ± 0.01</td><td class="colsep0 rowsep0" align="center">>10</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="center">>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>71a</b></td><td class="colsep0 rowsep0" align="char" char=".">0.024</td><td class="colsep0 rowsep0" align="center">40 ± 10</td><td class="colsep0 rowsep0" align="center">0.013 ± 0.001</td><td class="colsep0 rowsep0" align="center">∼5</td><td class="colsep0 rowsep0" align="char" char=".">∼5</td><td class="colsep0 rowsep0" align="center">∼5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>38</b></td><td class="colsep0 rowsep0" align="char" char=".">0.12</td><td class="colsep0 rowsep0" align="center">>100</td><td class="colsep0 rowsep0" align="center">0.14 ± 0.02</td><td class="colsep0 rowsep0" align="center">>10</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="center">>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>63a</b></td><td class="colsep0 rowsep0" align="char" char=".">0.049</td><td class="colsep0 rowsep0" align="center">42</td><td class="colsep0 rowsep0" align="center">0.088 ± 0.009</td><td class="colsep0 rowsep0" align="center">>10</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="center">>10</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t8fn1"><div class="footnote" id="t8fn1"><sup>a</sup><p class="last">IC<sub>50</sub> values in μM shown with standard deviation.</p></div></div></div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Surface Plasmon Resonance: Binding Kinetics</h3><div class="NLM_p">To further analyze the binding characteristics of our compounds for Bcl-X<sub>L</sub>, we developed an assay that directly measures equilibrium binding constants (<i>K</i><sub>D</sub>) using surface plasmon resonance technology (SPR, <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information Figure S2">Supporting Information Figure S2</a>). To measure only the specific binding of compounds in the hydrophobic groove without the nonspecific background binding (binding to other areas of the protein), the experimental design took advantage of the three detection spots available within each individual flow cell on the SPR measurement chip and of its capability to hydrodynamic addressing the individual spots (see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>).<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> Thus, one spot presented anti-GST antibody captured GST-Bcl-X<sub>L</sub> prebound to a 26-mer Bim peptide (r1), the second spot presented anti-GST antibody captured GST-Bcl-X<sub>L</sub> only (r2), and the third was left blank as a reference spot (r, see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> for experimental setup scheme). The high affinity of the Bim peptide to Bcl-X<sub>L</sub>, due to extremely slow dissociation rate, makes it behave practically as an irreversible ligand over the time course of the experiment (∼5 min).<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> Therefore, the observed difference of signals between r2 and r1 gives a measurement of the specific binding of any compound within the hydrophobic groove.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> In addition to the direct equilibrium binding constants (<i>K</i><sub>D</sub>), the SPR experiments provided us with other valuable information such as the stoichiometry and the kinetics of binding in the form of association (<i>k</i><sub>a</sub>) and dissociation rate (<i>k</i><sub>d</sub>) constants. We included compounds <b>12a</b>, <b>38</b>, and <b>59b</b> in this study as these represented milestones in terms of binding affinities during our hit-to-lead campaign. For reference, we also added two compounds from the acylsulfonamide series (<b>1</b> and <b>4</b>).</div><div class="NLM_p">Results of these experiments are presented in Table <a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">9</a> and Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a> (for detailed sensorgrams and summary of data, see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information Table S1">Supporting Information Table S1</a>). Pleasingly, the <i>K</i><sub>D</sub> values determined either from steady-state or kinetic analyses as measured by SPR are in relative agreement with the IC<sub>50</sub> values obtained with the primary LPA binding assay, providing further evidence of binding by an independent assay technology. The steady-state curves also demonstrated that the compounds are binding in a 1:1 complex with Bcl-X<sub>L</sub> (expected response for one small molecule binding onto the target protein, see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>).</div><div class="NLM_table-wrap" id="tbl9"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 9. Surface Plasmon Resonance Results of Direct Binding of Various Ligands against Bcl-X<sub>L</sub> (All Affinity Values in Micromolar)<a class="ref internalNav" href="#t9fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="×" /></col><col align="center" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">IC<sub>50</sub> (LPA, μM)</th><th class="colsep0 rowsep0" align="center" char="."><i>K</i><sub>D</sub>(μM)<a class="ref internalNav" href="#t9fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char="×"><i>k</i><sub>a</sub>(M·s<sup>–1</sup>)</th><th class="colsep0 rowsep0" align="center"><i>k</i><sub>d</sub> (s<sup>–1</sup>)</th><th class="colsep0 rowsep0" align="center" char="."><i>K</i><sub>d</sub>(μM)<a class="ref internalNav" href="#t9fn3" aria-label="c">c</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="char" char=".">0.0005</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="×">7.91 × 10<sup>5</sup></td><td class="colsep0 rowsep0" align="center">2.93 × 10<sup>–4</sup></td><td class="colsep0 rowsep0" align="char" char=".">0.00013</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="char" char=".">2.2</td><td class="colsep0 rowsep0" align="char" char=".">0.9</td><td class="colsep0 rowsep0" align="char" char="×">4.75 × 10<sup>5</sup></td><td class="colsep0 rowsep0" align="center">0.76</td><td class="colsep0 rowsep0" align="char" char=".">1.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12a</b></td><td class="colsep0 rowsep0" align="char" char=".">2.2</td><td class="colsep0 rowsep0" align="char" char=".">9</td><td class="colsep0 rowsep0" align="char" char="×">8.61 × 10<sup>5</sup></td><td class="colsep0 rowsep0" align="center">0.91</td><td class="colsep0 rowsep0" align="char" char=".">12</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>38</b></td><td class="colsep0 rowsep0" align="char" char=".">0.12</td><td class="colsep0 rowsep0" align="char" char=".">0.061</td><td class="colsep0 rowsep0" align="char" char="×">2.37 × 10<sup>6</sup></td><td class="colsep0 rowsep0" align="center">0.081</td><td class="colsep0 rowsep0" align="char" char=".">0.079</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>59b</b></td><td class="colsep0 rowsep0" align="char" char=".">0.023</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="×">2.91 × 10<sup>6</sup></td><td class="colsep0 rowsep0" align="center">9.92 × 10<sup>–3</sup></td><td class="colsep0 rowsep0" align="char" char=".">0.0041</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Bim-26mer</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="×">3.75 × 10<sup>6</sup></td><td class="colsep0 rowsep0" align="center">5.36 × 10<sup>–4</sup></td><td class="colsep0 rowsep0" align="char" char=".">0.00014</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t9fn1"><div class="footnote" id="t9fn1"><sup>a</sup><p class="last">All values obtained from plasmon surface resonance are average of at least two separate experiments (see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information Table S1">Supporting Information Table S1</a> for details).</p></div><div class="footnote" id="t9fn2"><sup>b</sup><p class="last">Direct binding constant measured at steady state.</p></div><div class="footnote" id="t9fn3"><sup>c</sup><p class="last">Direct binding constant calculated from kinetic parameters. <i>k</i><sub>a</sub>, association rate; <i>k</i><sub>d</sub>, dissociation rate.</p></div></div></div><figure id="fig4" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-13/jm400556w/production/images/medium/jm-2013-00556w_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-13/jm400556w/production/images/large/jm-2013-00556w_0006.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Kinetic analysis of three key benzothiazole analogues, two molecules from the acylsulfonamide series, and wt-Bim26mer peptide. (A) Sensorgrams for compound <b>59b</b> (concentrations: 100, 50, 25, 12.5, 6.25, 3.13 nM). (B) Sensorgrams for compound <b>1</b> (concentrations: 270, 90, 30, 10, 3.3 nM). (C) Kinetic plot for compounds <b>1</b>, <b>4</b>, <b>12a</b>, <b>38</b>, <b>59b</b>, and wt-Bim26mer.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-13/jm400556w/production/images/large/jm-2013-00556w_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400556w&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">As anticipated, the kinetic data provided more detailed insight into the structure–activity relationship of our series. With low micromolar affinity, compound <b>12a</b> classically displayed relatively fast association and dissociation rates. The kinetic data on picolinic acid derivative <b>38</b>, which gave us our first significant increase in activity, demonstrated that this improvement is due to both an increase in the association rate and a decrease in the dissociation rates (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>C). Factors influencing the association rate are difficult to determine as multiple parameters can affect the dynamics of formation of the molecular complex. Although desolvation may contribute significantly to this parameter, we also propose that, compared to compound <b>12a</b>, compound <b>38</b> more readily recognizes the binding site of Bcl-X<sub>L</sub>. We base this interpretation on the fact that the picolinic acid motif could provide an ideal interacting partner of guanidine groups. Arg 139 located within the hydrophobic groove may be a key recognition element attracting the picolinic acid derivatives toward its binding site. This privileged interaction would decrease the number of possible nonproductive interactions between the molecule and the protein target, leading to an increase in the association rate.</div><div class="NLM_p">With constrained compound <b>59b</b>, we anticipated that the association rate would also be affected. However, the results obtained with compound <b>38</b> suggest that this parameter is already nearly optimal (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>C). Interestingly, we observed that the increase in binding affinity for <b>59b</b> is primarily due to a decreased dissociation rate (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>C). This indicates that the complex of Bcl-X<sub>L</sub> with <b>59b</b> is significantly more stable than with <b>12a</b> or <b>38</b>. Apart from an increased lipophilicity with the tetralone ring, it seems unlikely that <b>59b</b> creates any new interaction with the protein. Its conformational preference could, however, explain this result. The SAR leading to compound <b>38</b> indicated that this molecule comprises two essential pharmacophores linked by a flexible aryl-hydrazone bond: the benzothiazole/hydrazone moiety and the terminal aryl acid moiety. Because of the central rotatable bond, the two pharmacophores are partially independent. This conformational flexibility allows each pharmacophore to independently interact with the protein. Thus the three possible binding modes could be: benzothiazole only, biaryl acid only, or benzothiazole + biaryl acid. The constrained compound <b>59b</b> renders the two pharmacophores geometrically dependent and precludes them from adopting other nonbinding conformations. Thus: the half-life of the complex is extended.</div><div class="NLM_p last">Finally, comparison of the binding affinity and kinetic parameters of compound <b>1</b> put our results in perspective. Compound <b>59b</b> is a potent ligand of Bcl-X<sub>L</sub> but is still at least 1 order of magnitude weaker than <b>1</b>. Visual comparison of the sensorgrams of <b>1</b> and <b>59b</b> clearly highlights the difference in residency time (i.e., dissociation rates) of the two compounds within the hydrophobic groove (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>A,B).</div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> Cytochrome <i>c</i> Release</h3><div class="NLM_p">We have described a series of compounds exhibiting potent and selective binding to Bcl-X<sub>L</sub>. We next wanted to see if the affinity of the most potent analogues was sufficient to induce a mechanism-based apoptotic response in cells. At this stage, carefully assessing the mode of action of this series of compounds was of great importance as we intended to show that induction of apoptosis was indeed the result of selective and direct inhibition of Bcl-X<sub>L</sub>. We first evaluated the compounds in a cytochrome <i>c</i> release assay in permeabilized cells. This assay circumvents both serum protein binding and cell membrane permeability, either of which can compromise intact cell experiments. Mouse embryonic fibroblasts (MEF) were used in these experiments as a number of genetically modified lines are available for mechanism-of-action studies.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> We utilized mitochondria from wild-type (<i>wt</i>) MEFs as well as genetically modified MEFs: <i>mcl-1</i><sup><i>–/–</i></sup> or <i>bax</i><sup>–/–</sup>/<i>bak</i><sup>–/–</sup> MEFs. Pro-apoptotic activity of BH3-only proteins such as Bim is abrogated if Bax and Bak are absent.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> The Bax/Bak dependency is therefore necessary to demonstrate functional mimicry of the BH3-only protein activity. Bcl-X<sub>L</sub> and Mcl-1 have also been shown to be the primary regulators of Bak’s pro-apoptotic activity.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> Mcl-1 knockout (KO) MEFs are therefore dependent on only Bcl-X<sub>L</sub> for survival, hence compounds selectively inhibiting Bcl-X<sub>L</sub> should induce cytochrome <i>c</i> release from mitochondria in these cells. Together, the experiments using <i>wt</i> MEFs, Mcl-1 KO, and Bax/Bak double knockout MEFs provide us with information on the ability of this chemical series to induce cytochrome <i>c</i> release by selectively inhibiting Bcl-X<sub>L</sub> (in <i>mcl-1</i><sup>–/–</sup> vs <i>wt</i> MEFs) and excluded nonspecific, off-target activities (in <i>bax</i><sup>–/–</sup><i>bak</i><sup>–/–</sup> MEFs).<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a></div><div class="NLM_p">While no cytochrome <i>c</i> release was observed for selected compounds (<b>12a</b>, <b>48</b>, <b>74a</b>, and <b>38</b>) using mitochondria extracted from <i>wt</i> MEFs, the release was observed for compounds with activity around and below 0.5 μM using mitochondria derived from <i>mcl-1</i><sup>–/–</sup> MEFs (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>A). Interestingly, at the concentration tested (10 μM), compound <b>38</b> (IC<sub>50</sub> = 0.12 μM) releases cytochrome <i>c</i> as efficiently as compound <b>59b</b> (IC<sub>50</sub> = 0.023 μM) or <b>1</b> (IC<sub>50</sub> = 0.0002 μM).<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> No cytochrome <i>c</i> release was observed with any compounds tested on the permeabilized Bax/Bak MEFs (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>B). These initial results support a mechanism-based effect: the ability of the small molecules to provoke cytochrome <i>c</i> release, albeit related to reaching a certain threshold of binding affinity for Bcl-X<sub>L</sub>, which is dependent on Bax/Bak.</div><figure id="fig5" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-13/jm400556w/production/images/medium/jm-2013-00556w_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-13/jm400556w/production/images/large/jm-2013-00556w_0007.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (A) Cytochrome <i>c</i> release experiments on <i>mcl-1</i><sup>–/–</sup> MEF cells. In red: IC<sub>50</sub> for each compound. Cells treated with compounds at a concentration of 10 μM. Abscissa: compounds. Left ordinate: cytochrome <i>c</i> release as % of that released by Bim 26-mer BH3 peptide. Right ordinate: binding IC<sub>50</sub> in μM (LPA). Error bars: standard error. (B) Cytochrome <i>c</i> release experiments on <i>mcl-1</i><sup>–/–</sup> MEF cells and bax<sup>–/–</sup>/bak<sup>–/–</sup> MEF cells. Left ordinate: cytochrome <i>c</i> release as % of Bim 26-mer BH3 peptide. Abscissa: compounds. Error bars: Standard Error.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-13/jm400556w/production/images/large/jm-2013-00556w_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400556w&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> Cell-Based Activity</h3><div class="NLM_p">The ability of the compounds to affect cell viability through a mechanism-based induction of apoptosis on whole cells was evaluated with the most potent analogues of our series. In these experiments, the compounds were tested in <i>mcl-1</i><sup>–/–</sup> and wild-type (<i>wt</i>) MEFs. In the wt cells, both Bcl-X<sub>L</sub> and Mcl-1 are present and inhibit Bak’s pro-apoptotic activity. Hence a compound selectively inhibiting the Bcl-X<sub>L</sub>-dependent pathway should not significantly impair their viability because Mcl-1 can still prevent activation of Bak. Conversely, inhibiting the Bcl-X<sub>L</sub>-dependent <i>mcl-1</i><sup>–/–</sup> MEFs should result in apoptosis, while little or no difference between <i>mcl-1</i><sup>–/–</sup> and wt MEF viability would suggest that the compounds are nonselective cytotoxics. As with the cytochrome <i>c</i> release assay, <i>bax</i><sup>–/–</sup>/<i>bak</i><sup>–/–</sup> MEF cells were included as an additional control. Finally, the level of serum (fetal bovine serum, FBS) was varied between a low (1% v/v) and a higher concentration (10% v/v) to observe its effect on compound activity because previously developed molecules targeting the hydrophobic groove of pro-survival proteins have demonstrated affinity for the binding site of human serum albumin domain III (HSA).<a onclick="showRef(event, 'ref46 ref47'); return false;" href="javascript:void(0);" class="ref ref46 ref47">(46, 47)</a> Although binding kinetics may eventually favor binding to the target protein (through differences in dissociation rates),<a onclick="showRef(event, 'ref48 ref49'); return false;" href="javascript:void(0);" class="ref ref48 ref49">(48, 49)</a> strong binding to HSA would impact on the compounds’ ability to efficiently reach their targets. As reported in other accounts in this field, great efforts have been devoted to separating the SAR for HSA and Bcl-X<sub>L</sub> and Bcl-2.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Similarly, the series of compounds we have developed might bind strongly to serum proteins as they also are lipophilic acids.</div><div class="NLM_p">The results of these experiments are presented in Table <a class="ref showTableEvent internalNav" data-ID="tbl10" href="#tbl10">10</a>. In the presence of 1% serum, the most potent compounds from the series (as measured by LPA assays) impaired the viability of <i>mcl-1</i><sup>–/–</sup> MEFs, with submicromolar EC<sub>50</sub> values (<b>59b</b>, <b>63d</b>, and <b>70a</b>, EC<sub>50</sub> values between 0.13 and 0.29 μM). Very weak or no activity was measured in the wild-type MEF and Bax/Bak DKO MEF cells, supporting a mechanism-based activity. However, as expected, the cell-based activity was strongly attenuated in the presence of 10% FBS. Only analogue <b>63d</b> retained a submicromolar level of activity with an EC<sub>50</sub> value of 0.85 μM. Although comparison with compound <b>1</b> shows that both potency and serum binding need to be improved to reach a therapeutically relevant level of cellular activity, the results obtained with our benzothiazole series of compounds illustrate moderate and selective cellular activity with low molecular weight molecules. This successful hit-to-lead campaign will allow further improvements toward more potent and drug-like compounds.</div><div class="NLM_table-wrap" id="tbl10"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 10. Cellular Activity for Selected Compounds<a class="ref internalNav" href="#tbl10-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">binding assay, IC<sub>50</sub><a class="ref internalNav" href="#t10fn1" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">EC<sub>50</sub> (Mcl-1<sup>–/–</sup> MEF, 1% FBS)</th><th class="colsep0 rowsep0" align="center" char=".">EC<sub>50</sub> (Mcl-1<sup>–/–</sup> MEF, 10% FBS)</th><th class="colsep0 rowsep0" align="center" char=".">EC<sub>50</sub> (wt MEF, 10% FBS)</th><th class="colsep0 rowsep0" align="center" char=".">EC<sub>50</sub> (Bax/Bak-DKO-MEF, 1% FBS)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="char" char=".">0.0005</td><td class="colsep0 rowsep0" align="char" char=".">0.004</td><td class="colsep0 rowsep0" align="char" char=".">0.08</td><td class="colsep0 rowsep0" align="char" char=".">>5</td><td class="colsep0 rowsep0" align="char" char=".">>20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>59b</b></td><td class="colsep0 rowsep0" align="char" char=".">0.023</td><td class="colsep0 rowsep0" align="char" char=".">0.29</td><td class="colsep0 rowsep0" align="char" char=".">1.9</td><td class="colsep0 rowsep0" align="char" char=".">>5</td><td class="colsep0 rowsep0" align="char" char=".">>20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>63b</b></td><td class="colsep0 rowsep0" align="char" char=".">0.010</td><td class="colsep0 rowsep0" align="char" char=".">1.6</td><td class="colsep0 rowsep0" align="char" char=".">>20</td><td class="colsep0 rowsep0" align="char" char=".">>5</td><td class="colsep0 rowsep0" align="char" char=".">>20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>63d</b></td><td class="colsep0 rowsep0" align="char" char=".">0.017</td><td class="colsep0 rowsep0" align="char" char=".">0.13</td><td class="colsep0 rowsep0" align="char" char=".">0.85</td><td class="colsep0 rowsep0" align="char" char=".">>5</td><td class="colsep0 rowsep0" align="char" char=".">6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>63e</b></td><td class="colsep0 rowsep0" align="char" char=".">0.055</td><td class="colsep0 rowsep0" align="char" char=".">1.4</td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">>5</td><td class="colsep0 rowsep0" align="char" char=".">>20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>71a</b></td><td class="colsep0 rowsep0" align="char" char=".">0.024</td><td class="colsep0 rowsep0" align="char" char=".">0.26</td><td class="colsep0 rowsep0" align="char" char=".">1.7</td><td class="colsep0 rowsep0" align="char" char=".">>5</td><td class="colsep0 rowsep0" align="char" char=".">>13</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl10-fn1"><div class="footnote" id="tbl10-fn1"><sup>a</sup><p class="last">All values in μM as average of at least two replicates.</p></div><div class="footnote" id="t10fn1"><sup>b</sup><p class="last">Measured by LPA. MEF: mouse embryonic fibroblasts. FBS: fetal bovine serum.</p></div></div></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i29">Discussion and Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13675" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13675" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Targeting proteins of the Bcl-2 family remains a challenge. The signaling cascade involving this family relies on protein–protein interactions, still often considered as “undruggable”.<a onclick="showRef(event, 'ref50 ref51'); return false;" href="javascript:void(0);" class="ref ref50 ref51">(50, 51)</a> Despite the considerable efforts devoted to the development of inhibitors of pro-survival proteins, only a handful of successful programs have been published.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> By highlighting problems and their solutions, reports on new series of Bcl-2 inhibitors provide invaluable information to medicinal chemists who are interested in the design of new drugs against this class of protein. Here, we present novel selective inhibitors of Bcl-X<sub>L</sub> derived from a high-throughput screening campaign. Other compounds partially selective for Bcl-X<sub>L</sub> have been described, notably [(<i>R</i>)-4-(3-dimethylamino-1-phenylsulfanylmethyl-propylamino)-<i>N</i>-[4-(4,4-dimethyl-piperidin-1-yl)-benzoyl]-3-nitro-benzenesulfonamide (A-385358)<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> and (<i>R</i>)-4-(4-(biphenyl-3-ylmethyl)piperazin-1-yl)-<i>N</i>-(4-(4-(dimethylamino)-1-(phenylthio)butan-2-ylamino)-3-nitrophenylsulfonyl)benzamide (W1191542)<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> have high affinities for Bcl-X<sub>L</sub> (<i>K</i><sub>i</sub> = 0.17 nM and IC<sub>50</sub> = 11 nM, respectively) but are still potent Bcl-2 inhibitors (<i>K</i><sub>i</sub> = 67 nM and IC<sub>50</sub> = 130 nM, respectively). We have shown that structure-guided optimization of <b>55b</b> (IC<sub>50</sub> (Bcl-X<sub>L</sub>) = 23 nM) maintained this exquisite selectivity.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a></div><div class="NLM_p">Compounds directly inhibiting the pro-survival activity of Bcl-2 proteins should essentially replicate the functional activity of the pro-apoptotic BH3-only proteins. Along with potency, an important goal during the development of Bcl-2 inhibitors is the validation of their mechanism of action. Genuine inhibitors of the Bcl-2 family of proteins should exhibit some key characteristics, among others Bax/Bak-dependent cell killing and high affinity for the target protein<a onclick="showRef(event, 'ref21 ref54'); return false;" href="javascript:void(0);" class="ref ref21 ref54">(21, 54)</a> It is possible to develop assays that allow studies of the mechanism of action supporting these criteria. All the binding affinity data we have presented strongly confirms selective and direct binding to Bcl-X<sub>L</sub>. We have observed a coherent SAR within the series with an increase in potency to low nanomolar levels. The binding affinity has been measured using three separate assay technologies: two competition-based assays (LPA and SPR) and one experiment measuring direct binding (SPR). The most potent compounds demonstrate low nanomolar affinities in all three assays (IC<sub>50</sub> < 20 nM, <i>K</i><sub>D</sub> < 10 nM). These molecules also demonstrate selectivity for Bcl-X<sub>L</sub> over other members of the family. This selectivity is a surprising result: most of the known small molecules reported to bind to the pro-survival family of proteins have more than one target, including <b>1</b>, which binds avidly to Bcl-2, Bcl-w, and Bcl-X<sub>L</sub>.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> The phenylpyrazole series of molecules developed by Celltech show preferential selectivity for Bcl-2 but retain some affinity for Bcl-X<sub>L</sub>.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> More recently, Abbvie disclosed a selective Bcl-2 inhibitor derived from the acylsufonamide <b>1</b> series.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Our results suggest a high level of structural complementarity between protein and compound. In particular, the SAR highlights that the benzothiazole and the hydrazone moieties are probably located in a narrow pocket able to accommodate a hydrophobic moiety and that key interactions occur between the protein and this portion of the molecule. The binding affinity results also suggest that a hydrogen bond-donating group located in the binding groove of Bcl-X<sub>L</sub> interacts specifically with the terminal carboxylic acid and that this interaction is optimal with a picolinic acid motif. Subsequent structural biology studies have confirmed these binding hypotheses as well as shed some light as to why this series exhibits strong selectivity for Bcl-X<sub>L</sub>.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a></div><div class="NLM_p">With biological tools, we have provided initial evidence that the benzothiazole series exert its cellular activity through a pathway involving Bcl-X<sub>L</sub>. In both mitochondria cytochrome <i>c</i> and whole-cell assays, activity was only observed in the absence of Mcl-1 and is abrogated in the absence of Bax and Bak (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>A,B). In the whole-cell assay, our results confirm that the compounds are not nonselective cytotoxic agents, as no activity was observed in wild-type MEF cells (Table <a class="ref showTableEvent internalNav" data-ID="tbl10" href="#tbl10">10</a>). Whereas in mitochondria from permeabilized MEFs, cytochrome <i>c</i> release is observed with compounds possessing IC<sub>50</sub> values of 0.5 μM or below, the cell-killing activity is only observed with more potent compounds (IC<sub>50</sub> < 20 nM) and is strongly influenced by the level of serum protein in the media. Finally, our compounds are not yet sufficiently potent to show killing activity in Bcl-X<sub>L</sub>-dependent cancer cell lines (data not shown).</div><div class="NLM_p">One key question in the development of Bcl-2-family inhibitors is the level of potency required for cell-based activity and, ultimately, in vivo activity in animal models of cancer. Data available from the research program that led to <b>1</b> and from BH3-peptides indicates that, in biochemical binding assays, inhibition of the target protein(s) at subnanomolar concentrations is necessary. Compound <b>1</b> achieves this by covering a large area of interaction within the hydrophobic groove of Bcl-2 and Bcl-X<sub>L</sub>. Its molecular weight is 812 Da, and its structure challenges most of the rules set out by Lipinski and others for good oral bioavailability.<a onclick="showRef(event, 'ref56 ref57'); return false;" href="javascript:void(0);" class="ref ref56 ref57">(56, 57)</a> Our work shows that it is possible to obtain potent ligands for Bcl-X<sub>L</sub> while maintaining a reasonable molecular weight (414 Da for compound <b>59b</b>) and that, even for challenging targets such as the Bcl-2 proteins, hit-to-lead progression can be done through core optimization using classical medicinal chemistry.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> However, further improvements are still required to reach therapeutically relevant levels of activity. Looking ahead, some important issues related to properties and structure will require attention in the next stage of our research. Once again, the sensitivity to serum protein levels will need to be addressed.</div><div class="NLM_p last">In conclusion, we have described a series of selective and potent ligands of Bcl-X<sub>L</sub>. Initial evidence of mechanism-based activity has been provided supporting inhibition of a Bcl-X<sub>L</sub>-driven pathway in a Bax/Bak dependent manner. Beyond its importance for the development of new drugs modulating the activity of Bcl-2 proteins, our work provides important tools that will help clarify the role of Bcl-X<sub>L</sub> in the progression of various types of cancers and its involvement in other biological mechanisms such as normal tissue homeostasis.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i30">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_58518" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_58518" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> Chemistry</h3><div id="sec4_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> General Chemistry Methods</h4><div class="NLM_p last">All nonaqueous reactions were performed in oven-dried glassware under an atmosphere of dry nitrogen unless otherwise specified. Tetrahydrofuran was freshly distilled from sodium/benzophenone under nitrogen. Dichloromethane was freshly distilled from CaH<sub>2</sub> under N<sub>2</sub>. All other solvents were reagent grade. Petroleum ether describes a mixture of hexanes in the bp range 40–60 °C. Analytical thin-layer chromatography was performed on Merck silica gel 60F<sub>254</sub> aluminum-backed plates and were visualized by fluorescence quenching under UV light. Flash chromatography was performed with silica gel 60 (particle size 0.040–0.063 mm). NMR spectra were recorded on a Bruker Avance DRX 300 with the solvents indicated (<sup>1</sup>H NMR at 300 MHz). Chemical shifts are reported in ppm on the δ scale and referenced to the appropriate solvent peak. HRMS were recorded at the Australian National University Mass Spectrometry Facility using a Waters LCT Premier XE (ESI TOF mass spectrometer). Unless otherwise noted, all tested compounds were found to be >95% pure. Compounds <b>19a</b>–<b>b</b> and <b>20a</b>–<b>f</b> were obtained following known procedures. Compound <b>6</b> was originally purchased from Specs. Compound <b>14</b> is commercially available.</div></div><div id="sec4_1_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> General Method A: Preparation of Meerwein Adducts</h4><div class="NLM_p">Preparation of 3-(5-formylfuran-2-yl)-2-methylbenzoic acid (<b>9a</b>). 3-Amino-2-methylbenzoic acid (1.5 g, 10 mmol) in 5 mL of water and 15 mL of concentrated HCl was treated over 5 min at 0–5 °C with NaNO<sub>2</sub> (0.8 g, 11.6 mmol) dissolved in 4 mL of water. Solutions of furaldehyde (1 g, 10.4 mmol) in 6 mL of acetone and CuCl<sub>2</sub>·2H<sub>2</sub>O (0.5 g, 3 mmol) in 3 mL of water were then added simultaneously. The reaction was stirred at room temperature for 10 h. After that time, a dark precipitate had formed. It was collected by filtration and dried in vacuo. The crude solid was purified by flash chromatography using SiO<sub>2</sub> (CH<sub>2</sub>Cl<sub>2</sub>/MeOH 95:5). A yellow solid was obtained (<i>m</i> = 230 mg, 10%). (<sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, ppm): δ 9.65 (s, 1H), 7.80 (d, <i>J</i> = 7.3 Hz, 1H), 7.77 (d, <i>J</i> = 7.0 Hz, 1H), 7.68 (d, <i>J</i> = 3.8 Hz, 1H), 7.43 (t, <i>J</i> = 7.9 Hz, 1H), 7.07 (d, <i>J</i> = 3.7 Hz, 1H), 2.57 (s, 3H). LCMS <i>m</i>/<i>z</i> 229.1 [M – 1].</div><div id="sec4_1_1_1_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i34" class="anchor-spacer"></div><h5 class="article-section__title" id="_i34"> 3-(5-Formylfuran-2-yl)-benzoic Acid (<b>9b</b>)</h5><div class="NLM_p last">Prepared according to method A using 3-aminobenzoic acid (3.43 g, 25 mmol) and furaldehyde (2.4 g, 25 mmol). A brown solid was obtained (<i>m</i> = 2.59 g, 48%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, ppm): δ 9.61 (σ, 1H), 8.08 (d, <i>J</i> = 8.0 Hz, 1H), 7.96 (d, <i>J</i> = 7.8 Hz, 1H), 7.64 (d, <i>J</i> = 3.8 Hz, 1H), 7.61 (t, <i>J</i> = 7.8 Hz, 1H), 7.38 (d, <i>J</i> = 3.8 Hz, 1H). LCMS <i>m</i>/<i>z</i> 215.3 [M – 1].</div></div><div id="sec4_1_1_1_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i35" class="anchor-spacer"></div><h5 class="article-section__title" id="_i35"> 3-(5-Acetylfuran-2-yl)-benzoic Acid (<b>10a</b>)</h5><div class="NLM_p last">Prepared according to method A using 3-aminobenzoic acid (2.75 g, 20 mmol) and 2-furyl methyl ketone (2.2 g, 20 mmol). A brown solid was obtained (<i>m</i> = 1.3 g, 28%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, ppm): δ 8.37 (s, 1H), 8.11 (d, <i>J</i> = 7.8 Hz, 1H), 7.98 (d, <i>J</i> = 7.7 Hz, 1H), 7.65 (t, <i>J</i> = 7.8 Hz, 1H), 7.60 (d, <i>J</i> = 3.6 Hz, 1H), 7.35 (d, <i>J</i> = 3.7 Hz, 1H), 2.49 (s, 3H). LCMS <i>m</i>/<i>z</i> 229 [M – 1].</div></div><div id="sec4_1_1_1_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i36" class="anchor-spacer"></div><h5 class="article-section__title" id="_i36"> 4-(5-Acetylfuran-2-yl)-benzoic Acid (<b>10b</b>)</h5><div class="NLM_p last">Prepared according to method A using 4-aminobenzoic acid (1.4 g, 10 mmol) and 2-furyl methyl ketone (1.1 g, 10 mmol). A light-brown solid was obtained (<i>m</i> = 0.96 g, 42%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, ppm): δ 8.85 (d, <i>J</i> = 8.3 Hz, 2H), 7.83 (d, <i>J</i> = 8.2 Hz, 2H), 7.26 (d, <i>J</i> = 4.7 Hz, 1H), 6.88 (d, <i>J</i> = 3.7 Hz, 1H), 2.52 (s, 3H). LCMS <i>m</i>/<i>z</i> 228.8 [M – 1].</div></div><div id="sec4_1_1_1_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i37" class="anchor-spacer"></div><h5 class="article-section__title" id="_i37"> 2-(5-Acetylfuran-2-yl)-benzoic Acid (<b>10c</b>)</h5><div class="NLM_p last">Prepared according to method A using 2-aminobenzoic acid (3 g, 22 mmol) and 2-furyl methyl ketone (2.2 g, 20 mmol). A brown solid was obtained (<i>m</i> = 750 mg, 16%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, ppm): δ 9.85 (br s, 1H), 7.92 (d, <i>J</i> = 7.7 Hz, 1H), 7.71 (d, <i>J</i> = 5.8 Hz, 1H), 7.60 (t, <i>J</i> = 7.4 Hz, 1H), 7.49 (t, <i>J</i> = 7.6 Hz, 1H), 7.27 (d, <i>J</i> = 3.7 Hz, 1H), 6.75 (d, <i>J</i> = 3.6 Hz, 1H), 2.49 (s, 3H). LCMS <i>m</i>/<i>z</i> 228.8 [M – 1].</div></div><div id="sec4_1_1_1_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i38" class="anchor-spacer"></div><h5 class="article-section__title" id="_i38"> 3-(5-Acetylfuran-2-yl)-4-chlorobenzoic Acid (<b>10d</b>)</h5><div class="NLM_p last">Prepared according to method A using 3-amino-4-chlorobenzoic acid (3.4 g, 20 mmol) and 2-furyl methyl ketone (2.0 g, 18 mmol). A brown solid was obtained (<i>m</i> = 4.2 g, 79%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, ppm): δ 8.42 (d, <i>J</i> = 2 Hz, 1H), 7.94 (dd, <i>J</i> = 2.1 and 8.4 Hz, 1H), 7.75 (d, <i>J</i> = 8.3 Hz, 1H), 7.61 (d, <i>J</i> = 3.8 Hz, 1H), 7.39 (d, <i>J</i> = 3.8 Hz, 1H), 2.50 (s, 3H). LCMS <i>m</i>/<i>z</i> 263 [M – 1].</div></div><div id="sec4_1_1_1_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i39" class="anchor-spacer"></div><h5 class="article-section__title" id="_i39"> 5-(5-Acetylfuran-2-yl)-2-chlorobenzoic Acid (<b>10e</b>)</h5><div class="NLM_p last">Prepared according to method A using 2-chloro-5-aminobenzoic acid (3.4 g, 20 mmol) and 2-furyl methyl ketone (2.0 g, 18 mmol). A brown solid was obtained (<i>m</i> = 1.1 g, 21%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, ppm): δ 8.19 (δ, <i>J</i> = 2.3 Hz, 1H), 7.98 (dd, <i>J</i> = 2.3 and 8.5 Hz, 1H), 7.67 (d, <i>J</i> = 8.4 Hz, 1H), 7.58 (d, <i>J</i> = 3.8 Hz, 1H), 7.36 (d, <i>J</i> = 3.7 Hz, 1H), 2.47 (s, 3H). LCMS <i>m</i>/<i>z</i> 262.8 [M – 1].</div></div><div id="sec4_1_1_1_7" class="NLM_sec NLM_sec_level_4"><div id="ac_i40" class="anchor-spacer"></div><h5 class="article-section__title" id="_i40"> 3-(5-Acetylfuran-2-yl)-2-chlorobenzoic Acid (<b>10f</b>)</h5><div class="NLM_p last">Prepared according to method A using 2-chloro-3-aminobenzoic acid (1 g, 5.8 mmol) and 2-furyl methyl ketone (642 mg, 5.8 mmol). A brown solid was obtained (<i>m</i> = 137 mg, 9%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, ppm): δ 7.99 (δ <i>J</i> = 1.5 and 7.8 Hz, 1H), 7.73 (dd, <i>J</i> = 1.5 and 7.6 Hz, 1H), 7.57 (t, <i>J</i> = 8.3 Hz, 1H), 7.58 (d, <i>J</i> = 3.9 Hz, 1H), 7.32 (d, <i>J</i> = 3.8 Hz, 1H), 2.51 (s, 3H). LCMS <i>m</i>/<i>z</i> 263.2 [M – 1].</div></div><div id="sec4_1_1_1_8" class="NLM_sec NLM_sec_level_4"><div id="ac_i41" class="anchor-spacer"></div><h5 class="article-section__title" id="_i41"> 5-(5-Acetylfuran-2-yl)isophthalic Acid (<b>10g</b>)</h5><div class="NLM_p last">Prepared according to method A using 5-aminoisophthalic acid (718 mg, 3.96 mmol) and 2-furyl methyl ketone (436 mg, 3.96 mmol). A yellow solid was obtained (<i>m</i> = 515 mg, 47%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, ppm): δ 8.54 (d, <i>J</i> = 1.5 Hz, 1H), 8.46 (t, <i>J</i> = 1.5 Hz, 1H), 7.59 (d, <i>J</i> = 3.8 Hz, 1H), 7.47 (d, <i>J</i> = 3.7 Hz, 1H), 2.49 (s, 3H). LCMS <i>m</i>/<i>z</i> 273.1 [M – 1].</div></div><div id="sec4_1_1_1_9" class="NLM_sec NLM_sec_level_4"><div id="ac_i42" class="anchor-spacer"></div><h5 class="article-section__title" id="_i42"> 3-(5-Acetylfuran-2-yl)-2-methylbenzoic Acid (<b>10h</b>)</h5><div class="NLM_p last">Prepared according to method A using 3-amino-2-methylbenzoic acid (1.5 g, 10 mmol) and 2-furyl methyl ketone (1.1 mg, 10 mmol). A light-brown solid was obtained (<i>m</i> = 235 mg, 10%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, ppm): δ 7.80 (dd, <i>J</i> = 1.1 and 7.9 Hz, 1H), 7.76 (d, <i>J</i> = 7.7 Hz, 1H), 7.57 (d, <i>J</i> = 3.7 Hz, 1H), 7.42 (t, <i>J</i> = 7.8 Hz, 1H), 6.99 (d, <i>J</i> = 3.7 Hz, 1H), 2.57 (s, 3H), 2.47 (s, 3H). LCMS <i>m</i>/<i>z</i> 169.2 [M – 1].</div></div><div id="sec4_1_1_1_10" class="NLM_sec NLM_sec_level_4"><div id="ac_i43" class="anchor-spacer"></div><h5 class="article-section__title" id="_i43"> 5-(5-Acetylfuran-2-yl)-2-nitrobenzoic Acid (<b>10i</b>)</h5><div class="NLM_p last">Prepared according to method A using 5-amino-2-nitrobenzoic acid (1 g, 5.5 mmol) and 2-furyl methyl ketone (605 mg, 5.5 mmol). A brown solid was obtained (<i>m</i> = 1.44 g, 48%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, ppm): δ 8.23–8.13 (m, 3H), 7.62 (d, <i>J</i> = 3.8 Hz, 1H), 7.57 (d, <i>J</i> = 3.8 Hz, 1H), 2.51 (s, 3H). LCMS <i>m</i>/<i>z</i> 274.2 [M – 1].</div></div><div id="sec4_1_1_1_11" class="NLM_sec NLM_sec_level_4"><div id="ac_i44" class="anchor-spacer"></div><h5 class="article-section__title" id="_i44"> 5-(5-Acetylfuran-2-yl)-2-aminobenzoic Acid (<b>10j</b>)</h5><div class="NLM_p last">Ammonium formate (1.72 g, 27.3 mmol) was dissolved in 40 mL of dry methanol. Compound <b>10i</b> (500 mg, 1.82 mmol) was then added followed by Pd/C (10%, 220 mg). Once the reaction was complete as indicated by TLC (CH<sub>2</sub>Cl<sub>2</sub>/MeOH, 5:1), it was filtered through a plug of Celite. The solids were washed with MeOH. The filtrate was concentrated to an orange solid, which was suspended in water and filtered to give a brown solid dried in a vacuum oven (281 mg, 63%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, ppm): δ 8.16 (d, <i>J</i> = 1.3 Hz, 1H), 7.71 (dd, <i>J</i> = 1.8 and 8.7 Hz, 1H), 7.51 (d, <i>J</i> = 3.5 Hz, 1H), 6.90 (d, <i>J</i> = 3.5 Hz, 1H), 6.85 (d, <i>J</i> = 8.7 Hz, 1H), 2.41 (s, 3H). LCMS <i>m</i>/<i>z</i> 246.1 [M + 1].</div></div></div><div id="sec4_1_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> General Method B: Preparation of Hydrazones</h4><div class="NLM_p">Preparation of 3-(5-((2-(benzo[<i>d</i>]thiazol-2-yl)hydrazono)methyl)furan-2-yl)-2-methylbenzoic acid (<b>6</b>). Compound <b>9a</b> (100 mg, 0.44 mmol) was dissolved in 8 mL of ethanol with gentle warming. A solution of 2-hydrazinobenzothiazole (60 mg, 0.36 mmol) in 8 mL of ethanol was added to <b>9a</b>, and the reaction was heated to 80 °C and cooled down slowly. A brown precipitate appeared. It was collected by filtration, rinsed with cold ethanol, and dried in a vacuum oven (<i>m</i> = 54 mg, 40%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, ppm): δ 8.06 (s, 1H), 7.80 (d, <i>J</i> = 8.4 Hz, 1H), 7.77 (d, <i>J</i> = 9.2 Hz, 1H), 7.70 (d, <i>J</i> = 7.7 Hz, 1H), 7.44–7.40 (m, 2H), 7.29 (t, <i>J</i> = 7.2 Hz, 1H), 7.10 (t, <i>J</i> = 7.8 Hz, 1H), 7.01 (d, <i>J</i> = 3.5 Hz, 1H), 6.92 (d, <i>J</i> = 3.5 Hz, 1H), 2.61 (s, 3H). LCMS <i>m</i>/<i>z</i> 378.6 [M + 1]. HRMS calculated mass, 378.0912 [M + 1]; measured, 378.0909 [M + 1]. Data identical to commercial sample from Specs.</div><div id="sec4_1_1_2_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i46" class="anchor-spacer"></div><h5 class="article-section__title" id="_i46"> 3-(5-((2-(Benzo[<i>d</i>]thiazol-2-yl)hydrazono)methyl)furan-2-yl)-benzoic Acid (<b>11</b>)</h5><div class="NLM_p last">Procedure B was followed using compound <b>9b</b> (72 mg, 0.31 mmol) and 2-hydrazinobenzothiazole (60 mg, 0.36 mmol). A yellow solid was obtained (<i>m</i> = 72 mg, 64%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, ppm): δ 8.31 (s, 1H), 8.06 (s, 1H), 8.01 (d, <i>J</i> = 7.7 Hz, 1H), 7.87 (d, <i>J</i> = 7.8 Hz, 1H), 7.77 (d, <i>J</i> = 7.6 Hz, 1H), 7.68–7.53 (m, 2H), 7.41 (d, <i>J</i> = 8.0 Hz, 1H), 7.30 (t, <i>J</i> = 7.9 Hz, 1H), 7.25 (d, <i>J</i> = 3.5 Hz, 1H), 7.10 (t, <i>J</i> = 7.4 Hz, 1H), 6.99 (d, <i>J</i> = 3.6 Hz, 1H). LCMS <i>m</i>/<i>z</i> 364.2 [M + 1].</div></div><div id="sec4_1_1_2_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i47" class="anchor-spacer"></div><h5 class="article-section__title" id="_i47"> 3-(5-(1-(2-(Benzo[<i>d</i>]thiazol-2-yl)hydrazono)ethyl)furan-2-yl)benzoic Acid (<b>12a</b>)</h5><div class="NLM_p last">Procedure B was followed using compound <b>10a</b> (50 mg, 0.22 mmol) and 2-hydrazinobenzothiazole (50 mg, 0.30 mmol). A light-brown solid was obtained (<i>m</i> = 55 mg, 66%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, ppm): δ 12.5 (br s, 2H), 8.32 (s, 1H), 8.02 (d, <i>J</i> = 8.0 Hz, 1H), 7.89 (d, <i>J</i> = 7.8 Hz, 1H), 7.71 (d, <i>J</i> = 7.8 Hz, 1H), 7.61 (t, <i>J</i> = 7.8 Hz, 1H), 7.31–7.25 (m, 2H), 7.22 (d, <i>J</i> = 3.5 Hz, 1H), 7.08 (t, <i>J</i> = 8.1 Hz, 1H), 7.01 (d, <i>J</i> = 3.5 Hz, 1H), 2.41 and 2.33 (s, 3H). LCMS <i>m</i>/<i>z</i> 378.4 [M + 1]. HRMS calculated mass, 378.0912 [M + 1]; measured, 378.0908 [M + 1].</div></div><div id="sec4_1_1_2_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i48" class="anchor-spacer"></div><h5 class="article-section__title" id="_i48"> 4-(5-(1-(2-(Benzo[<i>d</i>]thiazol-2-yl)hydrazono)ethyl)furan-2-yl)benzoic Acid (<b>12b</b>)</h5><div class="NLM_p last">Procedure B was followed using compound <b>10b</b> (140 mg, 0.65 mmol) and 2-hydrazinobenzothiazole (95 mg, 0.58 mmol). A cream solid was obtained (<i>m</i> = 128 mg, 58%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, ppm): Mixture of two isomers δ 8.02 (d, <i>J</i> = 8.2 Hz, 2H), 7.89 (d, <i>J</i> = 8.4 Hz, 2H), 7.72 (d, <i>J</i> = 7.6 Hz, 1H), 7.35–7.22 (m, 3H), 7.09 (t, <i>J</i> = 7.8 Hz, 1H), 7.03 (d, <i>J</i> = 3.5 Hz, 1H), 2.42 and 2.33 (2 s, 3H). LCMS <i>m</i>/<i>z</i> 378.7 [M + 1].</div></div><div id="sec4_1_1_2_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i49" class="anchor-spacer"></div><h5 class="article-section__title" id="_i49"> 2-(5-(1-(2-(Benzo[<i>d</i>]thiazol-2-yl)hydrazono)ethyl)furan-2-yl)benzoic Acid (<b>12c</b>)</h5><div class="NLM_p last">Procedure B was followed using compound <b>10c</b> (70 mg, 0.3 mmol) and 2-hydrazinobenzothiazole (50 mg, 0.3 mmol). A brown solid was obtained (<i>m</i> = 56 mg, 50%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, ppm): δ 7.74 (d, <i>J</i> = 7.8 Hz, 1H), 7.68 (d, <i>J</i> = 7.7 Hz, 1H), 7.63–7.57 (m, 2H), 7.45 (t, <i>J</i> = 7.5 Hz, 1H), 7.32–7.24 (m, 2H), 7.07 (t, <i>J</i> = 7.9 Hz, 1H), 6.96 (d, <i>J</i> = 3.5 Hz, 1H), 6.88 (d, <i>J</i> = 3.6 Hz, 1H), 2.30 (s, 3H). LCMS <i>m</i>/<i>z</i> 378.7 [M + 1]. HRMS calculated mass, 378.0912 [M + 1]; measured, 378.0911 [M + 1].</div></div><div id="sec4_1_1_2_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i50" class="anchor-spacer"></div><h5 class="article-section__title" id="_i50"> 3-(5-(1-(2-(Benzo[<i>d</i>]thiazol-2-yl)hydrazono)ethyl)furan-2-yl)-4-chlorobenzoic Acid (<b>12d</b>)</h5><div class="NLM_p last">Procedure B was followed using compound <b>10d</b> (100 mg, 0.38 mmol) and 2-hydrazinobenzothiazole (50 mg, 0.3 mmol). A cream solid was obtained (<i>m</i> = 55 mg, 45%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, ppm): δ 8.54 (d, <i>J</i> = 2.0 Hz, 1H), 7.87 (dd, <i>J</i> = 8.3 and 2.1 Hz, 1H), 7.72 (d, <i>J</i> = 8.3 Hz, 1H), 7.69 (d, <i>J</i> = 5.9 Hz, 1H), 7.34 (d, <i>J</i> = 3.6 Hz, 1H), 7.31–7.25 (m, 2H), 7.09 (t, <i>J</i> = 7.9 Hz, 1H), 7.05 (d, <i>J</i> = 3.7 Hz, 1H), 2.33 (s, 3H). LCMS <i>m</i>/<i>z</i> 413.0 [M + 1].</div></div><div id="sec4_1_1_2_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i51" class="anchor-spacer"></div><h5 class="article-section__title" id="_i51"> 5-(5-(1-(2-(Benzo[<i>d</i>]thiazol-2-yl)hydrazono)ethyl)furan-2-yl)-2-chlorobenzoic Acid (<b>12e</b>)</h5><div class="NLM_p last">Procedure B was followed using compound <b>10e</b> (100 mg, 0.38 mmol) and 2-hydrazinobenzothiazole (50 mg, 0.30 mmol). An off-white solid was obtained (<i>m</i> = 80 mg, 65%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, ppm): δ 8.15 (d, <i>J</i> = 2.1 Hz, 1H), 7.90 (dd, <i>J</i> = 8.4 and 2.2 Hz, 1H), 7.70 (d, <i>J</i> = 7.6 Hz, 1H), 7.65 (d, <i>J</i> = 8.5 Hz, 1H), 7.34–7.28 (m, 2H), 7.25 (d, <i>J</i> = 3.6 Hz, 1H), 7.09 (t, <i>J</i> = 8.0 Hz, 1H), 7.01 (d, <i>J</i> = 3.6 Hz, 1H), 2.32 (s, 3H). LCMS <i>m</i>/<i>z</i> 412.1 [M + 1]. HRMS calculated mass, 412.0517 [M + 1]; measured, 412.0518 [M + 1].</div></div><div id="sec4_1_1_2_7" class="NLM_sec NLM_sec_level_4"><div id="ac_i52" class="anchor-spacer"></div><h5 class="article-section__title" id="_i52"> 3-(5-(1-(2-(Benzo[<i>d</i>]thiazol-2-yl)hydrazono)ethyl)furan-2-yl)-2-chlorobenzoic Acid (<b>12f</b>)</h5><div class="NLM_p last">Procedure B was followed using compound <b>10f</b> (50 mg, 0.19 mmol) and 2-hydrazinobenzothiazole (31 mg, 0.19 mmol). An orange solid was obtained (<i>m</i> = 57 mg, 62%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, ppm): δ 8.01 (d, <i>J</i> = 7.7 Hz, 1H), 7.71 (d, <i>J</i> = 7.5 Hz, 1H), 7.66–7.63 (m, 1H), 7.58 (t, <i>J</i> = 6.5 Hz, 1H), 7.37–7.22 (m, 3H), 7.09 (d, <i>J</i> = 7.8 Hz, 1H), 7.05 (d, <i>J</i> = 4.8 Hz, 1H), 2.33 (s, 3H). LCMS <i>m</i>/<i>z</i> 412.0 [M + 1].</div></div><div id="sec4_1_1_2_8" class="NLM_sec NLM_sec_level_4"><div id="ac_i53" class="anchor-spacer"></div><h5 class="article-section__title" id="_i53"> 5-(5-(1-(2-(Benzo[<i>d</i>]thiazol-2-yl)hydrazono)ethyl)furan-2-yl)isophthalic Acid (<b>12g</b>)</h5><div class="NLM_p last">Procedure B was followed using compound <b>10g</b> (100 mg, 0.36 mmol) and 2-hydrazinobenzothiazole (60 mg, 0.36 mmol). An off-white solid was obtained (<i>m</i> = 90 mg, 59%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, ppm): δ 8.51 (s, 2H), 8.39 (s, 1H), 7.69 (d, <i>J</i> = 7.4 Hz, 1H), 7.36 (d, <i>J</i> = 3.5 Hz, 1H), 7.30–7.26 (m, 2H), 7.09 (t, <i>J</i> = 8.1 Hz, 1H), 7.03 (d, <i>J</i> = 3.3 Hz, 1H), 2.36 (s, 3H). LCMS <i>m</i>/<i>z</i> 422.7 [M + 1].</div></div><div id="sec4_1_1_2_9" class="NLM_sec NLM_sec_level_4"><div id="ac_i54" class="anchor-spacer"></div><h5 class="article-section__title" id="_i54"> 3-(5-(1-(2-(Benzo[<i>d</i>]thiazol-2-yl)hydrazono)ethyl)furan-2-yl)-2-methylbenzoic Acid (<b>12h</b>)</h5><div class="NLM_p last">Procedure B was followed using compound <b>10h</b> (80 mg, 0.33 mmol) and 2-hydrazinobenzothiazole (40 mg, 0.24 mmol). A brown solid was obtained (<i>m</i> = 45 mg, 48%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, ppm): 1:2 mixture of two isomers δ 7.83 and 7.81 (2 d, <i>J</i> = 8.3 and 8.0 Hz, 1H), 7.70 (t, <i>J</i> = 6.8 Hz, 2H), 7.56 (d, <i>J</i> = 7.3 Hz, 0.3H), 7.41 (t, <i>J</i> = 7.7 Hz, 1H), 7.33–7.22 (m, 1.7H) 7.16 (d, <i>J</i> = 7.5 Hz, 0.3H), 7.07 (t, <i>J</i> = 8.2 Hz, 0.7H), 7.02 (d, <i>J</i> = 3.6 Hz, 1H), 6.99 (d, <i>J</i> = 3.6 Hz, 0.3H), 6.90 (d, <i>J</i> = 3.6 Hz, 0.7H), 2.38 and 2.31 (2 s, 3H). LCMS <i>m</i>/<i>z</i> 392.0 [M + 1].</div></div><div id="sec4_1_1_2_10" class="NLM_sec NLM_sec_level_4"><div id="ac_i55" class="anchor-spacer"></div><h5 class="article-section__title" id="_i55"> 5-(5-(1-(2-(Benzo[<i>d</i>]thiazol-2-yl)hydrazono)ethyl)furan-2-yl)-2-nitrobenzoic Acid (<b>12i</b>)</h5><div class="NLM_p last">Procedure B was followed using compound <b>10i</b> (250 mg, 0.91 mmol) and 2-hydrazinobenzothiazole (150 mg, 0.91 mmol). An off-white solid was obtained (<i>m</i> = 344 mg, 89%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, ppm): 14:86 mixture of two isomers δ 8.17–8.12 (m, 2H), 8.05 (dd, <i>J</i> = 1.7 and 8.5 Hz, 0.86H), 7.79 (d, <i>J</i> = 3.7 Hz, 0.14H), 7.70 (d, <i>J</i> = 7.7 Hz, 0.86H), 7.59–7.56 (m, 0.28H), 7.51 (d, <i>J</i> = 3.7 Hz, 0.86H), 7.34–7.23 (m, 2H), 7.12–7.01 (m, 2H), 2.42 (s, 0.42H), 2,34 (s, 2.58H). LCMS <i>m</i>/<i>z</i> 423.1 [M + 1]. HRMS calculated mass, 423.0758 [M + 1]; measured, 423.0754 [M + 1].</div></div><div id="sec4_1_1_2_11" class="NLM_sec NLM_sec_level_4"><div id="ac_i56" class="anchor-spacer"></div><h5 class="article-section__title" id="_i56"> 5-(5-(1-(2-(Benzo[<i>d</i>]thiazol-2-yl)hydrazono)ethyl)furan-2-yl)-2-aminobenzoic Acid (<b>12j</b>)</h5><div class="NLM_p last">Procedure B was followed using compound <b>10j</b> (67 mg, 0.28 mmol) and 2-hydrazinobenzothiazole (45 mg, 0.28 mmol). A white solid was obtained (<i>m</i> = 53 mg, 48%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, ppm): 29:71 mixture of two isomers δ 9.3 (br s, 3H), 8.15 (s, 1H), 7.71–7.64 (m, 2H), 7.46 (d, <i>J</i> = 3.7 Hz, 0.29H), 7.33–7.24 (m, 1.71), 7.07 (t, <i>J</i> = 7.3 Hz, 1H), 6.90–6.85 (m, 2H), 6.74 (d, <i>J</i> = 3.3 Hz, 1H), 2.41 (s, 0.87H), 2.30 (s, 2.13H). LCMS <i>m</i>/<i>z</i> 393.1 [M + 1]. HRMS calculated mass, 393.1016 [M + 1]; measured, 393.1018 [M + 1].</div></div><div id="sec4_1_1_2_12" class="NLM_sec NLM_sec_level_4"><div id="ac_i57" class="anchor-spacer"></div><h5 class="article-section__title" id="_i57"> 3-(5-Formylfuran-2-yl)benzamide (<b>15a</b>)</h5><div class="NLM_p last">Prepared according to method A using 3-aminobenzamide (1 g, 7.3 mmol) and 1-(furan-2-yl)ethanone (809 mg, 7.3 mmol). A white solid was obtained (<i>m</i> = 246 mg, 15%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, ppm): δ 8.34 (s, 1H), 8.14 (s, 1H), 8.01 (d, <i>J</i> = 7.7 Hz, 1H), 7.92 (d, <i>J</i> = 6.9 Hz, 1H), 7.63–7.58 (m, 2H), 7.53 (s, 1H), 7.29 (d, <i>J</i> = 3.5 Hz, 1H), 2.5 (s, 3H). LCMS <i>m</i>/<i>z</i> 216.2 [M + 1].</div></div><div id="sec4_1_1_2_13" class="NLM_sec NLM_sec_level_4"><div id="ac_i58" class="anchor-spacer"></div><h5 class="article-section__title" id="_i58"> 2-(3-(5-Acetylfuran-2-yl)phenyl)acetic Acid (<b>15b</b>)</h5><div class="NLM_p last">Prepared according to method A using 2-(3-aminophenyl)acetic acid (0.9 g, 6.0 mmol) and 1-(furan-2-yl)ethanone (700 mg, 6.4 mmol). A yellow crystalline solid was obtained (<i>m</i> = 70 mg, 5%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, ppm): δ 7.72 (s, 1H), 7.70 (s, 1H), 7.41 (t, <i>J</i> = 7.9 Hz, 1H), 7.30 (d, <i>J</i> = 7.5 Hz, 1H), 7.27–7.26 (m, 2H), 6.79 (d, <i>J</i> = 3.7 Hz, 1H), 3.72 (s, 2H), 2.54 (s, 3H). LCMS <i>m</i>/<i>z</i> 245.4 [M + 1].</div></div><div id="sec4_1_1_2_14" class="NLM_sec NLM_sec_level_4"><div id="ac_i59" class="anchor-spacer"></div><h5 class="article-section__title" id="_i59"> 2-(2-((5-(3-Nitrophenyl)furan-2-yl)methylene)hydrazinyl)benzothiazole (<b>16a</b>)</h5><div class="NLM_p last">Procedure B was followed using compound <b>14</b> (65 mg, 0.3 mmol) and 2-hydrazinobenzothiazole (50 mg, 0.3 mmol). An orange solid was obtained (<i>m</i> = 80 mg, 73%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, ppm): δ 8.53 (t, <i>J</i> = 1.9 Hz, 1H), 8.23–8.16 (m, 2H), 8.08 (s, 1H), 7.80 (br s, 1H), 7.78 (t, <i>J</i> = 7.9 Hz, 1H), 7.43 (d, <i>J</i> = 3.6 Hz, 1H), 7.41 (br s, 1H), 7.30 (td, <i>J</i> = 8.5 and 1.2 Hz, 1H), 7.11 (td, <i>J</i> = 8.3 and 1.1 Hz, 1H), 7.03 (d, <i>J</i> = 3.7 Hz, 1H). LCMS <i>m</i>/<i>z</i> 365.3 [M + 1]. HRMS calculated mass, 365.0703 [M + 1]; measured, 365.0702 [M + 1].</div></div><div id="sec4_1_1_2_15" class="NLM_sec NLM_sec_level_4"><div id="ac_i60" class="anchor-spacer"></div><h5 class="article-section__title" id="_i60"> Methyl 3-(5-((2-(Benzothiazol-2-yl)hydrazono)methyl)furan-2-yl)benzoate (<b>16b</b>)</h5><div class="NLM_p last">Compound <b>11</b> (50 mg, 0.14 mmol) was suspended in 20 mL of methanol and treated with a few drops of H<sub>2</sub>SO<sub>4</sub>. The reaction was then refluxed for 8 h. The cooled reaction mixture was concentrated and the residue taken up in CH<sub>2</sub>Cl<sub>2</sub>. The organic layer was washed with a cold dilute aqueous solution of NaHCO<sub>3</sub>, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated. An off-white solid was obtained (<i>m</i> = 40 mg, 76%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, ppm): δ 8.42 (s, 1H), 8.34 (s, 1H), 8.01 (dt, <i>J</i> = 6.2 and 1.7 Hz, 1H), 7.97 (dt, <i>J</i> = 7.9 and 1.3 Hz, 1H), 7.70 (d, <i>J</i> = 7.2 Hz, 1H), 7.65 (d, <i>J</i> = 7.9 Hz, 1H), 7.56–7.47 (m, 2H), 7.37 (t, <i>J</i> = 8.0 Hz, 1H), 7.00 (d, <i>J</i> = 3.7 Hz, 1H), 6.89 (d, <i>J</i> = 3.6 Hz, 1H), 3.98 (s, 3H). LCMS <i>m</i>/<i>z</i> 378.8 [M + 1]. HRMS calculated mass, 378.0907 [M + 1]; measured, 378.0907 [M + 1].</div></div><div id="sec4_1_1_2_16" class="NLM_sec NLM_sec_level_4"><div id="ac_i61" class="anchor-spacer"></div><h5 class="article-section__title" id="_i61"> 3-(5-(1-(2-(Benzothiazol-2-yl)hydrazono)ethyl)furan-2-yl)benzamide (<b>17a</b>)</h5><div class="NLM_p last">Procedure B was followed using compound <b>12a</b> (100 mg, 0.44 mmol) and 2-hydrazinobenzothiazole (72 mg, 0.44 mmol). An off-white solid was obtained (<i>m</i> = 42 mg, 26%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, ppm): δ 11.71 (br s, 1H) 8.26 (s, 1H), 8.09 (s, 1H), 7.91 (d, <i>J</i> = 7.6 Hz, 1H), 7.82 (d, <i>J</i> = 7.6 Hz, 1H), 7.71 (br s, 1H), 7.57 (t, <i>J</i> = 6.8 Hz, 1H), 7.48 (s, 1H), 7.28 (s, 1H), 7.16 (s, 1H), 7.08 (s, 1H), 7.02 (s, 1H), 2.34 (s, 3H). LCMS <i>m</i>/<i>z</i> 377.1 [M + 1]. HRMS calculated mass, 377.1067 [M + 1]; measured, 377.1065 [M + 1].</div></div><div id="sec4_1_1_2_17" class="NLM_sec NLM_sec_level_4"><div id="ac_i62" class="anchor-spacer"></div><h5 class="article-section__title" id="_i62"> 2-(3-(5-(1-(2-(Benzothiazol-2-yl)hydrazono)ethyl)furan-2-yl)phenyl)acetic Acid (<b>17b</b>)</h5><div class="NLM_p last">Procedure B was followed using compound <b>12b</b> (68 mg, 0.28 mmol) and 2-hydrazinobenzothiazole (54 mg, 0.33 mmol). A cream solid was obtained (<i>m</i> = 65 mg, 59%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, ppm): δ 7.72–7.66 (m, 3H), 7.42 (t, <i>J</i> = 7.6 Hz, 1H), 7.33–7.29 (m, 1H), 7.25 (t, <i>J</i> = 7.2 Hz, 2H), 7.11–7.05 (m, 1H), 7.08 (d, <i>J</i> = 3.5 Hz, 1H), 6.99 (d, <i>J</i> = 3.5 Hz, 1H), 3.65 (s, 2H), 2.32 (s, 3H). LCMS <i>m</i>/<i>z</i> 392.1 [M + 1]. HRMS calculated mass, 392.1063 [M + 1]; measured, 392.1062 [M + 1].</div></div><div id="sec4_1_1_2_18" class="NLM_sec NLM_sec_level_4"><div id="ac_i63" class="anchor-spacer"></div><h5 class="article-section__title" id="_i63"> 2-Hydrazinylbenzoxazole (<b>19a</b>)</h5><div class="NLM_p last">Hydrazine (1 mL, 32 mmol) was added to 2-chlorobenzo[<i>d</i>]oxazole (1 g, 6.5 mmol) dissolved in 1 mL of EtOH. The reaction temperature rose to 60–70 °C. It was stirred for 1 h and allowed to reach room temperature. A white precipitate appeared. It was collected by filtration and dried in vacuum (<i>m</i> = 735 mg, 76%). Analysis match previously reported data.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a></div></div><div id="sec4_1_1_2_19" class="NLM_sec NLM_sec_level_4"><div id="ac_i64" class="anchor-spacer"></div><h5 class="article-section__title" id="_i64"> 2-Hydrazino-1-methyl-1<i>H</i>-benzimidazole (<b>19b</b>)</h5><div class="NLM_p last">The procedure used to prepare <b>19a</b> was followed for the preparation of <b>19b</b> from 2-chloro-1-methyl-1<i>H</i>-benzo[<i>d</i>]imidazole. Analysis matched previously reported data.<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a></div></div></div><div id="sec4_1_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> General Method C: Preparation of Hydrazone Compounds from Substituted Benzothiazole</h4><div class="NLM_p">2-Chloro-5-(5-(1-(2-(6-fluorobenzothiazol-2-yl)hydrazono)ethyl)furan-2-yl)-benzoic acid (<b>22a</b>): to a suspension of 6-fluorobenzothiazol-2-amine <b>21a</b> (84 mg, 0.5 mmol) in 2 mL of ethylene glycol were added successively hydrazine hydrate (234 μL, 4.1 mmol) and hydrazine dihydrochloride (210 mg, 2 mmol). The reaction was heated at 140 °C overnight, leading to the formation of 6-fluoro-2-hydrazinobenzothiazole. At room temperature, compound <b>10e</b> (132 mg, 0.5 mmol) dissolved in 4 mL of EtOH was added to the reaction mixture followed by 30 μL of acetic acid. This reaction was heated at 60 °C for 10 h. At room temperature, the precipitate was collected by filtration, washed with EtOH, and dried in a vacuum oven (<i>m</i> = 34 mg, 16% from <b>21a</b>). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, ppm): δ 8.12 (d, <i>J</i> = 2.0 Hz, 1H), 7.85 (dd, <i>J</i> = 8.4 and 2.0 Hz, 1H), 7.66 (dd, <i>J</i> = 8.6 and 2.5 Hz, 1H), 7.61 (d, <i>J</i> = 8.5 Hz, 1H), 7.36–7.29 (m, 1H), 7.22 (d, <i>J</i> = 3.6 Hz, 1H), 7.10 (td, <i>J</i> = 9.1 and 2.6 Hz, 1H), 6.97 (d, <i>J</i> = 3.6 Hz, 1H), 2.28 (s, 3H). LCMS <i>m</i>/<i>z</i> 430.0 [M + 1].</div><div id="sec4_1_1_3_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i66" class="anchor-spacer"></div><h5 class="article-section__title" id="_i66"> 2-Chloro-5-(5-(1-(2-(6-chlorobenzothiazol-2-yl)hydrazono)ethyl)furan-2-yl)-benzoic Acid (<b>22b</b>)</h5><div class="NLM_p last">Procedure C was followed using 6-chlorobenzothiazol-2-amine (<b>21b</b>) on the same scale (<i>m</i> = 19 mg, 9% from <b>21b</b>). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, ppm): δ 8.12 (d, <i>J</i> = 2.0 Hz, 1H), 7.85 (dd, <i>J</i> = 8.6 and 2.1 Hz, 1H), 7.84 (s, 1H), 7.61 (d, <i>J</i> = 8.4 Hz, 1H), 7.33–7.26 (m, 2H), 7.22 (d, <i>J</i> = 3.6 Hz, 1H), 6.99 (d, <i>J</i> = 3.5 Hz, 1H), 2.28 (s, 3H). LCMS <i>m</i>/<i>z</i> 446.1 [M + 1]. HRMS calculated mass, 446.0127 [M + 1]; measured, 446.0128 [M + 1].</div></div><div id="sec4_1_1_3_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i67" class="anchor-spacer"></div><h5 class="article-section__title" id="_i67"> 2-Chloro-5-(5-(1-(2-(6-bromobenzothiazol-2-yl)hydrazono)ethyl)furan-2-yl)-benzoic Acid (<b>22c</b>)</h5><div class="NLM_p last">Procedure C was followed using 6-bromobenzothiazol-2-amine (<b>21c</b>) on the same scale (<i>m</i> = 68 mg, 28% from <b>21c</b>). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, ppm): δ 8.12 (d, <i>J</i> = 2.2 Hz, 1H), 7.95 (d, <i>J</i> = 1.8 Hz, 1H), 7.86 (dd, <i>J</i> = 8.4 and 2.2 Hz, 1H), 7.61 (d, <i>J</i> = 8.5 Hz, 1H), 7.39 (dd, <i>J</i> = 8.5 and 2.0 Hz, 1H), 7.25 (d, <i>J</i> = 8.6 Hz, 1H), 7.22 (d, <i>J</i> = 3.6 Hz, 1H), 6.99 (d, <i>J</i> = 3.6 Hz, 1H), 2.28 (s, 3H). LCMS <i>m</i>/<i>z</i> 491.8 [M + 1].</div></div><div id="sec4_1_1_3_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i68" class="anchor-spacer"></div><h5 class="article-section__title" id="_i68"> 2-Chloro-5-(5-(1-(2-(6-(trifluoromethyl)benzothiazol-2-yl)hydrazono)ethyl)furan-2-yl)benzoic Acid (<b>22d</b>)</h5><div class="NLM_p last">Procedure C was followed using 6-trifluoromethylbenzothiazol-2-amine (<b>21d</b>) on the same scale (<i>m</i> = 67 mg, 28% from <b>21d</b>). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, ppm): <i>d</i> 8.18 (s, 1H), 8.02 (s, 1H), 7.79 (dd, <i>J</i> = 8.3 and 1.9 Hz, 1H), 7.59 (d, <i>J</i> = 8.3 Hz, 1H) 7.55 (d, <i>J</i> = 8.4 Hz, 1H), 7.48 (d, <i>J</i> = 8.5 Hz, 1H), 7.21 (d, <i>J</i> = 3.5 Hz, 1H), 7.04 (d, <i>J</i> = 3.5 Hz, 1H), 2.34 (s, 3H). LCMS <i>m</i>/<i>z</i> 480.1 [M + 1]. HRMS calculated mass, 480.0391 [M + 1]; measured, 480.0392 [M + 1].</div></div><div id="sec4_1_1_3_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i69" class="anchor-spacer"></div><h5 class="article-section__title" id="_i69"> 2-Chloro-5-(5-(1-(2-(5-bromobenzothiazol-2-yl)hydrazono)ethyl)furan-2-yl)benzoic Acid (<b>22e</b>)</h5><div class="NLM_p last">Procedure C was followed using 5-bromobenzothiazol-2-amine (<b>21e</b>) on the same scale (<i>m</i> = 30 mg, 12% from <b>21e</b>). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, ppm): δ 8.11 (d, <i>J</i> = 2.2 Hz, 1H), 7.86 (dd, <i>J</i> = 8.4 and 2.3 Hz, 1H), 7.68 (d, <i>J</i> = 8.3 Hz, 1H), 7.61 (d, <i>J</i> = 8.5 Hz, 1H), 7.50 (s, 1H), 7.25–7.18 (m, 2H), 7.00 (d, <i>J</i> = 3.6 Hz, 1H), 2.29 (s, 3H). LCMS <i>m</i>/<i>z</i> 492.0 [M + 1]. HRMS calculated mass, 489.9622 [M + 1]; measured, 489.9625 [M + 1].</div></div><div id="sec4_1_1_3_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i70" class="anchor-spacer"></div><h5 class="article-section__title" id="_i70"> 2-Chloro-5-(5-(1-(2-(4-fluorobenzothiazol-2-yl)hydrazono)ethyl)furan-2-yl)benzoic Acid (<b>22f</b>)</h5><div class="NLM_p last">Procedure C was followed using 4-fluorobenzothiazol-2-amine (<b>21f</b>) on the same scale (<i>m</i> = 10 mg, 5% from <b>21f</b>). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, ppm): δ 8.15 (s, 1H), 7.92 (d, <i>J</i> = 9.1 Hz, 1H), 7.89 (d, <i>J</i> = 10.2 Hz, 1H), 7.66–7.63 (m, 2H), 7.31–7.16 (m, 3H), 7.04 (d, <i>J</i> = 3.1 Hz, 1H), 2.32 (s, 3H). LCMS <i>m</i>/<i>z</i> 430.1 [M + 1]. HRMS calculated mass, 430.0423 [M + 1]; measured, 430.0424 [M + 1].</div></div><div id="sec4_1_1_3_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i71" class="anchor-spacer"></div><h5 class="article-section__title" id="_i71"> 3-(5-(1-(2-(Benzoxazol-2-yl)hydrazono)ethyl)furan-2-yl)-2-methylbenzoic Acid (<b>23</b>)</h5><div class="NLM_p last">Procedure B was followed using compound <b>10h</b> (36 mg, 0.15 mmol) and <b>19a</b> (25 mg, 0.17 mmol). A white solid was obtained (<i>m</i> = 31 mg, 55%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, ppm): 1:2 mixture of two isomers δ 7.86 (d, <i>J</i> = 7.7 Hz, 0.3H), 7.78 (d, <i>J</i> = 8.1 Hz, 0.7H), 7.70 (t, <i>J</i> = 7.0 Hz, 1H), 7.51 (d, <i>J</i> = 7.7 Hz, 0.7H), 7.42 (d, <i>J</i> = 8.0 Hz, 1H), 7.39 (d, <i>J</i> = 8.7 Hz, 1H), 7.31 (d, <i>J</i> = 7.8 Hz, 0.3H), 7.21 (t, <i>J</i> = 7.1 Hz, 1H), 7.14–7.01 (m, 2H), 7.06 (d, <i>J</i> = 3.4 Hz, 1H), 6.89 (d, <i>J</i> = 3.4 Hz, 0.3H), 6.87 (d, <i>J</i> = 3.5 Hz, 1H), 2.59 (s, 0.9H), 2.58 (s, 2.1H), 2.32 (s, 2.1H), 2.31 (s, 0.9H). LCMS <i>m</i>/<i>z</i> 376.1 [M + 1]. HRMS calculated mass, 376.1292 [M + 1]; measured, 376.1292 [M + 1].</div></div><div id="sec4_1_1_3_7" class="NLM_sec NLM_sec_level_4"><div id="ac_i72" class="anchor-spacer"></div><h5 class="article-section__title" id="_i72"> 2-Chloro-5-(5-(1-(2-(1-methyl-1<i>H</i>-benzimidazol-2-yl)hydrazono)ethyl)furan-2-yl)benzoic Acid (<b>24</b>)</h5><div class="NLM_p last">Procedure B was followed using compound <b>10e</b> (62 mg, 0.23 mmol) and <b>19b</b> (200 mg, 1.2 mmol). A dark solid was obtained (<i>m</i> = 33 mg, 35%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, ppm): δ 10.90 (br s, 1H), 8.11 (d, <i>J</i> = 2.2 Hz, 1H), 7.93 (dd, <i>J</i> = 8.5 and 2.3 Hz, 1H), 7.59 (d, <i>J</i> = 8.5 Hz, 1H), 7.22 (d, <i>J</i> = 3.5 Hz, 1H), 7.16–7.09 (m, 2H), 7.02–6.99 (m, 3H), 3.46 (s, 3H), 2.33 (s, 3H). LCMS <i>m</i>/<i>z</i> 409.1 [M + 1]. HRMS calculated mass, 409.1062 [M + 1]; measured, 409.1059 [M + 1].</div></div><div id="sec4_1_1_3_8" class="NLM_sec NLM_sec_level_4"><div id="ac_i73" class="anchor-spacer"></div><h5 class="article-section__title" id="_i73"> 2-Chloro-5-(5-(1-(2-(quinolin-2-yl)hydrazono)ethyl)furan-2-yl)benzoic Acid (<b>25</b>)</h5><div class="NLM_p last">Procedure B was followed using compound <b>10e</b> (48 mg, 0.18 mmol) and 2-hydrazinylquinoline (29 mg, 0.18 mmol) and acetic acid as the solvent. A yellow solid was obtained (<i>m</i> = 41 mg, 56%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, ppm): δ 10.35 (br s, 1H), 8.19 (d, <i>J</i> = 7.1 Hz, 1H), 8.13–8.12 (m, 2H), 7.90 (d, <i>J</i> = 7.1 Hz, 1H), 7.79 (d, <i>J</i> = 6.6 Hz, 1H), 7.22–7.53 (m, 4H), 7.31–7.23 (m, 2H), 7.01 (br s, 1H), 2.34 (s, 3H). LCMS <i>m</i>/<i>z</i> 406.2 [M + 1].</div></div><div id="sec4_1_1_3_9" class="NLM_sec NLM_sec_level_4"><div id="ac_i74" class="anchor-spacer"></div><h5 class="article-section__title" id="_i74"> 3-(5-((2-(4-Phenylthiazol-2-yl)hydrazono)methyl)furan-2-yl)benzoic Acid (<b>26</b>)</h5><div class="NLM_p last">Procedure B was followed using compound <b>9b</b> (72 mg, 0.33 mmol) and 2-hydrazinyl-4-phenylthiazole (95 mg, 0.5 mmol). A brown solid was obtained (<i>m</i> = 73 mg, 57%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, ppm): δ 8.30 (s, 1H), 8.01 (d, <i>J</i> = 7.9 Hz, 1H), 7.97 (s, 1H), 7.90 (d, <i>J</i> = 7.9 Hz, 1H), 7.86 (d, <i>J</i> = 7.3 Hz, 2H), 7.60 (t, <i>J</i> = 7.8 Hz, 1H), 7.41 (t, <i>J</i> = 7.3 Hz, 2H), 7.34 (s, 1H), 7.30 (t, <i>J</i> = 7.3 Hz, 1H), 7.23 (d, <i>J</i> = 3.6 Hz, 1H), 6.95 (d, <i>J</i> = 3.6 Hz, 1H). LCMS <i>m</i>/<i>z</i> 390.1 [M + 1]. HRMS calculated mass, 390.0907 [M + 1]; measured, 390.0903 [M + 1].</div></div><div id="sec4_1_1_3_10" class="NLM_sec NLM_sec_level_4"><div id="ac_i75" class="anchor-spacer"></div><h5 class="article-section__title" id="_i75"> 3-(5-(1-(2-Benzoylhydrazono)ethyl)furan-2-yl)benzoic Acid (<b>27</b>)</h5><div class="NLM_p last">Procedure B was followed using compound <b>10a</b> (45 mg, 0.2 mmol) and benzohydrazide (30 mg, 0.22 mmol). A cream solid was obtained (<i>m</i> = 43 mg, 62%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, ppm): δ 10.78 (br s, 1H), 8.31 (s, 1H), 8.03 (d, <i>J</i> = 7.1 Hz, 1H), 7.90 (d, <i>J</i> = 7.5 Hz, 3H), 7.63–7.51 (m, 4H), 7.23 (s, 1H), 7.13 (s, 1H), 2.35 (s, 3H). LCMS <i>m</i>/<i>z</i> 349.1 [M + 1]. HRMS calculated mass, 349.1183 [M + 1]; measured, 349.1184 [M + 1].</div></div><div id="sec4_1_1_3_11" class="NLM_sec NLM_sec_level_4"><div id="ac_i76" class="anchor-spacer"></div><h5 class="article-section__title" id="_i76"> 5-(5-(1-(2-(Benzo[<i>d</i>]thiazol-2-yl)hydrazono)ethyl)thiophen-2-yl)-2-chlorobenzoic Acid (<b>30a</b>)</h5><div class="NLM_p last">The intermadiate 5-(5-acetylthiophen-2-yl)-2-chlorobenzoic acid (<b>29a</b>) was prepared according to method A using 1-(thiophen-2-yl)ethanone (370 mg, 2.9 mmol) and <b>8f</b> (500 mg, 2.9 mmol). Then 50 mg (0.18 mmol) of this material was reacted directly with 2-hydrazinylbenzothiazole (32 mg, 0.2 mmol) using procedure B. A yellow solid was obtained (<i>m</i> = 35 mg, 41% from <b>29a</b>). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, ppm): δ 8.02 (d, <i>J</i> = 1.9 Hz, 1H), 7.86 (dd, <i>J</i> = 8.4 and 2.0 Hz, 1H), 7.70 (d, <i>J</i> = 7.7 Hz, 1H), 7.62–7.59 (m, 2H), 7.44 (d, <i>J</i> = 3.8 Hz, 1H), 7.26–7.25 (m, 2H), 7.09–7.04 (m, 1H), 2.36 (s, 3H). LCMS <i>m</i>/<i>z</i> 428.6 [M + 1].</div></div><div id="sec4_1_1_3_12" class="NLM_sec NLM_sec_level_4"><div id="ac_i77" class="anchor-spacer"></div><h5 class="article-section__title" id="_i77"> 5-(5-Acetyl-1-methyl-1<i>H</i>-pyrrol-2-yl)-2-chlorobenzoic Acid (<b>29b</b>)</h5><div class="NLM_p last">Prepared according to method A using 1-(1-methyl-1<i>H</i>-pyrrol-2-yl)ethanone (500 mg, 4.1 mmol) and <b>8f</b> (697 mg, 4.1 mmol). A white solid was obtained (<i>m</i> = 299 mg, 26%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, ppm): δ 13.5 (br s, 1H), 7.82 (s, 1H), 7.64 (s, 2H), 7.19 (d, <i>J</i> = 4.1 Hz, 1H), 6.37 (d, <i>J</i> = 4.1 Hz, 1H), 3.80 (s, 3H), 2.42 (s, 3H). LCMS <i>m</i>/<i>z</i> 278.1 [M + 1].</div></div><div id="sec4_1_1_3_13" class="NLM_sec NLM_sec_level_4"><div id="ac_i78" class="anchor-spacer"></div><h5 class="article-section__title" id="_i78"> 5-(5-Acetyl-1<i>H</i>-pyrrol-2-yl)-2-chlorobenzoic Acid (<b>29c</b>)</h5><div class="NLM_p last">Prepared according to method A using 1-(1<i>H</i>-pyrrol-2-yl)ethanone (500 mg, 4.6 mmol) and <b>8f</b> (787 mg, 4.6 mmol). An off-white solid was obtained (<i>m</i> = 328 mg, 27%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, ppm): δ 8.30 (d, <i>J</i> = 2.3 Hz, 1H), 8.00 (dd, <i>J</i> = 8.5 and 2.3 Hz, 1H), 7.54 (d, <i>J</i> = 8.5 Hz, 1H), 7.08–7.06 (m, 1H), 6.79–6.77 (m, 1H), 2.39 (s, 3H). LCMS <i>m</i>/<i>z</i> 264.6 [M + 1].</div></div><div id="sec4_1_1_3_14" class="NLM_sec NLM_sec_level_4"><div id="ac_i79" class="anchor-spacer"></div><h5 class="article-section__title" id="_i79"> 5-(5-(1-(2-(Benzothiazol-2-yl)hydrazono)ethyl)-1-methyl-1<i>H</i>-pyrrol-2-yl)-2-chlorobenzoic Acid (<b>30b</b>)</h5><div class="NLM_p last">Procedure B was followed using compound <b>29b</b> (100 mg, 0.4 mmol) and 2-hydrazinylbenzothiazole (60 mg, 0.4 mmol). A light-brown solid was obtained (<i>m</i> = 44 mg, 29%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, ppm): δ 7.81 (d, <i>J</i> = 1.7 Hz, 1H), 7.67 (d, <i>J</i> = 7.9 Hz, 1H), 7.63–7.58 (m, 3H), 7.30–7.23 (m, 2H), 7.05 (td, <i>J</i> = 8.1 and 2.0 Hz, 1H), 6.67 (d, <i>J</i> = 3.9 Hz, 1H), 6.34 (d, <i>J</i> = 3.9 Hz, 1H), 3.91 (s, 3H), 2.34 (s, 3H). LCMS <i>m</i>/<i>z</i> 425.1 [M + 1].</div></div><div id="sec4_1_1_3_15" class="NLM_sec NLM_sec_level_4"><div id="ac_i80" class="anchor-spacer"></div><h5 class="article-section__title" id="_i80"> 5-(5-(1-(2-(Benzothiazol-2-yl)hydrazono)ethyl)-1<i>H</i>-pyrrol-2-yl)-2-chlorobenzoic Acid (<b>30c</b>)</h5><div class="NLM_p last">Procedure B was followed using compound <b>29c</b> (100 mg, 0.4 mmol) and 2-hydrazinylbenzothiazole (63 mg, 0.4 mmol). A brown solid was obtained (<i>m</i> = 124 mg, 79%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, ppm): 2:1 mixture of isomers δ 12.5 (br s, 1H), 12.20 (s, 0.3H), 11.23 (s, 0.7H), 8.30 (d, <i>J</i> = 2.1 Hz, 0.3H), 8.19 (d, <i>J</i> = 1.9 Hz, 0.7H), 8.00 (dd, <i>J</i> = 8.6 and 2.3 Hz, 0.3H), 7.91 (dd, <i>J</i> = 8.5 and 2.0 Hz, 0.7H), 7.69 (d, <i>J</i> = 7.7 Hz, 0.7H), 7.56–7.54 (m, 0.3H), 7.52 (d, <i>J</i> = 8.4 Hz, 0.7H), 7.30–7.22 (m, 1 + 2 × 0.33), 7.07–7.02 (m, 1H), 6.78 (t, <i>J</i> = 2.9 Hz, 0.3H), 6.71 (t, <i>J</i> = 3.2 Hz, 1H), 6.62 (t, <i>J</i> = 2.1 Hz, 0.7H), 2.39 (s, 0.9H), 2.30 (s, 2.1H). LCMS <i>m</i>/<i>z</i> 411.1 [M + 1]. HRMS calculated mass, 411.0677 [M + 1]; measured, 411.0676 [M + 1].</div></div><div id="sec4_1_1_3_16" class="NLM_sec NLM_sec_level_4"><div id="ac_i81" class="anchor-spacer"></div><h5 class="article-section__title" id="_i81"> 5-(3-(1-(2-(Benzothiazol-2-yl)hydrazono)ethyl)phenyl)furan-2-carboxylic (<b>34</b>) Acid</h5><div class="NLM_p last">5-(3-Acetylphenyl)furan-2-carboxylic acid (<b>33</b>) was prepared according to method A using furan-2-carboxylic acid (1.1 g, 10 mmol) and 1-(3-aminophenyl)ethanone (1.4 g, 10.3 mmol). A brown solid was obtained (<i>m</i> = 70 mg, 3%) and treated directly with 2-hydrazinylbenzothiazole (40 mg, 0.24 mmol) using general procedure B. A pale-brown solid was obtained (35 mg, 31%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, ppm): δ 8.17 (s, 1H), 7.87 (d, <i>J</i> = 7.8 Hz, 1H), 7.83 (d, <i>J</i> = 8.0 Hz, 1H), 7.71 (d, <i>J</i> = 7.3 Hz, 1H), 7.55 (t, <i>J</i> = 7.7 Hz, 1H), 7.36 (d, <i>J</i> = 3.6 Hz, 1H), 7.34 (d, <i>J</i> = 3.3 Hz, 1H), 7.29 (t, <i>J</i> = 7.7 Hz, 1H), 7.22 (d, <i>J</i> = 3.6 Hz, 1H), 7.09 (t, <i>J</i> = 7.7 Hz, 1H), 2.43 (s, 3H). LCMS <i>m</i>/<i>z</i> 378.1 [M + 1]. HRMS calculated mass, 378.0907 [M + 1]; measured, 378.0902 [M + 1].</div></div></div><div id="sec4_1_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i82" class="anchor-spacer"></div><h4 class="article-section__title" id="_i82"> General Method D: Formation of Biaryl Ketone Using the Suzuki Coupling Reaction</h4><div class="NLM_p">Preparation of 6-(3-acetylphenyl)picolinic acid (<b>37</b>): A mixture of 6-bromopicolinic acid (1.5 g, 7.4 mmol), 3-acetylphenylboronic acid (1.6 g, 9.6 mmol), tetrabutylammonium bromide (225 mg, 0.7 mmol), potassium carbonate (2.79 g, 20 mmol), and Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub> (270 mg, 0.4 mmol) in 30 mL of dioxane and 15 mL of water were heated at 100 °C in a microwave reactor (120W) for 60 min. After cooling, water and AcOEt were added and aqueous HCl was then added until the pH of aqueous phase reached 3. A precipitate appeared. It was collected by filtration and dried in a vacuum oven. As this solid contained traces of side products, it was redissolved in an aqueous solution of potassium carbonate (10%). The solution was then acidified to pH 4–5 with HCl 2N. The precipitate that formed was collected by filtration and dried in a vacuum oven. A white solid was obtained (<i>m</i> = 835 mg, 47%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, ppm): δ 8.69 (t, <i>J</i> = 1.8 Hz, 1H), 8.43 (dd, <i>J</i> = 7.8 and 1.9 Hz, 1H), 8.30 (dd, <i>J</i> = 7.8 and 1.2 Hz, 1H), 8.11 (t, <i>J</i> = 7.7 Hz, 1H), 8.05 (td, <i>J</i> = 7.7 and 1.1 Hz, 2H), 7.69 (t, <i>J</i> = 7.8 Hz, 1H), 2.68 (s, 3H). LCMS <i>m</i>/<i>z</i> 242.2 [M + 1].</div><div id="sec4_1_1_4_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i83" class="anchor-spacer"></div><h5 class="article-section__title" id="_i83"> 6-(3-(1-(2-(Benzothiazol-2-yl)hydrazono)ethyl)phenyl)picolinic Acid (<b>38</b>)</h5><div class="NLM_p last">Procedure B was followed using compound <b>37</b> (200 mg, 0.83 mmol) and 2-hydrazinylbenzothiazole (137 mg, 0.83 mmol). A white solid was obtained (<i>m</i> = 289 mg, 90%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, ppm): δ 8.51 (t, <i>J</i> = 1.6 Hz, 1H), 8.21 (dd, <i>J</i> = 7.9 and 1.1 Hz, 1H), 8.15 (dt, <i>J</i> = 7.8 and 1.1 Hz, 1H), 8.08 (t, <i>J</i> = 7.7 Hz, 1H), 8.00 (dd, <i>J</i> = 7.6 and 1.1 Hz, 1H), 7.92 (dt, <i>J</i> = 7.8 and 1.1 Hz, 1H), 7.68 (d, <i>J</i> = 7.6 Hz, 1H), 7.56 (t, <i>J</i> = 7.8 Hz, 1H), 7.32 (d, <i>J</i> = 8.1 Hz, 1H), 7.25 (td, <i>J</i> = 7.2 and 1.1 Hz, 1H), 7.05 (td, <i>J</i> = 7.8 and 1.3 Hz, 1H), 2.34 (s, 3H). LCMS <i>m</i>/<i>z</i> 389.1 [M + 1]. HRMS calculated mass, 389.1067 [M + 1]; measured, 389.1063 [M + 1].</div></div><div id="sec4_1_1_4_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i84" class="anchor-spacer"></div><h5 class="article-section__title" id="_i84"> 5-(3-Acetylphenyl)nicotinic Acid (<b>40</b>)</h5><div class="NLM_p last">Procedure D was followed using 5-bromonicotinic acid (700 mg, 1.5 mmol) and 3-acetylphenylboronic acid (341 mg, 2.1 mmol). A pale-yellow solid was obtained (<i>m</i> = 250 mg, 69%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, ppm): δ 9.18 (d, <i>J</i> = 2.3 Hz, 1H), 9.10 (d, <i>J</i> = 1.8 Hz, 1H), 8.53 (t, <i>J</i> = 2.1 Hz, 1H), 8.3 (t, <i>J</i> = 1.5 Hz, 1H), 8.04 (t, <i>J</i> = 7.8 Hz, 1H), 7.69 (t, <i>J</i> = 7.8 Hz, 1H), 2.69 (s, 3H). LCMS <i>m</i>/<i>z</i> 242.2 [M + 1].</div></div><div id="sec4_1_1_4_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i85" class="anchor-spacer"></div><h5 class="article-section__title" id="_i85"> 5-(3-(1-(2-(Benzothiazol-2-yl)hydrazono)ethyl)phenyl)nicotinic Acid (<b>41</b>)</h5><div class="NLM_p last">Procedure B was followed using compound <b>40</b> (20 mg, 0.08 mmol) and 2-hydrazinylbenzothiazole (14 mg, 0.08 mmol). An off-white solid was obtained (<i>m</i> = 16 mg, 50%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, ppm): δ 9.16 (d, <i>J</i> = 1.9 Hz, 1H), 9.10 (d, <i>J</i> = 1.8 Hz, 1H), 8.52 (t, <i>J</i> = 2.1 Hz, 1H), 8.13 (s, 1H), 7.94 (d, <i>J</i> = 7.9 Hz, 1H), 7.80 (d, <i>J</i> = 7.8 Hz, 1H), 7.71 (d, <i>J</i> = 7.6 Hz, 1H), 7.60 (t, <i>J</i> = 7.7 Hz, 1H), 7.35 (d, <i>J</i> = 8.0 Hz, 1H), 7.28 (t, <i>J</i> = 7.2 Hz, 1H), 7.08 (t, <i>J</i> = 7.7 Hz, 1H), 2.45 (s, 3H). LCMS <i>m</i>/<i>z</i> 389.1 [M + 1]. HRMS calculated mass, 389.1067 [M + 1]; measured, 389.1067 [M + 1].</div></div><div id="sec4_1_1_4_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i86" class="anchor-spacer"></div><h5 class="article-section__title" id="_i86"> 6-(3-Acetylphenyl)pyrazine-2-carboxylic Acid (<b>43</b>)</h5><div class="NLM_p last">Procedure D was followed using 6-chloropyrazine-2-carbonitrile (250 mg, 1.8 mm ol) and 3-acetylphenylboronic acid (354 mg, 2.2 mmol). A white solid was obtained (<i>m</i> = 100 mg, 25%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, ppm): δ 9.28 (s, 1H), 8.86 (s, 1H), 8.62 (t, <i>J</i> = 1.9 Hz, 1H), 8.27 (dd, <i>J</i> = 7.8 and 1.9 Hz, 1H), 8.11 (dd, <i>J</i> = 7.8 and 1.7 Hz, 1H), 7.66 (t, <i>J</i> = 7.8 Hz, 1H), 2.68 (s, 3H). Then 50 mg of the coupled product (0.22 mmol) were reacted with 3.3 mL of 6.25N aqueous NaOH in 5 mL of a 1:1 THF/MeOH mixture at 60 °C for 4 h. The reaction was cooled and concentrated to leave the basic aqueous phase. This solution was acidified with 6N HCl to pH 4, leading ro the formation of a precipitate. The aqueous phase was extracted twice with EtOAc, and the combined organic layers were dried over MgSO<sub>4</sub>. Concentration afforded a pale-yellow solid (<i>m</i> = 20 mg, 38%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, ppm): δ 9.55 (s, 1H), 9.17 (s, 1H), 8.72 (t, <i>J</i> = 1.8 Hz, 1H), 8.47 (dd, <i>J</i> = 7.8 and 1.8 Hz, 1H), 8.12 (dd, <i>J</i> = 7.8 and 1.7 Hz, 1H), 7.74 (t, <i>J</i> = 7.8 Hz, 1H), 2.69 (s, 3H). LCMS <i>m</i>/<i>z</i> 241.3 [M + 1].</div></div><div id="sec4_1_1_4_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i87" class="anchor-spacer"></div><h5 class="article-section__title" id="_i87"> 6-(3-(1-(2-(Benzothiazol-2-yl)hydrazono)ethyl)phenyl)pyrazine-2-carboxylic Acid (<b>44</b>)</h5><div class="NLM_p last">Procedure B was followed using compound <b>43</b> (35 mg, 0.15 mmol) and 2-hydrazinylbenzothiazole (26 mg, 0.16 mmol). A cream solid was obtained (<i>m</i> = 43 mg, 74%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, ppm): δ 9.48 (s, 1H), 9.14 (s, 1H), 8.55 (s, 1H), 8.19 <i>J</i> = 7.8 Hz, 1H), 7.98 (d, <i>J</i> = 8.4 Hz, 1H), 7.68 (d, <i>J</i> = 7.8 Hz, 1H), 7.61 (t, <i>J</i> = 7.8 Hz, 1H), 7.32 (d, <i>J</i> = 7.7 Hz, 1H), 7.27 (t, <i>J</i> = 8.0 Hz, 1H), 2.43 (s, 3H). LCMS <i>m</i>/<i>z</i> 390.1 [M + 1]. HRMS calculated mass, 390.1019 [M + 1]; measured, 390.1012 [M + 1].</div></div><div id="sec4_1_1_4_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i88" class="anchor-spacer"></div><h5 class="article-section__title" id="_i88"> 6-(5-Acetylthiophen-2-yl)picolinic Acid (<b>47</b>)</h5><div class="NLM_p last">Procedure D was followed using 6-bromopicolinic acid (100 mg, 0.5 mmol) and 5-acetylthiophen-2-ylboronic acid <b>45</b> (109 mg, 0.65 mmol). A cream solid was obtained (<i>m</i> = 37 mg, 30%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, ppm): δ 8.25 (dd, <i>J</i> = 7.8 and 1.1 Hz, 1H), 8.08 (t, <i>J</i> = 7.7 Hz, 1H), 8.01–7.97 (m, 3H), 2.57 (s, 3H). LCMS <i>m</i>/<i>z</i> 248.4 [M + 1].</div></div><div id="sec4_1_1_4_7" class="NLM_sec NLM_sec_level_4"><div id="ac_i89" class="anchor-spacer"></div><h5 class="article-section__title" id="_i89"> 6-(5-(1-(2-(Benzothiazol-2-yl)hydrazono)ethyl)thiophen-2-yl)picolinic Acid (<b>48</b>)</h5><div class="NLM_p last">Procedure B was followed using compound <b>47</b> (25 mg, 0.10 mmol) and 2-hydrazinylbenzothiazole (17 mg, 0.10 mmol). A cream solid was obtained (<i>m</i> = 30 mg, 76%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, ppm): δ 8.16 (dd, <i>J</i> = 7.9 and 1.1 Hz, 1H), 8.01 (t, <i>J</i> = 7.7 Hz, 1H), 7.92 (dd, <i>J</i> = 7.6 and 1.1 Hz, 1H), 7.86 (d, <i>J</i> = 4.0 Hz, 1H), 7.74 (d, <i>J</i> = 7.8 Hz, 1H), 7.47 (d, <i>J</i> = 4.0 Hz, 1H), 7.27 (d, <i>J</i> = 4.1 Hz, 2H), 7.10–7.04 (m, 1H), 2.39 (s, 3H). LCMS <i>m</i>/<i>z</i> 395.4 [M + 1].</div></div><div id="sec4_1_1_4_8" class="NLM_sec NLM_sec_level_4"><div id="ac_i90" class="anchor-spacer"></div><h5 class="article-section__title" id="_i90"> 5-(5-Acetylthiophen-2-yl)furan-2-carboxylic Acid (<b>50</b>)</h5><div class="NLM_p last">Procedure D was followed using 5-bromofuran-2-carboxylic acid <b>49</b> (200 mg, 1.04 mmol) and 5-acetylthiophen-2-ylboronic acid <b>45</b> (250 mg, 1.4 mmol). A yellow solid was obtained (<i>m</i> = 115 mg, 46%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, ppm): δ 7.96 (d, <i>J</i> = 4.2 Hz, 1H), 7.65 (d, <i>J</i> = 3.9 Hz, 1H), 7.35 (d, <i>J</i> = 3.6 Hz, 1H), 7.20 (d, <i>J</i> = 3.6 Hz, 1H), 2.56 (s, 3H). LCMS <i>m</i>/<i>z</i> 234.9 [M – 1].</div></div><div id="sec4_1_1_4_9" class="NLM_sec NLM_sec_level_4"><div id="ac_i91" class="anchor-spacer"></div><h5 class="article-section__title" id="_i91"> 5-(5-(1-(2-(Benzothiazol-2-yl)hydrazono)ethyl)thiophen-2-yl)furan-2-carboxylic Acid (<b>51</b>)</h5><div class="NLM_p last">Procedure B was followed using compound <b>50</b> (20 mg, 0.08 mmol) and 2-hydrazinylbenzothiazole (15 mg, 0.9 mmol). A brown solid was obtained (<i>m</i> = 25 mg, 82%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, ppm): δ 7.72 (d, <i>J</i> = 7.8 Hz, 1H), 7.53 (d, <i>J</i> = 3.9 Hz, 1H), 7.44 (d, <i>J</i> = 3.9 Hz, 1H), 7.33 (d, <i>J</i> = 3.6 Hz, 1H), 7.27–7.25 (m, 2H), 7.10–7.07 (m, 1H), 7.04 (d, <i>J</i> = 3.6 Hz, 1H), 2.37 (s, 3H). LCMS <i>m</i>/<i>z</i> 384.1 [M + 1].</div></div><div id="sec4_1_1_4_10" class="NLM_sec NLM_sec_level_4"><div id="ac_i92" class="anchor-spacer"></div><h5 class="article-section__title" id="_i92"> 4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-2,3-dihydro-1<i>H</i>-inden-1-one (<b>53</b>)</h5><div class="NLM_p last">4-Bromo-2,3-dihydro-1<i>H</i>-inden-1-one <b>52</b> (366 mg, 1.73 mmol), bis(pinacolato)diboron (572 mg, 2.24 mmol), potassium acetate (372 mg, 3.44 mmol), and Pd(dppf)Cl<sub>2</sub>.CH<sub>2</sub>Cl<sub>2</sub> (35 mg, 4 mol %) were stirred in 7 mL of dry methanol at 60 °C for 10 h. The reaction was cooled down to room temperature and filtered over Celite, and the solid residue was washed with AcOEt. Concentration of the filtrate afforded a brown solid, which was purified by flash chromatography on SiO<sub>2</sub> using AcOEt/petroleum ether (0:100 to 15:85). A white solid was obtained (<i>m</i> = 101 mg, 23%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, ppm): δ 8.04 (dd, <i>J</i> = 7.2 and 1.3 Hz, 1H), 7.84 (dd, <i>J</i> = 7.7 and 1.4 Hz, 1H), 7.37 (t, <i>J</i> = 7.2 Hz, 1H), 3.36–3.32 (m, 2H), 2.69–2.65 (m, 2H), 1.36 (s, 12H).</div></div><div id="sec4_1_1_4_11" class="NLM_sec NLM_sec_level_4"><div id="ac_i93" class="anchor-spacer"></div><h5 class="article-section__title" id="_i93"> 6-(1-Oxo-2,3-dihydro-1<i>H</i>-inden-4-yl)picolinic Acid (<b>54</b>)</h5><div class="NLM_p last">Procedure D was followed using 6-bromopicolinic acid <b>36</b> (56 mg, 0.28 mmol) and <b>53</b> (96 mg, 0.36 mol). A white solid was obtained (<i>m</i> = 56 mg, 62%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, ppm): δ 8.27 (dd, <i>J</i> = 7.7 and 1.1 Hz, 1H), 8.11 (t, <i>J</i> = 7.8 Hz, 1H), 7.95–7.90 (m, 3H), 7.58 (t, <i>J</i> = 7.6 Hz, 1H), 3.42–3.38 (m, 2H), 2.79–2.76 (m, 2H). LCMS <i>m</i>/<i>z</i> 254.0 [M + 1].</div></div><div id="sec4_1_1_4_12" class="NLM_sec NLM_sec_level_4"><div id="ac_i94" class="anchor-spacer"></div><h5 class="article-section__title" id="_i94"> 6-(1-(2-(Benzothiazol-2-yl)hydrazono)-2,3-dihydro-1<i>H</i>-inden-4-yl)picolinic Acid (<b>55</b>)</h5><div class="NLM_p last">Procedure B was followed using compound <b>53</b> (22 mg, 0.08 mmol) and 2-hydrazinylbenzothiazole (14 mg, 0.08 mmol). An off-white solid was obtained (<i>m</i> = 15 mg, 45%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, ppm): δ 8.13–8.01 (m, 3H), 7.85 (dd, <i>J</i> = 7.6 and 1.1 Hz, 1H), 7.78 (dd, <i>J</i> = 7.7 and 1.1 Hz, 1H), 7.74 (br d, <i>J</i> = 6.6 Hz, 1H), 7.51 (t, <i>J</i> = 7.6 Hz, 1H), 7.38 (br d, <i>J</i> = 7.4 Hz, 1H), 7.28 (td, <i>J</i> = 7.3 and 1.3 Hz, 1H), 7.09 (td, <i>J</i> = 7.8 and 1.2 Hz, 1H), 3.47–3.43 (m, 2H), 2.97–2.93 (m, 2H). LCMS <i>m</i>/<i>z</i> 401.2 [M + 1].</div></div><div id="sec4_1_1_4_13" class="NLM_sec NLM_sec_level_4"><div id="ac_i95" class="anchor-spacer"></div><h5 class="article-section__title" id="_i95"> 6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-2,3-dihydro-1<i>H</i>-inden-1-one (<b>57a</b>)</h5><div class="NLM_p last">The procedure used for the preparation of compound <b>53</b> was used with 6-bromo-2,3-dihydro-1<i>H</i>-inden-1-one <b>56a</b> (183 mg, 0.86 mmol). A white solid was obtained (<i>m</i> = 50 mg, 23%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, ppm): δ 8.24 (d, <i>J</i> = 0.2 Hz, 1H), 8.00 (dd, <i>J</i> = 7.7 and 1.2 Hz, 1H), 7.47 (dd, <i>J</i> = 7.7 and 1.0 Hz, 1H), 3.18–3.14 (m, 2H), 2.71–2.67 (m, 2H), 1.35 (s, 12H).</div></div><div id="sec4_1_1_4_14" class="NLM_sec NLM_sec_level_4"><div id="ac_i96" class="anchor-spacer"></div><h5 class="article-section__title" id="_i96"> 7-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydronaphthalen-1(2<i>H</i>)-one (<b>57b</b>)</h5><div class="NLM_p last">The procedure used for the preparation of compound <b>53</b> was used with 7-bromo-3,4-dihydronaphthalen-1(2<i>H</i>)-one <b>56b</b> (200 mg, 0.89 mmol). A white solid was obtained (<i>m</i> = 160 mg, 66%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, ppm): δ 8.49 (d, <i>J</i> = 0.9 Hz, 1H), 7.87 (dd, <i>J</i> = 7.6 and 1.4 Hz, 1H), 7.24 (dd, <i>J</i> = 7.6 and 0.6 Hz, 1H), 2.97 (t, <i>J</i> = 6.1 Hz, 2H), 2.68–2.64 (m, 2H), 2.13 (q, <i>J</i> = 5.9 Hz, 2H), 1.33 (s, 12H).</div></div><div id="sec4_1_1_4_15" class="NLM_sec NLM_sec_level_4"><div id="ac_i97" class="anchor-spacer"></div><h5 class="article-section__title" id="_i97"> 6-(3-Oxo-2,3-dihydro-1<i>H</i>-inden-5-yl)picolinic Acid (<b>58a</b>)</h5><div class="NLM_p last">Procedure D was followed using 6-bromopicolinic acid <b>36</b> (34 mg, 0.17 mmol) and <b>57a</b> (50 mg, 0.2 mol). A brown solid was obtained (<i>m</i> = 25 mg, 60%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, ppm): δ 8.34 (d, <i>J</i> = 1.8 Hz, 1H), 8.29 (dd, <i>J</i> = 8.0 and 1.8 Hz, 1H), 8.19 (t, <i>J</i> = 4.3 Hz, 1H), 8.16 (dd, <i>J</i> = 7.3 and 1.3 Hz, 1H), 8.04 (dd, <i>J</i> = 4.4 and 0.7 Hz, 1H), 7.63 (dd, <i>J</i> = 8.0 and 0.8 Hz, 1H), 3.24–3.20 (m, 2H), 2.80–2.76 (m, 2H). LCMS <i>m</i>/<i>z</i> 254.2 [M + 1].</div></div><div id="sec4_1_1_4_16" class="NLM_sec NLM_sec_level_4"><div id="ac_i98" class="anchor-spacer"></div><h5 class="article-section__title" id="_i98"> 6-(8-Oxo-5,6,7,8-tetrahydronaphthalen-2-yl)picolinic Acid (<b>58b</b>)</h5><div class="NLM_p last">Procedure D was followed using 6-bromopicolinic acid <b>36</b> (139 mg, 0.424 mmol) and <b>57b</b> (150 mg, 0.55 mmol). A cream solid was obtained (<i>m</i> = 89 mg, 78%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, ppm): δ 8.63 (d, <i>J</i> = 1.9 Hz, 1H), 8.35 (dd, <i>J</i> = 8.0 and 2.1 Hz, 1H), 8.22 (dd, <i>J</i> = 7.8 and 1.2 Hz, 1H), 8.07 (t, <i>J</i> = 7.7 Hz, 1H), 8.00 (dd, <i>J</i> = 7.7 and 1.2 Hz, 1H), 7.52 (d, <i>J</i> = 8.1 Hz, 1H), 3.02 (t, <i>J</i> = 6.0 Hz, 2H), 2.69–2.65 (m, 2H), 2.09 (q, <i>J</i> = 5.9 Hz, 1H). LCMS <i>m</i>/<i>z</i> 268.4 [M + 1].</div></div><div id="sec4_1_1_4_17" class="NLM_sec NLM_sec_level_4"><div id="ac_i99" class="anchor-spacer"></div><h5 class="article-section__title" id="_i99"> 6-(3-(2-(Benzothiazol-2-yl)hydrazono)-2,3-dihydro-1<i>H</i>-inden-5-yl)picolinic Acid (<b>59a</b>)</h5><div class="NLM_p last">Procedure B was followed using compound <b>58a</b> (25 mg, 0.1 mmol) and 2-hydrazinylbenzothiazole (25 mg, 0.15 mmol). A white solid was obtained (<i>m</i> = 16 mg, 40%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, ppm): δ 8.36 (d, <i>J</i> = 1.4 Hz, 1H), 8.22 (dd, <i>J</i> = 7.8 and 1.1 Hz, 1H), 8.18 (dd, <i>J</i> = 8.0 and 1.8 Hz, 1H), 8.10 (t, <i>J</i> = 7.7 Hz, 1H), 8.02 (dd, <i>J</i> = 7.6 and 1.1 Hz, 1H), 7.75 (d, <i>J</i> = 7.6 Hz, 1H), 7.55 (d, <i>J</i> = 8.0 Hz, 1H), 7.38 (br d, <i>J</i> = 8.0 Hz, 1H), 7.29 (td, <i>J</i> = 7.4 and 1.2 Hz, 1H), 7.09 (td, <i>J</i> = 7.7 and 1.2 Hz, 1H), 3.19–3.15 (m, 2H), 3.02–2.98 (m, 2H). LCMS <i>m</i>/<i>z</i> 401.1 [M + 1]. HRMS calculated mass, 401.1067 [M + 1]; measured, 401.1066 [M + 1].</div></div><div id="sec4_1_1_4_18" class="NLM_sec NLM_sec_level_4"><div id="ac_i100" class="anchor-spacer"></div><h5 class="article-section__title" id="_i100"> 6-(8-(2-(Benzothiazol-2-yl)hydrazono)-5,6,7,8-tetrahydronaphthalen-2-yl)picolinic Acid (<b>59b</b>)</h5><div class="NLM_p last">Procedure B was followed using compound <b>58b</b> (34 mg, 0.13 mmol) and 2-hydrazinylbenzothiazole (32 mg, 0.19 mmol). A white solid was obtained (<i>m</i> = 25 mg, 47%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, ppm): δ 8.81 (d, <i>J</i> = 1.9 Hz, 1H), 8.16–8.09 (m, 2H), 8.08 (dd, <i>J</i> = 8.0 and 2.0 Hz, 1H), 8.02 (dd, <i>J</i> = 6.7 and 2.0 Hz, 1H), 7.75 (d, <i>J</i> = 7.7 Hz, 1H), 7.36 (d, <i>J</i> = 8.01 Hz, 1H), 7.28 (td, <i>J</i> = 7.3 and 1.2 Hz, 1H), 7.10 (td, <i>J</i> = 7.8 and 1.2 Hz, 1H), 2.86–2.81 (m, 4H), 1.90 (q, <i>J</i> = 5.8 Hz, 1H). LCMS <i>m</i>/<i>z</i> 413.0 [M – 1]. HRMS calculated mass, 415.1223 [M + 1]; measured, 415.1219 [M + 1].</div></div><div id="sec4_1_1_4_19" class="NLM_sec NLM_sec_level_4"><div id="ac_i101" class="anchor-spacer"></div><h5 class="article-section__title" id="_i101"> 1-Ethyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2,3-dihydroquinolin-4(1<i>H</i>)-one (<b>61a</b>)</h5><div class="NLM_p last">The procedure used for the preparation of compound <b>53</b> was used with 6-bromo-1-ethyl-2,3-dihydroquinolin-4(1<i>H</i>)-one <b>60a</b> (290 mg, 0.97 mmol). An off-white solid was obtained (<i>m</i> = 185 mg, 64%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, ppm): δ 8.38 (d, <i>J</i> = 1.7 Hz, 1H), 7.75 (dd, <i>J</i> = 8.6 and 1.7 Hz, 1H), 6.70 (d, <i>J</i> = 8.6 Hz, 1H), 3.54–3.45 (m, 4H), 2.72–2.67 (m, 2H), 1.31 (s, 12H).</div></div><div id="sec4_1_1_4_20" class="NLM_sec NLM_sec_level_4"><div id="ac_i102" class="anchor-spacer"></div><h5 class="article-section__title" id="_i102"> 3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-6,7,8,9-tetrahydro-5<i>H</i>-benzo[7] Annulen-5-one (<b>61b</b>)</h5><div class="NLM_p last">The procedure used for the preparation of compound <b>53</b> was used with <b>60b</b> (215 mg, 0.9 mmol). A light-brown solid was obtained (<i>m</i> = 145 mg, 56%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, ppm): δ 8.14 (d, <i>J</i> = 1.1 Hz, 1H), 7.83 (dd, <i>J</i> = 7.5 and 1.4 Hz, 1H), 7.19 (dd, <i>J</i> = 7.5 and 0.5 Hz, 1H), 2.95–2.91 (m, 2H), 2.73–2.69 (m, 2H), 1.92–1.75 (m, 4H), 1.33 (s, 12H).</div></div><div id="sec4_1_1_4_21" class="NLM_sec NLM_sec_level_4"><div id="ac_i103" class="anchor-spacer"></div><h5 class="article-section__title" id="_i103"> 2-Methyl-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydronaphthalen-1(2<i>H</i>)-one (<b>61c</b>)</h5><div class="NLM_p last">A mixture of 7-bromo-2-methyl-3,4-dihydronaphthalen-1(2<i>H</i>)-one <b>60c</b> (152 mg, 0.64 mmol), bis(pinacolato)diboron (179 mg, 0.70 mmol), Pd(dppf)Cl<sub>2</sub>.DCM (11 mg, 2 mol %), and potassium acetate (188 mg, 1.9 mmol) in 3 mL of toluene was heated at 150 °C for 6 min in a microwave oven (150 W). The crude mixture was passed through a pad of Celite eluting with AcOEt. The filtrate was concentrated, affording a brown solid, which did not require further purification and was used directly in the next step (273 mg, quantitative). <sup>1</sup>H NMR (CDCl<sub>3</sub>, ppm): δ 8.48 (s, 1H), 7.86 (dd, <i>J</i> = 7.6 and 1.3 Hz, 1H), 7.23 (d, <i>J</i> = 7.6 Hz, 1H), 3.10–2.93 (m, 2H), 2.65–2.53 (m, 1H), 2.24–2.15 (m, 1H), 1.99–1.80 (m, 1H), 1.34 (s, 12H), 1.26 (d, <i>J</i> = 6.8 Hz, 3H).</div></div><div id="sec4_1_1_4_22" class="NLM_sec NLM_sec_level_4"><div id="ac_i104" class="anchor-spacer"></div><h5 class="article-section__title" id="_i104"> 3-Methyl-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydronaphthalen-1(2<i>H</i>)-one (<b>61d</b>)</h5><div class="NLM_p last">The procedure used for the preparation of compound <b>61c</b> was used with <b>60d</b> (250 mg, 1.05 mmol). The crude residue was purified by flash chromatography on SiO<sub>2</sub> using AcOEt/petroleum ether (0:100 to 15:85). A white solid was obtained (<i>m</i> = 225 mg, 75%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, ppm): δ 8.48 (d, <i>J</i> = 0.9 Hz, 1H), 7.88 (dd, <i>J</i> = 7.6, 1.4 Hz, 1H), 7.24 (d, <i>J</i> = 7.7 Hz, 1H), 3.02–2.96 (m, 1H), 2.80–2.66 (m, 2H), 2.37–2.26 (m, 2H), 1.34 (s, 12H), 1.14 (d, <i>J</i> = 6.3 Hz, 3H).</div></div><div id="sec4_1_1_4_23" class="NLM_sec NLM_sec_level_4"><div id="ac_i105" class="anchor-spacer"></div><h5 class="article-section__title" id="_i105"> 6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)chroman-4-one (<b>61e</b>)</h5><div class="NLM_p last">The procedure used for the preparation of compound <b>61c</b> was used with 6-bromochroman-4-one <b>60e</b> (1 g, 4.4 mmol). The crude residue was purified by flash chromatography on SiO<sub>2</sub> using AcOEt/petroleum ether (0:100 to 15:85). A white solid was obtained (<i>m</i> = 1.08 g, 89%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, ppm): δ 8.38 (d, <i>J</i> = 1.4 Hz, 1H), 7.87 (dd, <i>J</i> = 8.3 and 1.7 Hz, 1H), 6.94 (d, <i>J</i> = 8.3 Hz, 1H), 4.57–4.52 (m, 2H), 2.83–2.79 (m, 2H), 1.32 (s, 12H).</div></div><div id="sec4_1_1_4_24" class="NLM_sec NLM_sec_level_4"><div id="ac_i106" class="anchor-spacer"></div><h5 class="article-section__title" id="_i106"> 6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)thiochroman-4-one (<b>61f</b>)</h5><div class="NLM_p last">The procedure used for the preparation of compound <b>61c</b> was used with 6-bromo-thiochroman-4-one <b>60f</b> (1 g, 4.1 mmol). The crude residue was purified by flash chromatography on SiO<sub>2</sub> using AcOEt/petroleum ether (0:100 to 15:85). An off-white solid was obtained (<i>m</i> = 840 mg, 78%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, ppm): δ 8.54 (d, <i>J</i> = 1.5 Hz, 1H), 7.75 (dd, <i>J</i> = 7.9 and 1.5 Hz, 1H), 7.26 (d, <i>J</i> = 8.0 Hz, 1H), 3.26–3.22 (m, 2H), 3.00–2.96 (m, 2H), 1.33 (s, 12H).</div></div><div id="sec4_1_1_4_25" class="NLM_sec NLM_sec_level_4"><div id="ac_i107" class="anchor-spacer"></div><h5 class="article-section__title" id="_i107"> 6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-2,3-dihydroquinolin-4(1<i>H</i>)-one (<b>61g</b>)</h5><div class="NLM_p last">The procedure used for the preparation of compound <b>53</b> was used with <b>60g</b> (115 mg, 0.51 mmol). A white solid was obtained (<i>m</i> = 60 mg, 35%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, ppm): δ 8.34 (d, <i>J</i> = 1.1 Hz, 1H), 7.69 (dd, <i>J</i> = 8.2 and 1.6 Hz, 1H), 6.65 (d, <i>J</i> = 8.1 Hz, 1H), 3.63–3.58 (m, 2H), 2.73–2.69 (m, 2H).</div></div><div id="sec4_1_1_4_26" class="NLM_sec NLM_sec_level_4"><div id="ac_i108" class="anchor-spacer"></div><h5 class="article-section__title" id="_i108"> 2,2-Dimethyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)chroman-4-one (<b>61h</b>)</h5><div class="NLM_p last">The procedure used for the preparation of compound <b>61c</b> was used with <b>60h</b> (200 mg, 0.76 mmol). The crude residue was purified by flash chromatography on SiO<sub>2</sub> using AcOEt/petroleum ether (5:95 to 30:70). A yellow solid was obtained (<i>m</i> = 293 mg, quantitative). <sup>1</sup>H NMR (CDCl<sub>3</sub>, ppm): δ 8.34 (d, <i>J</i> = 1.7 Hz, 1H), 7.86 (dd, <i>J</i> = 8.3 and 1.7 Hz, 1H), 6.89 (d, <i>J</i> = 8.3 Hz, 1H), 1.44 (s, 6H), 1.31 (s, 12H).</div></div><div id="sec4_1_1_4_27" class="NLM_sec NLM_sec_level_4"><div id="ac_i109" class="anchor-spacer"></div><h5 class="article-section__title" id="_i109"> 4-Methyl-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydronaphthalen-1(2<i>H</i>)-one (<b>61i</b>)</h5><div class="NLM_p last">The procedure used for the preparation of compound <b>61c</b> was used with <b>60i</b> (170 mg, 0.71 mmol). The crude residue was purified by flash chromatography on SiO<sub>2</sub> using AcOEt/petroleum ether (0:100 to 10:90). An off-white solid was obtained (<i>m</i> = 130 mg, 64%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, ppm): δ 8.46 (d, <i>J</i> = 1.4 Hz, 1H), 7.89 (dd, <i>J</i> = 7.7 and 1.4 Hz, 1H), 7.29 (d, <i>J</i> = 7.7 Hz, 1H), 3.12–3.01 (m, 1H), 2.82–2.71 (m, 1H), 2.62–2.52 (m, 1H), 2.27–2.16 (m, 1H), 1.92–1.81 (m, 1H), 1.36 (d, <i>J</i> = 7.1 Hz, 1H), 1.31 (s, 12H).</div></div><div id="sec4_1_1_4_28" class="NLM_sec NLM_sec_level_4"><div id="ac_i110" class="anchor-spacer"></div><h5 class="article-section__title" id="_i110"> 6-(1-Ethyl-4-oxo-1,2,3,4-tetrahydroquinolin-6-yl)picolinic Acid (<b>62a</b>)</h5><div class="NLM_p last">Procedure D was followed using 6-bromopicolinic acid (48 mg, 0.44 mmol) and <b>61a</b> (88 mg, 0.29 mmol). A white solid was obtained (<i>m</i> = 49 mg, 57%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, ppm): δ 8.50 (d, <i>J</i> = 2.2 Hz, 1H), 8.13.(dd, <i>J</i> = 9.0 and 2.5 Hz, 1H), 8.08 (dd, <i>J</i> = 6.7 and 1.8 Hz, 1H), 8.00–7.93 (m, 2H), 6.89 (d, <i>J</i> = 9.2 Hz, 1H), 3.61–3.58 (m, 2H), 3.56 (q, <i>J</i> = 7.1 Hz, 2H), 2.80–2.76 (m, 2H), 1.26 (t, <i>J</i> = 7.1 Hz, 3H). LCMS <i>m</i>/<i>z</i> 297.2 [M + 1].</div></div><div id="sec4_1_1_4_29" class="NLM_sec NLM_sec_level_4"><div id="ac_i111" class="anchor-spacer"></div><h5 class="article-section__title" id="_i111"> 6-(9-Oxo-6,7,8,9-tetrahydro-5<i>H</i>-benzo[7]annulen-2-yl)picolinic Acid (<b>62b</b>)</h5><div class="NLM_p last">Procedure D was followed using 6-bromopicolinic acid (83 mg, 0.41 mmol) and <b>61b</b> (137 mg, 0.48 mmol). A light-brown solid was obtained (<i>m</i> = 50 mg, 46%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, ppm): δ 8.33 (d, <i>J</i> = 2.0 Hz, 1H), 8.23 (dd, <i>J</i> = 7.9 and 2.1 Hz, 1H), 8.17 (dd, <i>J</i> = 7.8 and 1.1 Hz, 1H), 8.03 (t, <i>J</i> = 7.7 Hz, 1H), 7.96 (dd, <i>J</i> = 7.6 and 1.1 Hz, 1H), 7.42 (d, <i>J</i> = 8.0 Hz, 1H), 2.99–2.95 (m, 2H), 2.73–2.69 (m, 2H), 1.82–1.67 (m, 4H). LCMS <i>m</i>/<i>z</i> 282.1 [M + 1].</div></div></div><div id="sec4_1_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i112" class="anchor-spacer"></div><h4 class="article-section__title" id="_i112"> General Procedure E: 6-(7-Methyl-8-oxo-5,6,7,8-tetrahydronaphthalen-2-yl)picolinic Acid (<b>62c</b>)</h4><div class="NLM_p">6-Bromopicolinic acid (146 mg, 0.72 mmol), <b>61c</b> (268 mg, 0.94 mmol), Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub> (22 mg, 4 mol %), and 348 μL of a 2 M sodium carbonate aqueous in 1.3 mL of a 1:1:1 mixture of water/DME/EtOH solution were stirred at 90 °C for 6 h. After this time, the reaction was concentrated. The residue was partitioned in a mixture of water/AcOEt. The aqueous phase was extracted three times with AcOEt. The combined organic layers were washed with water and brine and dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated. The residues was purified by flash chromatography using SiO<sub>2</sub> (petroleum ehter/AcOEt 5:95 to 50:50). An off-white solid was obtained (<i>m</i> = 100 mg, 49%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, ppm): δ 8.62 (d, <i>J</i> = 2.0 Hz, 1H), 8.34 (dd, <i>J</i> = 8.0 and 2.0 Hz, 1H), 8.22 (dd, <i>J</i> = 7.7 and 1.1 Hz, 1H), 8.07 (t, <i>J</i> = 7.7 Hz, 1H), 8.00 (dd, <i>J</i> = 7.6 and 1.1 Hz, 1H), 7.50 (d, <i>J</i> = 8.1 Hz, 1H), 3.18–2.97 (m, 2H), 2.77–2.65 (m, 1H), 2.23–2.15 (m, 1H), 1.91–1.77 (m, 1H), 1.19 (d, <i>J</i> = 6.8 Hz, 1H).</div><div id="sec4_1_1_5_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i113" class="anchor-spacer"></div><h5 class="article-section__title" id="_i113"> 6-(6-Methyl-8-oxo-5,6,7,8-tetrahydronaphthalen-2-yl)picolinic Acid (<b>62d</b>)</h5><div class="NLM_p last">Procedure D was followed using 6-bromopicolinic acid (120 mg, 0.6 mmol) and <b>61d</b> (222 mg, 0.77 mmol). A cream solid was obtained (<i>m</i> = 84 mg, 39%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, ppm): δ 8.59 (d, <i>J</i> = 1.9 Hz, 1H), 8.19 (td, <i>J</i> = 6.8 and 1.8 Hz, 2H), 8.10–8.02 (m, 2H), 7.44 (d, <i>J</i> = 8.0 Hz, 1H), 3.12–3.06 (m, 1H), 2.87–2.73 (m, 2H), 2.44–2.34 (m, 2H), 1.19 (d, <i>J</i> = 6.2 Hz, 3H).</div></div><div id="sec4_1_1_5_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i114" class="anchor-spacer"></div><h5 class="article-section__title" id="_i114"> 6-(4-Oxochroman-6-yl)picolinic Acid (<b>62e</b>)</h5><div class="NLM_p last">Procedure D was followed using 6-bromopicolinic acid (395 mg, 1.98 mmol) and <b>61e</b> (700 mg, 2.55 mmol). A cream solid was obtained (<i>m</i> = 434 mg, 81%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, ppm): δ 8.55 (d, <i>J</i> = 2.1 Hz, 1H), 8.38 (dd, <i>J</i> = 8.8 and 2.4 Hz, 1H), 8.18 (dd, <i>J</i> = 7.9 and 1.2 Hz, 1H), 8.04 (t, <i>J</i> = 7.7 Hz, 1H), 7.96 (dd, <i>J</i> = 7.6 and 1.1 Hz, 1H), 7.19 (d, <i>J</i> = 8.7 Hz, 1H), 4.62 (m, 2H), 2.87 (m, 2H).</div></div><div id="sec4_1_1_5_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i115" class="anchor-spacer"></div><h5 class="article-section__title" id="_i115"> 6-(4-Oxothiochroman-6-yl)picolinic Acid (<b>62f</b>)</h5><div class="NLM_p last">Procedure D was followed using 6-bromopicolinic acid (67 mg, 0.33 mmol) and <b>61f</b> (125 mg, 0.43 mmol). A light-brown solid was obtained (<i>m</i> = 40 mg, 33%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, ppm): δ 8.73 (d, <i>J</i> = 2.0 Hz, 1H), 8.28 (dd, <i>J</i> = 8.4 and 2.2 Hz, 1H), 8.06 (t, <i>J</i> = 7.4 Hz, 1H), 7.99 (dd, <i>J</i> = 7.7 and 1.1 Hz, 1H), 7.53 (d, <i>J</i> = 8.4 Hz, 1H), 3.41–3.37 (m, 2H), 2.99–2.95 (m, 2H).</div></div><div id="sec4_1_1_5_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i116" class="anchor-spacer"></div><h5 class="article-section__title" id="_i116"> 6-(4-Oxo-1,2,3,4-tetrahydroquinolin-6-yl)picolinic Acid (<b>62g</b>)</h5><div class="NLM_p last">Procedure D was followed using 6-bromopicolinic acid (24 mg, 0.12 mmol) and <b>61g</b> (40 mg, 0.15 mmol). A brown solid was obtained (<i>m</i> = 23 mg, 57%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, ppm): δ 8.40 (d, <i>J</i> = 2.3 Hz, 1H), 8.15 (dd, <i>J</i> = 8.8 and 2.3 Hz, 1H), 8.04 (dd, <i>J</i> = 8.0 and 1.2 Hz, 1H), 7.96 (t, <i>J</i> = 7.5 Hz, 1H), 7.19 (br s, 1H), 6.89 (d, <i>J</i> = 8.8 Hz, 1H), 3.53–3.48 (m, 2H), 2.62–2.57 (m, 2H).</div></div><div id="sec4_1_1_5_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i117" class="anchor-spacer"></div><h5 class="article-section__title" id="_i117"> 6-(2,2-Dimethyl-4-oxochroman-6-yl)picolinic Acid (<b>62h</b>)</h5><div class="NLM_p last">Procedure E was followed using 6-bromopicolinic acid (148 mg, 0.78 mmol) and <b>61h</b> (266 mg, 0.88 mmol). A white solid was obtained (<i>m</i> = 131 mg, 60%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, ppm): δ 8.52 (d, <i>J</i> = 2.2 Hz, 1H), 8.38 (dd, <i>J</i> = 8.7 and 2.5 Hz, 1H), 8.18 (dd, <i>J</i> = 7.9 and 1.1 Hz, 1H), 8.04 (t, <i>J</i> = 7.7 Hz, 1H), 7.96 (dd, <i>J</i> = 7.6 and 1.1 Hz, 1H), 7.14 (d, <i>J</i> = 8.7 Hz, 1H), 2.78 (s, 2H), 1.44 (s, 6H).</div></div><div id="sec4_1_1_5_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i118" class="anchor-spacer"></div><h5 class="article-section__title" id="_i118"> 6-(5-Methyl-8-oxo-5,6,7,8-tetrahydronaphthalen-2-yl)picolinic Acid (<b>62i</b>)</h5><div class="NLM_p last">Procedure D was followed using 6-bromopicolinic acid (70 mg, 0.35 mmol) and <b>61i</b> (130 mg, 0.45 mmol). A light-brown solid was obtained (<i>m</i> = 28 mg, 28%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, ppm): δ 8.62 (d, <i>J</i> = 2.1 Hz, 1H), 8.37 (dd, <i>J</i> = 8.1 and 2.1 Hz, 1H), 8.22 (dd, <i>J</i> = 7.8 and 1.2 Hz, 1H), 8.07 (t, <i>J</i> = 7.7 Hz, 1H), 8.00 (dd, <i>J</i> = 7.7 and 1.2 Hz, 1H), 7.60 (d, <i>J</i> = 8.4 Hz, 1H), 3.22–3.13 (m, 1H), 2.83–2.73 (m, 1H), 2.69–2.58 (m, 1H), 2.28–2.17 (m, 1H), 1.93–1.81 (m, 1H), 1.40 (d, <i>J</i> = 7.0 Hz, 1H).</div></div><div id="sec4_1_1_5_7" class="NLM_sec NLM_sec_level_4"><div id="ac_i119" class="anchor-spacer"></div><h5 class="article-section__title" id="_i119"> 6-(4-(2-(Benzothiazol-2-yl)hydrazono)-1-ethyl-1,2,3,4-tetrahydroquinolin-6-yl) picolinic Acid (<b>63a</b>)</h5><div class="NLM_p last">Procedure B was followed using compound <b>62a</b> (30 mg, 0.1 mmol) and 2-hydrazinylbenzothiazole (17 mg, 0.1 mmol). A light-brown solid was obtained (<i>m</i> = 26 mg, 59%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, ppm): δ 8.73 (d, <i>J</i> = 2.3 Hz, 1H), 8.06 (dd, <i>J</i> = 8.8 and 2.3 Hz, 1H), 8.03–7.99 (m, 2H) 7.89 (dd, <i>J</i> = 6.1 and 2.4 Hz, 1H), 7.70 (br d, <i>J</i> = 7.8 Hz, 1H), 7.29–7.24 (m, 2H), 7.09–7.04 (m, 1H), 6.93 (d, <i>J</i> = 8.9 Hz, 1H), 3.50 (q, <i>J</i> = 7.1 Hz, 2H), 3.36 (t, <i>J</i> = 6.8 Hz, 2H), 2.93 (t, <i>J</i> = 6.3 Hz, 2H), 1.13 (t, <i>J</i> = 7.0 Hz, 1H). LCMS <i>m</i>/<i>z</i> 444.2 [M + 1]. HRMS calculated mass, 444.1489 [M + 1]; measured, 444.1487 [M + 1].</div></div><div id="sec4_1_1_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i120" class="anchor-spacer"></div><h5 class="article-section__title" id="_i120"> 6-(9-(2-(Benzothiazol-2-yl)hydrazono)-6,7,8,9-tetrahydro-5<i>H</i>-benzo[7]annulen-2-yl)picolinic Acid (<b>63b</b>)</h5><div class="NLM_p last">Procedure B was followed using compound <b>62b</b> (27 mg, 0.1 mmol) and 2-hydrazinylbenzothiazole (15 mg, 0.1 mmol). A light-brown solid was obtained (<i>m</i> = 15 mg, 35%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, ppm): δ 8.19 (d, <i>J</i> = 1.9 Hz, 1H), 8.13 (dd, <i>J</i> = 7.9 and 1.1 Hz, 1H), 8.06 (d, <i>J</i> = 7.9 Hz, 1H), 8.04 (t, <i>J</i> = 7.6 Hz, 1H), 7.96 (dd, <i>J</i> = 7.5 and 1.1 Hz, 1H), 7.65 (d, <i>J</i> = 7.7 Hz, 1H), 7.35–7.30 (m, 2H), 7.23 (td, <i>J</i> = 6.2 and 1.2 Hz, 1H), 7.03 (td, <i>J</i> = 7.8 and 1.2 Hz, 1H), 2.80–2.74 (m, 4H), 1.77–1.73 (m, 2H), 1.64–1.60 (m, 2H). LCMS <i>m</i>/<i>z</i> 427.0 [M – 1]. HRMS calculated mass, 429.1380 [M + 1]; measured, 429.1383 [M + 1].</div></div><div id="sec4_1_1_6_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i121" class="anchor-spacer"></div><h5 class="article-section__title" id="_i121"> 6-(8-(2-(Benzothiazol-2-yl)hydrazono)-7-methyl-5,6,7,8-tetrahydronaphthalen-2-yl)picolinic Acid (<b>63c</b>)</h5><div class="NLM_p last">Procedure B was followed using compound <b>62c</b> (50 mg, 0.18 mmol) and 2-hydrazinylbenzothiazole (29 mg, 0.18 mmol). A white solid was obtained (<i>m</i> = 38 mg, 49%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, ppm): δ 8.87 (d, <i>J</i> = 1.9 Hz, 1H), 8.15–8.08 (m, 2H), 8.08 (dd, <i>J</i> = 8.0 and 2.0 Hz, 1H), 8.01 (dd, <i>J</i> = 6.5 and 2.2 Hz, 1H), 7.71 (d, <i>J</i> = 7.9 Hz, 1H), 7.36 (d, <i>J</i> = 8.0 Hz, 1H), 7.29–7.24 (m, 2H), 7.10–7.05 (m, 1H), 3.65–3.63 (m, 1H), 3.10–2.98 (m, 1H), 2.82–2.76 (m, 1H), 2.02–1.82 (m, 2H), 1.15 (d, <i>J</i> = 7.1 Hz, 1H). LCMS <i>m</i>/<i>z</i> 429.3 [M + 1]. HRMS calculated mass, 429.1380 [M + 1]; measured, 429.1383 [M + 1].</div></div><div id="sec4_1_1_6_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i122" class="anchor-spacer"></div><h5 class="article-section__title" id="_i122"> 6-(8-(2-(Benzothiazol-2-yl)hydrazono)-6-methyl-5,6,7,8-tetrahydronaphthalen-2-yl)picolinic Acid (<b>63d</b>)</h5><div class="NLM_p last">Procedure B was followed using compound <b>62d</b> (50 mg, 0.18 mmol) and 2-hydrazinylbenzothiazole (29 mg, 0.18 mmol). A white solid was obtained (<i>m</i> = 53 mg, 69%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, ppm): δ 8.81 (d, <i>J</i> = 1.7 Hz, 1H), 8.16–8.09 (m, 2H), 8.07 (dd, <i>J</i> = 8.0 and 1.9 Hz, 1H), 8.02 (dd, <i>J</i> = 6.8 and 1.9 Hz, 1H), 7.73 (d, <i>J</i> = 7.7 Hz, 1H), 7.35 (d, <i>J</i> = 8.0 Hz, 2H), 7.28 (t, <i>J</i> = 7.1 Hz, 1H), 7.09 (t, <i>J</i> = 8.0 Hz, 1H), 3.16 (dd, <i>J</i> = 17.6 and 3.7 Hz, 1H), 2.89 (dd, <i>J</i> = 15.4 and 2.4 Hz, 1H), 2.61–2.51 (m, 1H), 2.31–2.22 (m, 1H), 2.08–1.94 (m, 1H), 1.10 (d, <i>J</i> = 6.5 Hz, 1H). LCMS <i>m</i>/<i>z</i> 427.0 [M – 1]. HRMS calculated mass, 429.1380 [M + 1]; measured, 429.1378 [M + 1].</div></div><div id="sec4_1_1_6_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i123" class="anchor-spacer"></div><h5 class="article-section__title" id="_i123"> 6-(4-(2-(Benzothiazol-2-yl)hydrazono)chroman-6-yl)picolinic Acid (<b>63e</b>)</h5><div class="NLM_p last">Procedure B was followed using compound <b>62e</b> (200 mg, 0.74 mmol) and 2-hydrazinylbenzothiazole (122 mg, 0.74 mmol). A cream solid was obtained (<i>m</i> = 292 mg, 95%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, ppm): δ 8.70 (d, <i>J</i> = 2.2 Hz, 1H), 8.10–8.02 (m, 3H), 7.98–7.93 (m, 1H), 7.67 (d, <i>J</i> = 7.7 Hz, 1H), 7.28–7.21 (m, 2H), 7.08–7.02 (m, 2H), 4.34–4.30 (m, 2H), 3.02–2.98 (m, 2H). LCMS <i>m</i>/<i>z</i> 415.0 [M – 1]. HRMS calculated mass, 417.1016 [M + 1]; measured, 417.1013 [M + 1].</div></div><div id="sec4_1_1_6_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i124" class="anchor-spacer"></div><h5 class="article-section__title" id="_i124"> 6-(4-(2-(Benzothiazol-2-yl)hydrazono)thiochroman-6-yl)picolinic Acid (<b>63f</b>)</h5><div class="NLM_p last">Procedure B was followed using compound <b>62f</b> (20 mg, 0.07 mmol) and 2-hydrazinylbenzothiazole (12 mg, 0.07 mmol). A white solid was obtained (<i>m</i> = 10 mg, 33%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, ppm): δ 8.88 (s, 1H), 8.13–8.05 (m, 2H), 8.02 (dd, <i>J</i> = 8.3 and 2.1 Hz, 1H), 7.97 (dd, <i>J</i> = 7.0 and 1.7 Hz, 1H), 7.68 (d, <i>J</i> = 7.7 Hz, 1H), 7.37 (d, <i>J</i> = 8.3 Hz, 1H), 7.28–7.22 (m, 2H), 7.08–7.03 (m, 1H), 3.15–3.10 (m, 4H). LCMS <i>m</i>/<i>z</i> 431.0 [M – 1]. HRMS calculated mass, 433.0787 [M + 1]; measured, 433.0784 [M + 1].</div></div><div id="sec4_1_1_6_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i125" class="anchor-spacer"></div><h5 class="article-section__title" id="_i125"> 6-(4-(2-(Benzothiazol-2-yl)hydrazono)-1,2,3,4-tetrahydroquinolin-6-yl)picolinic Acid (<b>63g</b>)</h5><div class="NLM_p last">Procedure B was followed using compound <b>62g</b> (23 mg, 0.09 mmol) and 2-hydrazinylbenzothiazole (14 mg, 0.09 mmol). A light-yellow solid was obtained (<i>m</i> = 25 mg, 70%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, ppm): δ 8.63 (d, <i>J</i> = 2.2 Hz, 1H), 8.04–7.95 (m, 3H), 7.88 (dd, <i>J</i> = 6.8 and 1.7 Hz, 1H), 7.70 (d, <i>J</i> = 7.7 Hz, 1H), 7.32–7.23 (m, 2H), 7.09–7.04 (m, 1H), 6.79 (d, <i>J</i> = 8.6 Hz, 1H), 6.58 (s, 1H), 3.38–3.26 (m, 2H), 2.88–2.84 (m, 2H). LCMS <i>m</i>/<i>z</i> 416.1 [M + 1].</div></div><div id="sec4_1_1_6_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i126" class="anchor-spacer"></div><h5 class="article-section__title" id="_i126"> 6-(4-(2-(Benzothiazol-2-yl)hydrazono)-2,2-dimethylchroman-6-yl)picolinic Acid (<b>63h</b>)</h5><div class="NLM_p last">Procedure B was followed using compound <b>62g</b> (70 mg, 0.24 mmol) and 2-hydrazinylbenzothiazole (39 mg, 0.24 mmol). A white solid was obtained (<i>m</i> = 75 mg, 70%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, ppm): δ 8.70 (d, <i>J</i> = 2.3 Hz, 1H), 8.13–8.08 (m, 3H), 7.97 (dd, <i>J</i> = 5.5 and 3.2 Hz, 1H), 7.69 (d, <i>J</i> = 7.9 Hz, 1H), 7.28–7.27 (m, 2H), 7.11–7.05 (m, 1H), 7.01 (d, <i>J</i> = 8.6 Hz, 1H), 3.01 (s, 2H), 1.39 (s, 6H). LCMS <i>m</i>/<i>z</i> 443.0 [M – 1]. HRMS calculated mass, 445.1329 [M + 1]; measured, 445.1332 [M + 1].</div></div><div id="sec4_1_1_6_7" class="NLM_sec NLM_sec_level_4"><div id="ac_i127" class="anchor-spacer"></div><h5 class="article-section__title" id="_i127"> 6-(8-(2-(Benzothiazol-2-yl)hydrazono)-5-methyl-5,6,7,8-tetrahydronaphthalen-2-yl)picolinic Acid (<b>63i</b>)</h5><div class="NLM_p last">Procedure B was followed using compound <b>62i</b> (22 mg, 0.08 mmol) and 2-hydrazinylbenzothiazole (13 mg, 0.08 mmol). A light-brown solid was obtained (<i>m</i> = 12 mg, 36%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, ppm): δ 8.80 (d, <i>J</i> = 2.0 Hz, 1H), 8.15–8.08 (m, 3H), 8.01 (dd, <i>J</i> = 6.4 and 2.4 Hz, 1H), 7.75 (d, <i>J</i> = 7.5 Hz, 1H), 7.44 (d, <i>J</i> = 8.2 Hz, 1H), 7.39–7.37 (m, 1H), 7.29 (t, <i>J</i> = 7.0 Hz, 1H), 7.10 (t, <i>J</i> = 7.7 Hz, 1H), 3.04 (m, 1H), 2.88–2.85 (m, 1H), 2.04–1.97 (m, 1H), 1.78–1.69 (m, 1H), 1.31 (d, <i>J</i> = 7.0 Hz, 1H). LCMS <i>m</i>/<i>z</i> 429.2 [M + 1]. HRMS calculated mass, 429.1380 [M + 1]; measured, 429.1381 [M + 1].</div></div><div id="sec4_1_1_6_8" class="NLM_sec NLM_sec_level_4"><div id="ac_i128" class="anchor-spacer"></div><h5 class="article-section__title" id="_i128"> <i>tert</i>-Butyl 6-(4-Oxothiochroman-6-yl)picolinate (<b>64</b>)</h5><div class="NLM_p last">Procedure D was followed using <i>t</i>-butyl 6-bromopicolinate (144 mg, 0.56 mmol) and <b>61f</b> (290 mg, 0.73 mmol). The product was purified by flash chromatography using SiO<sub>2</sub> (AcOEt/petroleum ether, 5:95 to 50:50). An off-white solid was obtained. It was triturated a diethyl ether/petroleum ether mixture. A white solid was obtained (<i>m</i> = 205 mg, 69%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, ppm): δ 8.68 (d, <i>J</i> = 2.0 Hz, 1H), 3.36 (dd, <i>J</i> = 8.4 and 2.2 Hz, 1H), 7.98–7.94 (m, 2H), 7.86 (t, <i>J</i> = 7.6 Hz, 1H), 7.41 (d, <i>J</i> = 8.3 Hz, 1H), 3.31–3.27 (m, 2H), 3.05–3.00 (m, 2H), 1.66 (s, 9H).</div></div><div id="sec4_1_1_6_9" class="NLM_sec NLM_sec_level_4"><div id="ac_i129" class="anchor-spacer"></div><h5 class="article-section__title" id="_i129"> <i>tert</i>-Butyl 6-(2,3-Dihydro-1-oxide-4<i>H</i>-1-benzothiopyran-4-yl)picolinate (<b>65a</b>)</h5><div class="NLM_p last">Compound <b>64</b> (50 mg, 0.15 mmol) dissolved in 0.3 mL of CHCl<sub>3</sub> was treated at room temperature every 5 min with 25 μL aliquots of a solution of <i>m</i>-CPBA (33 mg of 77% mixture, 0.15 mmol) in 0.3 mL of CHCl<sub>3</sub>. The reaction was followed by TLC (AcOEt/Pet. Et. 30:70) and stopped after 1 h 30 min. A saturated aqueous solution of NaHCO<sub>3</sub> was added and the mixture vigorously stirred. The aqueous layer was decanted, and the organic layer was treated in the same manner two more times. It was then washed three times with water. The organic layer was applied directly onto a SiO<sub>2</sub> column and the mixture eluted with CH<sub>2</sub>Cl<sub>2</sub>/MeOH (100:0 to 98.5:1.5). A white solid was obtained (<i>m</i> = 48 mg, 89%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, ppm): δ 8.75 (d, <i>J</i> = 1.9 Hz, 1H), 8.67 (dd, <i>J</i> = 8.1 and 2.0 Hz, 1H), 8.05 (dd, <i>J</i> = 7.4 and 1.3 Hz, 1H), 8.02 (dd, <i>J</i> = 8.1 and 0.4 Hz, 1H), 8.01 (dd, <i>J</i> = 7.9 and 1.3 Hz, 1H), 7.93 (t, <i>J</i> = 7.4 Hz, 1H), 3.59–3.48 (m, 3H), 3.02–2.88 (m, 1H), 1.66 (s, 9H). LCMS <i>m</i>/<i>z</i> 358.1 [M + 1].</div></div><div id="sec4_1_1_6_10" class="NLM_sec NLM_sec_level_4"><div id="ac_i130" class="anchor-spacer"></div><h5 class="article-section__title" id="_i130"> <i>tert</i>-Butyl 6-(2,3-Dihydro-1,1-dioxide-4<i>H</i>-1-benzothiopyran-4-yl)picolinate (<b>65b</b>)</h5><div class="NLM_p last">Compound <b>64</b> (86 mg, 0.25 mmol) dissolved in 0.5 mL of CH<sub>2</sub>Cl<sub>2</sub> was treated at 0 °C with a solution of <i>m</i>-CPBA (112 mg of 77% mixture, 0.5 mmol) in 0.5 mL of CH<sub>2</sub>Cl<sub>2</sub>. The reaction was warmed to room temperature and stirred for 3 h. A saturated aqueous solution of NaHCO<sub>3</sub> was added and the mixture vigorously stirred. The aqueous layer was extracted twice with CH<sub>2</sub>Cl<sub>2</sub>. The combined organic layers were washed with saturated aqueous NaHCO<sub>3</sub>, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated. The residue was purified by column chromatography using SiO<sub>2</sub> and AcOEt/petroleum ether (50:50 to 100:0). A yellow solid was obtained (<i>m</i> = 60 mg, 64%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, ppm): δ 8.65 (s, 1H), 8.64 (dd, <i>J</i> = 8.3 and 1.9 Hz, 1H), 8.09–8.03 (m, 2H), 7.99–7.95 (m, 1H), 7.93 (t, <i>J</i> = 7.1 Hz, 1H), 3.75–3.71 (m, 2H), 3.46–3.41 (m, 2H), 1.64 (s, 9H).</div></div><div id="sec4_1_1_6_11" class="NLM_sec NLM_sec_level_4"><div id="ac_i131" class="anchor-spacer"></div><h5 class="article-section__title" id="_i131"> 6-(2,3-Dihydro-1-oxide-4<i>H</i>-1-benzothiopyran-4-yl)picolinic Acid (<b>66a</b>)</h5><div class="NLM_p last">Compound <b>65a</b> (25 mg, 0.07 mmol) was treated with 0.5 mL of formic acid. The reaction was stirred at room temperature for 20 h. The mixture was then concentrated, and diethyl ether was added to the residue. The solids were triturated. Once the solids had settled down, the ethereal layer was removed. The solids were triturated with diethyl ether two more times, and the resulting solids were dried in vacuum (<i>m</i> = 17 mg, 81%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, ppm): δ 8.79 (d, <i>J</i> = 1.7 Hz, 1H), 8.64 (dd, <i>J</i> = 8.1 and 2.0 Hz, 1H), 8.35 (dd, <i>J</i> = 7.7 and 1.2 Hz, 1H), 8.14 (t, <i>J</i> = 7.7 Hz, 1H), 8.07 (dd, <i>J</i> = 7.7 and 1.2 Hz, 1H), 8.05 (d, <i>J</i> = 8.0 Hz, 1H), 3.78–3.69 (m, 1H), 3.61–3.52 (m, 1H), 3.33–3.23 (m, 1H), 3.04–2.94 (m, 1H).</div></div><div id="sec4_1_1_6_12" class="NLM_sec NLM_sec_level_4"><div id="ac_i132" class="anchor-spacer"></div><h5 class="article-section__title" id="_i132"> <i>tert</i>-Butyl 6-(4-(2-(Benzo[<i>d</i>]thiazol-2-yl)hydrazono)-2,3-dihydro-1,1-dioxide-4<i>H</i>-1-benzothiopyran-4-yl)picolinate (<b>66b</b>)</h5><div class="NLM_p last">Procedure B was followed using compound <b>65b</b> (28 mg, 0.08 mmol) and 2-hydrazinylbenzothiazole (12 mg, 0.08 mmol). A yellow solid was obtained (<i>m</i> = 32 mg, 82%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, ppm): δ 8.99 (d, <i>J</i> = 1.4 Hz, 1H), 8.31 (dd, <i>J</i> = 8.3 and 1.8 Hz, 1H), 8.27 (dd, <i>J</i> = 7.9 and 1.0 Hz, 1H), 8.18 (t, <i>J</i> = 7.7 Hz, 1H), 8.05 (dd, <i>J</i> = 7.6 and 1.0 Hz, 1H), 8.01 (d, <i>J</i> = 8.2 Hz, 1H), 7.63 (br s, 1H), 7.33–7.28 (m, 2H), 7.15–7.10 (m, 1H), 3.78–3.74 (m, 2H), 3.46–3.42 (m, 2H), 1.63 (s, 9H). LCMS <i>m</i>/<i>z</i> 521.2 [M + 1].</div></div><div id="sec4_1_1_6_13" class="NLM_sec NLM_sec_level_4"><div id="ac_i133" class="anchor-spacer"></div><h5 class="article-section__title" id="_i133"> 6-(4-(2-(Benzothiazol-2-yl)hydrazono)-2,3-dihydro-1-oxide-4<i>H</i>-1-benzothiopyran-4-yl)picolinic Acid (<b>67a</b>)</h5><div class="NLM_p last">Procedure B was followed using compound <b>66a</b> (9 mg, 0.03 mmol) and 2-hydrazinylbenzothiazole (5 mg, 0.03 mmol). A white solid was obtained (<i>m</i> = 11 mg, 59%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, ppm): δ 8.97 (d, <i>J</i> = 1.8 Hz, 1H), 8.34 (dd, <i>J</i> = 8.1, 1.9 Hz, 1H), 8.26 (dd, <i>J</i> = 7.8 and 1.1 Hz, 1H), 8.17 (t, <i>J</i> = 7.7 Hz, 1H), 8.09 (dd, <i>J</i> = 7.6 and 1.1 Hz, 1H), 7.90 (d, <i>J</i> = 8.4 Hz, 1H), 7.73 (d, <i>J</i> = 7.6 Hz, 1H), 7.32–7.27 (m, 2H), 7.14–7.09 (m, 1H), 3.45–3.15 (m, 4H). LCMS <i>m</i>/<i>z</i> 449.1 [M + 1].</div></div><div id="sec4_1_1_6_14" class="NLM_sec NLM_sec_level_4"><div id="ac_i134" class="anchor-spacer"></div><h5 class="article-section__title" id="_i134"> 6-(4-(2-(Benzothiazol-2-yl)hydrazono)-2,3-dihydro-1,1-dioxide-4<i>H</i>-1-benzothiopyran-4-yl)picolinic Acid (<b>67b</b>)</h5><div class="NLM_p last">Compound <b>66b</b> (15 mg, 0.03 mmol) was treated with 0.2 mL of formic acid. The reaction was stirred at room temperature for 16 h. The reaction mixture was concentrated. The residue was triturated in methanol. The solids were collected by filtration, rinsed with methanol, and dried under vacuum. A yellow solid was obtained (<i>m</i> = 11 mg, 82%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, ppm): δ 9.03 (d, <i>J</i> = 1.6 Hz, 1H), 8.38 (dd, <i>J</i> = 8.3 and 1.8 Hz, 1H), 8.28 (dd, <i>J</i> = 7.8 and 1.2 Hz, 1H), 8.19 (t, <i>J</i> = 7.7 Hz, 1H), 8.11 (dd, <i>J</i> = 7.6 and 1.2 Hz, 1H), 8.01 (d, <i>J</i> = 8.3 Hz, 1H), 7.73 (d, <i>J</i> = 7.8 Hz, 1H), 7.32–7.30 (m, 2H), 7.15–7.10 (m, 1H), 3.78–3.74 (m, 2H), 3.46–3.41 (m, 2H). LCMS <i>m</i>/<i>z</i> 465.1 [M + 1]. HRMS calculated mass, 465.0686 [M + 1]; measured, 465.0687 [M + 1].</div></div><div id="sec4_1_1_6_15" class="NLM_sec NLM_sec_level_4"><div id="ac_i135" class="anchor-spacer"></div><h5 class="article-section__title" id="_i135"> Ethyl 2-(8-Oxo-5,6,7,8-tetrahydronaphthalen-2-yl)thiazole-4-carboxylate (<b>69a</b>)</h5><div class="NLM_p last">Procedure D was followed using ethyl 2-bromothiazole-4-carboxylate <b>68a</b> (153 mg, 0.65 mmol) and <b>57b</b> (250 mg, 0.92 mmol). The product was purified by flash chromatography using SiO<sub>2</sub> (AcOEt/petroleum ether, 0:100 to 15:85). A white solid was obtained (<i>m</i> = 62 mg, 22%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, ppm): δ 8.50 (d, <i>J</i> = 1.9 Hz, 1H), 8.27 (dd, <i>J</i> = 8.0 and 2.1 Hz, 1H), 8.17 (s, 1H), 7.37 (d, <i>J</i> = 7.6 Hz, 1H), 4.45 (q, <i>J</i> = 7.1 Hz, 1H), 3.02 (t, <i>J</i> = 6.2 Hz, 1H), 2.73–2.69 (m, 2H), 2.18 (quint., <i>J</i> = 6.0 Hz, 1H), 1.44 (t, <i>J</i> = 6.0 Hz, 1H).</div></div><div id="sec4_1_1_6_16" class="NLM_sec NLM_sec_level_4"><div id="ac_i136" class="anchor-spacer"></div><h5 class="article-section__title" id="_i136"> Ethyl 2-(8-Oxo-5,6,7,8-tetrahydronaphthalen-2-yl)oxazole-4-carboxylate (<b>69b</b>)</h5><div class="NLM_p last">Procedure D was followed using ethyl 2-bromooxazole-4-carboxylate <b>68b</b> (50 mg, 0.28 mmol) and <b>57b</b> (94 mg, 0.36 mmol). The product was purified by flash chromatography using SiO<sub>2</sub> (AcOEt/petroleum ether, 5:95 to 40:60). A white solid was obtained (<i>m</i> = 43 mg, 54%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, ppm): δ 8.69 (d, <i>J</i> = 2.0 Hz, 1H), 8.27 (s, 1H), 8.25 (dd, <i>J</i> = 8.0 and 2.0 Hz, 1H), 7.37 (d, <i>J</i> = 8.0 Hz, 1H), 4.42 (q, <i>J</i> = 7.1 Hz, 1H), 3.02 (t, <i>J</i> = 6.0 Hz, 2H), 2.71–2.67 (m, 2H), 2.18 (quint., <i>J</i> = 5.9 Hz, 2H), 1.40 (t, <i>J</i> = 7.1 Hz, 3H).</div></div><div id="sec4_1_1_6_17" class="NLM_sec NLM_sec_level_4"><div id="ac_i137" class="anchor-spacer"></div><h5 class="article-section__title" id="_i137"> 2-(8-Oxo-5,6,7,8-tetrahydronaphthalen-2-yl)thiazole-4-carboxylic Acid (<b>70a</b>)</h5><div class="NLM_p last">Compound <b>69a</b> (56 mg, 0.19 mmol) was dissolved in 2 mL of MeOH and treated with 2 mL of a 1 M NaOH aqueous solution. The reaction was stirred at 90 °C for 2.5 h. After this time, the reaction was concentrated. Then 10% aqueous citric acid solution was added to the residue followed by AcOEt. The aqueous layer was extracted twice with AcOEt. The combined organic layers were washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated. A light-yellow solid was obtained (<i>m</i> = 46 mg, 89%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, ppm): δ 8.51 (s, 1H), 8.40 (s, 1H), 8.12 (d, <i>J</i> = 8.1 Hz, 1H), 7.53 (d, <i>J</i> = 7.5 Hz, 1H), 3.02–3.04 (m, 2H), 2.69–2.68 (m, 2H), 2.10–2.07 (m, 2H). LCMS <i>m</i>/<i>z</i> 274.1 [M + 1].</div></div><div id="sec4_1_1_6_18" class="NLM_sec NLM_sec_level_4"><div id="ac_i138" class="anchor-spacer"></div><h5 class="article-section__title" id="_i138"> 2-(8-Oxo-5,6,7,8-tetrahydronaphthalen-2-yl)oxazole-4-carboxylic Acid (<b>70b</b>)</h5><div class="NLM_p last">Compound <b>69b</b> (43 mg, 0.15 mmol) was dissolved in 0.2 mL of MeOH and treated with 0.2 mL of a 1 M NaOH aqueous solution. The reaction was stirred at 90 °C for 5 min until all solids disappeared and at room temperature for 1 h. After this time, the reaction was concentrated. Water and diethyl ether were added. The aqueous phase was extracted two times with diethyl ether. It was then acidified to pH 1 with 2 M HCl. A white solid precipitated. It was collected by filtration, rinsed with water, and dried in a vacuum oven. A white solid was obtained (<i>m</i> = 23 mg, 61%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, ppm): δ 8.84 (s, 1H), 8.44 (d, <i>J</i> = 1.9 Hz, 1H), 8.13 (dd, <i>J</i> = 8.0 and 2.0 Hz, 1H), 7.57 (d, <i>J</i> = 8.0 Hz, 1H), 3.02 (t, <i>J</i> = 5.7 Hz, 2H), 2.69–2.65 (m, 2H), 2.08 (quint, <i>J</i> = 5.7 Hz, 1H).</div></div><div id="sec4_1_1_6_19" class="NLM_sec NLM_sec_level_4"><div id="ac_i139" class="anchor-spacer"></div><h5 class="article-section__title" id="_i139"> 2-(8-(2-(Benzothiazol-2-yl)hydrazono)-5,6,7,8-tetrahydronaphthalen-2-yl)thiazole-4-carboxylic Acid (<b>71a</b>)</h5><div class="NLM_p last">Procedure B was followed using compound <b>70a</b> (40 mg, 0.15 mmol) and 2-hydrazinylbenzothiazole (24 mg, 0.15 mmol). The solids obtained were stirred in hot methanol. After cooling, the solids were isolated by filtration and dried in vacuum. A white solid was obtained (<i>m</i> = 24 mg, 39%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, ppm): δ 8.55 (d, <i>J</i> = 1.9 Hz, 1H), 8.48 (s, 1H), 7.85 (dd, <i>J</i> = 8.0 and 2.0 Hz, 1H), 7.72 (d, <i>J</i> = 7.7 Hz, 1H), 7.34 (d, <i>J</i> = 8.0 Hz, 1H), 7.32 (d, <i>J</i> = 7.1 Hz, 1H), 7.25 (td, <i>J</i> = 7.2 and 1.1 Hz, 1H), 7.06 (t, <i>J</i> = 7.8 Hz, 1H), 2.80–2.77 (m, 4H), 1.87–1.84 (m, 2H). LCMS <i>m</i>/<i>z</i> 421.1 [M + 1]. HRMS calculated mass, 421.0787 [M + 1]; measured, 421.0787 [M + 1].</div></div><div id="sec4_1_1_6_20" class="NLM_sec NLM_sec_level_4"><div id="ac_i140" class="anchor-spacer"></div><h5 class="article-section__title" id="_i140"> 2-(8-(2-(Benzothiazol-2-yl)hydrazono)-5,6,7,8-tetrahydronaphthalen-2-yl)oxazole-4-carboxylic Acid (<b>71b</b>)</h5><div class="NLM_p last">Procedure B was followed using compound <b>70b</b> (23 mg, 0.09 mmol) and 2-hydrazinylbenzothiazole (15 mg, 0.09 mmol). A brown solid was obtained (<i>m</i> = 22 mg, 61%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, ppm): δ 8.84 (s, 1H), 8.66 (d, <i>J</i> = 1.9 Hz, 1H), 7.90 (dd, <i>J</i> = 7.9 and 1.9 Hz, 1H), 7.77 (d, <i>J</i> = 8.1 Hz, 1H), 7.41 (d, <i>J</i> = 8.0 Hz, 1H), 7.36 (d, <i>J</i> = 8.5 Hz, 1H), 7.29 (t, <i>J</i> = 7.2 Hz, 1H), 7.09 (t, <i>J</i> = 7.9 Hz, 1H), 2.85–2.82 (m, 4H), 1.91–1.88 (m, 2H). LCMS <i>m</i>/<i>z</i> 405.1 [M + 1]. HRMS calculated mass, 405.1016 [M + 1]; measured, 405.1017 [M + 1].</div></div><div id="sec4_1_1_6_21" class="NLM_sec NLM_sec_level_4"><div id="ac_i141" class="anchor-spacer"></div><h5 class="article-section__title" id="_i141"> 2-(8-Oxo-5,6,7,8-tetrahydronaphthalen-2-yl)pyrimidine-4-carboxylic Acid (<b>73a</b>)</h5><div class="NLM_p last">Procedure E was followed using 2-chloropyrimidine-4-carboxylic acid <b>72a</b> (63 mg, 0.28 mmol) and <b>57b</b> (100 mg, 0.37 mmol). A light-brown solid was obtained (<i>m</i> = 57 mg, 76%). <sup>1</sup>H (DMSO-<i>d</i><sub>6</sub>, ppm): δ 9.16 (d, <i>J</i> = 5.0 Hz, 1H), 8.96 (d, <i>J</i> = 1.9 Hz, 1H), 8.61 (dd, <i>J</i> = 8.0 and 2.0 Hz, 1H), 7.92 (d, <i>J</i> = 5.0 Hz, 1H), 7.56 (d, <i>J</i> = 8.4 Hz, 1H), 3.04, (t, <i>J</i> = 6.0 Hz, 2H), 2.70–2.66 (m, 2H), 2.14–2.06 (m, 2H). LCMS <i>m</i>/<i>z</i> 269.1 [M + 1].</div></div><div id="sec4_1_1_6_22" class="NLM_sec NLM_sec_level_4"><div id="ac_i142" class="anchor-spacer"></div><h5 class="article-section__title" id="_i142"> 4-(8-Oxo-5,6,7,8-tetrahydronaphthalen-2-yl)picolinic Acid (<b>73b</b>)</h5><div class="NLM_p last">Procedure D was followed using 4-chloropicolinic acid <b>72b</b> (100 mg, 0.63 mmol) and <b>57b</b> (206 mg, 0.76 mmol). A pale-yellow solid was obtained (<i>m</i> = 78 mg, 46%). <sup>1</sup>H NMR (CDCl<sub>3</sub>, ppm): δ 8.77 (dd, <i>J</i> = 5.1 and 0.7 Hz, 1H), 8.29 (d, <i>J</i> = 1.9 Hz, 1H), 8.24 (d, <i>J</i> = 2.1 Hz, 1H), 8.05 (dd, <i>J</i> = 8.0 and 2.2 Hz, 1H), 7.98 (dd, <i>J</i> = 5.1 and 1.9 Hz, 1H), 7.55 (d, <i>J</i> = 8.2 Hz, 1H), 3.03 (t, <i>J</i> = 5.7 Hz, 2H), 2.69–2.65 (m, 2H), 2.09 (quint., <i>J</i> = 6.1 Hz, 2H).</div></div><div id="sec4_1_1_6_23" class="NLM_sec NLM_sec_level_4"><div id="ac_i143" class="anchor-spacer"></div><h5 class="article-section__title" id="_i143"> 2-(8-(2-(Benzothiazol-2-yl)hydrazono)-5,6,7,8-tetrahydronaphthalen-2-yl)pyrimidine-4-carboxylic Acid (<b>74a</b>)</h5><div class="NLM_p last">Procedure B was followed using compound <b>73a</b> (50 mg, 0.19 mmol) and 2-hydrazinylbenzothiazole (31 mg, 0.19 mmol). A light-brown solid was obtained (<i>m</i> = 61 mg, 77%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, ppm): δ 9.21 (d, <i>J</i> = 1.7 Hz, 1H), 9.19 (d, <i>J</i> = 5.0 Hz, 1H), 8.35 (dd, <i>J</i> = 8.0 and 1.8 Hz, 1H), 7.91 (d, <i>J</i> = 5.0 Hz, 1H), 7.75 (d, <i>J</i> = 7.7 Hz, 1H), 7.39 (d, <i>J</i> = 8.0 Hz, 1H), 7.36 (br s, 1H), 7.29 (t, <i>J</i> = 7.2 Hz, 1H), 7.10 (t, <i>J</i> = 7.5 Hz, 1H), 2.86–2.81 (m, 4H), 1.92–1.89 (m, 2H). LCMS <i>m</i>/<i>z</i> 416.1 [M + 1]. HRMS calculated mass, 416.1176 [M + 1]; measured, 416.1178 [M + 1].</div></div><div id="sec4_1_1_6_24" class="NLM_sec NLM_sec_level_4"><div id="ac_i144" class="anchor-spacer"></div><h5 class="article-section__title" id="_i144"> 4-(8-(2-(Benzothiazol-2-yl)hydrazono)-5,6,7,8-tetrahydronaphthalen-2-yl)picolinic Acid (<b>74b</b>)</h5><div class="NLM_p last">Procedure B was followed using compound <b>73b</b> (18 mg, 0.07 mmol) and 2-hydrazinylbenzothiazole (11 mg, 0.07 mmol). A pale-yellow solid was obtained (<i>m</i> = 26 mg, 90%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, ppm): δ 8.80 (d, <i>J</i> = 5.1 Hz, 1H), 8.43 (s, 1H), 8.32 (s, 1H), 7.93 (dd, <i>J</i> = 5.1 and 1.6 Hz, 1H), 7.74 (dd, <i>J</i> = 7.8 and 1.7 Hz, 1H), 7.71 (d, <i>J</i> = 7.8 Hz, 1H), 7.41–7.35 (m, 2H), 7.28 (t, <i>J</i> = 7.1 Hz, 1H), 7.08 (t, <i>J</i> = 7.4 Hz, 1H), 2.84–2.79 (m, 4H), 1.90–1.87 (m, 2H). LCMS <i>m</i>/<i>z</i> 415.2 [M + 1]. HRMS calculated mass, 415.1223 [M + 1]; measured, 415.1223 [M + 1].</div></div></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i145" class="anchor-spacer"></div><h3 class="article-section__title" id="_i145"> AlphaScreen Assay</h3><div class="NLM_p">The aim of the BH3 proteins AlphaScreen assay is to identify active small molecules inhibiting the protein–protein interaction between Bcl-w or Bcl-X<sub>L</sub> and BH3-only proteins such as Bim or BH3-peptides derived from Bak and Bax.</div><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i146" class="anchor-spacer"></div><h4 class="article-section__title" id="_i146"> Reagents and Materials</h4><div class="NLM_p last">GST-Bcl-w (ΔC29), GST- Bcl-X<sub>L</sub>, GST-Mcl-1, and biotinylated-GST (for the counter-screen) proteins were prepared and provided by Peter Czabotar.<a onclick="showRef(event, 'ref17 ref61'); return false;" href="javascript:void(0);" class="ref ref17 ref61">(17, 61)</a> These were stored as stock solutions at −80 °C. The biotinylated-Bak and biotinylated-Bim 26mer peptides were obtained from Auspep and were stored as 500 μM stock solutions in 100% DMSO at −20 °C. The AlphaScreen GST (glutathione <i>S</i>-yransferase) detection kits were obtained from Perkin-Elmer Lifesciences. White, 384, low-volume assay plates and polypropylene, 384, compound storage plates were obtained from Greiner Bio One and Matrical, respectively. Optical-grade, adhesive plate seals for assay plates were obtained from Applied Biosystems, while adhesive aluminum foil seals used for compound plate storage were obtained from Beckman-Coulter. DMSO was purchased from AnalaR. Assay buffer (25 mM HEPES/25 mM Tris-HCl/50 mM NaCl, pH 7.5) stock was warmed to room temperature from 4 °C, followed by the addition of 5 mM DTT (aliquots stored at −20 °C), 0.1 mg/mL casein (sodium salt; aliquots stored at −20 °C), and 0.03% v/v Tween 20 (all final concentrations) fresh on a daily basis.</div></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i147" class="anchor-spacer"></div><h4 class="article-section__title" id="_i147"> Methods</h4><div id="sec4_2_2_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i148" class="anchor-spacer"></div><h5 class="article-section__title" id="_i148"> AlphaScreen Assay</h5><div class="NLM_p">AlphaScreen is a bead-based technology that facilitates the measurement of the interaction between molecules. The assay consisted of two hydrogel coated beads which, when brought into close proximity by a binding interaction, allow the transfer of singlet oxygen from a donor bead to an acceptor bead. Upon binding and excitation with laser light at 680 nm, a photosensitizer in the donor bead converts ambient oxygen to a more excited singlet state. This singlet oxygen then diffuses across to react with a chemiluminescer in the acceptor bead. Fluorophores within the same bead are activated, resulting in the emission of light at 580–620 nm. Screening of the test compounds was performed using the AlphaScreen GST (glutathione <i>S</i>-transferase) detection kit system (Perkin-Elmer Lifesciences). Briefly, test compounds were titrated into the assay, which consisted of GST tagged Bcl-X<sub>L</sub> ΔC25 protein (0.6 nM final concentration) and biotinylated Bim BH3-26mer peptide, biotin-DLRPEIRIAQELRRIGDEFNETYTRR (5.0 nM final concentration), anti-GST coated acceptor beads, and streptavidin coated donor beads (both bead types at a final concentration of 15 μg/mL) and a room temperature incubation time of 4 h before reading. More specifically: (i) a 384-well plate was prepared with 4.75 μL of buffer and 0.25 μL of compound stock (20 mM in DMSO) per well; (ii) binding partners were mixed, in one tube Bcl-X<sub>L</sub> was added with the acceptor beads, while in the second tube the biotinylated BH3 peptide was added with the donor beads; (iii) these two pairs of binding partners were preincubated for 30 min; (iv) 10 μL of the acceptor beads/Bcl-X<sub>L</sub> protein complex was then added to each of the 384 wells; (v) plates were sealed and incubated at room temperature for a further 30 min; (vi) 10 μL of the donor bead/BH3 peptide complex was then added to each of the 384 wells; (vii) plates were sealed, covered with foil, and incubated for a further 4 h and then read. Assay buffer contained 50 mM Hepes pH 7.4, 10 mM DTT, 100 mM NaCl, 0.05% Tween20, and 0.1 mg/mL casein. Bead dilution buffer contained 50 mM Tris-HCl, pH 7.5, 0.01% Tween20, and 0.1 mg/mL casein. The final DMSO concentration in the assay was 1.0% (v/v). Assays were performed in 384-well white Optiplates (Perkin-Elmer Lifesciences) and analyzed on the Perkin-Elmer Fusion Alpha plate reader (Ex680, Em520–620 nM).</div><div class="NLM_p last">The conditions for the assay with Mcl-1 and Bcl-w were essentially the same using the following final concentrations: GST-Mcl-1 (0.8 nM), Biot-Bak (4 nM), GST-Bcl-w (0.9 nM), and Biot-Bim (3 nM). The counter-screen assay was performed using the donor and acceptor beads in presence of Biotinylated-GST (final concentration 2 nM).</div></div></div><div id="sec4_2_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i149" class="anchor-spacer"></div><h4 class="article-section__title" id="_i149"> Determination of Selectivity Profile by Biacore S3000 SPR Analysis</h4><div id="sec4_2_2_2_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i150" class="anchor-spacer"></div><h5 class="article-section__title" id="_i150"> Recombinant Proteins</h5><div class="NLM_p last">Expression and purification of the loop-deleted form of human Bcl-x<sub>L</sub> (Δ27–82, ΔC24) and Bcl-2 ΔC22, Bcl-x<sub>L</sub> ΔC24, Bcl-w C29S/A128E ΔC29, and human/mouse chimeric Mcl-1 (ΔN170,ΔC23) for Biacore studies was performed as described previously.<a onclick="showRef(event, 'ref17 ref61 ref62'); return false;" href="javascript:void(0);" class="ref ref17 ref61 ref62">(17, 61, 62)</a></div></div><div id="sec4_2_2_2_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i151" class="anchor-spacer"></div><h5 class="article-section__title" id="_i151"> Binding Affinity Measurements: Solution Competition Assays</h5><div class="NLM_p last">Solution competition assays were performed using a Biacore 3000 instrument as described previously.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> Briefly, pro-survival proteins (10 nM) were incubated with varying concentrations of compounds for at least 2 h in running buffer (10 mM HEPES, 150 mM NaCl, 3.4 mM EDTA, 0.005% (v/v) Tween 20, pH 7.4) prior to injection onto a CM5 sensor chip on which either a wild-type BimBH3 peptide or an inert BimBH3 mutant peptide was immobilized. Specific binding of the pro-survival protein to the surface in the presence and absence of compounds was quantified by subtracting the signal from the Bim mutant channel from that obtained on the wild-type Bim channel. The IC<sub>50</sub> was calculated by nonlinear curve-fitting of the data with Kaleidagraph (Synergy Software).</div></div></div><div id="sec4_2_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i152" class="anchor-spacer"></div><h4 class="article-section__title" id="_i152"> Surface Plasmon Resonance Assay (Biacore S51)</h4><div id="sec4_2_2_3_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i153" class="anchor-spacer"></div><h5 class="article-section__title" id="_i153">A Methods for Potent Binders (<i>K</i><sub>d</sub> < 5 nM)</h5><div class="NLM_p">Immobilization of Anti-GST antibody: Anti-GST antibody surfaces were prepared by using standard amine-coupling procedures as instructed by the GST Capture Kit from Biacore. The running buffer was 10 mM NaH<sub>2</sub>PO<sub>4</sub>·H<sub>2</sub>O, 40 mM Na<sub>2</sub>HPO<sub>4</sub>·2H<sub>2</sub>O, 150 mM NaCl, 1.0 mM EDTA, 0.03% Tween 20, 5% DMSO, pH 7.4. Flow cells (both spot 1 and spot 2) were activated by injecting 200 μL of NHS (11.5 mg/mL) and EDC (75 mg/mL). Then 50 μL of anti-GST antibody (30 μg/mL) in 10 mM sodium acetate pH 5.0 was injected for 10 min at 5 μL/min, followed by the injection of 175 μL of ethanolamine (1 M) and injection of Biadesorb1 solution (0.5% SDS, 36 s) and of Biadesorb2 solution (50 mM glycine pH 9.5, 40 s) at 30 μL/min at the end of the run. These resulted in about 10000 RU anti-GST antibody immobilized.</div><div class="NLM_p">Capture of GST-Bcl-X<sub>L</sub>: The running buffer utilized was the same as for immobilization of anti-GST antibody. GST-Bcl-X<sub>L</sub> (0.1 mg/mL to 0.2 mg/mL) in the running buffer was injected at 10 μL/min for 3 min across spot 2 only, resulting in the capture of about 1200 RU protein.</div><div class="NLM_p">Kinetic analysis of potent small molecules and GST-Bcl-X<sub>L</sub> interactions: A concentration series of each compound was injected at a flow rate of 90 μL/min over three spots (spot 1, immobilized with anti-GST antibody only; spot 2, coated with GST-Bcl-X<sub>L</sub> captured by the anti-GST antibody; spot r, free) at 25 °C. The association time and dissociation time were 90 and 240 s, respectively. The buffer blank was also injected periodically for double referencing. The buffer samples containing 4–6% DMSO were injected for solvent correction. The antibody surface was regenerated between binding cycles with 40 s injection of 10 mM glycine-HCl, pH 2.2, and 40 s injection of 0.05% SDS. The protein was injected at 10 μL/min for 3 min across spot 2 only at the beginning of each cycle.</div><div class="NLM_p last">Data Analysis: All sensorgrams were processed by using double referencing. (1) The response from the reference spot (spot 1) was subtracted from the binding response (spot 2), followed by solvent correction. (2) The response from an average of buffer injection was subtracted. To obtain kinetic rate constants (<i>k</i><sub>a</sub> and <i>k</i><sub>d</sub>), corrected response data were then fitted to a one to one binding site model, which includes correction for mass transport limitations. The equilibrium dissociation constant (<i>K</i><sub>d</sub>) was determined by <i>k</i><sub>d</sub>/<i>k</i><sub>a</sub>.</div></div><div id="sec4_2_2_3_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i154" class="anchor-spacer"></div><h5 class="article-section__title" id="_i154">B Methods for Weaker Binders (<i>K</i><sub>d</sub> > 5 nM)</h5><div class="NLM_p">Immobilization of anti-GST antibody: The anti-GST antibody was immobilized on both spot 1 and spot 2 of the same flow cell. The method used was similar to the one described for tight binders.</div><div class="NLM_p">Capture of GST-Bcl-X<sub>L</sub>: The GST-Bcl-X<sub>L</sub> (about 1300 RU) was captured on both spot 1 and spot 2 of the same flow cell using a method similar to the one described for tight binders.</div><div class="NLM_p">Kinetic analysis of nonpotent small molecules and GST-Bcl-X<sub>L</sub> interactions: First, 30 nM of 26-mer-wt-Bim (10 μL/min × 3 min) was loaded into spot 1 only at the beginning of each cycle using hydronamic addressing resulting in Bcl-X<sub>L</sub> BH3 binding groove “pre-blocked” with wt-Bim 26mer. A concentration series of each compound was then injected at a flow rate of 90 μL/min over three spots (spot 1, coated with Bcl-X<sub>L</sub> and Bim peptide; spot 2, coated with GST-Bcl-X<sub>L</sub>; spot r, free) at 25 °C. The association and dissociation measurement times were 60 and 120 s, respectively. The buffer blanks were also injected periodically for double referencing. The buffer samples containing 4–6% DMSO were injected for solvent correction. The sensorgrams of (spot 1–spot r) reflect the nonspecific binding to the GST-Bcl-X<sub>L</sub> protein (prior to DMSO solvent correction). The sensorgrams of (spot 2–spot 1) reflect the specific binding to the GST-Bcl-X<sub>L</sub> protein’s binding groove (prior to DMSO solvent correction).</div><div class="NLM_p last">Data analysis: The same method described for tight binders was used.</div></div></div></div><div id="sec4_2_2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i155" class="anchor-spacer"></div><h3 class="article-section__title" id="_i155"> Cytochrome <i>c</i> Assay Release Assay</h3><div class="NLM_p last">Mouse embryonic fibroblasts (<i>mcl-1</i><sup>–/–</sup> and <i>bax</i><sup>–/–</sup>/<i>bak</i><sup>–/–</sup>) (∼2 × 10<sup>6</sup>) were permeabilized in 20 mM HEPES pH 7.2, 100 mM KCl, 5 mM MgCl<sub>2</sub>, 1 mM EDTA, 1 mM EGTA, 250 mM sucrose, and 0.05% (w/v) digitonin (Calbiochem) supplemented with protease inhibitors (Roche) for 10 min on ice. These mitochondria-containing crude lysates were then incubated with 10 μM compound or peptide at 30 °C for 1 h before pelleting and removal of the supernatant (soluble fraction). The relative amount of cytochrome <i>c</i> in 3 μL (5% of the total) of this fraction was determined by ELISA (Rat/Mouse Total Cytochrome <i>c</i> DuoSet IC; R&D Systems), performed according to the manufacturer’s instructions.</div></div><div id="sec4_2_2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i156" class="anchor-spacer"></div><h3 class="article-section__title" id="_i156"> Cell-Based Assays</h3><div class="NLM_p">Mouse embryonic fibroblasts (wild-type, <i>mcl-1</i><sup>–/–</sup> and <i>bax</i><sup>–/–</sup>/<i>bak</i><sup>–/–</sup>) were routinely cultured in Iwaki 75-cm<sup>2</sup> tissue-culture flasks (cat. no. 3123-075) and were grown in DMEM/Kelso consisting of 10% heat-inactivated fetal calf serum (FCS; Hyclone cat. no. SH30396.03), 0.1 mM asparagine (Fluka cat. no. 11149), and 3.5 μM of 2-mercaptoethanol (Sigma cat. no. M7522).</div><div class="NLM_p">For assays, cells were seeded in the above media except containing only 1% FCS. Cells were seeded in 384-well tissue-culture-grade black plates with flat, clear bottoms (Corning cat. no. 3712) at a calculated dilution necessary to achieve a density of 1 × 10<sup>4</sup> cells ml<sup>–1</sup> (500 cells per well in 50 μL media) and incubated overnight at 37 °C with 5% CO<sub>2</sub> in air. Compounds were made up in 384-well 50 μL V-bottomed plates (Matrical cat. no. MP101-2-PP), from which 100 nL was added to the cells, resulting in a highest final concentration of compound of 20 μM serially titrated. The plates were then returned to 37 °C overnight. On the final day, 10 μL of prewarmed CellTiter-Blue (Promega, cat. no. G8081) was added to all wells of the assay plates and incubated at 37 °C for a further period of 4–8 h before plates were read using an EnVision 2103 (Perkin-Elmer) plate reader used to measure the viability via the detection of the fluorescent dye, resorufin, at λ<sub>ex</sub> 535 nm/λ<sub>em</sub> 590 nm. Data were saved in “.csv” format and imported into an ActivityBase database (IDBS Solutions). The percent inhibition was calculated using the following equation:<span class="NLM_disp-formula" id="ueq1"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-13/jm400556w/production/images/jm-2013-00556w_m001.gif" alt="" /></img></span><i>x</i> = CPS obtained after sample compound treatment, μ<sup>–</sup> = CPS obtained for the negative controls (columns 24), and μ<sup>+</sup> = CPS obtained for the positive controls (columns 23).</div><div class="NLM_p">IC<sub>50</sub> values were obtained by nonlinear least-squares fitting of the data using the four-parameter logistic fit (XLFit 4 eq 205)<span class="NLM_disp-formula" id="ueq2"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-13/jm400556w/production/images/jm-2013-00556w_m002.gif" alt="" /></img></span></div><div class="NLM_p last">The quality of the assay results was monitored by determination of the <i>Z</i>′ factor for each assay plate, where <i>Z</i>′ ≥ 0.5 for the results was considered as robust.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i157"><a href="/doi/suppl/10.1021/jm400556w">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_10135" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_10135" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Screening cascade, the synthesis of <b>60a</b>–<b>d</b>, all steady state curves, sensorgrams and parameters from SPR experiments for compounds <b>1</b>, <b>4</b>, <b>12a</b>, <b>38</b>, <b>59b</b>, and wtBim-26mer, Biacore 3000 competition assay details.  This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm400556w/suppl_file/jm400556w_si_001.pdf">jm400556w_si_001.pdf (3.47 MB)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm400556w" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_10005" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_10005" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Guillaume Lessene</span> - <span class="hlFld-Affiliation affiliation">The Walter
and
Eliza Hall Institute of Medical Research, 1G Royal Parade,
Parkville VIC-3052, Australia</span>; 
    <span class="hlFld-Affiliation affiliation">Department of Medical Biology, The University of Melbourne, Parkville VIC-3010, Australia</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#5d3a31382e2e3833381d2a38353473383928733c28"><span class="__cf_email__" data-cfemail="593e353c2a2a3c373c192e3c3130773c3d2c77382c">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Brad E. Sleebs</span> - <span class="hlFld-Affiliation affiliation">The Walter
and
Eliza Hall Institute of Medical Research, 1G Royal Parade,
Parkville VIC-3052, Australia</span>; 
    <span class="hlFld-Affiliation affiliation">Department of Medical Biology, The University of Melbourne, Parkville VIC-3010, Australia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wilhemus J. A. Kersten</span> - <span class="hlFld-Affiliation affiliation">The Walter
and
Eliza Hall Institute of Medical Research, 1G Royal Parade,
Parkville VIC-3052, Australia</span>; 
    <span class="hlFld-Affiliation affiliation">Department of Medical Biology, The University of Melbourne, Parkville VIC-3010, Australia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sanji Kulasegaram</span> - <span class="hlFld-Affiliation affiliation">The Walter
and
Eliza Hall Institute of Medical Research, 1G Royal Parade,
Parkville VIC-3052, Australia</span>; 
    <span class="hlFld-Affiliation affiliation">Department of Medical Biology, The University of Melbourne, Parkville VIC-3010, Australia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">George Nikolakopoulos</span> - <span class="hlFld-Affiliation affiliation">The Walter
and
Eliza Hall Institute of Medical Research, 1G Royal Parade,
Parkville VIC-3052, Australia</span>; 
    <span class="hlFld-Affiliation affiliation">Department of Medical Biology, The University of Melbourne, Parkville VIC-3010, Australia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Effie Hatzis</span> - <span class="hlFld-Affiliation affiliation">The Walter
and
Eliza Hall Institute of Medical Research, 1G Royal Parade,
Parkville VIC-3052, Australia</span>; 
    <span class="hlFld-Affiliation affiliation">Department of Medical Biology, The University of Melbourne, Parkville VIC-3010, Australia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rebecca M. Moss</span> - <span class="hlFld-Affiliation affiliation">The Walter
and
Eliza Hall Institute of Medical Research, 1G Royal Parade,
Parkville VIC-3052, Australia</span>; 
    <span class="hlFld-Affiliation affiliation">Department of Medical Biology, The University of Melbourne, Parkville VIC-3010, Australia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John P. Parisot</span> - <span class="hlFld-Affiliation affiliation">The Walter
and
Eliza Hall Institute of Medical Research, 1G Royal Parade,
Parkville VIC-3052, Australia</span>; 
    <span class="hlFld-Affiliation affiliation">Department of Medical Biology, The University of Melbourne, Parkville VIC-3010, Australia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hong Yang</span> - <span class="hlFld-Affiliation affiliation">The Walter
and
Eliza Hall Institute of Medical Research, 1G Royal Parade,
Parkville VIC-3052, Australia</span>; 
    <span class="hlFld-Affiliation affiliation">Department of Medical Biology, The University of Melbourne, Parkville VIC-3010, Australia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Peter E. Czabotar</span> - <span class="hlFld-Affiliation affiliation">The Walter
and
Eliza Hall Institute of Medical Research, 1G Royal Parade,
Parkville VIC-3052, Australia</span>; 
    <span class="hlFld-Affiliation affiliation">Department of Medical Biology, The University of Melbourne, Parkville VIC-3010, Australia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">W. Douglas Fairlie</span> - <span class="hlFld-Affiliation affiliation">The Walter
and
Eliza Hall Institute of Medical Research, 1G Royal Parade,
Parkville VIC-3052, Australia</span>; 
    <span class="hlFld-Affiliation affiliation">Department of Medical Biology, The University of Melbourne, Parkville VIC-3010, Australia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Erinna F. Lee</span> - <span class="hlFld-Affiliation affiliation">The Walter
and
Eliza Hall Institute of Medical Research, 1G Royal Parade,
Parkville VIC-3052, Australia</span>; 
    <span class="hlFld-Affiliation affiliation">Department of Medical Biology, The University of Melbourne, Parkville VIC-3010, Australia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jerry M. Adams</span> - <span class="hlFld-Affiliation affiliation">The Walter
and
Eliza Hall Institute of Medical Research, 1G Royal Parade,
Parkville VIC-3052, Australia</span>; 
    <span class="hlFld-Affiliation affiliation">Department of Medical Biology, The University of Melbourne, Parkville VIC-3010, Australia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lin Chen</span> - <span class="hlFld-Affiliation affiliation">The Walter
and
Eliza Hall Institute of Medical Research, 1G Royal Parade,
Parkville VIC-3052, Australia</span>; 
    <span class="hlFld-Affiliation affiliation">Department of Medical Biology, The University of Melbourne, Parkville VIC-3010, Australia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mark F. van Delft</span> - <span class="hlFld-Affiliation affiliation">The Walter
and
Eliza Hall Institute of Medical Research, 1G Royal Parade,
Parkville VIC-3052, Australia</span>; 
    <span class="hlFld-Affiliation affiliation">Department of Medical Biology, The University of Melbourne, Parkville VIC-3010, Australia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kym N. Lowes</span> - <span class="hlFld-Affiliation affiliation">The Walter
and
Eliza Hall Institute of Medical Research, 1G Royal Parade,
Parkville VIC-3052, Australia</span>; 
    <span class="hlFld-Affiliation affiliation">Department of Medical Biology, The University of Melbourne, Parkville VIC-3010, Australia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andrew Wei</span> - <span class="hlFld-Affiliation affiliation">The Walter
and
Eliza Hall Institute of Medical Research, 1G Royal Parade,
Parkville VIC-3052, Australia</span>; 
    <span class="hlFld-Affiliation affiliation">Department of Medical Biology, The University of Melbourne, Parkville VIC-3010, Australia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David C.S. Huang</span> - <span class="hlFld-Affiliation affiliation">The Walter
and
Eliza Hall Institute of Medical Research, 1G Royal Parade,
Parkville VIC-3052, Australia</span>; 
    <span class="hlFld-Affiliation affiliation">Department of Medical Biology, The University of Melbourne, Parkville VIC-3010, Australia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Peter M. Colman</span> - <span class="hlFld-Affiliation affiliation">The Walter
and
Eliza Hall Institute of Medical Research, 1G Royal Parade,
Parkville VIC-3052, Australia</span>; 
    <span class="hlFld-Affiliation affiliation">Department of Medical Biology, The University of Melbourne, Parkville VIC-3010, Australia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ian P. Street</span> - <span class="hlFld-Affiliation affiliation">The Walter
and
Eliza Hall Institute of Medical Research, 1G Royal Parade,
Parkville VIC-3052, Australia</span>; 
    <span class="hlFld-Affiliation affiliation">Department of Medical Biology, The University of Melbourne, Parkville VIC-3010, Australia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jonathan B. Baell</span> - <span class="hlFld-Affiliation affiliation">The Walter
and
Eliza Hall Institute of Medical Research, 1G Royal Parade,
Parkville VIC-3052, Australia</span>; 
    <span class="hlFld-Affiliation affiliation">Department of Medical Biology, The University of Melbourne, Parkville VIC-3010, Australia</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Keith Watson</span> - <span class="hlFld-Affiliation affiliation">The Walter
and
Eliza Hall Institute of Medical Research, 1G Royal Parade,
Parkville VIC-3052, Australia</span>; 
    <span class="hlFld-Affiliation affiliation">Department of Medical Biology, The University of Melbourne, Parkville VIC-3010, Australia</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d302e8949-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i162">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_26063" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_26063" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Steve Elmore and Abbvie for providing <b>1</b>. We also thank our colleagues at the Hall Institute for their work on the Bcl-2 family of proteins that has led to this contribution and for discussions during this work. In particular: Andreas Strasser and Suzanne Cory. This work was supported by fellowships and grants from the Australian Research Council (fellowship to P.E.C.), the National Health and Medical Research Council (NHMRC, fellowships to J.M.A., J.B.B., P.M.C. and D.C.S.H.; development grant 305536 and program grants 257502, 461221 and 1016701), the Leukemia and Lymphoma Society (specialized center of research grant nos. 7015 and 7413), the Cancer Council of Victoria (fellowship to P.M.C.; grant-in-aid 461239) and the Australian Cancer Research Foundation. Infrastructure support from the NHMRC Independent Research Institutes Infrastructure Support Scheme grant no. 361646 and a Victorian State Government OIS grant are gratefully acknowledged.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i163" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i163"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i164" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i164"> Abbreviations Used</h2><tr><td class="NLM_term">AS</td><td class="NLM_def"><p class="first last">AlphaScreen (amplified luminescent proximity homogeneous assay)</p></td></tr><tr><td class="NLM_term">Bak</td><td class="NLM_def"><p class="first last">Bcl-2 homologous antagonist/killer</p></td></tr><tr><td class="NLM_term">Bax</td><td class="NLM_def"><p class="first last">Bcl-2 associated X protein</p></td></tr><tr><td class="NLM_term">Bcl-2</td><td class="NLM_def"><p class="first last">B-cell lymphoma 2</p></td></tr><tr><td class="NLM_term">Bcl-X<sub>L</sub></td><td class="NLM_def"><p class="first last">B-cell lymphoma extra large</p></td></tr><tr><td class="NLM_term">Bcl-w</td><td class="NLM_def"><p class="first last">Bcl-2-like protein 2</p></td></tr><tr><td class="NLM_term">Bim</td><td class="NLM_def"><p class="first last">Bcl-2 interacting mediator of cell death</p></td></tr><tr><td class="NLM_term">BE</td><td class="NLM_def"><p class="first last">binding efficiency</p></td></tr><tr><td class="NLM_term">BH</td><td class="NLM_def"><p class="first last">Bcl-2 homology domain</p></td></tr><tr><td class="NLM_term">DKO</td><td class="NLM_def"><p class="first last">double knockout</p></td></tr><tr><td class="NLM_term">FBS</td><td class="NLM_def"><p class="first last">fetal bovine serum</p></td></tr><tr><td class="NLM_term">HSA</td><td class="NLM_def"><p class="first last">human serum albumin domain III</p></td></tr><tr><td class="NLM_term">KO</td><td class="NLM_def"><p class="first last">knock out</p></td></tr><tr><td class="NLM_term">Mcl-1</td><td class="NLM_def"><p class="first last">myeloid cell leukemia sequence 1</p></td></tr><tr><td class="NLM_term">LPA</td><td class="NLM_def"><p class="first last">luminescence proximity assay</p></td></tr><tr><td class="NLM_term">MEF</td><td class="NLM_def"><p class="first last">mouse embryonic fibroblasts</p></td></tr><tr><td class="NLM_term">RU</td><td class="NLM_def"><p class="first last">resonance units</p></td></tr><tr><td class="NLM_term">SPR</td><td class="NLM_def"><p class="first last">surface plasmon resonance</p></td></tr><tr><td class="NLM_term">TMS</td><td class="NLM_def"><p class="first last">trimethylsilyl</p></td></tr><tr><td class="NLM_term">wt</td><td class="NLM_def"><p class="first last">wild-type</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i165">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_87645" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_87645" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 64 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Cory, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, J. M.</span><span> </span><span class="NLM_article-title">Killing cancer cells by flipping the Bcl-2/Bax switch</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">5</span><span class="NLM_x">–</span> <span class="NLM_lpage">6</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2005&pages=5-6&author=S.+Coryauthor=J.+M.+Adams&title=Killing+cancer+cells+by+flipping+the+Bcl-2%2FBax+switch"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCory%26aufirst%3DS.%26aulast%3DAdams%26aufirst%3DJ.%2BM.%26atitle%3DKilling%2520cancer%2520cells%2520by%2520flipping%2520the%2520Bcl-2%252FBax%2520switch%26jtitle%3DCancer%2520Cell%26date%3D2005%26volume%3D8%26spage%3D5%26epage%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Strasser, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cory, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, J. M.</span><span> </span><span class="NLM_article-title">Deciphering the rules of programmed cell death to improve therapy of cancer and other diseases</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">3667</span><span class="NLM_x">–</span> <span class="NLM_lpage">3683</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2011&pages=3667-3683&author=A.+Strasserauthor=S.+Coryauthor=J.+M.+Adams&title=Deciphering+the+rules+of+programmed+cell+death+to+improve+therapy+of+cancer+and+other+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStrasser%26aufirst%3DA.%26aulast%3DCory%26aufirst%3DS.%26aulast%3DAdams%26aufirst%3DJ.%2BM.%26atitle%3DDeciphering%2520the%2520rules%2520of%2520programmed%2520cell%2520death%2520to%2520improve%2520therapy%2520of%2520cancer%2520and%2520other%2520diseases%26jtitle%3DEMBO%2520J.%26date%3D2011%26volume%3D30%26spage%3D3667%26epage%3D3683" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Hanahan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinberg, R. A.</span><span> </span><span class="NLM_article-title">The hallmarks of cancer</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">57</span><span class="NLM_x">–</span> <span class="NLM_lpage">70</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm400556w&amp;key=10.1016%2FS0092-8674%2800%2981683-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm400556w&amp;key=10647931" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm400556w&amp;key=1%3ACAS%3A528%3ADC%252BD3cXks1CktA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2000&pages=57-70&author=D.+Hanahanauthor=R.+A.+Weinberg&title=The+hallmarks+of+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The hallmarks of cancer</span></div><div class="casAuthors">Hanahan, Douglas; Weinberg, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">57-70</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review is given with many refs. on principles governing the transformation of normal human cells into malignant cancers.  The authors suggest that research over the past decades has revealed a small no. of mol., biochem., and cellular traits (acquired capabilities) shared by most and perhaps all types of cancer.  Topics included are the acquired capabilities self-sufficiency in growth signals, insensitivity to antigrowth signals, evading apoptosis, limitless replicative potential, sustained angiogenesis, and tissue invasion and metastasis followed by genome instability as an enabling characteristic and alternative pathways to cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooXmGqKjM1C7Vg90H21EOLACvtfcHk0lgaa_j6OMcqbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXks1CktA%253D%253D&md5=1d23c4400dad34c7f32d4a0c41890349</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2800%2981683-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252800%252981683-9%26sid%3Dliteratum%253Aachs%26aulast%3DHanahan%26aufirst%3DD.%26aulast%3DWeinberg%26aufirst%3DR.%2BA.%26atitle%3DThe%2520hallmarks%2520of%2520cancer%26jtitle%3DCell%26date%3D2000%26volume%3D100%26spage%3D57%26epage%3D70" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Labi, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erlacher, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiessling, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villunger, A.</span><span> </span><span class="NLM_article-title">BH3-only proteins in cell death initiation, malignant disease and anticancer therapy</span> <span class="citation_source-journal">Cell Death Differ.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1325</span><span class="NLM_x">–</span> <span class="NLM_lpage">1338</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm400556w&amp;key=10.1038%2Fsj.cdd.4401940" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm400556w&amp;key=16645634" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm400556w&amp;key=1%3ACAS%3A528%3ADC%252BD28XmvFaitr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2006&pages=1325-1338&author=V.+Labiauthor=M.+Erlacherauthor=S.+Kiesslingauthor=A.+Villunger&title=BH3-only+proteins+in+cell+death+initiation%2C+malignant+disease+and+anticancer+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">BH3-only proteins in cell death initiation, malignant disease and anticancer therapy</span></div><div class="casAuthors">Labi, V.; Erlacher, M.; Kiessling, S.; Villunger, A.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death and Differentiation</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1325-1338</span>CODEN:
                <span class="NLM_cas:coden">CDDIEK</span>;
        ISSN:<span class="NLM_cas:issn">1350-9047</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Induction of apoptosis in tumor cells, either by direct activation of the death receptor pathway using agonistic antibodies or recombinant ligands, or direct triggering of the Bcl-2-regulated intrinsic apoptosis pathway by small mol. drugs, carries high hopes to overcome the shortcomings of current anticancer therapies.  The latter therapy concept builds on a more detailed understanding of how Bcl-2-like mols. maintain mitochondrial integrity and how BH3-only proteins and Bax/Bak-like mols. can undermine it.  Means to unleash the apoptotic potential of BH3-only proteins in tumor cells, or bypass the need for BH3-only proteins by blocking possible interactions of Bcl-2-like prosurvival mols. with Bax and/or Bak allowing their direct activation, constitute interesting options for the design of novel anticancer therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofpeJbnadPqLVg90H21EOLACvtfcHk0lhS-SaTBsCU-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmvFaitr4%253D&md5=c714f82592b1c8fe9df9d385c104414d</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fsj.cdd.4401940&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.cdd.4401940%26sid%3Dliteratum%253Aachs%26aulast%3DLabi%26aufirst%3DV.%26aulast%3DErlacher%26aufirst%3DM.%26aulast%3DKiessling%26aufirst%3DS.%26aulast%3DVillunger%26aufirst%3DA.%26atitle%3DBH3-only%2520proteins%2520in%2520cell%2520death%2520initiation%252C%2520malignant%2520disease%2520and%2520anticancer%2520therapy%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2006%26volume%3D13%26spage%3D1325%26epage%3D1338" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Villunger, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labi, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouillet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strasser, A.</span><span> </span><span class="NLM_article-title">Can the analysis of BH3-only protein knockout mice clarify the issue of ‘direct versus indirect’ activation of Bax and Bak?</span> <span class="citation_source-journal">Cell Death Differ.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1545</span><span class="NLM_x">–</span> <span class="NLM_lpage">1546</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm400556w&amp;key=10.1038%2Fcdd.2011.100" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm400556w&amp;key=21909118" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm400556w&amp;key=1%3ACAS%3A280%3ADC%252BC3MfivValtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=1545-1546&author=A.+Villungerauthor=V.+Labiauthor=P.+Bouilletauthor=J.+Adamsauthor=A.+Strasser&title=Can+the+analysis+of+BH3-only+protein+knockout+mice+clarify+the+issue+of+%E2%80%98direct+versus+indirect%E2%80%99+activation+of+Bax+and+Bak%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Can the analysis of BH3-only protein knockout mice clarify the issue of 'direct versus indirect' activation of Bax and Bak?</span></div><div class="casAuthors">Villunger A; Labi V; Bouillet P; Adams J; Strasser A</div><div class="citationInfo"><span class="NLM_cas:title">Cell death and differentiation</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1545-6</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTtkSGMVo1DgTdblLE_E9PWfW6udTcc2ebSOthiUyTDkLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3MfivValtw%253D%253D&md5=4e52b5b315a799e7a504e4383f42660f</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fcdd.2011.100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcdd.2011.100%26sid%3Dliteratum%253Aachs%26aulast%3DVillunger%26aufirst%3DA.%26aulast%3DLabi%26aufirst%3DV.%26aulast%3DBouillet%26aufirst%3DP.%26aulast%3DAdams%26aufirst%3DJ.%26aulast%3DStrasser%26aufirst%3DA.%26atitle%3DCan%2520the%2520analysis%2520of%2520BH3-only%2520protein%2520knockout%2520mice%2520clarify%2520the%2520issue%2520of%2520%25E2%2580%2598direct%2520versus%2520indirect%25E2%2580%2599%2520activation%2520of%2520Bax%2520and%2520Bak%253F%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2011%26volume%3D18%26spage%3D1545%26epage%3D1546" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Leber, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, D. W.</span><span> </span><span class="NLM_article-title">Embedded together: the life and death consequences of interaction of the Bcl-2 family with membranes</span> <span class="citation_source-journal">Apoptosis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">897</span><span class="NLM_x">–</span> <span class="NLM_lpage">911</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2007&pages=897-911&author=B.+Leberauthor=J.+Linauthor=D.+W.+Andrews&title=Embedded+together%3A+the+life+and+death+consequences+of+interaction+of+the+Bcl-2+family+with+membranes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLeber%26aufirst%3DB.%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DAndrews%26aufirst%3DD.%2BW.%26atitle%3DEmbedded%2520together%253A%2520the%2520life%2520and%2520death%2520consequences%2520of%2520interaction%2520of%2520the%2520Bcl-2%2520family%2520with%2520membranes%26jtitle%3DApoptosis%26date%3D2007%26volume%3D12%26spage%3D897%26epage%3D911" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Leber, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, D. W.</span><span> </span><span class="NLM_article-title">Still embedded together binding to membranes regulates Bcl-2 protein interactions</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">5221</span><span class="NLM_x">–</span> <span class="NLM_lpage">5230</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2010&pages=5221-5230&author=B.+Leberauthor=J.+Linauthor=D.+W.+Andrews&title=Still+embedded+together+binding+to+membranes+regulates+Bcl-2+protein+interactions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLeber%26aufirst%3DB.%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DAndrews%26aufirst%3DD.%2BW.%26atitle%3DStill%2520embedded%2520together%2520binding%2520to%2520membranes%2520regulates%2520Bcl-2%2520protein%2520interactions%26jtitle%3DOncogene%26date%3D2010%26volume%3D29%26spage%3D5221%26epage%3D5230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Lindsten, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zong, W. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rathmell, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiels, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ulrich, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waymire, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahar, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frauwirth, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eng, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adelman, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simon, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golden, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korsmeyer, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacGregor, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, C. B.</span><span> </span><span class="NLM_article-title">The combined functions of proapoptotic Bcl-2 family members bak and bax are essential for normal development of multiple tissues</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1389</span><span class="NLM_x">–</span> <span class="NLM_lpage">1399</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2000&pages=1389-1399&author=T.+Lindstenauthor=A.+J.+Rossauthor=A.+Kingauthor=W.+X.+Zongauthor=J.+C.+Rathmellauthor=H.+A.+Shielsauthor=E.+Ulrichauthor=K.+G.+Waymireauthor=P.+Maharauthor=K.+Frauwirthauthor=Y.+Chenauthor=M.+Weiauthor=V.+M.+Engauthor=D.+M.+Adelmanauthor=M.+C.+Simonauthor=A.+Maauthor=J.+A.+Goldenauthor=G.+Evanauthor=S.+J.+Korsmeyerauthor=G.+R.+MacGregorauthor=C.+B.+Thompson&title=The+combined+functions+of+proapoptotic+Bcl-2+family+members+bak+and+bax+are+essential+for+normal+development+of+multiple+tissues"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLindsten%26aufirst%3DT.%26aulast%3DRoss%26aufirst%3DA.%2BJ.%26aulast%3DKing%26aufirst%3DA.%26aulast%3DZong%26aufirst%3DW.%2BX.%26aulast%3DRathmell%26aufirst%3DJ.%2BC.%26aulast%3DShiels%26aufirst%3DH.%2BA.%26aulast%3DUlrich%26aufirst%3DE.%26aulast%3DWaymire%26aufirst%3DK.%2BG.%26aulast%3DMahar%26aufirst%3DP.%26aulast%3DFrauwirth%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DWei%26aufirst%3DM.%26aulast%3DEng%26aufirst%3DV.%2BM.%26aulast%3DAdelman%26aufirst%3DD.%2BM.%26aulast%3DSimon%26aufirst%3DM.%2BC.%26aulast%3DMa%26aufirst%3DA.%26aulast%3DGolden%26aufirst%3DJ.%2BA.%26aulast%3DEvan%26aufirst%3DG.%26aulast%3DKorsmeyer%26aufirst%3DS.%2BJ.%26aulast%3DMacGregor%26aufirst%3DG.%2BR.%26aulast%3DThompson%26aufirst%3DC.%2BB.%26atitle%3DThe%2520combined%2520functions%2520of%2520proapoptotic%2520Bcl-2%2520family%2520members%2520bak%2520and%2520bax%2520are%2520essential%2520for%2520normal%2520development%2520of%2520multiple%2520tissues%26jtitle%3DMol.%2520Cell%26date%3D2000%26volume%3D6%26spage%3D1389%26epage%3D1399" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Wei, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zong, W. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsten, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panoutsakopoulou, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacGregor, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korsmeyer, S. J.</span><span> </span><span class="NLM_article-title">Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">292</span><span class="NLM_x">, </span> <span class="NLM_fpage">727</span><span class="NLM_x">–</span> <span class="NLM_lpage">730</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm400556w&amp;key=10.1126%2Fscience.1059108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm400556w&amp;key=11326099" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm400556w&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjt1eltr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=292&publication_year=2001&pages=727-730&author=M.+C.+Weiauthor=W.+X.+Zongauthor=E.+H.+Chengauthor=T.+Lindstenauthor=V.+Panoutsakopoulouauthor=A.+J.+Rossauthor=K.+A.+Rothauthor=G.+R.+MacGregorauthor=C.+B.+Thompsonauthor=S.+J.+Korsmeyer&title=Proapoptotic+BAX+and+BAK%3A+a+requisite+gateway+to+mitochondrial+dysfunction+and+death"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Proapoptotic BAX and BAK: A requisite gateway to mitochondrial dysfunction and death</span></div><div class="casAuthors">Wei, Michael C.; Zong, Wei-Xing; Cheng, Emily H. -Y.; Lindsten, Tullia; Panoutsakopoulou, Vily; Ross, Andrea J.; Roth, Kevin A.; MacGregor, Grant R.; Thompson, Craig B.; Korsmeyer, Stanley J.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">292</span>
        (<span class="NLM_cas:issue">5517</span>),
    <span class="NLM_cas:pages">727-730</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Multiple death signals influence mitochondria during apoptosis, yet the crit. initiating event for mitochondrial dysfunction in vivo has been unclear.  TBID, the caspase-activated form of a "BH3-domain-only" BCL-2 family member, triggers the homooligomerization of "multidomain" conserved proapoptotic family members BAK or BAX, resulting in the release of cytochrome c from mitochondria.  The authors find that cells lacking both Bax and Bak, but not cells lacking only one of these components, are completely resistant to tBID-induced cytochrome c release and apoptosis.  Moreover, doubly deficient cells are resistant to multiple apoptotic stimuli that act through disruption of mitochondrial function: staurosporine, UV radiation, growth factor deprivation, etoposide, and the endoplasmic reticulum stress stimuli thapsigargin and tunicamycin.  Thus, activation of a "multidomain" proapoptotic member, BAX or BAK, appears to be an essential gateway to mitochondrial dysfunction required for cell death in response to diverse stimuli.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUXoRFmyvptbVg90H21EOLACvtfcHk0lipOKtx_eYMYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjt1eltr0%253D&md5=2eae779df72480afc9e9378217ec1a9b</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1126%2Fscience.1059108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1059108%26sid%3Dliteratum%253Aachs%26aulast%3DWei%26aufirst%3DM.%2BC.%26aulast%3DZong%26aufirst%3DW.%2BX.%26aulast%3DCheng%26aufirst%3DE.%2BH.%26aulast%3DLindsten%26aufirst%3DT.%26aulast%3DPanoutsakopoulou%26aufirst%3DV.%26aulast%3DRoss%26aufirst%3DA.%2BJ.%26aulast%3DRoth%26aufirst%3DK.%2BA.%26aulast%3DMacGregor%26aufirst%3DG.%2BR.%26aulast%3DThompson%26aufirst%3DC.%2BB.%26aulast%3DKorsmeyer%26aufirst%3DS.%2BJ.%26atitle%3DProapoptotic%2520BAX%2520and%2520BAK%253A%2520a%2520requisite%2520gateway%2520to%2520mitochondrial%2520dysfunction%2520and%2520death%26jtitle%3DScience%26date%3D2001%26volume%3D292%26spage%3D727%26epage%3D730" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Lessene, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czabotar, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colman, P. M.</span><span> </span><span class="NLM_article-title">BCL-2 family antagonists for cancer therapy</span> <span class="citation_source-journal">Nature Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">989</span><span class="NLM_x">–</span> <span class="NLM_lpage">1000</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=989-1000&author=G.+Lesseneauthor=P.+E.+Czabotarauthor=P.+M.+Colman&title=BCL-2+family+antagonists+for+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLessene%26aufirst%3DG.%26aulast%3DCzabotar%26aufirst%3DP.%2BE.%26aulast%3DColman%26aufirst%3DP.%2BM.%26atitle%3DBCL-2%2520family%2520antagonists%2520for%2520cancer%2520therapy%26jtitle%3DNature%2520Rev.%2520Drug%2520Discovery%26date%3D2008%26volume%3D7%26spage%3D989%26epage%3D1000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Czabotar, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lessene, G.</span><span> </span><span class="NLM_article-title">Bcl-2 Family Proteins as Therapeutic Targets</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">3132</span><span class="NLM_x">–</span> <span class="NLM_lpage">3148</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm400556w&amp;key=10.2174%2F138161210793292429" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm400556w&amp;key=20687882" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm400556w&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVKlurrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2010&pages=3132-3148&author=P.+E.+Czabotarauthor=G.+Lessene&title=Bcl-2+Family+Proteins+as+Therapeutic+Targets"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Bcl-2 family proteins as therapeutic targets</span></div><div class="casAuthors">Czabotar, Peter E.; Lessene, Guillaume</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">3132-3148</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The mitochondrion provides the stage for the interplay of mol. interactions that regulate apoptosis via the intrinsic pathway.  The release of apoptogenic factors from this compartment constitutes a crit. juncture in this apoptotic pathway.  Regulation of the integrity of the outer mitochondrial membrane (OMM) is the task of the Bcl-2 family of proteins.  A network of interactions between the various subgroups of the family decides the apoptotic fate of a cell and, as such, an imbalance within this network can lead to a variety of disease states.  In particular, over-expression of pro-survival Bcl-2 family proteins is a hallmark of many cancers.  Here we discuss recent advances in targeting the Bcl-2 family with both peptides and small mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpoBLy-8vLMRbVg90H21EOLACvtfcHk0lipOKtx_eYMYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVKlurrL&md5=42a0f634b9bc21d2c93b5696914e56be</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.2174%2F138161210793292429&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161210793292429%26sid%3Dliteratum%253Aachs%26aulast%3DCzabotar%26aufirst%3DP.%2BE.%26aulast%3DLessene%26aufirst%3DG.%26atitle%3DBcl-2%2520Family%2520Proteins%2520as%2520Therapeutic%2520Targets%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2010%26volume%3D16%26spage%3D3132%26epage%3D3148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Souers, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leverson, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boghaert, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ackler, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catron, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dayton, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Enschede, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fairbrother, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hymowitz, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khaw, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kovar, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maecker, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsh, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitten, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nimmer, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oleksijew, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sampath, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seymour, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sullivan, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tahir, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tse, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wendt, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xue, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humerickhouse, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenberg, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elmore, S. W.</span><span> </span><span class="NLM_article-title">ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets</span> <span class="citation_source-journal">Nature Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">202</span><span class="NLM_x">–</span> <span class="NLM_lpage">208</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=202-208&author=A.+J.+Souersauthor=J.+D.+Leversonauthor=E.+R.+Boghaertauthor=S.+L.+Acklerauthor=N.+D.+Catronauthor=J.+Chenauthor=B.+D.+Daytonauthor=H.+Dingauthor=S.+H.+Enschedeauthor=W.+J.+Fairbrotherauthor=D.+C.+Huangauthor=S.+G.+Hymowitzauthor=S.+Jinauthor=S.+L.+Khawauthor=P.+J.+Kovarauthor=L.+T.+Lamauthor=J.+Leeauthor=H.+L.+Maeckerauthor=K.+C.+Marshauthor=K.+D.+Masonauthor=M.+J.+Mittenauthor=P.+M.+Nimmerauthor=A.+Oleksijewauthor=C.+H.+Parkauthor=C.+M.+Parkauthor=D.+C.+Phillipsauthor=A.+W.+Robertsauthor=D.+Sampathauthor=J.+F.+Seymourauthor=M.+L.+Smithauthor=G.+M.+Sullivanauthor=S.+K.+Tahirauthor=C.+Tseauthor=M.+D.+Wendtauthor=Y.+Xiaoauthor=J.+C.+Xueauthor=H.+Zhangauthor=R.+A.+Humerickhouseauthor=S.+H.+Rosenbergauthor=S.+W.+Elmore&title=ABT-199%2C+a+potent+and+selective+BCL-2+inhibitor%2C+achieves+antitumor+activity+while+sparing+platelets"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSouers%26aufirst%3DA.%2BJ.%26aulast%3DLeverson%26aufirst%3DJ.%2BD.%26aulast%3DBoghaert%26aufirst%3DE.%2BR.%26aulast%3DAckler%26aufirst%3DS.%2BL.%26aulast%3DCatron%26aufirst%3DN.%2BD.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DDayton%26aufirst%3DB.%2BD.%26aulast%3DDing%26aufirst%3DH.%26aulast%3DEnschede%26aufirst%3DS.%2BH.%26aulast%3DFairbrother%26aufirst%3DW.%2BJ.%26aulast%3DHuang%26aufirst%3DD.%2BC.%26aulast%3DHymowitz%26aufirst%3DS.%2BG.%26aulast%3DJin%26aufirst%3DS.%26aulast%3DKhaw%26aufirst%3DS.%2BL.%26aulast%3DKovar%26aufirst%3DP.%2BJ.%26aulast%3DLam%26aufirst%3DL.%2BT.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DMaecker%26aufirst%3DH.%2BL.%26aulast%3DMarsh%26aufirst%3DK.%2BC.%26aulast%3DMason%26aufirst%3DK.%2BD.%26aulast%3DMitten%26aufirst%3DM.%2BJ.%26aulast%3DNimmer%26aufirst%3DP.%2BM.%26aulast%3DOleksijew%26aufirst%3DA.%26aulast%3DPark%26aufirst%3DC.%2BH.%26aulast%3DPark%26aufirst%3DC.%2BM.%26aulast%3DPhillips%26aufirst%3DD.%2BC.%26aulast%3DRoberts%26aufirst%3DA.%2BW.%26aulast%3DSampath%26aufirst%3DD.%26aulast%3DSeymour%26aufirst%3DJ.%2BF.%26aulast%3DSmith%26aufirst%3DM.%2BL.%26aulast%3DSullivan%26aufirst%3DG.%2BM.%26aulast%3DTahir%26aufirst%3DS.%2BK.%26aulast%3DTse%26aufirst%3DC.%26aulast%3DWendt%26aufirst%3DM.%2BD.%26aulast%3DXiao%26aufirst%3DY.%26aulast%3DXue%26aufirst%3DJ.%2BC.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DHumerickhouse%26aufirst%3DR.%2BA.%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26aulast%3DElmore%26aufirst%3DS.%2BW.%26atitle%3DABT-199%252C%2520a%2520potent%2520and%2520selective%2520BCL-2%2520inhibitor%252C%2520achieves%2520antitumor%2520activity%2520while%2520sparing%2520platelets%26jtitle%3DNature%2520Med.%26date%3D2013%26volume%3D19%26spage%3D202%26epage%3D208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Oltersdorf, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elmore, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoemaker, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armstrong, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Augeri, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belli, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruncko, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deckwerth, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinges, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajduk, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joseph, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitada, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korsmeyer, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kunzer, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Letai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitten, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nettesheim, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ng, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nimmer, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connor, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oleksijew, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petros, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tahir, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomaselli, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wendt, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fesik, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenberg, S. H.</span><span> </span><span class="NLM_article-title">An inhibitor of Bcl-2 family proteins induces regression of solid tumours</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">435</span><span class="NLM_x">, </span> <span class="NLM_fpage">677</span><span class="NLM_x">–</span> <span class="NLM_lpage">681</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm400556w&amp;key=10.1038%2Fnature03579" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm400556w&amp;key=15902208" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm400556w&amp;key=1%3ACAS%3A528%3ADC%252BD2MXks1Ogtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=435&publication_year=2005&pages=677-681&author=T.+Oltersdorfauthor=S.+W.+Elmoreauthor=A.+R.+Shoemakerauthor=R.+C.+Armstrongauthor=D.+J.+Augeriauthor=B.+A.+Belliauthor=M.+Brunckoauthor=T.+L.+Deckwerthauthor=J.+Dingesauthor=P.+J.+Hajdukauthor=M.+K.+Josephauthor=S.+Kitadaauthor=S.+J.+Korsmeyerauthor=A.+R.+Kunzerauthor=A.+Letaiauthor=C.+Liauthor=M.+J.+Mittenauthor=D.+G.+Nettesheimauthor=S.+Ngauthor=P.+M.+Nimmerauthor=J.+M.+O%E2%80%99Connorauthor=A.+Oleksijewauthor=A.+M.+Petrosauthor=J.+C.+Reedauthor=W.+Shenauthor=S.+K.+Tahirauthor=C.+B.+Thompsonauthor=K.+J.+Tomaselliauthor=B.+L.+Wangauthor=M.+D.+Wendtauthor=H.+C.+Zhangauthor=S.+W.+Fesikauthor=S.+H.+Rosenberg&title=An+inhibitor+of+Bcl-2+family+proteins+induces+regression+of+solid+tumours"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">An inhibitor of Bcl-2 family proteins induces regression of solid tumours</span></div><div class="casAuthors">Oltersdorf, Tilman; Elmore, Steven W.; Shoemaker, Alexander R.; Armstrong, Robert C.; Augeri, David J.; Belli, Barbara A.; Bruncko, Milan; Deckwerth, Thomas L.; Dinges, Jurgen; Hajduk, Philip J.; Joseph, Mary K.; Kitada, Shinichi; Korsmeyer, Stanley J.; Kunzer, Aaron R.; Letai, Anthony; Li, Chi; Mitten, Michael J.; Nettesheim, David G.; Ng, Shi Chung; Nimmer, Paul M.; O'Connor, Jacqueline M.; Oleksijew, Anatol; Petros, Andrew M.; Reed, John C.; Shen, Wang; Tahir, Stephen K.; Thompson, Craig B.; Tomaselli, Kevin J.; Wang, Baole; Wendt, Michael D.; Zhang, Haichao; Fesik, Stephen W.; Rosenberg, Saul H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">435</span>
        (<span class="NLM_cas:issue">7042</span>),
    <span class="NLM_cas:pages">677-681</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Proteins in the Bcl-2 family are central regulators of programmed cell death, and members that inhibit apoptosis, such as Bcl-XL and Bcl-2, are overexpressed in many cancers and contribute to tumor initiation, progression and resistance to therapy.  Bcl-XL expression correlates with chemo-resistance of tumor cell lines, and redns. in Bcl-2 increase sensitivity to anticancer drugs and enhance in vivo survival.  The development of inhibitors of these proteins as potential anticancer therapeutics has been previously explored, but obtaining potent small-mol. inhibitors has proved difficult owing to the necessity of targeting a protein-protein interaction.  Here, using NMR-based screening, parallel synthesis and structure-based design, the authors have discovered ABT-737, a small-mol. inhibitor of the antiapoptotic proteins Bcl-2, Bcl-XL and Bcl-w, with an affinity two to three orders of magnitude more potent than previously reported compds.  Mechanistic studies reveal that ABT-737 does not directly initiate the apoptotic process, but enhances the effects of death signals, displaying synergistic cytotoxicity with chemotherapeutics and radiation.  ABT-737 exhibits single-agent-mechanism-based killing of cells from lymphoma and small-cell lung carcinoma lines, as well as primary patient-derived cells, and in animal models, ABT-737 improves survival, causes regression of established tumors, and produces cures in a high percentage of the mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBt7_zVt8HrbVg90H21EOLACvtfcHk0lg9VrUK0FrReg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXks1Ogtb0%253D&md5=4940d06838506f181b6310d3458a595f</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fnature03579&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature03579%26sid%3Dliteratum%253Aachs%26aulast%3DOltersdorf%26aufirst%3DT.%26aulast%3DElmore%26aufirst%3DS.%2BW.%26aulast%3DShoemaker%26aufirst%3DA.%2BR.%26aulast%3DArmstrong%26aufirst%3DR.%2BC.%26aulast%3DAugeri%26aufirst%3DD.%2BJ.%26aulast%3DBelli%26aufirst%3DB.%2BA.%26aulast%3DBruncko%26aufirst%3DM.%26aulast%3DDeckwerth%26aufirst%3DT.%2BL.%26aulast%3DDinges%26aufirst%3DJ.%26aulast%3DHajduk%26aufirst%3DP.%2BJ.%26aulast%3DJoseph%26aufirst%3DM.%2BK.%26aulast%3DKitada%26aufirst%3DS.%26aulast%3DKorsmeyer%26aufirst%3DS.%2BJ.%26aulast%3DKunzer%26aufirst%3DA.%2BR.%26aulast%3DLetai%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DMitten%26aufirst%3DM.%2BJ.%26aulast%3DNettesheim%26aufirst%3DD.%2BG.%26aulast%3DNg%26aufirst%3DS.%26aulast%3DNimmer%26aufirst%3DP.%2BM.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DJ.%2BM.%26aulast%3DOleksijew%26aufirst%3DA.%26aulast%3DPetros%26aufirst%3DA.%2BM.%26aulast%3DReed%26aufirst%3DJ.%2BC.%26aulast%3DShen%26aufirst%3DW.%26aulast%3DTahir%26aufirst%3DS.%2BK.%26aulast%3DThompson%26aufirst%3DC.%2BB.%26aulast%3DTomaselli%26aufirst%3DK.%2BJ.%26aulast%3DWang%26aufirst%3DB.%2BL.%26aulast%3DWendt%26aufirst%3DM.%2BD.%26aulast%3DZhang%26aufirst%3DH.%2BC.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26atitle%3DAn%2520inhibitor%2520of%2520Bcl-2%2520family%2520proteins%2520induces%2520regression%2520of%2520solid%2520tumours%26jtitle%3DNature%26date%3D2005%26volume%3D435%26spage%3D677%26epage%3D681" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Bruncko, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oost, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belli, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joseph, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kunzer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martineau, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McClellan, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitten, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ng, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nimmer, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oltersdorf, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petros, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoemaker, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, X. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wendt, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fesik, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenberg, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elmore, S. W.</span><span> </span><span class="NLM_article-title">Studies leading to potent, dual inhibitors of Bcl-2 and Bcl-x<sub>L</sub></span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">641</span><span class="NLM_x">–</span> <span class="NLM_lpage">662</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm061152t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm400556w&amp;key=1%3ACAS%3A528%3ADC%252BD2sXptVGmug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=641-662&author=M.+Brunckoauthor=T.+K.+Oostauthor=B.+A.+Belliauthor=H.+Dingauthor=M.+K.+Josephauthor=A.+Kunzerauthor=D.+Martineauauthor=W.+J.+McClellanauthor=M.+Mittenauthor=S.+C.+Ngauthor=P.+M.+Nimmerauthor=T.+Oltersdorfauthor=C.+M.+Parkauthor=A.+M.+Petrosauthor=A.+R.+Shoemakerauthor=X.+H.+Songauthor=X.+L.+Wangauthor=M.+D.+Wendtauthor=H.+C.+Zhangauthor=S.+W.+Fesikauthor=S.+H.+Rosenbergauthor=S.+W.+Elmore&title=Studies+leading+to+potent%2C+dual+inhibitors+of+Bcl-2+and+Bcl-xL"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Studies Leading to Potent, Dual Inhibitors of Bcl-2 and Bcl-xL</span></div><div class="casAuthors">Bruncko, Milan; Oost, Thorsten K.; Belli, Barbara A.; Ding, Hong; Joseph, Mary K.; Kunzer, Aaron; Martineau, Darlene; McClellan, William J.; Mitten, Michael; Ng, Shi-Chung; Nimmer, Paul M.; Oltersdorf, Tilman; Park, Cheol-Min; Petros, Andrew M.; Shoemaker, Alexander R.; Song, Xiaohong; Wang, Xilu; Wendt, Michael D.; Zhang, Haichao; Fesik, Stephen W.; Rosenberg, Saul H.; Elmore, Steven W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">641-662</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Overexpression of the antiapoptotic proteins Bcl-2 and Bcl-xL provides a common mechanism through which cancer cells gain a survival advantage and become resistant to conventional chemotherapy.  Inhibition of these prosurvival proteins is an attractive strategy for cancer therapy.  We recently described the discovery of a selective Bcl-xL antagonist that potentiates the antitumor activity of chemotherapy and radiation.  Here we describe the use of structure-guided design to exploit a deep hydrophobic binding pocket on the surface of these proteins to develop the first dual, subnanomolar inhibitors of Bcl-xL and Bcl-2.  This study culminated in the identification of 2 (I), which exhibited EC50 values of 8 nM and 30 nM in Bcl-2 and Bcl-xL dependent cells, resp.  Compd. 2 demonstrated single agent efficacy against human follicular lymphoma cell lines that overexpress Bcl-2, and efficacy in a murine xenograft model of lymphoma when given both as a single agent and in combination with etoposide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpF2G6VoJIheLVg90H21EOLACvtfcHk0lh_QwWQEq9hbQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXptVGmug%253D%253D&md5=e7bf502c69c4247c39ce7e070984b3a6</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fjm061152t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm061152t%26sid%3Dliteratum%253Aachs%26aulast%3DBruncko%26aufirst%3DM.%26aulast%3DOost%26aufirst%3DT.%2BK.%26aulast%3DBelli%26aufirst%3DB.%2BA.%26aulast%3DDing%26aufirst%3DH.%26aulast%3DJoseph%26aufirst%3DM.%2BK.%26aulast%3DKunzer%26aufirst%3DA.%26aulast%3DMartineau%26aufirst%3DD.%26aulast%3DMcClellan%26aufirst%3DW.%2BJ.%26aulast%3DMitten%26aufirst%3DM.%26aulast%3DNg%26aufirst%3DS.%2BC.%26aulast%3DNimmer%26aufirst%3DP.%2BM.%26aulast%3DOltersdorf%26aufirst%3DT.%26aulast%3DPark%26aufirst%3DC.%2BM.%26aulast%3DPetros%26aufirst%3DA.%2BM.%26aulast%3DShoemaker%26aufirst%3DA.%2BR.%26aulast%3DSong%26aufirst%3DX.%2BH.%26aulast%3DWang%26aufirst%3DX.%2BL.%26aulast%3DWendt%26aufirst%3DM.%2BD.%26aulast%3DZhang%26aufirst%3DH.%2BC.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26aulast%3DElmore%26aufirst%3DS.%2BW.%26atitle%3DStudies%2520leading%2520to%2520potent%252C%2520dual%2520inhibitors%2520of%2520Bcl-2%2520and%2520Bcl-xL%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D641%26epage%3D662" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Tse, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoemaker, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adickes, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsh, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitten, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nimmer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tahir, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fesik, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenberg, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elmore, S. W.</span><span> </span><span class="NLM_article-title">ABT-263: a potent and orally bioavailable Bcl-2 family inhibitor</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">3421</span><span class="NLM_x">–</span> <span class="NLM_lpage">3428</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm400556w&amp;key=10.1158%2F0008-5472.CAN-07-5836" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm400556w&amp;key=18451170" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm400556w&amp;key=1%3ACAS%3A528%3ADC%252BD1cXltlSltrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2008&pages=3421-3428&author=C.+Tseauthor=A.+R.+Shoemakerauthor=J.+Adickesauthor=M.+G.+Andersonauthor=J.+Chenauthor=S.+Jinauthor=E.+F.+Johnsonauthor=K.+C.+Marshauthor=M.+J.+Mittenauthor=P.+Nimmerauthor=L.+Robertsauthor=S.+K.+Tahirauthor=Y.+Xiaoauthor=X.+Yangauthor=H.+Zhangauthor=S.+Fesikauthor=S.+H.+Rosenbergauthor=S.+W.+Elmore&title=ABT-263%3A+a+potent+and+orally+bioavailable+Bcl-2+family+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">ABT-263: A Potent and Orally Bioavailable Bcl-2 Family Inhibitor</span></div><div class="casAuthors">Tse, Christin; Shoemaker, Alexander R.; Adickes, Jessica; Anderson, Mark G.; Chen, Jun; Jin, Sha; Johnson, Eric F.; Marsh, Kennan C.; Mitten, Michael J.; Nimmer, Paul; Roberts, Lisa; Tahir, Stephen K.; Xiao, Yu; Yang, Xiufen; Zhang, Haichao; Fesik, Stephen; Rosenberg, Saul H.; Elmore, Steven W.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3421-3428</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Overexpression of the prosurvival Bcl-2 family members (Bcl-2, Bcl-xL, and Mcl-1) is commonly assocd. with tumor maintenance, progression, and chemoresistance.  We previously reported the discovery of ABT-737, a potent, small-mol. Bcl-2 family protein inhibitor.  A major limitation of ABT-737 is that it is not orally bioavailable, which would limit chronic single agent therapy and flexibility to dose in combination regimens.  Here we report the biol. properties of ABT-263, a potent, orally bioavailable Bad-like BH3 mimetic (Ki's of <1 nmol/L for Bcl-2, Bcl-xL, and Bcl-w).  The oral bioavailability of ABT-263 in preclin. animal models is 20% to 50%, depending on formulation.  ABT-263 disrupts Bcl-2/Bcl-xL interactions with pro-death proteins (e.g., Bim), leading to the initiation of apoptosis within 2 h posttreatment.  In human tumor cells, ABT-263 induces Bax translocation, cytochrome c release, and subsequent apoptosis.  Oral administration of ABT-263 alone induces complete tumor regressions in xenograft models of small-cell lung cancer and acute lymphoblastic leukemia.  In xenograft models of aggressive B-cell lymphoma and multiple myeloma where ABT-263 exhibits modest or no single agent activity, it significantly enhances the efficacy of clin. relevant therapeutic regimens.  These data provide the rationale for clin. trials evaluating ABT-263 in small-cell lung cancer and B-cell malignancies.  The oral efficacy of ABT-263 should provide dosing flexibility to maximize clin. utility both as a single agent and in combination regimens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojLK8zIgyDWbVg90H21EOLACvtfcHk0lh_QwWQEq9hbQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXltlSltrs%253D&md5=a43029cc218d25d4e1fb6dd1186475c4</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-07-5836&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-07-5836%26sid%3Dliteratum%253Aachs%26aulast%3DTse%26aufirst%3DC.%26aulast%3DShoemaker%26aufirst%3DA.%2BR.%26aulast%3DAdickes%26aufirst%3DJ.%26aulast%3DAnderson%26aufirst%3DM.%2BG.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DJin%26aufirst%3DS.%26aulast%3DJohnson%26aufirst%3DE.%2BF.%26aulast%3DMarsh%26aufirst%3DK.%2BC.%26aulast%3DMitten%26aufirst%3DM.%2BJ.%26aulast%3DNimmer%26aufirst%3DP.%26aulast%3DRoberts%26aufirst%3DL.%26aulast%3DTahir%26aufirst%3DS.%2BK.%26aulast%3DXiao%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DFesik%26aufirst%3DS.%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26aulast%3DElmore%26aufirst%3DS.%2BW.%26atitle%3DABT-263%253A%2520a%2520potent%2520and%2520orally%2520bioavailable%2520Bcl-2%2520family%2520inhibitor%26jtitle%3DCancer%2520Res.%26date%3D2008%26volume%3D68%26spage%3D3421%26epage%3D3428" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Park, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruncko, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adickes, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauch, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kunzer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsh, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nimmer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoemaker, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tahir, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tse, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wendt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fesik, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenberg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elmore, S.</span><span> </span><span class="NLM_article-title">Discovery of an orally bioavailable small molecule inhibitor of prosurvival B-cell lymphoma 2 proteins</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">6902</span><span class="NLM_x">–</span> <span class="NLM_lpage">6915</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800669s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm400556w&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1WlsbvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=6902-6915&author=C.+M.+Parkauthor=M.+Brunckoauthor=J.+Adickesauthor=J.+Bauchauthor=H.+Dingauthor=A.+Kunzerauthor=K.+C.+Marshauthor=P.+Nimmerauthor=A.+Shoemakerauthor=X.+Songauthor=S.+Tahirauthor=C.+Tseauthor=X.+Wangauthor=M.+Wendtauthor=X.+Yangauthor=H.+Zhangauthor=S.+Fesikauthor=S.+Rosenbergauthor=S.+Elmore&title=Discovery+of+an+orally+bioavailable+small+molecule+inhibitor+of+prosurvival+B-cell+lymphoma+2+proteins"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of an Orally Bioavailable Small Molecule Inhibitor of Prosurvival B-Cell Lymphoma 2 Proteins</span></div><div class="casAuthors">Park, Cheol-Min; Bruncko, Milan; Adickes, Jessica; Bauch, Joy; Ding, Hong; Kunzer, Aaron; Marsh, Kennan C.; Nimmer, Paul; Shoemaker, Alexander R.; Song, Xiaohong; Tahir, Stephen K.; Tse, Christin; Wang, Xilu; Wendt, Michael D.; Yang, Xiufen; Zhang, Haichao; Fesik, Stephen W.; Rosenberg, Saul H.; Elmore, Steven W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6902-6915</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Overexpression of prosurvival proteins such as Bcl-2 and Bcl-XL has been correlated with tumorigenesis and resistance to chemotherapy, and thus, the development of antagonists of these proteins may provide a novel means for the treatment of cancer.  We recently described the discovery of 1 (ABT-737), which binds Bcl-2, Bcl-XL, and Bcl-w with high affinity, shows robust antitumor activity in murine tumor xenograft models, but is not orally bioavailable.  Herein, we report that targeted modifications at three key positions of 1 resulted in a 20-fold improvement in the pharmacokinetic/pharmacodynamic relationship (PK/PD) between oral exposure (AUC) and in vitro efficacy in human tumor cell lines (EC50).  The resulting compd., 2 (ABT-263), is orally efficacious in an established xenograft model of human small cell lung cancer, inducing complete tumor regressions in all animals.  Compd. 2 is currently in multiple phase 1 clin. trials in patients with small cell lung cancer and hematol. malignancies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrF1JFNLCqAULVg90H21EOLACvtfcHk0lh_QwWQEq9hbQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1WlsbvE&md5=83975ec5e8f642abc3507d35d00c9e14</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm800669s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800669s%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DC.%2BM.%26aulast%3DBruncko%26aufirst%3DM.%26aulast%3DAdickes%26aufirst%3DJ.%26aulast%3DBauch%26aufirst%3DJ.%26aulast%3DDing%26aufirst%3DH.%26aulast%3DKunzer%26aufirst%3DA.%26aulast%3DMarsh%26aufirst%3DK.%2BC.%26aulast%3DNimmer%26aufirst%3DP.%26aulast%3DShoemaker%26aufirst%3DA.%26aulast%3DSong%26aufirst%3DX.%26aulast%3DTahir%26aufirst%3DS.%26aulast%3DTse%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DWendt%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DFesik%26aufirst%3DS.%26aulast%3DRosenberg%26aufirst%3DS.%26aulast%3DElmore%26aufirst%3DS.%26atitle%3DDiscovery%2520of%2520an%2520orally%2520bioavailable%2520small%2520molecule%2520inhibitor%2520of%2520prosurvival%2520B-cell%2520lymphoma%25202%2520proteins%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D6902%26epage%3D6915" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Chen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willis, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fletcher, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hinds, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colman, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Day, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, D. C.</span><span> </span><span class="NLM_article-title">Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">393</span><span class="NLM_x">–</span> <span class="NLM_lpage">403</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm400556w&amp;key=10.1016%2Fj.molcel.2004.12.030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm400556w&amp;key=15694340" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm400556w&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhs1Oit78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2005&pages=393-403&author=L.+Chenauthor=S.+N.+Willisauthor=A.+Weiauthor=B.+J.+Smithauthor=J.+I.+Fletcherauthor=M.+G.+Hindsauthor=P.+M.+Colmanauthor=C.+L.+Dayauthor=J.+M.+Adamsauthor=D.+C.+Huang&title=Differential+targeting+of+prosurvival+Bcl-2+proteins+by+their+BH3-only+ligands+allows+complementary+apoptotic+function"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function</span></div><div class="casAuthors">Chen, Lin; Willis, Simon N.; Wei, Andrew; Smith, Brian J.; Fletcher, Jamie I.; Hinds, Mark G.; Colman, Peter M.; Day, Catherine L.; Adams, Jerry M.; Huang, David C. S.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">393-403</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Apoptosis is initiated when Bcl-2 and its prosurvival relatives are engaged by proapoptotic BH3-only proteins via interaction of its BH3 domain with a groove on the Bcl-2-like proteins.  These interactions have been considered promiscuous, but our anal. of the affinity of eight BH3 peptides for five Bcl-2-like proteins has revealed that the interactions vary over 10,000-fold in affinity, and accordingly, only certain protein pairs assoc. inside cells.  Bim and Puma potently engaged all the prosurvival proteins comparably.  Bad, however, bound tightly to Bcl-2, Bcl-xL, and Bcl-w but only weakly to A1 and not to Mcl-1.  Strikingly, Noxa bound only Mcl-1 and A1.  In accord with their complementary binding, Bad and Noxa cooperated to induce potent killing.  The results suggest that apoptosis relies on selective interactions between particular subsets of these proteins and that it should be feasible to discover BH3-mimetic drugs that inactivate specific prosurvival targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHzR4DFj95LbVg90H21EOLACvtfcHk0liSRoWrQ4297g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhs1Oit78%253D&md5=702d041ad86552b3581fed5198a96d7b</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2004.12.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2004.12.030%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DL.%26aulast%3DWillis%26aufirst%3DS.%2BN.%26aulast%3DWei%26aufirst%3DA.%26aulast%3DSmith%26aufirst%3DB.%2BJ.%26aulast%3DFletcher%26aufirst%3DJ.%2BI.%26aulast%3DHinds%26aufirst%3DM.%2BG.%26aulast%3DColman%26aufirst%3DP.%2BM.%26aulast%3DDay%26aufirst%3DC.%2BL.%26aulast%3DAdams%26aufirst%3DJ.%2BM.%26aulast%3DHuang%26aufirst%3DD.%2BC.%26atitle%3DDifferential%2520targeting%2520of%2520prosurvival%2520Bcl-2%2520proteins%2520by%2520their%2520BH3-only%2520ligands%2520allows%2520complementary%2520apoptotic%2520function%26jtitle%3DMol.%2520Cell%26date%3D2005%26volume%3D17%26spage%3D393%26epage%3D403" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Mason, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vandenberg, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cory, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, D. C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, A. W.</span><span> </span><span class="NLM_article-title">In vivo efficacy of the Bcl-2 antagonist ABT-737 against aggressive Myc-driven lymphomas</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">17961</span><span class="NLM_x">–</span> <span class="NLM_lpage">17966</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=17961-17966&author=K.+D.+Masonauthor=C.+J.+Vandenbergauthor=C.+L.+Scottauthor=A.+H.+Weiauthor=S.+Coryauthor=D.+C.+S.+Huangauthor=A.+W.+Roberts&title=In+vivo+efficacy+of+the+Bcl-2+antagonist+ABT-737+against+aggressive+Myc-driven+lymphomas"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMason%26aufirst%3DK.%2BD.%26aulast%3DVandenberg%26aufirst%3DC.%2BJ.%26aulast%3DScott%26aufirst%3DC.%2BL.%26aulast%3DWei%26aufirst%3DA.%2BH.%26aulast%3DCory%26aufirst%3DS.%26aulast%3DHuang%26aufirst%3DD.%2BC.%2BS.%26aulast%3DRoberts%26aufirst%3DA.%2BW.%26atitle%3DIn%2520vivo%2520efficacy%2520of%2520the%2520Bcl-2%2520antagonist%2520ABT-737%2520against%2520aggressive%2520Myc-driven%2520lymphomas%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2008%26volume%3D105%26spage%3D17961%26epage%3D17966" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">van Delft, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vandenberg, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czabotar, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willis, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Day, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cory, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, D. C. S.</span><span> </span><span class="NLM_article-title">The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">389</span><span class="NLM_x">–</span> <span class="NLM_lpage">399</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm400556w&amp;key=10.1016%2Fj.ccr.2006.08.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm400556w&amp;key=17097561" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm400556w&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1Glu7nK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2006&pages=389-399&author=M.+F.+van+Delftauthor=A.+H.+Weiauthor=K.+D.+Masonauthor=C.+J.+Vandenbergauthor=L.+Chenauthor=P.+E.+Czabotarauthor=S.+N.+Willisauthor=C.+L.+Scottauthor=C.+L.+Dayauthor=S.+Coryauthor=J.+M.+Adamsauthor=A.+W.+Robertsauthor=D.+C.+S.+Huang&title=The+BH3+mimetic+ABT-737+targets+selective+Bcl-2+proteins+and+efficiently+induces+apoptosis+via+Bak%2FBax+if+Mcl-1+is+neutralized"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized</span></div><div class="casAuthors">van Delft, Mark F.; Wei, Andrew H.; Mason, Kylie D.; Vandenberg, Cassandra J.; Chen, Lin; Czabotar, Peter E.; Willis, Simon N.; Scott, Clare L.; Day, Catherine L.; Cory, Suzanne; Adams, Jerry M.; Roberts, Andrew W.; Huang, David C. S.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">389-399</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Since apoptosis is impaired in malignant cells overexpressing prosurvival Bcl-2 proteins, drugs mimicking their natural antagonists, BH3-only proteins, might overcome chemoresistance.  Of seven putative BH3 mimetics tested, only ABT-737 triggered Bax/Bak-mediated apoptosis.  Despite its high affinity for Bcl-2, Bcl-xL, and Bcl-w, many cell types proved refractory to ABT-737.  We show that this resistance reflects ABT-737's inability to target another prosurvival relative, Mcl-1.  Downregulation of Mcl-1 by several strategies conferred sensitivity to ABT-737.  Furthermore, enforced Mcl-1 expression in a mouse lymphoma model conferred resistance.  In contrast, cells overexpressing Bcl-2 remained highly sensitive to ABT-737.  Hence, ABT-737 should prove efficacious in tumors with low Mcl-1 levels, or when combined with agents that inactivate Mcl-1, even to treat those tumors that overexpress Bcl-2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWAmMTX4bzgbVg90H21EOLACvtfcHk0liSRoWrQ4297g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1Glu7nK&md5=6c1de734427cb187fbb9002fd9269ca8</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2006.08.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2006.08.027%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BDelft%26aufirst%3DM.%2BF.%26aulast%3DWei%26aufirst%3DA.%2BH.%26aulast%3DMason%26aufirst%3DK.%2BD.%26aulast%3DVandenberg%26aufirst%3DC.%2BJ.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DCzabotar%26aufirst%3DP.%2BE.%26aulast%3DWillis%26aufirst%3DS.%2BN.%26aulast%3DScott%26aufirst%3DC.%2BL.%26aulast%3DDay%26aufirst%3DC.%2BL.%26aulast%3DCory%26aufirst%3DS.%26aulast%3DAdams%26aufirst%3DJ.%2BM.%26aulast%3DRoberts%26aufirst%3DA.%2BW.%26aulast%3DHuang%26aufirst%3DD.%2BC.%2BS.%26atitle%3DThe%2520BH3%2520mimetic%2520ABT-737%2520targets%2520selective%2520Bcl-2%2520proteins%2520and%2520efficiently%2520induces%2520apoptosis%2520via%2520Bak%252FBax%2520if%2520Mcl-1%2520is%2520neutralized%26jtitle%3DCancer%2520Cell%26date%3D2006%26volume%3D10%26spage%3D389%26epage%3D399" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nimmer, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tahir, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fryer, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hahn, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iciek, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgan, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nasarre, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Preusser, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinhart, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenberg, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elmore, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tse, C.</span><span> </span><span class="NLM_article-title">Bcl-2 family proteins are essential for platelet survival</span> <span class="citation_source-journal">Cell Death Differ.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">943</span><span class="NLM_x">–</span> <span class="NLM_lpage">951</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm400556w&amp;key=10.1038%2Fsj.cdd.4402072" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm400556w&amp;key=17205078" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm400556w&amp;key=1%3ACAS%3A528%3ADC%252BD2sXktlOitro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2007&pages=943-951&author=H.+Zhangauthor=P.+M.+Nimmerauthor=S.+K.+Tahirauthor=J.+Chenauthor=R.+M.+Fryerauthor=K.+R.+Hahnauthor=L.+A.+Iciekauthor=S.+J.+Morganauthor=M.+C.+Nasarreauthor=R.+Nelsonauthor=L.+C.+Preusserauthor=G.+A.+Reinhartauthor=M.+L.+Smithauthor=S.+H.+Rosenbergauthor=S.+W.+Elmoreauthor=C.+Tse&title=Bcl-2+family+proteins+are+essential+for+platelet+survival"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Bcl-2 family proteins are essential for platelet survival</span></div><div class="casAuthors">Zhang, H.; Nimmer, P. M.; Tahir, S. K.; Chen, J.; Fryer, R. M.; Hahn, K. R.; Iciek, L. A.; Morgan, S. J.; Nasarre, M. C.; Nelson, R.; Preusser, L. C.; Reinhart, G. A.; Smith, M. L.; Rosenberg, S. H.; Elmore, S. W.; Tse, C.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death and Differentiation</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">943-951</span>CODEN:
                <span class="NLM_cas:coden">CDDIEK</span>;
        ISSN:<span class="NLM_cas:issn">1350-9047</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Platelets are relatively short-lived, anucleated cells that are essential for proper hemostasis.  The regulation of platelet survival in the circulation remains poorly understood.  The process of platelet activation and senescence in vivo is assocd. with processes similar to those obsd. during apoptosis in nucleated cells, including loss of mitochondrial membrane potential, caspase activation, phosphatidylserine (PS) externalization, and cell shrinkage.  ABT-737, a potent antagonist of Bcl-2, Bcl-XL, and Bcl-w, induces apoptosis in nucleated cells dependent on these proteins for survival.  In vivo, ABT-737 induces a redn. of circulating platelets that is maintained during drug therapy, followed by recovery to normal levels within several days after treatment cessation.  Whole body scintog. utilizing [111]Indium-labeled platelets in dogs shows that ABT-737-induced platelet clearance is primarily mediated by the liver.  In vitro, ABT-737 treatment leads to activation of key apoptotic processes including cytochrome c release, caspase-3 activation, and PS externalization in isolated platelets.  Despite these changes, ABT-737 is ineffective in promoting platelet activation as measured by granule release markers and platelet aggregation.  Taken together, these data suggest that ABT-737 induces an apoptosis-like response in platelets that is distinct from platelet activation and results in enhanced clearance in vivo by the reticuloendothelial system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpG1nWthgLjMrVg90H21EOLACvtfcHk0liSRoWrQ4297g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXktlOitro%253D&md5=4ffa5dced24a6e58b7a3dd39d1ddf09f</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1038%2Fsj.cdd.4402072&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.cdd.4402072%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DNimmer%26aufirst%3DP.%2BM.%26aulast%3DTahir%26aufirst%3DS.%2BK.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DFryer%26aufirst%3DR.%2BM.%26aulast%3DHahn%26aufirst%3DK.%2BR.%26aulast%3DIciek%26aufirst%3DL.%2BA.%26aulast%3DMorgan%26aufirst%3DS.%2BJ.%26aulast%3DNasarre%26aufirst%3DM.%2BC.%26aulast%3DNelson%26aufirst%3DR.%26aulast%3DPreusser%26aufirst%3DL.%2BC.%26aulast%3DReinhart%26aufirst%3DG.%2BA.%26aulast%3DSmith%26aufirst%3DM.%2BL.%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26aulast%3DElmore%26aufirst%3DS.%2BW.%26aulast%3DTse%26aufirst%3DC.%26atitle%3DBcl-2%2520family%2520proteins%2520are%2520essential%2520for%2520platelet%2520survival%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2007%26volume%3D14%26spage%3D943%26epage%3D951" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Mason, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carpinelli, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fletcher, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collinge, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hilton, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellis, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ekert, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metcalf, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kile, B. T.</span><span> </span><span class="NLM_article-title">Programmed anuclear cell death delimits platelet life span</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">128</span><span class="NLM_x">, </span> <span class="NLM_fpage">1173</span><span class="NLM_x">–</span> <span class="NLM_lpage">1186</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm400556w&amp;key=10.1016%2Fj.cell.2007.01.037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm400556w&amp;key=17382885" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm400556w&amp;key=1%3ACAS%3A528%3ADC%252BD2sXkslGms7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2007&pages=1173-1186&author=K.+D.+Masonauthor=M.+R.+Carpinelliauthor=J.+I.+Fletcherauthor=J.+E.+Collingeauthor=A.+A.+Hiltonauthor=S.+Ellisauthor=P.+N.+Kellyauthor=P.+G.+Ekertauthor=D.+Metcalfauthor=A.+W.+Robertsauthor=D.+C.+Huangauthor=B.+T.+Kile&title=Programmed+anuclear+cell+death+delimits+platelet+life+span"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Programmed anuclear cell death delimits platelet life span</span></div><div class="casAuthors">Mason, Kylie D.; Carpinelli, Marina R.; Fletcher, Jamie I.; Collinge, Janelle E.; Hilton, Adrienne A.; Ellis, Sarah; Kelly, Priscilla N.; Ekert, Paul G.; Metcalf, Donald; Roberts, Andrew W.; Huang, David C. S.; Kile, Benjamin T.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">128</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1173-1186</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Platelets are anuclear cytoplasmic fragments essential for blood clotting and wound healing.  Despite much speculation, the factors detg. their life span in the circulation are unknown.  We show here that an intrinsic program for apoptosis controls platelet survival and dictates their life span.  Pro-survival Bcl-xL constrains the pro-apoptotic activity of Bak to maintain platelet survival, but as Bcl-xL degrades, aged platelets are primed for cell death.  Genetic ablation or pharmacol. inactivation of Bcl-xL reduces platelet half-life and causes thrombocytopenia in a dose-dependent manner.  Deletion of Bak corrects these defects, and platelets from Bak-deficient mice live longer than normal.  Thus, platelets are, by default, genetically programmed to die by apoptosis.  The antagonistic balance between Bcl-xL and Bak constitutes a mol. clock that dets. platelet life span: this represents an important paradigm for cellular homeostasis, and has profound implications for the diagnosis and treatment of disorders that affect platelet no. and function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOmRufdMqb1rVg90H21EOLACvtfcHk0lgG9l4GAGxsVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXkslGms7Y%253D&md5=c8fa8d967cf22317d15802cd25ceb365</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2007.01.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2007.01.037%26sid%3Dliteratum%253Aachs%26aulast%3DMason%26aufirst%3DK.%2BD.%26aulast%3DCarpinelli%26aufirst%3DM.%2BR.%26aulast%3DFletcher%26aufirst%3DJ.%2BI.%26aulast%3DCollinge%26aufirst%3DJ.%2BE.%26aulast%3DHilton%26aufirst%3DA.%2BA.%26aulast%3DEllis%26aufirst%3DS.%26aulast%3DKelly%26aufirst%3DP.%2BN.%26aulast%3DEkert%26aufirst%3DP.%2BG.%26aulast%3DMetcalf%26aufirst%3DD.%26aulast%3DRoberts%26aufirst%3DA.%2BW.%26aulast%3DHuang%26aufirst%3DD.%2BC.%26aulast%3DKile%26aufirst%3DB.%2BT.%26atitle%3DProgrammed%2520anuclear%2520cell%2520death%2520delimits%2520platelet%2520life%2520span%26jtitle%3DCell%26date%3D2007%26volume%3D128%26spage%3D1173%26epage%3D1186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Tahir, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, X. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgan-Lappe, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarthy, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warner, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ng, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fesik, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elmore, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenberg, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tse, C.</span><span> </span><span class="NLM_article-title">Influence of Bcl-2 family members on the cellular response of small-cell lung cancer cell lines to ABT-737</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">1176</span><span class="NLM_x">–</span> <span class="NLM_lpage">1183</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2007&pages=1176-1183&author=S.+K.+Tahirauthor=X.+F.+Yangauthor=M.+G.+Andersonauthor=S.+E.+Morgan-Lappeauthor=A.+V.+Sarthyauthor=J.+Chenauthor=R.+B.+Warnerauthor=S.+C.+Ngauthor=S.+W.+Fesikauthor=S.+W.+Elmoreauthor=S.+H.+Rosenbergauthor=C.+Tse&title=Influence+of+Bcl-2+family+members+on+the+cellular+response+of+small-cell+lung+cancer+cell+lines+to+ABT-737"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTahir%26aufirst%3DS.%2BK.%26aulast%3DYang%26aufirst%3DX.%2BF.%26aulast%3DAnderson%26aufirst%3DM.%2BG.%26aulast%3DMorgan-Lappe%26aufirst%3DS.%2BE.%26aulast%3DSarthy%26aufirst%3DA.%2BV.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DWarner%26aufirst%3DR.%2BB.%26aulast%3DNg%26aufirst%3DS.%2BC.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26aulast%3DElmore%26aufirst%3DS.%2BW.%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26aulast%3DTse%26aufirst%3DC.%26atitle%3DInfluence%2520of%2520Bcl-2%2520family%2520members%2520on%2520the%2520cellular%2520response%2520of%2520small-cell%2520lung%2520cancer%2520cell%2520lines%2520to%2520ABT-737%26jtitle%3DCancer%2520Res.%26date%3D2007%26volume%3D67%26spage%3D1176%26epage%3D1183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Beroukhim, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mermel, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porter, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raychaudhuri, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donovan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barretina, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boehm, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dobson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urashima, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henry, K. T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinchback, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ligon, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haery, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greulich, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reich, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winckler, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrence, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weir, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiang, D. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bass, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prensner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liefeld, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yecies, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Signoretti, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maher, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaye, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tepper, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fletcher, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tabernero, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baselga, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsao, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demichelis, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubin, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janne, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daly, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nucera, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levine, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ebert, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabriel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rustgi, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antonescu, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ladanyi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Letai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garraway, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beer, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">True, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamoto, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pomeroy, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golub, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lander, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Getz, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sellers, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyerson, M.</span><span> </span><span class="NLM_article-title">The landscape of somatic copy-number alteration across human cancers</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">463</span><span class="NLM_x">, </span> <span class="NLM_fpage">899</span><span class="NLM_x">–</span> <span class="NLM_lpage">905</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm400556w&amp;key=10.1038%2Fnature08822" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm400556w&amp;key=20164920" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm400556w&amp;key=1%3ACAS%3A528%3ADC%252BC3cXitFemsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=463&publication_year=2010&pages=899-905&author=R.+Beroukhimauthor=C.+H.+Mermelauthor=D.+Porterauthor=G.+Weiauthor=S.+Raychaudhuriauthor=J.+Donovanauthor=J.+Barretinaauthor=J.+S.+Boehmauthor=J.+Dobsonauthor=M.+Urashimaauthor=K.+T.+M.+Henryauthor=R.+M.+Pinchbackauthor=A.+H.+Ligonauthor=Y.+Choauthor=L.+Haeryauthor=H.+Greulichauthor=M.+Reichauthor=W.+Wincklerauthor=M.+S.+Lawrenceauthor=B.+A.+Weirauthor=K.+E.+Tanakaauthor=D.+Y.+Chiangauthor=A.+J.+Bassauthor=A.+Looauthor=C.+Hoffmanauthor=J.+Prensnerauthor=T.+Liefeldauthor=Q.+Gaoauthor=D.+Yeciesauthor=S.+Signorettiauthor=E.+Maherauthor=F.+J.+Kayeauthor=H.+Sasakiauthor=J.+E.+Tepperauthor=J.+A.+Fletcherauthor=J.+Taberneroauthor=J.+Baselgaauthor=M.+Tsaoauthor=F.+Demichelisauthor=M.+A.+Rubinauthor=P.+A.+Janneauthor=M.+J.+Dalyauthor=C.+Nuceraauthor=R.+L.+Levineauthor=B.+L.+Ebertauthor=S.+Gabrielauthor=A.+K.+Rustgiauthor=C.+R.+Antonescuauthor=M.+Ladanyiauthor=A.+Letaiauthor=L.+A.+Garrawayauthor=M.+Lodaauthor=D.+G.+Beerauthor=L.+D.+Trueauthor=A.+Okamotoauthor=S.+L.+Pomeroyauthor=S.+Singerauthor=T.+Golubauthor=E.+S.+Landerauthor=G.+Getzauthor=W.+R.+Sellersauthor=M.+Meyerson&title=The+landscape+of+somatic+copy-number+alteration+across+human+cancers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">The landscape of somatic copy-number alteration across human cancers</span></div><div class="casAuthors">Beroukhim, Rameen; Mermel, Craig H.; Porter, Dale; Wei, Guo; Raychaudhuri, Soumya; Donovan, Jerry; Barretina, Jordi; Boehm, Jesse S.; Dobson, Jennifer; Urashima, Mitsuyoshi; Mc Henry, Kevin T.; Pinchback, Reid M.; Ligon, Azra H.; Cho, Yoon-Jae; Haery, Leila; Greulich, Heidi; Reich, Michael; Winckler, Wendy; Lawrence, Michael S.; Weir, Barbara A.; Tanaka, Kumiko E.; Chiang, Derek Y.; Bass, Adam J.; Loo, Alice; Hoffman, Carter; Prensner, John; Liefeld, Ted; Gao, Qing; Yecies, Derek; Signoretti, Sabina; Maher, Elizabeth; Kaye, Frederic J.; Sasaki, Hidefumi; Tepper, Joel E.; Fletcher, Jonathan A.; Tabernero, Josep; Baselga, Jose; Tsao, Ming-Sound; Demichelis, Francesca; Rubin, Mark A.; Janne, Pasi A.; Daly, Mark J.; Nucera, Carmelo; Levine, Ross L.; Ebert, Benjamin L.; Gabriel, Stacey; Rustgi, Anil K.; Antonescu, Cristina R.; Ladanyi, Marc; Letai, Anthony; Garraway, Levi A.; Loda, Massimo; Beer, David G.; True, Lawrence D.; Okamoto, Aikou; Pomeroy, Scott L.; Singer, Samuel; Golub, Todd R.; Lander, Eric S.; Getz, Gad; Sellers, William R.; Meyerson, Matthew</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">463</span>
        (<span class="NLM_cas:issue">7283</span>),
    <span class="NLM_cas:pages">899-905</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A powerful way to discover key genes with causal roles in oncogenesis is to identify genomic regions that undergo frequent alteration in human cancers.  Here we present high-resoln. analyses of somatic copy-no. alterations (SCNAs) from 3131 cancer specimens, belonging largely to 26 histol. types.  We identify 158 regions of focal SCNA that are altered at significant frequency across several cancer types, of which 122 cannot be explained by the presence of a known cancer target gene located within these regions.  Several gene families are enriched among these regions of focal SCNA, including the BCL2 family of apoptosis regulators and the NF-κB pathway.  We show that cancer cells contg. amplifications surrounding the MCL1 and BCL2L1 anti-apoptotic genes depend on the expression of these genes for survival.  Finally, we demonstrate that a large majority of SCNAs identified in individual cancer types are present in several cancer types.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCxYRlqR0wXLVg90H21EOLACvtfcHk0lgG9l4GAGxsVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXitFemsr0%253D&md5=be6d81f5449cba96dfb4659106f706b0</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1038%2Fnature08822&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature08822%26sid%3Dliteratum%253Aachs%26aulast%3DBeroukhim%26aufirst%3DR.%26aulast%3DMermel%26aufirst%3DC.%2BH.%26aulast%3DPorter%26aufirst%3DD.%26aulast%3DWei%26aufirst%3DG.%26aulast%3DRaychaudhuri%26aufirst%3DS.%26aulast%3DDonovan%26aufirst%3DJ.%26aulast%3DBarretina%26aufirst%3DJ.%26aulast%3DBoehm%26aufirst%3DJ.%2BS.%26aulast%3DDobson%26aufirst%3DJ.%26aulast%3DUrashima%26aufirst%3DM.%26aulast%3DHenry%26aufirst%3DK.%2BT.%2BM.%26aulast%3DPinchback%26aufirst%3DR.%2BM.%26aulast%3DLigon%26aufirst%3DA.%2BH.%26aulast%3DCho%26aufirst%3DY.%26aulast%3DHaery%26aufirst%3DL.%26aulast%3DGreulich%26aufirst%3DH.%26aulast%3DReich%26aufirst%3DM.%26aulast%3DWinckler%26aufirst%3DW.%26aulast%3DLawrence%26aufirst%3DM.%2BS.%26aulast%3DWeir%26aufirst%3DB.%2BA.%26aulast%3DTanaka%26aufirst%3DK.%2BE.%26aulast%3DChiang%26aufirst%3DD.%2BY.%26aulast%3DBass%26aufirst%3DA.%2BJ.%26aulast%3DLoo%26aufirst%3DA.%26aulast%3DHoffman%26aufirst%3DC.%26aulast%3DPrensner%26aufirst%3DJ.%26aulast%3DLiefeld%26aufirst%3DT.%26aulast%3DGao%26aufirst%3DQ.%26aulast%3DYecies%26aufirst%3DD.%26aulast%3DSignoretti%26aufirst%3DS.%26aulast%3DMaher%26aufirst%3DE.%26aulast%3DKaye%26aufirst%3DF.%2BJ.%26aulast%3DSasaki%26aufirst%3DH.%26aulast%3DTepper%26aufirst%3DJ.%2BE.%26aulast%3DFletcher%26aufirst%3DJ.%2BA.%26aulast%3DTabernero%26aufirst%3DJ.%26aulast%3DBaselga%26aufirst%3DJ.%26aulast%3DTsao%26aufirst%3DM.%26aulast%3DDemichelis%26aufirst%3DF.%26aulast%3DRubin%26aufirst%3DM.%2BA.%26aulast%3DJanne%26aufirst%3DP.%2BA.%26aulast%3DDaly%26aufirst%3DM.%2BJ.%26aulast%3DNucera%26aufirst%3DC.%26aulast%3DLevine%26aufirst%3DR.%2BL.%26aulast%3DEbert%26aufirst%3DB.%2BL.%26aulast%3DGabriel%26aufirst%3DS.%26aulast%3DRustgi%26aufirst%3DA.%2BK.%26aulast%3DAntonescu%26aufirst%3DC.%2BR.%26aulast%3DLadanyi%26aufirst%3DM.%26aulast%3DLetai%26aufirst%3DA.%26aulast%3DGarraway%26aufirst%3DL.%2BA.%26aulast%3DLoda%26aufirst%3DM.%26aulast%3DBeer%26aufirst%3DD.%2BG.%26aulast%3DTrue%26aufirst%3DL.%2BD.%26aulast%3DOkamoto%26aufirst%3DA.%26aulast%3DPomeroy%26aufirst%3DS.%2BL.%26aulast%3DSinger%26aufirst%3DS.%26aulast%3DGolub%26aufirst%3DT.%26aulast%3DLander%26aufirst%3DE.%2BS.%26aulast%3DGetz%26aufirst%3DG.%26aulast%3DSellers%26aufirst%3DW.%2BR.%26aulast%3DMeyerson%26aufirst%3DM.%26atitle%3DThe%2520landscape%2520of%2520somatic%2520copy-number%2520alteration%2520across%2520human%2520cancers%26jtitle%3DNature%26date%3D2010%26volume%3D463%26spage%3D899%26epage%3D905" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Amundson, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myers, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scudiero, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitada, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fornace, A. J.,  Jr.</span><span> </span><span class="NLM_article-title">An informatics approach identifying markers of chemosensitivity in human cancer cell lines</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">6101</span><span class="NLM_x">–</span> <span class="NLM_lpage">6110</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm400556w&amp;key=11085534" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm400556w&amp;key=1%3ACAS%3A528%3ADC%252BD3cXotV2lsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2000&pages=6101-6110&author=S.+A.+Amundsonauthor=T.+G.+Myersauthor=D.+Scudieroauthor=S.+Kitadaauthor=J.+C.+Reedauthor=A.+J.+Fornace&title=An+informatics+approach+identifying+markers+of+chemosensitivity+in+human+cancer+cell+lines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">An informatics approach identifying markers of chemosensitivity in human cancer cell lines</span></div><div class="casAuthors">Amundson, Sally A.; Myers, Timothy G.; Scudiero, Dominic; Kitada, Shinichi; Reed, John C.; Fornace, Albert J., Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6101-6110</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">We have used a sensitive and reproducible method of measuring mRNA expression to compare basal levels of 10 transcripts in the 60 cell lines of the National Cancer Institute's in vitro anticancer drug screen (NCI-ACDS) under conditions of exponential growth.  The strongest correlation among these target genes was between levels of CIP1/WAF1 and BAX.  Levels of the three major growth arrest and DNA damage-inducible gene transcripts, (GADD34, GADD45, and GADD153), which are coordinately regulated in response to many stresses, were also correlated across the 60 cell lines.  Although the stress induction of several of the transcripts studied here has been shown to be dependent on wild-type p53 status, basal levels of only CIP1/WAF1 and BAX were found to correlate with p53 status.  As expected, basal expression of O6 alkyl guanine alkyl-transferase correlated well with resistance to O6-alkylating agents (r = -0.44) but not with resistance to alkylators with different mechanisms of action (r = -0.04).  When basal expression levels of the 10 genes across the NCI-ACDS panel were compared with sensitivities to a panel of 122 std. chemotherapy agents, the most striking relationship was a strong neg. correlation (r = -0.3) between basal BCL-X levels and sensitivity to drugs in all of the mechanistic classes except one class of antimetabolites.  Sensitivities to a maximally diverse sample of 1200 from 70,000 compds. tested in the NCI-ACDS of agents were also neg. correlated with BCL-X levels.  A novel application of factor anal. revealed that the newly discovered assocns. were independent of previously demonstrated sensitivity factors such as p53 mutation status and native population doubling time.  A similar pattern of correlation was seen for Bcl-XL protein levels.  Conversely, BAX and BCL2, two other genes assocd. with regulation of apoptosis, showed no overall correlation with drug sensitivities.  This suggests that BCL-X may play a unique role in general resistance to cytotoxic agents, with the cell lines demonstrating relative resistance to 70,000 cytotoxic agents in the NCI-ACDS being characterized by high BCL-X expression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGDcpza2WFJbVg90H21EOLACvtfcHk0lgupv7gW_faNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXotV2lsb4%253D&md5=0da385ff6e48e7351d16036c1a8fcf2e</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAmundson%26aufirst%3DS.%2BA.%26aulast%3DMyers%26aufirst%3DT.%2BG.%26aulast%3DScudiero%26aufirst%3DD.%26aulast%3DKitada%26aufirst%3DS.%26aulast%3DReed%26aufirst%3DJ.%2BC.%26aulast%3DFornace%26aufirst%3DA.%2BJ.%26atitle%3DAn%2520informatics%2520approach%2520identifying%2520markers%2520of%2520chemosensitivity%2520in%2520human%2520cancer%2520cell%2520lines%26jtitle%3DCancer%2520Res.%26date%3D2000%26volume%3D60%26spage%3D6101%26epage%3D6110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Lessene, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czabotar, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sleebs, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zobel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowes, K. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baell, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colman, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deshayes, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fairbrother, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flygare, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbons, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kersten, W. J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kulasegaram, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moss, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parisot, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Street, I. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, D. C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, K. G.</span><span> </span><span class="NLM_article-title">Structure-guided design of a selective BCL-X<sub>L</sub> inhibitor</span> <span class="citation_source-journal">Nature Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">390</span><span class="NLM_x">–</span> <span class="NLM_lpage">397</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm400556w&amp;key=10.1038%2Fnchembio.1246" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm400556w&amp;key=23603658" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm400556w&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmt1Whsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=390-397&author=G.+Lesseneauthor=P.+E.+Czabotarauthor=B.+E.+Sleebsauthor=K.+Zobelauthor=K.+N.+Lowesauthor=J.+M.+Adamsauthor=J.+B.+Baellauthor=P.+M.+Colmanauthor=K.+Deshayesauthor=W.+J.+Fairbrotherauthor=J.+A.+Flygareauthor=P.+Gibbonsauthor=W.+J.+A.+Kerstenauthor=S.+Kulasegaramauthor=R.+M.+Mossauthor=J.+P.+Parisotauthor=B.+J.+Smithauthor=I.+P.+Streetauthor=H.+Yangauthor=D.+C.+S.+Huangauthor=K.+G.+Watson&title=Structure-guided+design+of+a+selective+BCL-XL+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-guided design of a selective BCL-XL inhibitor</span></div><div class="casAuthors">Lessene, Guillaume; Czabotar, Peter E.; Sleebs, Brad E.; Zobel, Kerry; Lowes, Kym N.; Adams, Jerry M.; Baell, Jonathan B.; Colman, Peter M.; Deshayes, Kurt; Fairbrother, Wayne J.; Flygare, John A.; Gibbons, Paul; Kersten, Wilhelmus J. A.; Kulasegaram, Sanji; Moss, Rebecca M.; Parisot, John P.; Smith, Brian J.; Street, Ian P.; Yang, Hong; Huang, David C. S.; Watson, Keith G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">390-397</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The prosurvival BCL-2 family protein BCL-XL is often overexpressed in solid tumors and renders malignant tumor cells resistant to anticancer therapeutics.  Enhancing apoptotic responses by inhibiting BCL-XL will most likely have widespread utility in cancer treatment and, instead of inhibiting multiple prosurvival BCL-2 family members, a BCL-XL-selective inhibitor would be expected to minimize the toxicity to normal tissues.  We describe the use of a high-throughput screen to discover a new series of small mols. targeting BCL-XL and their structure-guided development by medicinal chem.  The optimized compd., WEHI-539 (7), has high affinity (subnanomolar) and selectivity for BCL-XL and potently kills cells by selectively antagonizing its prosurvival activity.  WEHI-539 will be an invaluable tool for distinguishing the roles of BCL-XL from those of its prosurvival relatives, both in normal cells and notably in malignant tumor cells, many of which may prove to rely upon BCL-XL for their sustained growth.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGph9LM-ZVEscrVg90H21EOLACvtfcHk0lgupv7gW_faNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmt1Whsb0%253D&md5=c9179ea71db5b72968b0b0e9f8a03eeb</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1246&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1246%26sid%3Dliteratum%253Aachs%26aulast%3DLessene%26aufirst%3DG.%26aulast%3DCzabotar%26aufirst%3DP.%2BE.%26aulast%3DSleebs%26aufirst%3DB.%2BE.%26aulast%3DZobel%26aufirst%3DK.%26aulast%3DLowes%26aufirst%3DK.%2BN.%26aulast%3DAdams%26aufirst%3DJ.%2BM.%26aulast%3DBaell%26aufirst%3DJ.%2BB.%26aulast%3DColman%26aufirst%3DP.%2BM.%26aulast%3DDeshayes%26aufirst%3DK.%26aulast%3DFairbrother%26aufirst%3DW.%2BJ.%26aulast%3DFlygare%26aufirst%3DJ.%2BA.%26aulast%3DGibbons%26aufirst%3DP.%26aulast%3DKersten%26aufirst%3DW.%2BJ.%2BA.%26aulast%3DKulasegaram%26aufirst%3DS.%26aulast%3DMoss%26aufirst%3DR.%2BM.%26aulast%3DParisot%26aufirst%3DJ.%2BP.%26aulast%3DSmith%26aufirst%3DB.%2BJ.%26aulast%3DStreet%26aufirst%3DI.%2BP.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DHuang%26aufirst%3DD.%2BC.%2BS.%26aulast%3DWatson%26aufirst%3DK.%2BG.%26atitle%3DStructure-guided%2520design%2520of%2520a%2520selective%2520BCL-XL%2520inhibitor%26jtitle%3DNature%2520Chem.%2520Biol.%26date%3D2013%26volume%3D9%26spage%3D390%26epage%3D397" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="note"><p class="first last">The LPA technology proved to be a reliable technology compared to others. In particular, it allowed us to screen at high starting concentrations and obtain reproducible and meaningful results. In addition, the conditions used in the screen removed misleading SAR patterns due to nonselective hydrophobic interactions.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Petros, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinges, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Augeri, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumeister, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Betebenner, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bures, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elmore, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajduk, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joseph, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landis, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nettesheim, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenberg, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zanze, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fesik, S. W.</span><span> </span><span class="NLM_article-title">Discovery of a potent inhibitor of the antiapoptotic protein Bcl-x<sub>L</sub> from NMR and parallel synthesis</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">656</span><span class="NLM_x">–</span> <span class="NLM_lpage">663</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0507532" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm400556w&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlant73J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=656-663&author=A.+M.+Petrosauthor=J.+Dingesauthor=D.+J.+Augeriauthor=S.+A.+Baumeisterauthor=D.+A.+Betebennerauthor=M.+G.+Buresauthor=S.+W.+Elmoreauthor=P.+J.+Hajdukauthor=M.+K.+Josephauthor=S.+K.+Landisauthor=D.+G.+Nettesheimauthor=S.+H.+Rosenbergauthor=W.+Shenauthor=S.+Thomasauthor=X.+Wangauthor=I.+Zanzeauthor=H.+Zhangauthor=S.+W.+Fesik&title=Discovery+of+a+potent+inhibitor+of+the+antiapoptotic+protein+Bcl-xL+from+NMR+and+parallel+synthesis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Potent Inhibitor of the Antiapoptotic Protein Bcl-xL from NMR and Parallel Synthesis</span></div><div class="casAuthors">Petros, Andrew M.; Dinges, Jurgen; Augeri, David J.; Baumeister, Steven A.; Betebenner, David A.; Bures, Mark G.; Elmore, Steven W.; Hajduk, Philip J.; Joseph, Mary K.; Landis, Shelley K.; Nettesheim, David G.; Rosenberg, Saul H.; Shen, Wang; Thomas, Sheela; Wang, Xilu; Zanze, Irini; Zhang, Haichao; Fesik, Stephen W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">656-663</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The antiapoptotic proteins Bcl-xL and Bcl-2 play key roles in the maintenance of normal cellular homeostasis.  However, their overexpression can lead to oncogenic transformation and is responsible for drug resistance in certain types of cancer.  This makes Bcl-xL and Bcl-2 attractive targets for the development of potential anticancer agents.  Here we describe the structure-based discovery of a potent Bcl-xL inhibitor directed at a hydrophobic groove on the surface of the protein.  This groove represents the binding site for BH3 peptides from proapoptotic Bcl-2 family members such as Bak and Bad.  Application of NMR-based screening yielded an initial biaryl acid with an affinity (Kd) of ∼300 μM for the protein.  Following the classical "SAR by NMR" approach, a second-site ligand was identified that bound proximal to the first-site ligand in the hydrophobic groove.  From NMR-based structural studies and parallel synthesis, a potent ligand was obtained, which binds to Bcl-xL with an inhibition const. (Ki) of 36 ± 2 nM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYP_kg1BoLW7Vg90H21EOLACvtfcHk0lg2emozgfYLyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlant73J&md5=ef6d8989682f6eaadeda9d7b6eae09e4</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm0507532&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0507532%26sid%3Dliteratum%253Aachs%26aulast%3DPetros%26aufirst%3DA.%2BM.%26aulast%3DDinges%26aufirst%3DJ.%26aulast%3DAugeri%26aufirst%3DD.%2BJ.%26aulast%3DBaumeister%26aufirst%3DS.%2BA.%26aulast%3DBetebenner%26aufirst%3DD.%2BA.%26aulast%3DBures%26aufirst%3DM.%2BG.%26aulast%3DElmore%26aufirst%3DS.%2BW.%26aulast%3DHajduk%26aufirst%3DP.%2BJ.%26aulast%3DJoseph%26aufirst%3DM.%2BK.%26aulast%3DLandis%26aufirst%3DS.%2BK.%26aulast%3DNettesheim%26aufirst%3DD.%2BG.%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26aulast%3DShen%26aufirst%3DW.%26aulast%3DThomas%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DZanze%26aufirst%3DI.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26atitle%3DDiscovery%2520of%2520a%2520potent%2520inhibitor%2520of%2520the%2520antiapoptotic%2520protein%2520Bcl-xL%2520from%2520NMR%2520and%2520parallel%2520synthesis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D656%26epage%3D663" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="note"><p class="first last">Both technologies are solution competition assays. We believe that the discrepancy between the two sets of values may originate from the way the data is presented. In ref <a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">27</a>, <i>K</i><sub>i</sub> values are derived from IC<sub>50</sub> values using a formula, which was not disclosed in the original publication. We note that, in our studies, the IC<sub>50</sub> values obtained with the AlphaScreen assay correlate closely with the direct binding <i>K</i><sub>D</sub>s obtained with surface plasmon resonance.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="note"><p class="first last">Our experience in targeting Bcl-2 family of proteins has led us to value consistency across multiple assay platforms rather than an absolute value of the binding affinity. For reasons inherent to these targets, e.g., hydrophobic nature of the groove with hydrogen bond donors at specific points, hydrophobic acidic molecules tend to appear often as nonselective hits. These proteins have led to a large number of “frequent hitters”, see ref <a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">31</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="note"><p class="first last">There was no other hit against either of the three proteins that showed consistent activity in both LPA and fluorescence polarization assays.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Baell, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holloway, G. A.</span><span> </span><span class="NLM_article-title">New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">2719</span><span class="NLM_x">–</span> <span class="NLM_lpage">2740</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901137j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm400556w&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsF2qsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2719-2740&author=J.+B.+Baellauthor=G.+A.+Holloway&title=New+substructure+filters+for+removal+of+pan+assay+interference+compounds+%28PAINS%29+from+screening+libraries+and+for+their+exclusion+in+bioassays"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays</span></div><div class="casAuthors">Baell, Jonathan B.; Holloway, Georgina A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2719-2740</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This report describes a no. of substructural features which can help to identify compds. that appear as frequent hitters (promiscuous compds.) in many biochem. high throughput screens.  The compds. identified by such substructural features are not recognized by filters commonly used to identify reactive compds.  Even though these substructural features were identified using only one assay detection technol., such compds. have been reported to be active from many different assays.  In fact, these compds. are increasingly prevalent in the literature as potential starting points for further exploration, whereas they may not be.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro_JARcceWjLVg90H21EOLACvtfcHk0lg2emozgfYLyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsF2qsLw%253D&md5=fbf397aa4910753c550425708c866fd2</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjm901137j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901137j%26sid%3Dliteratum%253Aachs%26aulast%3DBaell%26aufirst%3DJ.%2BB.%26aulast%3DHolloway%26aufirst%3DG.%2BA.%26atitle%3DNew%2520substructure%2520filters%2520for%2520removal%2520of%2520pan%2520assay%2520interference%2520compounds%2520%2528PAINS%2529%2520from%2520screening%2520libraries%2520and%2520for%2520their%2520exclusion%2520in%2520bioassays%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2719%26epage%3D2740" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><div class="note"><p class="first last">It is worrying to note that rhodanine-like structures are still published as Bcl-X<sub>L</sub> inhibitors in the recent literature. See for example</p></div><span class="NLM_contrib-group">Feng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, D.</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">3465</span><span class="NLM_x">–</span> <span class="NLM_lpage">3479</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901004c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=It+is+worrying+to+note+that+rhodanine-like+structures+are+still+published+as+Bcl-XL+inhibitors+in+the+recent+literature.+See+for+exampleFeng%2C+Y.%3B+Ding%2C+X.%3B+Chen%2C+T.%3B+Chen%2C+L.%3B+Liu%2C+F.%3B+Jia%2C+X.%3B+Luo%2C+X.%3B+Shen%2C+X.%3B+Chen%2C+K.%3B+Jiang%2C+H.%3B+Wang%2C+H.%3B+Liu%2C+H.%3B+Liu%2C+D.J.+Med.+Chem.+2010%2C+53%2C+3465%E2%80%933479"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjm901004c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901004c%26sid%3Dliteratum%253Aachs%26aulast%3DFeng%26aufirst%3DY.%26aulast%3DDing%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DT.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DF.%26aulast%3DJia%26aufirst%3DX.%26aulast%3DLuo%26aufirst%3DX.%26aulast%3DShen%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DJiang%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DD.%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D3465%26epage%3D3479" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Meerwein, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchner, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Emster, K.</span><span> </span><span class="NLM_article-title">Memorandum from the Chemistry Institute, University of Marburg. The action of aromatic diazo compound on alpha,beta-unsaturated carbonyl bonds</span> <span class="citation_source-journal">J. Prakt. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1939</span><span class="NLM_x">, </span> <span class="NLM_volume">152</span><span class="NLM_x">, </span> <span class="NLM_fpage">237</span><span class="NLM_x">–</span> <span class="NLM_lpage">266</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm400556w&amp;key=10.1002%2Fprac.19391520705" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm400556w&amp;key=1%3ACAS%3A528%3ADyaA1MXksVahtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=152&publication_year=1939&pages=237-266&author=H.+Meerweinauthor=E.+Buchnerauthor=K.+van+Emster&title=Memorandum+from+the+Chemistry+Institute%2C+University+of+Marburg.+The+action+of+aromatic+diazo+compound+on+alpha%2Cbeta-unsaturated+carbonyl+bonds"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Reaction of aromatic diazo compounds upon α,β-unsaturated carbonyl compounds</span></div><div class="casAuthors">Meerwein, Hans; Buchner, Eberhard; van Emster, Konrad</div><div class="citationInfo"><span class="NLM_cas:title">Journal fuer Praktische Chemie (Leipzig)</span>
        (<span class="NLM_cas:date">1939</span>),
    <span class="NLM_cas:volume">152</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">237-66</span>CODEN:
                <span class="NLM_cas:coden">JPCEAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-8383</span>.
    </div><div class="casAbstract">The following work shows that α,β-unsatd. CO compds., i. e., aldehydes, ketones and carboxylic acids and their derivs., react under suitable conditions with arom. diazo compds., during which N is split off and in most cases the aryl group of the diazo compd. replaces the H of the α-C atom.  In some cases the halogen of RMgX adds to the β-C atom and since this can be split off easily, it affords a method of prepg. unsatd. compds. with a substituent on the α-C atom adjoining the CO group.  A further modification of the reaction is obsd. in the case of RCH:CHCO2H, in which CO2 is split off to give RCH:CHAr.  C2H2 compds. behave similarly to those contg. a double bond.  The reaction of the diazo compds. with unsatd. CO compds. takes place in dil. acid soln. with addn. of salts of weak acids; an equal vol. of Me2CO is used to facilitate soln. but it also appears to have a sp. effect in the reaction.  Cupric (but not cuprous) salts act as catalysts.  An interesting side reaction is the formation of AcCH2X, the yield varying with the acidity of the soln. and with the nature of the diazo soln.  With 0.25 mol CuCl2, and 1.6 mol AcONa the following yields (%) of AcCH2Cl were obsd.: PhN2Cl 28.4, p-Cl deriv. 44.6, p-NO2 deriv. 41.5, o,p-di-Cl deriv. 64.8, p-MeO deriv. 18.5.  3-Arylcoumarins were prepd. as follows: p-ClC6H4N2Cl (from 15.9 g. p-ClC6H4NH2, 50 g. of 25% HCl and 9 g. NaNO2 in 18 cc. H2O), mixed with a soln. of 18.25 g. coumarin in 100 cc. Me2CO contg. 40 g. AcONa in suspension and 5 g. CuCl2 in 10 cc. H2O, gives 45.9% of 3-p-chlorophenyl deriv.; with MeCN in place of Me2CO the yield is 57%; 3-Ph deriv., 25.9%; 3-β-naphthyl deriv., m. 170°, 17.6%; 3-p-nitrophenyl deriv., 49.9%; o-isomer, S-yellow, m. 172-3°, 11%; 3-p-methoxyphenyl deriv., m. 136.5-8.5°, 35.3%; 3-p-acetaminophenyl deriv., m. 249.5°, 27.8%. p-HO3SC6H4N2Cl gives 43% of Na 3-phenylcoumarin-p-sulfonate, microneedles. p-HO2CC6H4N2Cl gives 46-52% of 3-phenylcoumarin-p-carboxylic acid, m. 288-90°.  Umbelliferone (I) and p-ClC6H4N2Cl give 48% of the 3-p-chlorophenyl deriv., m. 280-2°; if an excess of Na2CO3 is added to the Na deriv. of I, there results a chocolate-brown azo dye, C15H19O3N2Cl.  The prepn. of stilbene is carried out as follows: p-O2NC6H4N2Cl (from 17.25 g. base), 18.5 g. PhCH:CHCO2H (II) in 150 cc. Me2CO, 27.5 g. of AcONa and 5.3 g. of CuCl2 at 14-17° for 1.25 h. give AcCH2Cl, small quantities of p-O2NC6H4Cl and PhNO2, 3.4 g. of recovered II, 0.8 g. of α-p-nitrophenylcinnamic acid and 48% of nitrostilbene; the following yields (%) of stilbenes (base used given) are calcd. on the II entering into reaction: PhNH2 36.5, p-MeC6H4NH2 48.8, p-ClC6H4NH2 68.8, o,p-Cl2C6H3NH2 34.4, p-O2NC6H4NH2 58.4, o-isomer 43.9, p-MeOC6H4NH2 49.2, p-HO3SC6H4NH2 77.5.  Because of the difficulties of isolation of the stilbenes, the yields are probably much higher.  Na stilbene-p-sulfonate, needles, decomp. above 259°. p-HOC6H4CH:CHCO2H and p-ClC6H4N2Cl give 56.5% of p-chloro-p'-hydroxystilbene, m. 185.5-6°; p-MeOC6H4CH:CHCO2H gives 61.2% of p-ClC6H4CH:CHC6H4OMe-p and p-ClC6H4CH:CHCO2H gives 8% of (4-ClC6H4CH)2.  PhCH:CHCN and p-ClC6H4N2Cl give 76.5% of PhCH:C(C6H4Cl-p)CN.  PhCH:CHCO2Me in C5H5N-AcOH gives 30% of Me α-p-chlorophenyl-β-chlorohydrocinnamic acid (III), m. 124-4.5°; heating with AcONa in AcOH for 3 h. at 140° gives the Me ester, m. 85.5°, of α-p-chlorophenylcinnamic acid, m. 181.5°; p-ClC6H4N2Br gives the β-Br analog of III, m. 123°. p-O2NC6H4N2Cl and crotonic acid give 68% of p-nitrophenylcrotonic acid, pale yellow, m. 173.5-4.5°; the neutral fraction gives p,p'-dinitroazobenzene.  Me crotonate and o,p-Cl2C6H3N2Cl give the Me ester, b0.1 130-40°, of α-o,p-dichlorophenyl-β-chlorobutyric acid, m. 124.5-5° (22.4%). p-ClC6H4N2Cl and phenylpropiolic acid yield Me α-p-chlorophenyl-β-chlorocinnamate, b0.1 160-5°, m. 63°; Me fumarate gives 42.8% of Me α-p-chlorophenyl-β-chlorosuccinate (IV), m. 79°; boiling with 2 N EtOH-KOH gives a quant. yield of p-chlorophenylfumaric acid (V), m. 222°; the mother liquor from IV with EtOH-KOH gives 26.8% of V.  Distg. 10 g. V with 10 mg. chlorocymenesulfonic acid gives 5.8 g. of p-chlorophenylmaleic anhydride (VI), m. 146°.  VI with boiling H2O gives p-chlorophenylmaleic acid, m. 141-3°, whereas heating 10 g. VI with 4.5 N NaOH for 20 h. gives 4.3 g.V.  Me maleate and p-ClC6H4N2Cl give 7.5 g. IV and 9.3 g. V; if the reaction product is heated 2 h. with 2 N NaOH the products are 28% IV and 19.1% VI.  PhCH:CHO and p-ClC6H4N2Cl give 1-(p-chlorophenyl)cinnamaldehyde, m. 85-6°; the yellow concd. H2SO4 soln. turns emerald-green on standing; there also results a small quantity of an isomer, m. 128°.  Many diazo salts are sol. in liq. SO2; heating p-ClC6H4N2Cl in SO2 in the presence of CuCl2 gives 80% of 4-ClC6H4SO2Cl; with AcONa and CuCl2 there is formed an azo sulfone, 4-ClC6H4N:NSO2C6H4Cl-4.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXCjtxQL98tLVg90H21EOLACvtfcHk0lg2emozgfYLyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaA1MXksVahtQ%253D%253D&md5=19d0174c2e62aa3106d3cee27a05f5ed</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1002%2Fprac.19391520705&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fprac.19391520705%26sid%3Dliteratum%253Aachs%26aulast%3DMeerwein%26aufirst%3DH.%26aulast%3DBuchner%26aufirst%3DE.%26aulast%3Dvan%2BEmster%26aufirst%3DK.%26atitle%3DMemorandum%2520from%2520the%2520Chemistry%2520Institute%252C%2520University%2520of%2520Marburg.%2520The%2520action%2520of%2520aromatic%2520diazo%2520compound%2520on%2520alpha%252Cbeta-unsaturated%2520carbonyl%2520bonds%26jtitle%3DJ.%2520Prakt.%2520Chem.%26date%3D1939%26volume%3D152%26spage%3D237%26epage%3D266" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Racane, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tralic-Kulenovic, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boykin, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karminski-Zamola, G.</span><span> </span><span class="NLM_article-title">Synthesis of new cyano-substituted bis-benzothiazolyl arylfurans and arylthiophenes</span> <span class="citation_source-journal">Molecules</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">342</span><span class="NLM_x">–</span> <span class="NLM_lpage">348</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2003&pages=342-348&author=L.+Racaneauthor=V.+Tralic-Kulenovicauthor=D.+W.+Boykinauthor=G.+Karminski-Zamola&title=Synthesis+of+new+cyano-substituted+bis-benzothiazolyl+arylfurans+and+arylthiophenes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRacane%26aufirst%3DL.%26aulast%3DTralic-Kulenovic%26aufirst%3DV.%26aulast%3DBoykin%26aufirst%3DD.%2BW.%26aulast%3DKarminski-Zamola%26aufirst%3DG.%26atitle%3DSynthesis%2520of%2520new%2520cyano-substituted%2520bis-benzothiazolyl%2520arylfurans%2520and%2520arylthiophenes%26jtitle%3DMolecules%26date%3D2003%26volume%3D8%26spage%3D342%26epage%3D348" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Han, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castro, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgess, K.</span><span> </span><span class="NLM_article-title">Microwave-assisted functionalization of bromo-fluorescein and bromorhodamine derivatives</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">9359</span><span class="NLM_x">–</span> <span class="NLM_lpage">9362</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2003&pages=9359-9362&author=J.+W.+Hanauthor=J.+C.+Castroauthor=K.+Burgess&title=Microwave-assisted+functionalization+of+bromo-fluorescein+and+bromorhodamine+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DJ.%2BW.%26aulast%3DCastro%26aufirst%3DJ.%2BC.%26aulast%3DBurgess%26aufirst%3DK.%26atitle%3DMicrowave-assisted%2520functionalization%2520of%2520bromo-fluorescein%2520and%2520bromorhodamine%2520derivatives%26jtitle%3DTetrahedron%2520Lett.%26date%3D2003%26volume%3D44%26spage%3D9359%26epage%3D9362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="note"><p class="first last">The synthetic methodology for the preparation of the substrates not previously described in the literature is presented in detail in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="note"><p class="first last">The binding efficiency calculations presented herein are obtained from the following formula: (−1.4 × log(IC<sub>50</sub>))/(nb heavy atoms).</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="note"><p class="first last">A large number of analogues were prepared during the course of this study. This account describes only the most salient and representative findings of our work, see:</p></div><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Adams, J. M.; Baell, J. B.; Colman, P. M.; Czabotar, P. E.; Huang, D. C. S.; Lessene, G. L.; Sleebs, B. E.; Smith, B. J.; Street, I. P.; Watson, K. G.</span><span> </span><span class="NLM_article-title">Benzothiazole compounds</span>. PCT WO2009039553 A1,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=J.+M.+Adams&author=J.+B.+Baell&author=P.+M.+Colman&author=P.+E.+Czabotar&author=D.+C.+S.+Huang&author=G.+L.+Lessene&author=B.+E.+Sleebs&author=B.+J.+Smith&author=I.+P.+Street&author=K.+G.+Watson&title=Benzothiazole+compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DJ.%2BM.%26atitle%3DBenzothiazole%2520compounds%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="note"><p class="first last">In our laboratory, compounds are routinely tested against both Bcl-X<sub>L</sub> and Mcl-1 using the LPA assay.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Myszka, D. G.</span><span> </span><span class="NLM_article-title">Analysis of small-molecule interactions using Biacore S51 technology</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">329</span><span class="NLM_x">, </span> <span class="NLM_fpage">316</span><span class="NLM_x">–</span> <span class="NLM_lpage">323</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Fjm400556w&amp;key=10.1016%2Fj.ab.2004.03.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Fjm400556w&amp;key=15158493" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm400556w&amp;key=1%3ACAS%3A528%3ADC%252BD2cXkt1Wqsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=329&publication_year=2004&pages=316-323&author=D.+G.+Myszka&title=Analysis+of+small-molecule+interactions+using+Biacore+S51+technology"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Analysis of small-molecule interactions using Biacore S51 technology</span></div><div class="casAuthors">Myszka, David G.</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Biochemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">329</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">316-323</span>CODEN:
                <span class="NLM_cas:coden">ANBCA2</span>;
        ISSN:<span class="NLM_cas:issn">0003-2697</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science</span>)
        </div><div class="casAbstract">Biacore S51 is a new surface plasmon resonance-based biosensor developed by Biacore AB (Uppsala, Sweden).  The instrument was engineered specifically to support small-mol. drug discovery and development.  The platform includes increased sensitivity, larger sample handling capabilities, and automated data processing to improve throughput.  Compared to previously released Biacore instruments, the most significant design change relates to the introduction of the hydrodynamic-addressing flow cell.  This design allows two reaction surfaces and a ref. surface to be placed within the same flow cell, thereby improving data quality and extending the kinetic range of the instrument.  Using a set of small-mol. inhibitors of the enzyme carbonic anhydrase II, we tested the reproducibility, sensitivity, and dynamic range of the biosensor.  Given the S51's performance capabilities, it should play an active role in secondary screening by providing high-resoln. information for small-mol./target interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNguzVHOfT67Vg90H21EOLACvtfcHk0liUH6M_hPCJ_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXkt1Wqsrg%253D&md5=8e17fa2377f43c6eee2dcd51c00acfe6</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.ab.2004.03.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ab.2004.03.028%26sid%3Dliteratum%253Aachs%26aulast%3DMyszka%26aufirst%3DD.%2BG.%26atitle%3DAnalysis%2520of%2520small-molecule%2520interactions%2520using%2520Biacore%2520S51%2520technology%26jtitle%3DAnal.%2520Biochem.%26date%3D2004%26volume%3D329%26spage%3D316%26epage%3D323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Lee, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colman, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fairlie, W. D.</span><span> </span><span class="NLM_article-title">EGL-1 BH3 mutants reveal the importance of protein levels and target affinity for cell-killing potency</span> <span class="citation_source-journal">Cell Death Differ.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1609</span><span class="NLM_x">–</span> <span class="NLM_lpage">1618</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Fjm400556w&amp;key=10.1038%2Fcdd.2008.86" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Fjm400556w&amp;key=18566606" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm400556w&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFWht7jF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2008&pages=1609-1618&author=E.+F.+Leeauthor=L.+Chenauthor=H.+Yangauthor=P.+M.+Colmanauthor=D.+C.+Huangauthor=W.+D.+Fairlie&title=EGL-1+BH3+mutants+reveal+the+importance+of+protein+levels+and+target+affinity+for+cell-killing+potency"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">EGL-1 BH3 mutants reveal the importance of protein levels and target affinity for cell-killing potency</span></div><div class="casAuthors">Lee, E. F.; Chen, L.; Yang, H.; Colman, P. M.; Huang, D. C. S.; Fairlie, W. D.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death and Differentiation</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1609-1618</span>CODEN:
                <span class="NLM_cas:coden">CDDIEK</span>;
        ISSN:<span class="NLM_cas:issn">1350-9047</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Studies of the cell death pathway in the nematode Caenorhabditis elegans provided the first evidence of the evolutionary conservation of apoptosis signalling.  Here we show that the worm Bcl-2 homol. domain-3 (BH3)-only protein EGL-1 binds mammalian pro-survival proteins very poorly, but can be converted into a high-affinity ligand for Bcl-2 and Bcl-xL by subtle mutation of the cysteine residue at position 62 within the BH3 domain.  A 100-fold increase in affinity was obsd. following a single atom change (cysteine to serine substitution), and a further 10-fold increase by replacement with glycine.  The low affinity of wild-type EGL-1 for mammalian pro-survival proteins and its poor expression correlates with its weak killing activity in mammalian cells whereas the high-affinity C62G mutant is a very potent killer of cells lacking Mcl-1.  Cell killing by the C62S mutant with intermediate affinity only occurs when this EGL-1 BH3 domain is placed in a more stable context, namely that of BimS, which allows higher expression, though the kinetics of cell death now vary depending on whether Mcl-1 is neutralized by Noxa or genetically deleted.  These results demonstrate how levels of BH3-only proteins, target affinity and the spectrum of neutralization of pro-survival proteins all contribute to killing activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrh-TkkLAD7LbVg90H21EOLACvtfcHk0liUH6M_hPCJ_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFWht7jF&md5=ff2ddd1fb404d6a1f4131d343b885e21</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1038%2Fcdd.2008.86&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcdd.2008.86%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DE.%2BF.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DColman%26aufirst%3DP.%2BM.%26aulast%3DHuang%26aufirst%3DD.%2BC.%26aulast%3DFairlie%26aufirst%3DW.%2BD.%26atitle%3DEGL-1%2520BH3%2520mutants%2520reveal%2520the%2520importance%2520of%2520protein%2520levels%2520and%2520target%2520affinity%2520for%2520cell-killing%2520potency%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2008%26volume%3D15%26spage%3D1609%26epage%3D1618" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="note"><p class="first last">See detailed description in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Willis, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dewson, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naik, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fletcher, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, D. C.</span><span> </span><span class="NLM_article-title">Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins</span> <span class="citation_source-journal">Genes Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1294</span><span class="NLM_x">–</span> <span class="NLM_lpage">1305</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2005&pages=1294-1305&author=S.+N.+Willisauthor=L.+Chenauthor=G.+Dewsonauthor=A.+Weiauthor=E.+Naikauthor=J.+I.+Fletcherauthor=J.+M.+Adamsauthor=D.+C.+Huang&title=Proapoptotic+Bak+is+sequestered+by+Mcl-1+and+Bcl-xL%2C+but+not+Bcl-2%2C+until+displaced+by+BH3-only+proteins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWillis%26aufirst%3DS.%2BN.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DDewson%26aufirst%3DG.%26aulast%3DWei%26aufirst%3DA.%26aulast%3DNaik%26aufirst%3DE.%26aulast%3DFletcher%26aufirst%3DJ.%2BI.%26aulast%3DAdams%26aufirst%3DJ.%2BM.%26aulast%3DHuang%26aufirst%3DD.%2BC.%26atitle%3DProapoptotic%2520Bak%2520is%2520sequestered%2520by%2520Mcl-1%2520and%2520Bcl-xL%252C%2520but%2520not%2520Bcl-2%252C%2520until%2520displaced%2520by%2520BH3-only%2520proteins%26jtitle%3DGenes%2520Dev.%26date%3D2005%26volume%3D19%26spage%3D1294%26epage%3D1305" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="note"><p class="first last">The mechanism of action of potent analogues of this series is thoroughly investigated in ref <a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">25</a>. These compounds induce apoptosis by selectively and potently directly interacting with Bcl-x<sub>L</sub></p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="note"><p class="first last">Full titration would be required to thoroughly correlate the binding affinities of the compounds with their ability to induce cytochrome <i>c</i> release.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Wendt, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kunzer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McClellan, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruncko, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oost, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joseph, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nimmer, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ng, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoemaker, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petros, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oleksijew, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsh, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauch, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oltersdorf, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belli, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martineau, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fesik, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenberg, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elmore, S. W.</span><span> </span><span class="NLM_article-title">Discovery and structure–activity relationship of antagonists of B-cell lymphoma 2 family proteins with chemopotentiation activity in vitro and in vivo</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">1165</span><span class="NLM_x">–</span> <span class="NLM_lpage">1181</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050754u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Fjm400556w&amp;key=1%3ACAS%3A528%3ADC%252BD28XjsFemtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=1165-1181&author=M.+D.+Wendtauthor=W.+Shenauthor=A.+Kunzerauthor=W.+J.+McClellanauthor=M.+Brunckoauthor=T.+K.+Oostauthor=H.+Dingauthor=M.+K.+Josephauthor=H.+C.+Zhangauthor=P.+M.+Nimmerauthor=S.+C.+Ngauthor=A.+R.+Shoemakerauthor=A.+M.+Petrosauthor=A.+Oleksijewauthor=K.+Marshauthor=J.+Bauchauthor=T.+Oltersdorfauthor=B.+A.+Belliauthor=D.+Martineauauthor=S.+W.+Fesikauthor=S.+H.+Rosenbergauthor=S.+W.+Elmore&title=Discovery+and+structure%E2%80%93activity+relationship+of+antagonists+of+B-cell+lymphoma+2+family+proteins+with+chemopotentiation+activity+in+vitro+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Structure-Activity Relationship of Antagonists of B-Cell Lymphoma 2 Family Proteins with Chemopotentiation Activity in Vitro and in Vivo</span></div><div class="casAuthors">Wendt, Michael D.; Shen, Wang; Kunzer, Aaron; McClellan, William J.; Bruncko, Milan; Oost, Thorsten K.; Ding, Hong; Joseph, Mary K.; Zhang, Haichao; Nimmer, Paul M.; Ng, Shi-Chung; Shoemaker, Alexander R.; Petros, Andrew M.; Oleksijew, Anatol; Marsh, Kennan; Bauch, Joy; Oltersdorf, Tilman; Belli, Barbara A.; Martineau, Darlene; Fesik, Stephen W.; Rosenberg, Saul H.; Elmore, Steven W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1165-1181</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Development of a rationally designed potentiator of cancer chemotherapy, via inhibition of Bcl-XL function, is described.  Lead compds. generated by NMR screening and directed parallel synthesis displayed sub-μM binding but were strongly deactivated in the presence of serum.  The dominant component of serum deactivation was identified as domain III of human serum albumin (HSA); NMR soln. structures of inhibitors bound to both Bcl-XL and HSA domain III indicated two potential optimization sites for sepn. of affinities.  Modifications at both sites resulted in compds. with improved Bcl-XL binding and greatly increased activity in the presence of human serum, culminating in 73R, which bound to Bcl-XL with a Ki of 0.8 nM.  In a cellular assay 73R reversed the protection afforded by Bcl-XL overexpression against cytokine deprivation in FL5.12 cells with an EC50 of 0.47 μM.  73R showed little effect on the viability of the human non small cell lung cancer cell line A549.  However, consistent with the proposed mechanism, 73R potentiated the activity of paclitaxel and UV irradn. in vitro and potentiated the antitumor efficacy of paclitaxel in a mouse xenograft model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNcJMZIao1pbVg90H21EOLACvtfcHk0lg4WP-tB5CGzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjsFemtw%253D%253D&md5=a0311af587e06f1adf0f87d356137435</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fjm050754u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050754u%26sid%3Dliteratum%253Aachs%26aulast%3DWendt%26aufirst%3DM.%2BD.%26aulast%3DShen%26aufirst%3DW.%26aulast%3DKunzer%26aufirst%3DA.%26aulast%3DMcClellan%26aufirst%3DW.%2BJ.%26aulast%3DBruncko%26aufirst%3DM.%26aulast%3DOost%26aufirst%3DT.%2BK.%26aulast%3DDing%26aufirst%3DH.%26aulast%3DJoseph%26aufirst%3DM.%2BK.%26aulast%3DZhang%26aufirst%3DH.%2BC.%26aulast%3DNimmer%26aufirst%3DP.%2BM.%26aulast%3DNg%26aufirst%3DS.%2BC.%26aulast%3DShoemaker%26aufirst%3DA.%2BR.%26aulast%3DPetros%26aufirst%3DA.%2BM.%26aulast%3DOleksijew%26aufirst%3DA.%26aulast%3DMarsh%26aufirst%3DK.%26aulast%3DBauch%26aufirst%3DJ.%26aulast%3DOltersdorf%26aufirst%3DT.%26aulast%3DBelli%26aufirst%3DB.%2BA.%26aulast%3DMartineau%26aufirst%3DD.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26aulast%3DElmore%26aufirst%3DS.%2BW.%26atitle%3DDiscovery%2520and%2520structure%25E2%2580%2593activity%2520relationship%2520of%2520antagonists%2520of%2520B-cell%2520lymphoma%25202%2520family%2520proteins%2520with%2520chemopotentiation%2520activity%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D1165%26epage%3D1181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Mao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajduk, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craig, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bell, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borre, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fesik, S. W.</span><span> </span><span class="NLM_article-title">Rational design of diflunisal analogues with reduced affinity for human serum albumin</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">123</span><span class="NLM_x">, </span> <span class="NLM_fpage">10429</span><span class="NLM_x">–</span> <span class="NLM_lpage">10435</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja015955b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2001&pages=10429-10435&author=H.+Maoauthor=P.+J.+Hajdukauthor=R.+Craigauthor=R.+Bellauthor=T.+Borreauthor=S.+W.+Fesik&title=Rational+design+of+diflunisal+analogues+with+reduced+affinity+for+human+serum+albumin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fja015955b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja015955b%26sid%3Dliteratum%253Aachs%26aulast%3DMao%26aufirst%3DH.%26aulast%3DHajduk%26aufirst%3DP.%2BJ.%26aulast%3DCraig%26aufirst%3DR.%26aulast%3DBell%26aufirst%3DR.%26aulast%3DBorre%26aufirst%3DT.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26atitle%3DRational%2520design%2520of%2520diflunisal%2520analogues%2520with%2520reduced%2520affinity%2520for%2520human%2520serum%2520albumin%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2001%26volume%3D123%26spage%3D10429%26epage%3D10435" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Copeland, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pompliano, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meek, T. D.</span><span> </span><span class="NLM_article-title">Drug-target residence time and its implications for lead optimization</span> <span class="citation_source-journal">Nature Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">730</span><span class="NLM_x">–</span> <span class="NLM_lpage">739</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=730-739&author=R.+A.+Copelandauthor=D.+L.+Pomplianoauthor=T.+D.+Meek&title=Drug-target+residence+time+and+its+implications+for+lead+optimization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCopeland%26aufirst%3DR.%2BA.%26aulast%3DPompliano%26aufirst%3DD.%2BL.%26aulast%3DMeek%26aufirst%3DT.%2BD.%26atitle%3DDrug-target%2520residence%2520time%2520and%2520its%2520implications%2520for%2520lead%2520optimization%26jtitle%3DNature%2520Rev.%2520Drug%2520Discovery%26date%3D2006%26volume%3D5%26spage%3D730%26epage%3D739" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Tummino, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Copeland, R. A.</span><span> </span><span class="NLM_article-title">Residence time of receptor–ligand complexes and its effect on biological function</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">5481</span><span class="NLM_x">–</span> <span class="NLM_lpage">5492</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi8002023" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2008&pages=5481-5492&author=P.+J.+Tumminoauthor=R.+A.+Copeland&title=Residence+time+of+receptor%E2%80%93ligand+complexes+and+its+effect+on+biological+function"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Fbi8002023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi8002023%26sid%3Dliteratum%253Aachs%26aulast%3DTummino%26aufirst%3DP.%2BJ.%26aulast%3DCopeland%26aufirst%3DR.%2BA.%26atitle%3DResidence%2520time%2520of%2520receptor%25E2%2580%2593ligand%2520complexes%2520and%2520its%2520effect%2520on%2520biological%2520function%26jtitle%3DBiochemistry%26date%3D2008%26volume%3D47%26spage%3D5481%26epage%3D5492" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Verdine, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walensky, L. D.</span><span> </span><span class="NLM_article-title">The challenge of drugging undruggable targets in cancer: lessons learned from targeting BCL-2 family members</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">7264</span><span class="NLM_x">–</span> <span class="NLM_lpage">7270</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Fjm400556w&amp;key=10.1158%2F1078-0432.CCR-07-2184" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Fjm400556w&amp;key=18094406" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Fjm400556w&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVCktr%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=7264-7270&author=G.+L.+Verdineauthor=L.+D.+Walensky&title=The+challenge+of+drugging+undruggable+targets+in+cancer%3A+lessons+learned+from+targeting+BCL-2+family+members"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">The Challenge of Drugging Undruggable Targets in Cancer: Lessons Learned from Targeting BCL-2 Family Members</span></div><div class="casAuthors">Verdine, Gregory L.; Walensky, Loren D.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">7264-7270</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  The genomic and proteomic revolutions have provided us with an ever-increasing no. of mechanistic insights into cancer pathogenesis.  Mutated genes and pathol. protein products have emerged as the basis for modern anticancer drug development.  With the increasing realization of the importance of disrupting oncogenic protein-protein interaction, new challenges have emerged for classical small mol. and protein-based drug modalities, i.e., the crit. need to target flat and extended protein surfaces.  Here, we highlight two distinct technologies that are being used to bridge the pharmacol. gap between small mols. and protein therapeutics.  With the BCL-2 family of survival proteins as their substrate for intracellular targeting, we conclude that peptide stapling and fragment-based drug discovery show promise to traverse the crit. surface features of proteins that drive human cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgYQX3c_4_qLVg90H21EOLACvtfcHk0ljVnNsni5H0Wg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVCktr%252FK&md5=1b7fcbe41063e04470f7c34b50410a42</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-07-2184&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-07-2184%26sid%3Dliteratum%253Aachs%26aulast%3DVerdine%26aufirst%3DG.%2BL.%26aulast%3DWalensky%26aufirst%3DL.%2BD.%26atitle%3DThe%2520challenge%2520of%2520drugging%2520undruggable%2520targets%2520in%2520cancer%253A%2520lessons%2520learned%2520from%2520targeting%2520BCL-2%2520family%2520members%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2007%26volume%3D13%26spage%3D7264%26epage%3D7270" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Berg, T.</span><span> </span><span class="NLM_article-title">Small-molecule inhibitors of protein–protein interactions</span> <span class="citation_source-journal">Curr. Opin. Drug Discovery Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">666</span><span class="NLM_x">–</span> <span class="NLM_lpage">674</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2008&pages=666-674&author=T.+Berg&title=Small-molecule+inhibitors+of+protein%E2%80%93protein+interactions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBerg%26aufirst%3DT.%26atitle%3DSmall-molecule%2520inhibitors%2520of%2520protein%25E2%2580%2593protein%2520interactions%26jtitle%3DCurr.%2520Opin.%2520Drug%2520Discovery%2520Dev.%26date%3D2008%26volume%3D11%26spage%3D666%26epage%3D674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Shoemaker, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oleksijew, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauch, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belli, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borre, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruncko, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deckwirth, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frost, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarvis, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joseph, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsh, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McClellan, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nellans, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ng, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nimmer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connor, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oltersdorf, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qing, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stavropoulos, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tahir, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warner, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fesik, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenberg, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elmore, S. W.</span><span> </span><span class="NLM_article-title">A small-molecule inhibitor of Bcl-X<sub>L</sub> potentiates the activity of cytotoxic drugs in vitro and in vivo</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">8731</span><span class="NLM_x">–</span> <span class="NLM_lpage">8739</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2006&pages=8731-8739&author=A.+R.+Shoemakerauthor=A.+Oleksijewauthor=J.+Bauchauthor=B.+A.+Belliauthor=T.+Borreauthor=M.+Brunckoauthor=T.+Deckwirthauthor=D.+J.+Frostauthor=K.+Jarvisauthor=M.+K.+Josephauthor=K.+Marshauthor=W.+McClellanauthor=H.+Nellansauthor=S.+Ngauthor=P.+Nimmerauthor=J.+M.+O%E2%80%99Connorauthor=T.+Oltersdorfauthor=W.+Qingauthor=W.+Shenauthor=J.+Stavropoulosauthor=S.+K.+Tahirauthor=B.+L.+Wangauthor=R.+Warnerauthor=H.+C.+Zhangauthor=S.+W.+Fesikauthor=S.+H.+Rosenbergauthor=S.+W.+Elmore&title=A+small-molecule+inhibitor+of+Bcl-XL+potentiates+the+activity+of+cytotoxic+drugs+in+vitro+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShoemaker%26aufirst%3DA.%2BR.%26aulast%3DOleksijew%26aufirst%3DA.%26aulast%3DBauch%26aufirst%3DJ.%26aulast%3DBelli%26aufirst%3DB.%2BA.%26aulast%3DBorre%26aufirst%3DT.%26aulast%3DBruncko%26aufirst%3DM.%26aulast%3DDeckwirth%26aufirst%3DT.%26aulast%3DFrost%26aufirst%3DD.%2BJ.%26aulast%3DJarvis%26aufirst%3DK.%26aulast%3DJoseph%26aufirst%3DM.%2BK.%26aulast%3DMarsh%26aufirst%3DK.%26aulast%3DMcClellan%26aufirst%3DW.%26aulast%3DNellans%26aufirst%3DH.%26aulast%3DNg%26aufirst%3DS.%26aulast%3DNimmer%26aufirst%3DP.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DJ.%2BM.%26aulast%3DOltersdorf%26aufirst%3DT.%26aulast%3DQing%26aufirst%3DW.%26aulast%3DShen%26aufirst%3DW.%26aulast%3DStavropoulos%26aufirst%3DJ.%26aulast%3DTahir%26aufirst%3DS.%2BK.%26aulast%3DWang%26aufirst%3DB.%2BL.%26aulast%3DWarner%26aufirst%3DR.%26aulast%3DZhang%26aufirst%3DH.%2BC.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26aulast%3DElmore%26aufirst%3DS.%2BW.%26atitle%3DA%2520small-molecule%2520inhibitor%2520of%2520Bcl-XL%2520potentiates%2520the%2520activity%2520of%2520cytotoxic%2520drugs%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DCancer%2520Res.%26date%3D2006%26volume%3D66%26spage%3D8731%26epage%3D8739" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Lee, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czabotar, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sleebs, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lessene, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colman, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fairlie, W. D.</span><span> </span><span class="NLM_article-title">Conformational changes in Bcl-2 pro-survival proteins determine their capacity to bind ligands</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">284</span><span class="NLM_x">, </span> <span class="NLM_fpage">30508</span><span class="NLM_x">–</span> <span class="NLM_lpage">30517</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Fjm400556w&amp;key=10.1074%2Fjbc.M109.040725" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Fjm400556w&amp;key=19726685" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Fjm400556w&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlSru7rM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=30508-30517&author=E.+F.+Leeauthor=P.+E.+Czabotarauthor=H.+Yangauthor=B.+E.+Sleebsauthor=G.+Lesseneauthor=P.+M.+Colmanauthor=B.+J.+Smithauthor=W.+D.+Fairlie&title=Conformational+changes+in+Bcl-2+pro-survival+proteins+determine+their+capacity+to+bind+ligands"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Conformational Changes in Bcl-2 Pro-survival Proteins Determine their Capacity to Bind Ligands</span></div><div class="casAuthors">Lee, Erinna F.; Czabotar, Peter E.; Yang, Hong; Sleebs, Brad E.; Lessene, Guillaume; Colman, Peter M.; Smith, Brian J.; Fairlie, W. Douglas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">284</span>
        (<span class="NLM_cas:issue">44</span>),
    <span class="NLM_cas:pages">30508-30517</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Antagonists of anti-apoptotic Bcl-2 family members hold promise as cancer therapeutics.  Apoptosis is triggered when a peptide contg. a BH3 motif or a small mol. BH3 peptidomimetic, such as ABT 737, binds to the relevant Bcl-2 family members.  ABT-737 is an antagonist of Bcl-2, Bcl-xL, and Bcl-w but not of Mcl-1.  Here we describe new structures of mutant BH3 peptides bound to Bcl-xL and Mcl-1.  These structures suggested a rationale for the failure of ABT-737 to bind Mcl-1, but a designed variant of ABT-737 failed to acquire binding affinity for Mcl-1.  Rather, it was selective for Bcl-xL, a result attributable in part to significant backbone refolding and movements of helical segments in its ligand binding site.  To date there are few reported crystal structures of org. ligands in complex with their pro-survival protein targets.  Our structure of this new org. ligand provided insights into the structural transitions that occur within the BH3 binding groove, highlighting significant differences in the structural properties of members of the Bcl-2 pro-survival protein family.  Such differences are likely to influence and be important in the quest for compds. capable of selectively antagonizing the different family members.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrR0Yq3r-UYlrVg90H21EOLACvtfcHk0lhguGPf7RVAKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlSru7rM&md5=8be86f3bd7c1cdf1e7ba9b289baf248a</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M109.040725&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M109.040725%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DE.%2BF.%26aulast%3DCzabotar%26aufirst%3DP.%2BE.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DSleebs%26aufirst%3DB.%2BE.%26aulast%3DLessene%26aufirst%3DG.%26aulast%3DColman%26aufirst%3DP.%2BM.%26aulast%3DSmith%26aufirst%3DB.%2BJ.%26aulast%3DFairlie%26aufirst%3DW.%2BD.%26atitle%3DConformational%2520changes%2520in%2520Bcl-2%2520pro-survival%2520proteins%2520determine%2520their%2520capacity%2520to%2520bind%2520ligands%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26spage%3D30508%26epage%3D30517" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="note"><p class="first last">For a more detailed discussion, see refs <a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">10</a> and <a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">11</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Porter, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Payne, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Candole, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ford, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutchinson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trevitt, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watkins, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitcombe, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stubberfield, C.</span><span> </span><span class="NLM_article-title">Tetrahydroisoquinoline amide substituted phenyl pyrazoles as selective Bcl-2 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">230</span><span class="NLM_x">–</span> <span class="NLM_lpage">233</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=230-233&author=J.+Porterauthor=A.+Payneauthor=B.+De+Candoleauthor=D.+Fordauthor=B.+Hutchinsonauthor=G.+Trevittauthor=J.+Turnerauthor=C.+Edwardsauthor=C.+Watkinsauthor=I.+Whitcombeauthor=J.+Davisauthor=C.+Stubberfield&title=Tetrahydroisoquinoline+amide+substituted+phenyl+pyrazoles+as+selective+Bcl-2+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPorter%26aufirst%3DJ.%26aulast%3DPayne%26aufirst%3DA.%26aulast%3DDe%2BCandole%26aufirst%3DB.%26aulast%3DFord%26aufirst%3DD.%26aulast%3DHutchinson%26aufirst%3DB.%26aulast%3DTrevitt%26aufirst%3DG.%26aulast%3DTurner%26aufirst%3DJ.%26aulast%3DEdwards%26aufirst%3DC.%26aulast%3DWatkins%26aufirst%3DC.%26aulast%3DWhitcombe%26aufirst%3DI.%26aulast%3DDavis%26aufirst%3DJ.%26aulast%3DStubberfield%26aufirst%3DC.%26atitle%3DTetrahydroisoquinoline%2520amide%2520substituted%2520phenyl%2520pyrazoles%2520as%2520selective%2520Bcl-2%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D230%26epage%3D233" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Lipinski, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombardo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dominy, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feeney, P. J.</span><span> </span><span class="NLM_article-title">Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings</span> <span class="citation_source-journal">Adv. Drug Delivery Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">25</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Fjm400556w&amp;key=10.1016%2FS0169-409X%2896%2900423-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Fjm400556w&amp;key=1%3ACAS%3A528%3ADyaK2sXktlKlsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1997&pages=3-25&author=C.+A.+Lipinskiauthor=F.+Lombardoauthor=B.+W.+Dominyauthor=P.+J.+Feeney&title=Experimental+and+computational+approaches+to+estimate+solubility+and+permeability+in+drug+discovery+and+development+settings"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings</span></div><div class="casAuthors">Lipinski, Christopher A.; Lombardo, Franco; Dominy, Beryl W.; Feeney, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">3-25</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review with 50 refs.  Exptl. and computational approaches to est. soly. and permeability in discovery and development settings are described.  In the discovery setting 'the rule of 5' predicts that poor absorption or permeation is more likely when there are more than 5 H-bond donors, 10 H-bond acceptors, the mol. wt. (MWT) is >500 and the calcd. Log P (CLogP) is >5.  Computational methodol. for the rule-based Moriguchi Log P (MLogP) calcn. is described.  Turbidimetric soly. measurement is described and applied to known drugs.  High throughput screening (HTS) leads tend to have higher MWT and Log P and lower turbidimetric soly. than leads in the pre-HTS era.  In the development setting, soly. calcns. focus on exact value prediction and are difficult because of polymorphism.  Recent work on linear free energy relationships and Log P approaches are critically reviewed.  Useful predictions are possible in closely related analog series when coupled with exptl. thermodn. soly. measurements.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGon9gEeZ7cboLVg90H21EOLACvtfcHk0lhguGPf7RVAKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXktlKlsQ%253D%253D&md5=405f70b0594d428f1275e1d56642cd3a</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1016%2FS0169-409X%2896%2900423-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0169-409X%252896%252900423-1%26sid%3Dliteratum%253Aachs%26aulast%3DLipinski%26aufirst%3DC.%2BA.%26aulast%3DLombardo%26aufirst%3DF.%26aulast%3DDominy%26aufirst%3DB.%2BW.%26aulast%3DFeeney%26aufirst%3DP.%2BJ.%26atitle%3DExperimental%2520and%2520computational%2520approaches%2520to%2520estimate%2520solubility%2520and%2520permeability%2520in%2520drug%2520discovery%2520and%2520development%2520settings%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D1997%26volume%3D23%26spage%3D3%26epage%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Veber, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopple, K. D.</span><span> </span><span class="NLM_article-title">Molecular properties that influence the oral bioavailability of drug candidates</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">2615</span><span class="NLM_x">–</span> <span class="NLM_lpage">2623</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm020017n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Fjm400556w&amp;key=1%3ACAS%3A528%3ADC%252BD38XjsFCmt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=2615-2623&author=D.+F.+Veberauthor=S.+R.+Johnsonauthor=H.+Y.+Chengauthor=B.+R.+Smithauthor=K.+W.+Wardauthor=K.+D.+Kopple&title=Molecular+properties+that+influence+the+oral+bioavailability+of+drug+candidates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Properties That Influence the Oral Bioavailability of Drug Candidates</span></div><div class="casAuthors">Veber, Daniel F.; Johnson, Stephen R.; Cheng, Hung-Yuan; Smith, Brian R.; Ward, Keith W.; Kopple, Kenneth D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2615-2623</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Oral bioavailability measurements in rats for over 1100 drug candidates studied at Smith-Kline Beecham Pharmaceuticals (now Glaxo Smith-Kline) have allowed us to analyze the relative importance of mol. properties considered to influence that drug property.  Reduced mol. flexibility, as measured by the no. of rotatable bonds, and low polar surface area or total hydrogen bond count (sum of donors and acceptors) are found to be important predictors of good oral bioavailability, independent of mol. wt.  That on av. both the no. of rotatable bonds and polar surface area or hydrogen bond count tend to increase with mol. wt. may in part explain the success of the mol. wt. parameter in predicting oral bioavailability.  The commonly applied mol. wt. cutoff at 500 does not itself significantly sep. compds. with poor oral bioavailability from those with acceptable values in this extensive data set.  Our observations suggest that compds. which meet only the 2 criteria of (1) 10 or fewer rotatable bonds and (2) polar surface area ≤140 Å2 (or 12 or fewer H-bond donors and acceptors) will have a high probability of good oral bioavailability in the rat.  Data sets for the artificial membrane permeation rate and for clearance in the rat were also examd.  Reduced polar surface area correlates better with increased permeation rate than does lipophilicity (C log P), and increased rotatable bond count has a neg. effect on the permeation rate.  A threshold permeation rate is a prerequisite of oral bioavailability.  The rotatable bond count does not correlate with the data examd. here for the in vivo clearance rate in the rat.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3JtJEkO7yVLVg90H21EOLACvtfcHk0li0vDyWdGTvsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjsFCmt7g%253D&md5=eaad26ed6a259de82ad65a8834fc397d</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1021%2Fjm020017n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020017n%26sid%3Dliteratum%253Aachs%26aulast%3DVeber%26aufirst%3DD.%2BF.%26aulast%3DJohnson%26aufirst%3DS.%2BR.%26aulast%3DCheng%26aufirst%3DH.%2BY.%26aulast%3DSmith%26aufirst%3DB.%2BR.%26aulast%3DWard%26aufirst%3DK.%2BW.%26aulast%3DKopple%26aufirst%3DK.%2BD.%26atitle%3DMolecular%2520properties%2520that%2520influence%2520the%2520oral%2520bioavailability%2520of%2520drug%2520candidates%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D2615%26epage%3D2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="note"><p class="first last">Some researchers use screening hit binding efficiency as a criterion for go/no go progression. Our approach to lead generation assumes that any screening hit with molecular weight around 300 or more and displaying low micromolar target affinity is unlikely to also coincidentally be an optimum fit. Therefore, we use medicinal chemistry to seek out suboptimal substructures and improve them. Groups using fragment-based lead generation have adopted a parallel philosophy. See for example</p></div><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Hadjuk, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bures, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Praestgaard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fesik, S. W.</span><span> </span><span class="NLM_article-title">Privileged Molecules for Protein Binding Identified from NMR-Based Screening</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">3443</span><span class="NLM_x">–</span> <span class="NLM_lpage">3447</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=3443-3447&author=P.+J.+Hadjukauthor=M.+Buresauthor=J.+Praestgaardauthor=S.+W.+Fesik&title=Privileged+Molecules+for+Protein+Binding+Identified+from+NMR-Based+Screening"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHadjuk%26aufirst%3DP.%2BJ.%26aulast%3DBures%26aufirst%3DM.%26aulast%3DPraestgaard%26aufirst%3DJ.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26atitle%3DPrivileged%2520Molecules%2520for%2520Protein%2520Binding%2520Identified%2520from%2520NMR-Based%2520Screening%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D3443%26epage%3D3447" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="note"><p class="first last">We suggest that this strategy is relevant to any type of target, not just that described herein.</p></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Katz, L.</span><span> </span><span class="NLM_article-title">Antituberculous Compounds. 111. Benzothiazole and Benzoxazole Derivatives</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1952</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x">, </span> <span class="NLM_fpage">712</span><span class="NLM_x">–</span> <span class="NLM_lpage">714</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=1952&pages=712-714&author=L.+Katz&title=Antituberculous+Compounds.+111.+Benzothiazole+and+Benzoxazole+Derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKatz%26aufirst%3DL.%26atitle%3DAntituberculous%2520Compounds.%2520111.%2520Benzothiazole%2520and%2520Benzoxazole%2520Derivatives%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1952%26volume%3D75%26spage%3D712%26epage%3D714" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Iemura, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawashima, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukuda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsukamoto, G.</span><span> </span><span class="NLM_article-title">Synthesis of 2-(4-substituted-1-piperazinyl)benzimidazoles as H1-antihistaminic agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">1178</span><span class="NLM_x">–</span> <span class="NLM_lpage">1183</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00157a010" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=1986&pages=1178-1183&author=R.+Iemuraauthor=T.+Kawashimaauthor=T.+Fukudaauthor=K.+Itoauthor=G.+Tsukamoto&title=Synthesis+of+2-%284-substituted-1-piperazinyl%29benzimidazoles+as+H1-antihistaminic+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1021%2Fjm00157a010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00157a010%26sid%3Dliteratum%253Aachs%26aulast%3DIemura%26aufirst%3DR.%26aulast%3DKawashima%26aufirst%3DT.%26aulast%3DFukuda%26aufirst%3DT.%26aulast%3DIto%26aufirst%3DK.%26aulast%3DTsukamoto%26aufirst%3DG.%26atitle%3DSynthesis%2520of%25202-%25284-substituted-1-piperazinyl%2529benzimidazoles%2520as%2520H1-antihistaminic%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1986%26volume%3D29%26spage%3D1178%26epage%3D1183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">Czabotar, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Delft, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Day, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fairlie, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hinds, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colman, P. M.</span><span> </span><span class="NLM_article-title">Structural insights into the degradation of Mcl-1 induced by BH3 domains</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">6217</span><span class="NLM_x">–</span> <span class="NLM_lpage">6222</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Fjm400556w&amp;key=10.1073%2Fpnas.0701297104" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Fjm400556w&amp;key=17389404" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Fjm400556w&amp;key=1%3ACAS%3A528%3ADC%252BD2sXks1arurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2007&pages=6217-6222&author=P.+E.+Czabotarauthor=E.+F.+Leeauthor=M.+F.+van+Delftauthor=C.+L.+Dayauthor=B.+J.+Smithauthor=D.+C.+Huangauthor=W.+D.+Fairlieauthor=M.+G.+Hindsauthor=P.+M.+Colman&title=Structural+insights+into+the+degradation+of+Mcl-1+induced+by+BH3+domains"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Structural insights into the degradation of MCl-1 induced by BH3 domains</span></div><div class="casAuthors">Czabotar, Peter E.; Lee, Erinna F.; van Delft, Mark F.; Day, Catherine L.; Smith, Brian J.; Huang, David C. S.; Fairlie, W. Douglas; Hinds, Mark G.; Colman, Peter M.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">6217-6222</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Apoptosis is held in check by prosurvival proteins of the Bcl-2 family.  The distantly related BH3-only proteins bind to and antagonize Bcl-2 proteins, thereby promoting apoptosis.  Whereas binding of the BH3-only protein Noxa to prosurvival Mcl-1 induces Mcl-1 degrdn. by the proteasome, binding of another BH3-only ligand, Bim, elevates Mcl-1 protein levels.  We compared the three- dimensional structures of the complexes formed between BH3 peptides of both Bim and Noxa, and we show that a discrete C-terminal sequence of the Noxa BH3 is necessary to instigate Mcl-1 degrdn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprkT9u8IpxRLVg90H21EOLACvtfcHk0li0vDyWdGTvsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXks1arurw%253D&md5=f91d0194ce195855706f69364b7e6fb6</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0701297104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0701297104%26sid%3Dliteratum%253Aachs%26aulast%3DCzabotar%26aufirst%3DP.%2BE.%26aulast%3DLee%26aufirst%3DE.%2BF.%26aulast%3Dvan%2BDelft%26aufirst%3DM.%2BF.%26aulast%3DDay%26aufirst%3DC.%2BL.%26aulast%3DSmith%26aufirst%3DB.%2BJ.%26aulast%3DHuang%26aufirst%3DD.%2BC.%26aulast%3DFairlie%26aufirst%3DW.%2BD.%26aulast%3DHinds%26aufirst%3DM.%2BG.%26aulast%3DColman%26aufirst%3DP.%2BM.%26atitle%3DStructural%2520insights%2520into%2520the%2520degradation%2520of%2520Mcl-1%2520induced%2520by%2520BH3%2520domains%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2007%26volume%3D104%26spage%3D6217%26epage%3D6222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group">Lee, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czabotar, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Delft, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michalak, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyle, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willis, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puthalakath, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouillet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colman, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fairlie, W. D.</span><span> </span><span class="NLM_article-title">A novel BH3 ligand that selectively targets Mcl-1 reveals that apoptosis can proceed without Mcl-1 degradation</span> <span class="citation_source-journal">J. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">180</span><span class="NLM_x">, </span> <span class="NLM_fpage">341</span><span class="NLM_x">–</span> <span class="NLM_lpage">355</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=180&publication_year=2008&pages=341-355&author=E.+F.+Leeauthor=P.+E.+Czabotarauthor=M.+F.+van+Delftauthor=E.+M.+Michalakauthor=M.+J.+Boyleauthor=S.+N.+Willisauthor=H.+Puthalakathauthor=P.+Bouilletauthor=P.+M.+Colmanauthor=D.+C.+Huangauthor=W.+D.+Fairlie&title=A+novel+BH3+ligand+that+selectively+targets+Mcl-1+reveals+that+apoptosis+can+proceed+without+Mcl-1+degradation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DE.%2BF.%26aulast%3DCzabotar%26aufirst%3DP.%2BE.%26aulast%3Dvan%2BDelft%26aufirst%3DM.%2BF.%26aulast%3DMichalak%26aufirst%3DE.%2BM.%26aulast%3DBoyle%26aufirst%3DM.%2BJ.%26aulast%3DWillis%26aufirst%3DS.%2BN.%26aulast%3DPuthalakath%26aufirst%3DH.%26aulast%3DBouillet%26aufirst%3DP.%26aulast%3DColman%26aufirst%3DP.%2BM.%26aulast%3DHuang%26aufirst%3DD.%2BC.%26aulast%3DFairlie%26aufirst%3DW.%2BD.%26atitle%3DA%2520novel%2520BH3%2520ligand%2520that%2520selectively%2520targets%2520Mcl-1%2520reveals%2520that%2520apoptosis%2520can%2520proceed%2520without%2520Mcl-1%2520degradation%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2008%26volume%3D180%26spage%3D341%26epage%3D355" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group">Lee, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedorova, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zobel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyle, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perugini, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colman, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deshayes, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fairlie, W. D.</span><span> </span><span class="NLM_article-title">Novel Bcl-2 homology-3 domain-like sequences identified from screening randomized peptide libraries for inhibitors of the pro-survival Bcl-2 proteins</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">284</span><span class="NLM_x">, </span> <span class="NLM_fpage">31315</span><span class="NLM_x">–</span> <span class="NLM_lpage">31326</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=31315-31326&author=E.+F.+Leeauthor=A.+Fedorovaauthor=K.+Zobelauthor=M.+J.+Boyleauthor=H.+Yangauthor=M.+A.+Peruginiauthor=P.+M.+Colmanauthor=D.+C.+Huangauthor=K.+Deshayesauthor=W.+D.+Fairlie&title=Novel+Bcl-2+homology-3+domain-like+sequences+identified+from+screening+randomized+peptide+libraries+for+inhibitors+of+the+pro-survival+Bcl-2+proteins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DE.%2BF.%26aulast%3DFedorova%26aufirst%3DA.%26aulast%3DZobel%26aufirst%3DK.%26aulast%3DBoyle%26aufirst%3DM.%2BJ.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DPerugini%26aufirst%3DM.%2BA.%26aulast%3DColman%26aufirst%3DP.%2BM.%26aulast%3DHuang%26aufirst%3DD.%2BC.%26aulast%3DDeshayes%26aufirst%3DK.%26aulast%3DFairlie%26aufirst%3DW.%2BD.%26atitle%3DNovel%2520Bcl-2%2520homology-3%2520domain-like%2520sequences%2520identified%2520from%2520screening%2520randomized%2520peptide%2520libraries%2520for%2520inhibitors%2520of%2520the%2520pro-survival%2520Bcl-2%2520proteins%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26spage%3D31315%26epage%3D31326" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group">Zhang, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, T. D. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oldenburg, K. R.</span><span> </span><span class="NLM_article-title">A simple statistical parameter for use in evaluation and validation of high throughput screening assays</span> <span class="citation_source-journal">J. Biomol. Screening</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">67</span><span class="NLM_x">–</span> <span class="NLM_lpage">73</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Fjm400556w&amp;key=10.1177%2F108705719900400206" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Fjm400556w&amp;key=10838414" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Fjm400556w&amp;key=1%3ACAS%3A280%3ADC%252BC2sbit12juw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1999&pages=67-73&author=J.+H.+Zhangauthor=T.+D.+Y.+Chungauthor=K.+R.+Oldenburg&title=A+simple+statistical+parameter+for+use+in+evaluation+and+validation+of+high+throughput+screening+assays"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays</span></div><div class="casAuthors">Zhang; Chung; Oldenburg</div><div class="citationInfo"><span class="NLM_cas:title">Journal of biomolecular screening</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">67-73</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The ability to identify active compounds (3hits2) from large chemical libraries accurately and rapidly has been the ultimate goal in developing high-throughput screening (HTS) assays.  The ability to identify hits from a particular HTS assay depends largely on the suitability or quality of the assay used in the screening.  The criteria or parameters for evaluating the 3suitability2 of an HTS assay for hit identification are not well defined and hence it still remains difficult to compare the quality of assays directly.  In this report, a screening window coefficient, called 3Z-factor,2 is defined.  This coefficient is reflective of both the assay signal dynamic range and the data variation associated with the signal measurements, and therefore is suitable for assay quality assessment.  The Z-factor is a dimensionless, simple statistical characteristic for each HTS assay.  The Z-factor provides a useful tool for comparison and evaluation of the quality of assays, and can be utilized in assay optimization and validation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRkwW5JDdXnbsNIRw0GKUoEfW6udTcc2eb0SiKJPdpdW7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2sbit12juw%253D%253D&md5=0ec4ed2ccdd3b4a16521567a0975d31f</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1177%2F108705719900400206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F108705719900400206%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%2BH.%26aulast%3DChung%26aufirst%3DT.%2BD.%2BY.%26aulast%3DOldenburg%26aufirst%3DK.%2BR.%26atitle%3DA%2520simple%2520statistical%2520parameter%2520for%2520use%2520in%2520evaluation%2520and%2520validation%2520of%2520high%2520throughput%2520screening%2520assays%26jtitle%3DJ.%2520Biomol.%2520Screening%26date%3D1999%26volume%3D4%26spage%3D67%26epage%3D73" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':[],'ref27':['cit27'],'ref28':[],'ref29':[],'ref30':[],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':[],'ref37':[],'ref38':['cit38'],'ref39':[],'ref40':['cit40'],'ref41':['cit41'],'ref42':[],'ref43':['cit43'],'ref44':[],'ref45':[],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':[],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 45 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Zhi-Fu Tao, Xilu Wang, Jun Chen, Justin P. Ingram, Sha Jin, Russell A. Judge, Peter J. Kovar, Chang Park, Chaohong Sun, Brian D. Wakefield, Li Zhou, Haichao Zhang, Steven W. Elmore, Darren C. Phillips, Andrew S. Judd, Joel D. Leverson, <span class="NLM_string-name hlFld-ContribAuthor">Andrew J. Souers</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-Based Design of A-1293102, a Potent and Selective BCL-XL Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>12 </em>
                                    (6)
                                     , 1011-1016. <a href="https://doi.org/10.1021/acsmedchemlett.1c00162" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.1c00162</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.1c00162&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.1c00162%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DStructure-Based%252BDesign%252Bof%252BA-1293102%25252C%252Ba%252BPotent%252Band%252BSelective%252BBCL-XL%252BInhibitor%26aulast%3DTao%26aufirst%3DZhi-Fu%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D19032021%26date%3D07052021%26date%3D12052021%26volume%3D12%26issue%3D6%26spage%3D1011%26epage%3D1016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">William Nguyen, Erinna F. Lee, Marco Evangelista, Mihwa Lee, Tiffany J. Harris, Peter M. Colman, Nicholas A. Smith, Luke B. Williams, Kate E. Jarman, Kym N. Lowes, Cécile Haeberli, Jennifer Keiser, Brian J. Smith, W. Douglas Fairlie, <span class="NLM_string-name hlFld-ContribAuthor">Brad E. Sleebs</span>. </span><span class="cited-content_cbyCitation_article-title">Optimization of Benzothiazole and Thiazole Hydrazones as Inhibitors of Schistosome BCL-2. </span><span class="cited-content_cbyCitation_journal-name">ACS Infectious Diseases</span><span> <strong>2021,</strong> <em>7 </em>
                                    (5)
                                     , 1143-1163. <a href="https://doi.org/10.1021/acsinfecdis.0c00700" title="DOI URL">https://doi.org/10.1021/acsinfecdis.0c00700</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsinfecdis.0c00700&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsinfecdis.0c00700%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Infectious%2520Diseases%26atitle%3DOptimization%252Bof%252BBenzothiazole%252Band%252BThiazole%252BHydrazones%252Bas%252BInhibitors%252Bof%252BSchistosome%252BBCL-2%26aulast%3DNguyen%26aufirst%3DWilliam%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D07102020%26date%3D01022021%26volume%3D7%26issue%3D5%26spage%3D1143%26epage%3D1163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Michael J. Roy, Amelia Vom, Toru Okamoto, Brian J. Smith, Richard W. Birkinshaw, Hong Yang, Houda Abdo, Christine. A. White, David Segal, David C. S. Huang, Jonathan B. Baell, Peter M. Colman, Peter E. Czabotar, <span class="NLM_string-name hlFld-ContribAuthor">Guillaume Lessene</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-Guided Development of Potent Benzoylurea Inhibitors of BCL-XL and BCL-2. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (9)
                                     , 5447-5469. <a href="https://doi.org/10.1021/acs.jmedchem.0c01771" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01771</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01771&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01771%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-Guided%252BDevelopment%252Bof%252BPotent%252BBenzoylurea%252BInhibitors%252Bof%252BBCL-XL%252Band%252BBCL-2%26aulast%3DRoy%26aufirst%3DMichael%2BJ.%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D08102020%26date%3D27042021%26volume%3D64%26issue%3D9%26spage%3D5447%26epage%3D5469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Chaoqun You, Hongshuai Wu, Zhiguo Gao, Fanghui Chen, Like Ning, Yu Zhang, Yixin Dong, Baiwang Sun, <span class="NLM_string-name hlFld-ContribAuthor">Fei Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Enhanced Reactive Oxygen Species Levels by an Active Benzothiazole Complex-Mediated Fenton Reaction for Highly Effective Antitumor Therapy. </span><span class="cited-content_cbyCitation_journal-name">Molecular Pharmaceutics</span><span> <strong>2019,</strong> <em>16 </em>
                                    (12)
                                     , 4929-4939. <a href="https://doi.org/10.1021/acs.molpharmaceut.9b00819" title="DOI URL">https://doi.org/10.1021/acs.molpharmaceut.9b00819</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.molpharmaceut.9b00819&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.molpharmaceut.9b00819%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Pharmaceutics%26atitle%3DEnhanced%252BReactive%252BOxygen%252BSpecies%252BLevels%252Bby%252Ban%252BActive%252BBenzothiazole%252BComplex-Mediated%252BFenton%252BReaction%252Bfor%252BHighly%252BEffective%252BAntitumor%252BTherapy%26aulast%3DYou%26aufirst%3DChaoqun%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D30072019%26date%3D29102019%26date%3D14102019%26date%3D08112019%26date%3D29102019%26volume%3D16%26issue%3D12%26spage%3D4929%26epage%3D4939" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Mookda Pattarawarapan, Dolnapa Yamano, Nitaya Wiriya, <span class="NLM_string-name hlFld-ContribAuthor">Wong Phakhodee</span>. </span><span class="cited-content_cbyCitation_article-title">Metal-Free Synthesis of 2-N,N-Dialkylaminobenzoxazoles Using Tertiary Amines as the Nitrogen Source. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2019,</strong> <em>84 </em>
                                    (10)
                                     , 6516-6523. <a href="https://doi.org/10.1021/acs.joc.9b00797" title="DOI URL">https://doi.org/10.1021/acs.joc.9b00797</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.9b00797&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.9b00797%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DMetal-Free%252BSynthesis%252Bof%252B2-N%25252CN-Dialkylaminobenzoxazoles%252BUsing%252BTertiary%252BAmines%252Bas%252Bthe%252BNitrogen%252BSource%26aulast%3DPattarawarapan%26aufirst%3DMookda%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D21032019%26date%3D01052019%26date%3D24042019%26volume%3D84%26issue%3D10%26spage%3D6516%26epage%3D6523" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Stefan
M. Ivanov, Roland G. Huber, Irfan Alibay, Jim Warwicker, <span class="NLM_string-name hlFld-ContribAuthor">Peter J. Bond</span>. </span><span class="cited-content_cbyCitation_article-title">Energetic Fingerprinting of Ligand Binding to Paralogous Proteins: The Case of the Apoptotic Pathway. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2019,</strong> <em>59 </em>
                                    (1)
                                     , 245-261. <a href="https://doi.org/10.1021/acs.jcim.8b00765" title="DOI URL">https://doi.org/10.1021/acs.jcim.8b00765</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.8b00765&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.8b00765%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DEnergetic%252BFingerprinting%252Bof%252BLigand%252BBinding%252Bto%252BParalogous%252BProteins%25253A%252BThe%252BCase%252Bof%252Bthe%252BApoptotic%252BPathway%26aulast%3DIvanov%26aufirst%3DStefan%2BM.%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D30102018%26date%3D09012019%26date%3D24122018%26volume%3D59%26issue%3D1%26spage%3D245%26epage%3D261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Farzad  Jalali-Yazdi</span>, <span class="hlFld-ContribAuthor ">Terry T.  Takahashi</span>, and <span class="hlFld-ContribAuthor ">Richard W.  Roberts</span>  . </span><span class="cited-content_cbyCitation_article-title">General, Label-Free Method for Determining Kd and Ligand Concentration Simultaneously. </span><span class="cited-content_cbyCitation_journal-name">Analytical Chemistry</span><span> <strong>2015,</strong> <em>87 </em>
                                    (23)
                                     , 11755-11762. <a href="https://doi.org/10.1021/acs.analchem.5b03069" title="DOI URL">https://doi.org/10.1021/acs.analchem.5b03069</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.analchem.5b03069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.analchem.5b03069%26sid%3Dliteratum%253Aachs%26jtitle%3DAnalytical%2520Chemistry%26atitle%3DGeneral%25252C%252BLabel-Free%252BMethod%252Bfor%252BDetermining%252BKd%252Band%252BLigand%252BConcentration%252BSimultaneously%26aulast%3DJalali-Yazdi%26aufirst%3DFarzad%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D10082015%26date%3D20102015%26date%3D13112015%26date%3D01122015%26date%3D20102015%26volume%3D87%26issue%3D23%26spage%3D11755%26epage%3D11762" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Adriana  Grozav</span>, <span class="hlFld-ContribAuthor ">Ovidiu  Balacescu</span>, <span class="hlFld-ContribAuthor ">Loredana  Balacescu</span>, <span class="hlFld-ContribAuthor ">Thomas  Cheminel</span>, <span class="hlFld-ContribAuthor ">Ioana  Berindan-Neagoe</span>, and <span class="hlFld-ContribAuthor ">Bruno  Therrien</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis, Anticancer Activity, and Genome Profiling of Thiazolo Arene Ruthenium Complexes. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (21)
                                     , 8475-8490. <a href="https://doi.org/10.1021/acs.jmedchem.5b00855" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b00855</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b00855&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b00855%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%25252C%252BAnticancer%252BActivity%25252C%252Band%252BGenome%252BProfiling%252Bof%252BThiazolo%252BArene%252BRuthenium%252BComplexes%26aulast%3DGrozav%26aufirst%3DAdriana%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D04062015%26date%3D30102015%26date%3D12112015%26date%3D21102015%26volume%3D58%26issue%3D21%26spage%3D8475%26epage%3D8490" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jonathan B.  Baell</span>  . </span><span class="cited-content_cbyCitation_article-title">Screening-Based Translation of Public Research Encounters Painful Problems. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>6 </em>
                                    (3)
                                     , 229-234. <a href="https://doi.org/10.1021/acsmedchemlett.5b00032" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.5b00032</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.5b00032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.5b00032%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DScreening-Based%252BTranslation%252Bof%252BPublic%252BResearch%252BEncounters%252BPainful%252BProblems%26aulast%3DBaell%26aufirst%3DJonathan%2BB.%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D03022015%26date%3D23012015%26date%3D09022015%26date%3D12032015%26volume%3D6%26issue%3D3%26spage%3D229%26epage%3D234" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhi-Fu  Tao</span>, <span class="hlFld-ContribAuthor ">Lisa  Hasvold</span>, <span class="hlFld-ContribAuthor ">Le  Wang</span>, <span class="hlFld-ContribAuthor ">Xilu  Wang</span>, <span class="hlFld-ContribAuthor ">Andrew M.  Petros</span>, <span class="hlFld-ContribAuthor ">Chang H.  Park</span>, <span class="hlFld-ContribAuthor ">Erwin R.  Boghaert</span>, <span class="hlFld-ContribAuthor ">Nathaniel D.  Catron</span>, <span class="hlFld-ContribAuthor ">Jun  Chen</span>, <span class="hlFld-ContribAuthor ">Peter M.  Colman</span>, <span class="hlFld-ContribAuthor ">Peter E.  Czabotar</span>, <span class="hlFld-ContribAuthor ">Kurt  Deshayes</span>, <span class="hlFld-ContribAuthor ">Wayne J.  Fairbrother</span>, <span class="hlFld-ContribAuthor ">John A.  Flygare</span>, <span class="hlFld-ContribAuthor ">Sarah G.  Hymowitz</span>, <span class="hlFld-ContribAuthor ">Sha  Jin</span>, <span class="hlFld-ContribAuthor ">Russell A.  Judge</span>, <span class="hlFld-ContribAuthor ">Michael F. T.  Koehler</span>, <span class="hlFld-ContribAuthor ">Peter J.  Kovar</span>, <span class="hlFld-ContribAuthor ">Guillaume  Lessene</span>, <span class="hlFld-ContribAuthor ">Michael J.  Mitten</span>, <span class="hlFld-ContribAuthor ">Chudi O.  Ndubaku</span>, <span class="hlFld-ContribAuthor ">Paul  Nimmer</span>, <span class="hlFld-ContribAuthor ">Hans E.  Purkey</span>, <span class="hlFld-ContribAuthor ">Anatol  Oleksijew</span>, <span class="hlFld-ContribAuthor ">Darren C.  Phillips</span>, <span class="hlFld-ContribAuthor ">Brad E.  Sleebs</span>, <span class="hlFld-ContribAuthor ">Brian J.  Smith</span>, <span class="hlFld-ContribAuthor ">Morey L.  Smith</span>, <span class="hlFld-ContribAuthor ">Stephen K.  Tahir</span>, <span class="hlFld-ContribAuthor ">Keith G.  Watson</span>, <span class="hlFld-ContribAuthor ">Yu  Xiao</span>, <span class="hlFld-ContribAuthor ">John  Xue</span>, <span class="hlFld-ContribAuthor ">Haichao  Zhang</span>, <span class="hlFld-ContribAuthor ">Kerry  Zobel</span>, <span class="hlFld-ContribAuthor ">Saul H.  Rosenberg</span>, <span class="hlFld-ContribAuthor ">Chris  Tse</span>, <span class="hlFld-ContribAuthor ">Joel D.  Leverson</span>, <span class="hlFld-ContribAuthor ">Steven W.  Elmore</span>, and <span class="hlFld-ContribAuthor ">Andrew J.  Souers</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of a Potent and Selective BCL-XL Inhibitor with in Vivo Activity. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2014,</strong> <em>5 </em>
                                    (10)
                                     , 1088-1093. <a href="https://doi.org/10.1021/ml5001867" title="DOI URL">https://doi.org/10.1021/ml5001867</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ml5001867&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fml5001867%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Ba%252BPotent%252Band%252BSelective%252BBCL-XL%252BInhibitor%252Bwith%252Bin%252BVivo%252BActivity%26aulast%3DTao%26aufirst%3DZhi-Fu%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D08052014%26date%3D26082014%26date%3D08092014%26date%3D09102014%26date%3D26082014%26volume%3D5%26issue%3D10%26spage%3D1088%26epage%3D1093" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ryan M.  Brady</span>, <span class="hlFld-ContribAuthor ">Amelia  Vom</span>, <span class="hlFld-ContribAuthor ">Michael J.  Roy</span>, <span class="hlFld-ContribAuthor ">Nathan  Toovey</span>, <span class="hlFld-ContribAuthor ">Brian J.  Smith</span>, <span class="hlFld-ContribAuthor ">Rebecca M.  Moss</span>, <span class="hlFld-ContribAuthor ">Effie  Hatzis</span>, <span class="hlFld-ContribAuthor ">David C. S.  Huang</span>, <span class="hlFld-ContribAuthor ">John P.  Parisot</span>, <span class="hlFld-ContribAuthor ">Hong  Yang</span>, <span class="hlFld-ContribAuthor ">Ian P.  Street</span>, <span class="hlFld-ContribAuthor ">Peter M.  Colman</span>, <span class="hlFld-ContribAuthor ">Peter E.  Czabotar</span>, <span class="hlFld-ContribAuthor ">Jonathan B.  Baell</span>, and <span class="hlFld-ContribAuthor ">Guillaume  Lessene</span>  . </span><span class="cited-content_cbyCitation_article-title">De-Novo Designed Library of Benzoylureas as Inhibitors of BCL-XL: Synthesis, Structural and Biochemical Characterization. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (4)
                                     , 1323-1343. <a href="https://doi.org/10.1021/jm401948b" title="DOI URL">https://doi.org/10.1021/jm401948b</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm401948b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm401948b%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDe-Novo%252BDesigned%252BLibrary%252Bof%252BBenzoylureas%252Bas%252BInhibitors%252Bof%252BBCL-XL%25253A%252BSynthesis%25252C%252BStructural%252Band%252BBiochemical%252BCharacterization%26aulast%3DBrady%26aufirst%3DRyan%2BM.%26date%3D2014%26date%3D2014%26date%3D2013%26date%3D27092013%26date%3D05022014%26date%3D27022014%26date%3D23012014%26volume%3D57%26issue%3D4%26spage%3D1323%26epage%3D1343" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anuja  P. K.</span>, <span class="hlFld-ContribAuthor ">Priyankar  Paira</span>. </span><span class="cited-content_cbyCitation_article-title">Ruthenium(
              ii
              )
              p
              -cymene complexes of pyridine-2-carboxaldehyde and 2-amino benzothiazole-based ligands: cytoselective and
              in vitro
              live cell imaging agents. </span><span class="cited-content_cbyCitation_journal-name">New Journal of Chemistry</span><span> <strong>2021,</strong> <em>45 </em>
                                    (25)
                                     , 11317-11326. <a href="https://doi.org/10.1039/D0NJ04137H" title="DOI URL">https://doi.org/10.1039/D0NJ04137H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0NJ04137H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0NJ04137H%26sid%3Dliteratum%253Aachs%26jtitle%3DNew%2520Journal%2520of%2520Chemistry%26atitle%3DRuthenium%252528%252Bii%252B%252529%252Bp%252B-cymene%252Bcomplexes%252Bof%252Bpyridine-2-carboxaldehyde%252Band%252B2-amino%252Bbenzothiazole-based%252Bligands%25253A%252Bcytoselective%252Band%252Bin%252Bvitro%252Blive%252Bcell%252Bimaging%252Bagents%26aulast%3DP.%2BK.%26aufirst%3DAnuja%26date%3D2021%26date%3D2021%26volume%3D45%26issue%3D25%26spage%3D11317%26epage%3D11326" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jonathan B.  Baell</span>. </span><span class="cited-content_cbyCitation_article-title">Personal Accounts of Australian Drug Discovery at the Public–Private Interface. </span><span class="cited-content_cbyCitation_journal-name">Australian Journal of Chemistry</span><span> <strong>2021,</strong> <em>74 </em>
                                    (1)
                                     , 16. <a href="https://doi.org/10.1071/CH20244" title="DOI URL">https://doi.org/10.1071/CH20244</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1071/CH20244&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1071%2FCH20244%26sid%3Dliteratum%253Aachs%26jtitle%3DAustralian%2520Journal%2520of%2520Chemistry%26atitle%3DPersonal%252BAccounts%252Bof%252BAustralian%252BDrug%252BDiscovery%252Bat%252Bthe%252BPublic%2525E2%252580%252593Private%252BInterface%26aulast%3DBaell%26aufirst%3DJonathan%2BB.%26date%3D2021%26volume%3D74%26issue%3D1%26spage%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pelin  Çıkla-Süzgün</span>, <span class="hlFld-ContribAuthor ">Ş. Güniz  Küçükgüzel</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Advances in Apoptosis: THE Role of Hydrazones. </span><span class="cited-content_cbyCitation_journal-name">Mini-Reviews in Medicinal Chemistry</span><span> <strong>2019,</strong> <em>19 </em>
                                    (17)
                                     , 1427-1442. <a href="https://doi.org/10.2174/1389557519666190410125910" title="DOI URL">https://doi.org/10.2174/1389557519666190410125910</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1389557519666190410125910&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1389557519666190410125910%26sid%3Dliteratum%253Aachs%26jtitle%3DMini-Reviews%2520in%2520Medicinal%2520Chemistry%26atitle%3DRecent%252BAdvances%252Bin%252BApoptosis%25253A%252BTHE%252BRole%252Bof%252BHydrazones%26aulast%3D%25C3%2587%25C4%25B1kla-S%25C3%25BCzg%25C3%25BCn%26aufirst%3DPelin%26date%3D2019%26volume%3D19%26issue%3D17%26spage%3D1427%26epage%3D1442" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">S.  Mor</span>, <span class="hlFld-ContribAuthor ">S.  Sindhu</span>, <span class="hlFld-ContribAuthor ">M.  Khatri</span>, <span class="hlFld-ContribAuthor ">N.  Singh</span>, <span class="hlFld-ContribAuthor ">N.  Vasudeva</span>, <span class="hlFld-ContribAuthor ">N.  Panihar</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, Type II Diabetes Inhibitory Activity, and Antimicrobial Tests of Benzothiazole Derivatives Bridged with Indenedione by Methylenehydrazone. </span><span class="cited-content_cbyCitation_journal-name">Russian Journal of General Chemistry</span><span> <strong>2019,</strong> <em>89 </em>
                                    (9)
                                     , 1867-1873. <a href="https://doi.org/10.1134/S1070363219090226" title="DOI URL">https://doi.org/10.1134/S1070363219090226</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1134/S1070363219090226&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1134%2FS1070363219090226%26sid%3Dliteratum%253Aachs%26jtitle%3DRussian%2520Journal%2520of%2520General%2520Chemistry%26atitle%3DSynthesis%25252C%252BType%252BII%252BDiabetes%252BInhibitory%252BActivity%25252C%252Band%252BAntimicrobial%252BTests%252Bof%252BBenzothiazole%252BDerivatives%252BBridged%252Bwith%252BIndenedione%252Bby%252BMethylenehydrazone%26aulast%3DMor%26aufirst%3DS.%26date%3D2019%26date%3D2019%26volume%3D89%26issue%3D9%26spage%3D1867%26epage%3D1873" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qing  Wang</span>, <span class="hlFld-ContribAuthor ">Jiangbo  Wan</span>, <span class="hlFld-ContribAuthor ">Wenhao  Zhang</span>, <span class="hlFld-ContribAuthor ">Siguo  Hao</span>. </span><span class="cited-content_cbyCitation_article-title">MCL-1 or BCL-xL-dependent resistance to the BCL-2 antagonist (ABT-199) can be overcome by specific inhibitor as single agents and in combination with ABT-199 in acute myeloid leukemia cells. </span><span class="cited-content_cbyCitation_journal-name">Leukemia & Lymphoma</span><span> <strong>2019,</strong> <em>60 </em>
                                    (9)
                                     , 2170-2180. <a href="https://doi.org/10.1080/10428194.2018.1563694" title="DOI URL">https://doi.org/10.1080/10428194.2018.1563694</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/10428194.2018.1563694&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F10428194.2018.1563694%26sid%3Dliteratum%253Aachs%26jtitle%3DLeukemia%2520%2526%2520Lymphoma%26atitle%3DMCL-1%252Bor%252BBCL-xL-dependent%252Bresistance%252Bto%252Bthe%252BBCL-2%252Bantagonist%252B%252528ABT-199%252529%252Bcan%252Bbe%252Bovercome%252Bby%252Bspecific%252Binhibitor%252Bas%252Bsingle%252Bagents%252Band%252Bin%252Bcombination%252Bwith%252BABT-199%252Bin%252Bacute%252Bmyeloid%252Bleukemia%252Bcells%26aulast%3DWang%26aufirst%3DQing%26date%3D2019%26date%3D2019%26volume%3D60%26issue%3D9%26spage%3D2170%26epage%3D2180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anuradha</span>, <span class="hlFld-ContribAuthor ">Sagarkumar  Patel</span>, <span class="hlFld-ContribAuthor ">Rajkumar  Patle</span>, <span class="hlFld-ContribAuthor ">Preethi  Parameswaran</span>, <span class="hlFld-ContribAuthor ">Alok  Jain</span>, <span class="hlFld-ContribAuthor ">Amit  Shard</span>. </span><span class="cited-content_cbyCitation_article-title">Design, computational studies, synthesis and biological evaluation of thiazole-based molecules as anticancer agents. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Pharmaceutical Sciences</span><span> <strong>2019,</strong> <em>134 </em>, 20-30. <a href="https://doi.org/10.1016/j.ejps.2019.04.005" title="DOI URL">https://doi.org/10.1016/j.ejps.2019.04.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejps.2019.04.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejps.2019.04.005%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Pharmaceutical%2520Sciences%26atitle%3DDesign%25252C%252Bcomputational%252Bstudies%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bthiazole-based%252Bmolecules%252Bas%252Banticancer%252Bagents%26aulast%3DAnuradha%26date%3D2019%26volume%3D134%26spage%3D20%26epage%3D30" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gajanan Raosaheb  Jadhav</span>, <span class="hlFld-ContribAuthor ">Priyankar  Paira</span>. </span><span class="cited-content_cbyCitation_article-title">Cytotoxic 2‐(2′‐Hydroxyphenyl)benzothiazolylquinoline Analogues and their
              In Vitro
              Screening through Developmental Assays
              †. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2019,</strong> <em>4 </em>
                                    (12)
                                     , 3524-3530. <a href="https://doi.org/10.1002/slct.201803618" title="DOI URL">https://doi.org/10.1002/slct.201803618</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.201803618&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.201803618%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DCytotoxic%252B2%2525E2%252580%252590%2525282%2525E2%252580%2525B2%2525E2%252580%252590Hydroxyphenyl%252529benzothiazolylquinoline%252BAnalogues%252Band%252Btheir%252BIn%252BVitro%252BScreening%252Bthrough%252BDevelopmental%252BAssays%252B%2525E2%252580%2525A0%26aulast%3DJadhav%26aufirst%3DGajanan%2BRaosaheb%26date%3D2019%26date%3D2019%26volume%3D4%26issue%3D12%26spage%3D3524%26epage%3D3530" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Raj  Kamal</span>, <span class="hlFld-ContribAuthor ">Ravinder  Kumar</span>, <span class="hlFld-ContribAuthor ">Vipan  Kumar</span>, <span class="hlFld-ContribAuthor ">Vikas  Kumar</span>, <span class="hlFld-ContribAuthor ">Kushal K.  Bansal</span>, <span class="hlFld-ContribAuthor ">Prabodh C.  Sharma</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, Anthelmintic and Antimicrobial Evaluation of New 2‐Arylidene‐1‐(4‐methyl‐6‐phenylpyrimidin‐2‐yl)hydrazines. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2019,</strong> <em>4 </em>
                                    (2)
                                     , 713-717. <a href="https://doi.org/10.1002/slct.201802822" title="DOI URL">https://doi.org/10.1002/slct.201802822</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.201802822&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.201802822%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DSynthesis%25252C%252BAnthelmintic%252Band%252BAntimicrobial%252BEvaluation%252Bof%252BNew%252B2%2525E2%252580%252590Arylidene%2525E2%252580%2525901%2525E2%252580%252590%2525284%2525E2%252580%252590methyl%2525E2%252580%2525906%2525E2%252580%252590phenylpyrimidin%2525E2%252580%2525902%2525E2%252580%252590yl%252529hydrazines%26aulast%3DKamal%26aufirst%3DRaj%26date%3D2019%26date%3D2019%26volume%3D4%26issue%3D2%26spage%3D713%26epage%3D717" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pawan  Gupta</span>, <span class="hlFld-ContribAuthor ">Aleksandrs  Gutcaits</span>. </span><span class="cited-content_cbyCitation_article-title">Development and Validation of a Robust QSAR Model for Benzothiazole Hydrazone Derivatives as Bcl-XL Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Letters in Drug Design & Discovery</span><span> <strong>2018,</strong> <em>16 </em>
                                    (1)
                                     , 11-20. <a href="https://doi.org/10.2174/1570180815666180502093039" title="DOI URL">https://doi.org/10.2174/1570180815666180502093039</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1570180815666180502093039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1570180815666180502093039%26sid%3Dliteratum%253Aachs%26jtitle%3DLetters%2520in%2520Drug%2520Design%2520%2526%2520Discovery%26atitle%3DDevelopment%252Band%252BValidation%252Bof%252Ba%252BRobust%252BQSAR%252BModel%252Bfor%252BBenzothiazole%252BHydrazone%252BDerivatives%252Bas%252BBcl-XL%252BInhibitors%26aulast%3DGupta%26aufirst%3DPawan%26date%3D2018%26volume%3D16%26issue%3D1%26spage%3D11%26epage%3D20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Parthiban  Marimuthu</span>, <span class="hlFld-ContribAuthor ">Pavithra K.  Balasubramanian</span>, <span class="hlFld-ContribAuthor ">Kalaimathy  Singaravelu</span>. </span><span class="cited-content_cbyCitation_article-title">Deciphering the crucial molecular properties of a series of Benzothiazole Hydrazone inhibitors that targets anti-apoptotic Bcl-xL protein. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Structure and Dynamics</span><span> <strong>2018,</strong> <em>36 </em>
                                    (10)
                                     , 2654-2667. <a href="https://doi.org/10.1080/07391102.2017.1365771" title="DOI URL">https://doi.org/10.1080/07391102.2017.1365771</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07391102.2017.1365771&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07391102.2017.1365771%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Structure%2520and%2520Dynamics%26atitle%3DDeciphering%252Bthe%252Bcrucial%252Bmolecular%252Bproperties%252Bof%252Ba%252Bseries%252Bof%252BBenzothiazole%252BHydrazone%252Binhibitors%252Bthat%252Btargets%252Banti-apoptotic%252BBcl-xL%252Bprotein%26aulast%3DMarimuthu%26aufirst%3DParthiban%26date%3D2018%26date%3D2017%26volume%3D36%26issue%3D10%26spage%3D2654%26epage%3D2667" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Li  Wang</span>, <span class="hlFld-ContribAuthor ">Yihui  He</span>, <span class="hlFld-ContribAuthor ">Guangya  Xiang</span>, <span class="hlFld-ContribAuthor ">Xianmei  Shang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, cytotoxicity and anti-metastatic properties of new pyridyl-thiazole arene ruthenium(II) complexes. </span><span class="cited-content_cbyCitation_journal-name">Applied Organometallic Chemistry</span><span> <strong>2018,</strong> <em>32 </em>
                                    (5)
                                     , e4311. <a href="https://doi.org/10.1002/aoc.4311" title="DOI URL">https://doi.org/10.1002/aoc.4311</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/aoc.4311&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Faoc.4311%26sid%3Dliteratum%253Aachs%26jtitle%3DApplied%2520Organometallic%2520Chemistry%26atitle%3DSynthesis%25252C%252Bcytotoxicity%252Band%252Banti-metastatic%252Bproperties%252Bof%252Bnew%252Bpyridyl-thiazole%252Barene%252Bruthenium%252528II%252529%252Bcomplexes%26aulast%3DWang%26aufirst%3DLi%26date%3D2018%26date%3D2018%26volume%3D32%26issue%3D5%26spage%3De4311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Derya  Osmaniye</span>, <span class="hlFld-ContribAuthor ">Serkan  Levent</span>, <span class="hlFld-ContribAuthor ">Abdullah  Karaduman</span>, <span class="hlFld-ContribAuthor ">Sinem  Ilgın</span>, <span class="hlFld-ContribAuthor ">Yusuf  Özkay</span>, <span class="hlFld-ContribAuthor ">Zafer  Kaplancıklı</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of New Benzothiazole Acylhydrazones as Anticancer Agents. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2018,</strong> <em>23 </em>
                                    (5)
                                     , 1054. <a href="https://doi.org/10.3390/molecules23051054" title="DOI URL">https://doi.org/10.3390/molecules23051054</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules23051054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules23051054%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DSynthesis%252Bof%252BNew%252BBenzothiazole%252BAcylhydrazones%252Bas%252BAnticancer%252BAgents%26aulast%3DOsmaniye%26aufirst%3DDerya%26date%3D2018%26date%3D2018%26volume%3D23%26issue%3D5%26spage%3D1054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nikolay A.  Bumagin</span>, <span class="hlFld-ContribAuthor ">Sergey K.  Petkevich</span>, <span class="hlFld-ContribAuthor ">Alexey V.  Kletskov</span>, <span class="hlFld-ContribAuthor ">Vladimir I.  Potkin</span>. </span><span class="cited-content_cbyCitation_article-title">3,5-[5-Arylisoxazol-3-yl(4,5-dichloroisothiazol-3-yl)]-substituted 1,2,4- and 1,3,4-oxadiazoles: synthesis, palladium complexes, and catalysis of Suzuki reactions in aqueous media. </span><span class="cited-content_cbyCitation_journal-name">Chemistry of Heterocyclic Compounds</span><span> <strong>2017,</strong> <em>53 </em>
                                    (12)
                                     , 1340-1349. <a href="https://doi.org/10.1007/s10593-018-2216-z" title="DOI URL">https://doi.org/10.1007/s10593-018-2216-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10593-018-2216-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10593-018-2216-z%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520of%2520Heterocyclic%2520Compounds%26atitle%3D3%25252C5-%25255B5-Arylisoxazol-3-yl%2525284%25252C5-dichloroisothiazol-3-yl%252529%25255D-substituted%252B1%25252C2%25252C4-%252Band%252B1%25252C3%25252C4-oxadiazoles%25253A%252Bsynthesis%25252C%252Bpalladium%252Bcomplexes%25252C%252Band%252Bcatalysis%252Bof%252BSuzuki%252Breactions%252Bin%252Baqueous%252Bmedia%26aulast%3DBumagin%26aufirst%3DNikolay%2BA.%26date%3D2017%26date%3D2018%26volume%3D53%26issue%3D12%26spage%3D1340%26epage%3D1349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Larissa  Geiger</span>, <span class="hlFld-ContribAuthor ">Martin  Nieger</span>, <span class="hlFld-ContribAuthor ">Stefan  Bräse</span>. </span><span class="cited-content_cbyCitation_article-title">Suzuki-Miyaura Cross-Coupling Reactions of Tetrahydroxanthones and 4-Chromanone Lactones to Heteromeric Biaryls. </span><span class="cited-content_cbyCitation_journal-name">Advanced Synthesis & Catalysis</span><span> <strong>2017,</strong> <em>359 </em>
                                    (19)
                                     , 3421-3427. <a href="https://doi.org/10.1002/adsc.201700497" title="DOI URL">https://doi.org/10.1002/adsc.201700497</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adsc.201700497&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadsc.201700497%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Synthesis%2520%2526%2520Catalysis%26atitle%3DSuzuki-Miyaura%252BCross-Coupling%252BReactions%252Bof%252BTetrahydroxanthones%252Band%252B4-Chromanone%252BLactones%252Bto%252BHeteromeric%252BBiaryls%26aulast%3DGeiger%26aufirst%3DLarissa%26date%3D2017%26date%3D2017%26volume%3D359%26issue%3D19%26spage%3D3421%26epage%3D3427" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vishnupriya  Kanakaveti</span>, <span class="hlFld-ContribAuthor ">Ramasamy  Sakthivel</span>, <span class="hlFld-ContribAuthor ">S. K.  Rayala</span>, <span class="hlFld-ContribAuthor ">M. Michael  Gromiha</span>. </span><span class="cited-content_cbyCitation_article-title">Importance of functional groups in predicting the activity of small molecule inhibitors for Bcl-2 and Bcl-xL. </span><span class="cited-content_cbyCitation_journal-name">Chemical Biology & Drug Design</span><span> <strong>2017,</strong> <em>90 </em>
                                    (2)
                                     , 308-316. <a href="https://doi.org/10.1111/cbdd.12952" title="DOI URL">https://doi.org/10.1111/cbdd.12952</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cbdd.12952&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcbdd.12952%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Biology%2520%2526%2520Drug%2520Design%26atitle%3DImportance%252Bof%252Bfunctional%252Bgroups%252Bin%252Bpredicting%252Bthe%252Bactivity%252Bof%252Bsmall%252Bmolecule%252Binhibitors%252Bfor%252BBcl-2%252Band%252BBcl-xL%26aulast%3DKanakaveti%26aufirst%3DVishnupriya%26date%3D2017%26date%3D2017%26volume%3D90%26issue%3D2%26spage%3D308%26epage%3D316" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mohit  Chhabra</span>, <span class="hlFld-ContribAuthor ">Lavanya Thilak  Babu</span>, <span class="hlFld-ContribAuthor ">Ashaparna  Mondal</span>, <span class="hlFld-ContribAuthor ">Hongyan  Sun</span>, <span class="hlFld-ContribAuthor ">Priyankar  Paira</span>. </span><span class="cited-content_cbyCitation_article-title">Amberlite IRA 402(OH) Mediated Green Synthesis of Novel Benzothiazole–quinoline Conjugates as Cancer Theranostics. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2017,</strong> <em>2 </em>
                                    (8)
                                     , 2480-2486. <a href="https://doi.org/10.1002/slct.201700066" title="DOI URL">https://doi.org/10.1002/slct.201700066</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.201700066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.201700066%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DAmberlite%252BIRA%252B402%252528OH%252529%252BMediated%252BGreen%252BSynthesis%252Bof%252BNovel%252BBenzothiazole%2525E2%252580%252593quinoline%252BConjugates%252Bas%252BCancer%252BTheranostics%26aulast%3DChhabra%26aufirst%3DMohit%26date%3D2017%26date%3D2017%26volume%3D2%26issue%3D8%26spage%3D2480%26epage%3D2486" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ziqian  Wang</span>, <span class="hlFld-ContribAuthor ">Wenjie  Xu</span>, <span class="hlFld-ContribAuthor ">Ting  Song</span>, <span class="hlFld-ContribAuthor ">Zongwei  Guo</span>, <span class="hlFld-ContribAuthor ">Lu  Liu</span>, <span class="hlFld-ContribAuthor ">Yudan  Fan</span>, <span class="hlFld-ContribAuthor ">Anhui  Wang</span>, <span class="hlFld-ContribAuthor ">Zhichao  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Fragment-Based Design, Synthesis, and Biological Evaluation of 1-Substituted-indole-2-carboxylic Acids as Selective Mcl-1 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Archiv der Pharmazie</span><span> <strong>2017,</strong> <em>350 </em>
                                    (1)
                                     , e1600251. <a href="https://doi.org/10.1002/ardp.201600251" title="DOI URL">https://doi.org/10.1002/ardp.201600251</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ardp.201600251&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fardp.201600251%26sid%3Dliteratum%253Aachs%26jtitle%3DArchiv%2520der%2520Pharmazie%26atitle%3DFragment-Based%252BDesign%25252C%252BSynthesis%25252C%252Band%252BBiological%252BEvaluation%252Bof%252B1-Substituted-indole-2-carboxylic%252BAcids%252Bas%252BSelective%252BMcl-1%252BInhibitors%26aulast%3DWang%26aufirst%3DZiqian%26date%3D2017%26date%3D2016%26volume%3D350%26issue%3D1%26spage%3De1600251" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Edward J.  Hennessy</span>. </span><span class="cited-content_cbyCitation_article-title">Selective inhibitors of Bcl-2 and Bcl-xL: Balancing antitumor activity with on-target toxicity. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>26 </em>
                                    (9)
                                     , 2105-2114. <a href="https://doi.org/10.1016/j.bmcl.2016.03.032" title="DOI URL">https://doi.org/10.1016/j.bmcl.2016.03.032</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2016.03.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2016.03.032%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSelective%252Binhibitors%252Bof%252BBcl-2%252Band%252BBcl-xL%25253A%252BBalancing%252Bantitumor%252Bactivity%252Bwith%252Bon-target%252Btoxicity%26aulast%3DHennessy%26aufirst%3DEdward%2BJ.%26date%3D2016%26volume%3D26%26issue%3D9%26spage%3D2105%26epage%3D2114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">D  Merino</span>, <span class="hlFld-ContribAuthor ">S W  Lok</span>, <span class="hlFld-ContribAuthor ">J E  Visvader</span>, <span class="hlFld-ContribAuthor ">G J  Lindeman</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting BCL-2 to enhance vulnerability to therapy in estrogen receptor-positive breast cancer. </span><span class="cited-content_cbyCitation_journal-name">Oncogene</span><span> <strong>2016,</strong> <em>35 </em>
                                    (15)
                                     , 1877-1887. <a href="https://doi.org/10.1038/onc.2015.287" title="DOI URL">https://doi.org/10.1038/onc.2015.287</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/onc.2015.287&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fonc.2015.287%26sid%3Dliteratum%253Aachs%26jtitle%3DOncogene%26atitle%3DTargeting%252BBCL-2%252Bto%252Benhance%252Bvulnerability%252Bto%252Btherapy%252Bin%252Bestrogen%252Breceptor-positive%252Bbreast%252Bcancer%26aulast%3DMerino%26aufirst%3DD%26date%3D2016%26date%3D2015%26volume%3D35%26issue%3D15%26spage%3D1877%26epage%3D1887" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sabrina  Tassini</span>, <span class="hlFld-ContribAuthor ">Daniele  Castagnolo</span>, <span class="hlFld-ContribAuthor ">Nicolò  Scalacci</span>, <span class="hlFld-ContribAuthor ">Miroslava  Kissova</span>, <span class="hlFld-ContribAuthor ">Jorge I.  Armijos-Rivera</span>, <span class="hlFld-ContribAuthor ">Federica  Giagnorio</span>, <span class="hlFld-ContribAuthor ">Giovanni  Maga</span>, <span class="hlFld-ContribAuthor ">Gabriele  Costantino</span>, <span class="hlFld-ContribAuthor ">Emmanuele  Crespan</span>, <span class="hlFld-ContribAuthor ">Marco  Radi</span>. </span><span class="cited-content_cbyCitation_article-title">A multicomponent pharmacophore fragment-decoration approach to identify selective LRRK2-targeting probes. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2016,</strong> <em>7 </em>
                                    (3)
                                     , 484-494. <a href="https://doi.org/10.1039/C5MD00462D" title="DOI URL">https://doi.org/10.1039/C5MD00462D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5MD00462D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5MD00462D%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DA%252Bmulticomponent%252Bpharmacophore%252Bfragment-decoration%252Bapproach%252Bto%252Bidentify%252Bselective%252BLRRK2-targeting%252Bprobes%26aulast%3DTassini%26aufirst%3DSabrina%26date%3D2016%26date%3D2016%26volume%3D7%26issue%3D3%26spage%3D484%26epage%3D494" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zelong  Lim</span>, <span class="hlFld-ContribAuthor ">Peter J.  Duggan</span>, <span class="hlFld-ContribAuthor ">Soo San  Wan</span>, <span class="hlFld-ContribAuthor ">Guillaume  Lessene</span>, <span class="hlFld-ContribAuthor ">Adam G.  Meyer</span>, <span class="hlFld-ContribAuthor ">Kellie L.  Tuck</span>. </span><span class="cited-content_cbyCitation_article-title">Exploiting the Biginelli reaction: nitrogen-rich pyrimidine-based tercyclic α-helix mimetics. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2016,</strong> <em>72 </em>
                                    (9)
                                     , 1151-1160. <a href="https://doi.org/10.1016/j.tet.2015.12.044" title="DOI URL">https://doi.org/10.1016/j.tet.2015.12.044</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2015.12.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2015.12.044%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DExploiting%252Bthe%252BBiginelli%252Breaction%25253A%252Bnitrogen-rich%252Bpyrimidine-based%252Btercyclic%252B%2525CE%2525B1-helix%252Bmimetics%26aulast%3DLim%26aufirst%3DZelong%26date%3D2016%26volume%3D72%26issue%3D9%26spage%3D1151%26epage%3D1160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sushree Prangya Priyadarshinee  Pany</span>, <span class="hlFld-ContribAuthor ">Praneeth  Bommisetti</span>, <span class="hlFld-ContribAuthor ">K. V.  Diveshkumar</span>, <span class="hlFld-ContribAuthor ">P. I.  Pradeepkumar</span>. </span><span class="cited-content_cbyCitation_article-title">Benzothiazole hydrazones of furylbenzamides preferentially stabilize c-MYC and c-KIT1 promoter G-quadruplex DNAs. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2016,</strong> <em>14 </em>
                                    (24)
                                     , 5779-5793. <a href="https://doi.org/10.1039/C6OB00138F" title="DOI URL">https://doi.org/10.1039/C6OB00138F</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6OB00138F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6OB00138F%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DBenzothiazole%252Bhydrazones%252Bof%252Bfurylbenzamides%252Bpreferentially%252Bstabilize%252Bc-MYC%252Band%252Bc-KIT1%252Bpromoter%252BG-quadruplex%252BDNAs%26aulast%3DPany%26aufirst%3DSushree%2BPrangya%2BPriyadarshinee%26date%3D2016%26date%3D2016%26volume%3D14%26issue%3D24%26spage%3D5779%26epage%3D5793" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">N. A.  Bumagin</span>, <span class="hlFld-ContribAuthor ">V. M.  Zelenkovskii</span>, <span class="hlFld-ContribAuthor ">A. V.  Kletskov</span>, <span class="hlFld-ContribAuthor ">S. K.  Petkevich</span>, <span class="hlFld-ContribAuthor ">E. A.  Dikusar</span>, <span class="hlFld-ContribAuthor ">V. I.  Potkin</span>. </span><span class="cited-content_cbyCitation_article-title">Functionally substituted isoxazoles and isothiazoles: Synthesis, palladium(II) complexes and their catalytic activity. </span><span class="cited-content_cbyCitation_journal-name">Russian Journal of General Chemistry</span><span> <strong>2016,</strong> <em>86 </em>
                                    (1)
                                     , 68-81. <a href="https://doi.org/10.1134/S1070363216010138" title="DOI URL">https://doi.org/10.1134/S1070363216010138</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1134/S1070363216010138&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1134%2FS1070363216010138%26sid%3Dliteratum%253Aachs%26jtitle%3DRussian%2520Journal%2520of%2520General%2520Chemistry%26atitle%3DFunctionally%252Bsubstituted%252Bisoxazoles%252Band%252Bisothiazoles%25253A%252BSynthesis%25252C%252Bpalladium%252528II%252529%252Bcomplexes%252Band%252Btheir%252Bcatalytic%252Bactivity%26aulast%3DBumagin%26aufirst%3DN.%2BA.%26date%3D2016%26date%3D2016%26volume%3D86%26issue%3D1%26spage%3D68%26epage%3D81" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xifang  Yu</span>, <span class="hlFld-ContribAuthor ">Liqiao  Shi</span>, <span class="hlFld-ContribAuthor ">Shaoyong  Ke</span>. </span><span class="cited-content_cbyCitation_article-title">Acylhydrazone derivatives as potential anticancer agents: Synthesis, bio-evaluation and mechanism of action. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>25 </em>
                                    (24)
                                     , 5772-5776. <a href="https://doi.org/10.1016/j.bmcl.2015.10.069" title="DOI URL">https://doi.org/10.1016/j.bmcl.2015.10.069</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2015.10.069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2015.10.069%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DAcylhydrazone%252Bderivatives%252Bas%252Bpotential%252Banticancer%252Bagents%25253A%252BSynthesis%25252C%252Bbio-evaluation%252Band%252Bmechanism%252Bof%252Baction%26aulast%3DYu%26aufirst%3DXifang%26date%3D2015%26volume%3D25%26issue%3D24%26spage%3D5772%26epage%3D5776" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">John  Spencer</span>, <span class="hlFld-ContribAuthor ">Hannah  Coaker</span>. </span><span class="cited-content_cbyCitation_article-title">Highlights from SelectBio 2015: Academic Drug Discovery Conference, Cambridge, UK, 19–20 May 2015. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2015,</strong> <em>7 </em>
                                    (14)
                                     , 1839-1842. <a href="https://doi.org/10.4155/fmc.15.118" title="DOI URL">https://doi.org/10.4155/fmc.15.118</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc.15.118&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc.15.118%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DHighlights%252Bfrom%252BSelectBio%252B2015%25253A%252BAcademic%252BDrug%252BDiscovery%252BConference%25252C%252BCambridge%25252C%252BUK%25252C%252B19%2525E2%252580%25259320%252BMay%252B2015%26aulast%3DSpencer%26aufirst%3DJohn%26date%3D2015%26volume%3D7%26issue%3D14%26spage%3D1839%26epage%3D1842" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rangappa S.  Keri</span>, <span class="hlFld-ContribAuthor ">Mahadeo R.  Patil</span>, <span class="hlFld-ContribAuthor ">Siddappa A.  Patil</span>, <span class="hlFld-ContribAuthor ">Srinivasa  Budagumpi</span>. </span><span class="cited-content_cbyCitation_article-title">A comprehensive review in current developments of benzothiazole-based molecules in medicinal chemistry. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>89 </em>, 207-251. <a href="https://doi.org/10.1016/j.ejmech.2014.10.059" title="DOI URL">https://doi.org/10.1016/j.ejmech.2014.10.059</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2014.10.059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2014.10.059%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DA%252Bcomprehensive%252Breview%252Bin%252Bcurrent%252Bdevelopments%252Bof%252Bbenzothiazole-based%252Bmolecules%252Bin%252Bmedicinal%252Bchemistry%26aulast%3DKeri%26aufirst%3DRangappa%2BS.%26date%3D2015%26volume%3D89%26spage%3D207%26epage%3D251" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">J D  Leverson</span>, <span class="hlFld-ContribAuthor ">H  Zhang</span>, <span class="hlFld-ContribAuthor ">J  Chen</span>, <span class="hlFld-ContribAuthor ">S K  Tahir</span>, <span class="hlFld-ContribAuthor ">D C  Phillips</span>, <span class="hlFld-ContribAuthor ">J  Xue</span>, <span class="hlFld-ContribAuthor ">P  Nimmer</span>, <span class="hlFld-ContribAuthor ">S  Jin</span>, <span class="hlFld-ContribAuthor ">M  Smith</span>, <span class="hlFld-ContribAuthor ">Y  Xiao</span>, <span class="hlFld-ContribAuthor ">P  Kovar</span>, <span class="hlFld-ContribAuthor ">A  Tanaka</span>, <span class="hlFld-ContribAuthor ">M  Bruncko</span>, <span class="hlFld-ContribAuthor ">G S  Sheppard</span>, <span class="hlFld-ContribAuthor ">L  Wang</span>, <span class="hlFld-ContribAuthor ">S  Gierke</span>, <span class="hlFld-ContribAuthor ">L  Kategaya</span>, <span class="hlFld-ContribAuthor ">D J  Anderson</span>, <span class="hlFld-ContribAuthor ">C  Wong</span>, <span class="hlFld-ContribAuthor ">J  Eastham-Anderson</span>, <span class="hlFld-ContribAuthor ">M J C  Ludlam</span>, <span class="hlFld-ContribAuthor ">D  Sampath</span>, <span class="hlFld-ContribAuthor ">W J  Fairbrother</span>, <span class="hlFld-ContribAuthor ">I  Wertz</span>, <span class="hlFld-ContribAuthor ">S H  Rosenberg</span>, <span class="hlFld-ContribAuthor ">C  Tse</span>, <span class="hlFld-ContribAuthor ">S W  Elmore</span>, <span class="hlFld-ContribAuthor ">A J  Souers</span>. </span><span class="cited-content_cbyCitation_article-title">Potent and selective small-molecule MCL-1 inhibitors demonstrate on-target cancer cell killing activity as single agents and in combination with ABT-263 (navitoclax). </span><span class="cited-content_cbyCitation_journal-name">Cell Death & Disease</span><span> <strong>2015,</strong> <em>6 </em>
                                    (1)
                                     , e1590-e1590. <a href="https://doi.org/10.1038/cddis.2014.561" title="DOI URL">https://doi.org/10.1038/cddis.2014.561</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/cddis.2014.561&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fcddis.2014.561%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Death%2520%2526%2520Disease%26atitle%3DPotent%252Band%252Bselective%252Bsmall-molecule%252BMCL-1%252Binhibitors%252Bdemonstrate%252Bon-target%252Bcancer%252Bcell%252Bkilling%252Bactivity%252Bas%252Bsingle%252Bagents%252Band%252Bin%252Bcombination%252Bwith%252BABT-263%252B%252528navitoclax%252529%26aulast%3DLeverson%26aufirst%3DJ%2BD%26date%3D2015%26date%3D2015%26volume%3D6%26issue%3D1%26spage%3De1590%26epage%3De1590" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">V. I.  Potkin</span>, <span class="hlFld-ContribAuthor ">N. A.  Bumagin</span>, <span class="hlFld-ContribAuthor ">V. M.  Zelenkovskii</span>, <span class="hlFld-ContribAuthor ">S. K.  Petkevich</span>, <span class="hlFld-ContribAuthor ">M. V.  Livantsov</span>, <span class="hlFld-ContribAuthor ">N. E.  Golantsov</span>. </span><span class="cited-content_cbyCitation_article-title">5-(Naphth-1-yl)- and 5-[(1,1′-biphenyl)-4-yl]isoxazole-3-carbaldehyde oximes: Synthesis, complexes with palladium, and application in catalysis. </span><span class="cited-content_cbyCitation_journal-name">Russian Journal of General Chemistry</span><span> <strong>2014,</strong> <em>84 </em>
                                    (9)
                                     , 1782-1792. <a href="https://doi.org/10.1134/S1070363214090242" title="DOI URL">https://doi.org/10.1134/S1070363214090242</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1134/S1070363214090242&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1134%2FS1070363214090242%26sid%3Dliteratum%253Aachs%26jtitle%3DRussian%2520Journal%2520of%2520General%2520Chemistry%26atitle%3D5-%252528Naphth-1-yl%252529-%252Band%252B5-%25255B%2525281%25252C1%2525E2%252580%2525B2-biphenyl%252529-4-yl%25255Disoxazole-3-carbaldehyde%252Boximes%25253A%252BSynthesis%25252C%252Bcomplexes%252Bwith%252Bpalladium%25252C%252Band%252Bapplication%252Bin%252Bcatalysis%26aulast%3DPotkin%26aufirst%3DV.%2BI.%26date%3D2014%26date%3D2014%26volume%3D84%26issue%3D9%26spage%3D1782%26epage%3D1792" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">N. A.  Bumagin</span>, <span class="hlFld-ContribAuthor ">I. S.  Veselov</span>, <span class="hlFld-ContribAuthor ">D. S.  Belov</span>. </span><span class="cited-content_cbyCitation_article-title">An Effective Activation of Palladium Phosphine Complexes in Aqueous Phase Reactions of Hetero-Aromatic Boronic Acids with Aryl Halides. </span><span class="cited-content_cbyCitation_journal-name">Chemistry of Heterocyclic Compounds</span><span> <strong>2014,</strong> <em>50 </em>
                                    (1)
                                     , 19-25. <a href="https://doi.org/10.1007/s10593-014-1443-1" title="DOI URL">https://doi.org/10.1007/s10593-014-1443-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10593-014-1443-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10593-014-1443-1%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520of%2520Heterocyclic%2520Compounds%26atitle%3DAn%252BEffective%252BActivation%252Bof%252BPalladium%252BPhosphine%252BComplexes%252Bin%252BAqueous%252BPhase%252BReactions%252Bof%252BHetero-Aromatic%252BBoronic%252BAcids%252Bwith%252BAryl%252BHalides%26aulast%3DBumagin%26aufirst%3DN.%2BA.%26date%3D2014%26date%3D2014%26volume%3D50%26issue%3D1%26spage%3D19%26epage%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tracy L.  Nero</span>, <span class="hlFld-ContribAuthor ">Craig J.  Morton</span>, <span class="hlFld-ContribAuthor ">Jessica K.  Holien</span>, <span class="hlFld-ContribAuthor ">Jerome  Wielens</span>, <span class="hlFld-ContribAuthor ">Michael W.  Parker</span>. </span><span class="cited-content_cbyCitation_article-title">Oncogenic protein interfaces: small molecules, big challenges. </span><span class="cited-content_cbyCitation_journal-name">Nature Reviews Cancer</span><span> <strong>2014,</strong> <em>14 </em>
                                    (4)
                                     , 248-262. <a href="https://doi.org/10.1038/nrc3690" title="DOI URL">https://doi.org/10.1038/nrc3690</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/nrc3690&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fnrc3690%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Reviews%2520Cancer%26atitle%3DOncogenic%252Bprotein%252Binterfaces%25253A%252Bsmall%252Bmolecules%25252C%252Bbig%252Bchallenges%26aulast%3DNero%26aufirst%3DTracy%2BL.%26date%3D2014%26date%3D2014%26volume%3D14%26issue%3D4%26spage%3D248%26epage%3D262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">M J  Roy</span>, <span class="hlFld-ContribAuthor ">A  Vom</span>, <span class="hlFld-ContribAuthor ">P E  Czabotar</span>, <span class="hlFld-ContribAuthor ">G  Lessene</span>. </span><span class="cited-content_cbyCitation_article-title">Cell death and the mitochondria: therapeutic targeting of the BCL-2 family-driven pathway. </span><span class="cited-content_cbyCitation_journal-name">British Journal of Pharmacology</span><span> <strong>2014,</strong> <em>171 </em>
                                    (8)
                                     , 1973-1987. <a href="https://doi.org/10.1111/bph.12431" title="DOI URL">https://doi.org/10.1111/bph.12431</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/bph.12431&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fbph.12431%26sid%3Dliteratum%253Aachs%26jtitle%3DBritish%2520Journal%2520of%2520Pharmacology%26atitle%3DCell%252Bdeath%252Band%252Bthe%252Bmitochondria%25253A%252Btherapeutic%252Btargeting%252Bof%252Bthe%252BBCL-2%252Bfamily-driven%252Bpathway%26aulast%3DRoy%26aufirst%3DM%2BJ%26date%3D2014%26date%3D2014%26volume%3D171%26issue%3D8%26spage%3D1973%26epage%3D1987" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">N. A.  Bumagin</span>, <span class="hlFld-ContribAuthor ">S. K.  Petkevich</span>, <span class="hlFld-ContribAuthor ">A. V.  Kletskov</span>, <span class="hlFld-ContribAuthor ">M. V.  Livantsov</span>, <span class="hlFld-ContribAuthor ">N. E.  Golantsov</span>, <span class="hlFld-ContribAuthor ">V. I.  Potkin</span>. </span><span class="cited-content_cbyCitation_article-title">Isoxazol-3-yl(Isothiazol-3-yl)-1,2,4-Triazoles, Tetrazoles, and -1,3,4-Oxadiazoles: Synthesis, Palladium Complexes, and Catalytic Applications. </span><span class="cited-content_cbyCitation_journal-name">Chemistry of Heterocyclic Compounds</span><span> <strong>2014,</strong> <em>49 </em>
                                    (10)
                                     , 1515-1529. <a href="https://doi.org/10.1007/s10593-014-1403-9" title="DOI URL">https://doi.org/10.1007/s10593-014-1403-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10593-014-1403-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10593-014-1403-9%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520of%2520Heterocyclic%2520Compounds%26atitle%3DIsoxazol-3-yl%252528Isothiazol-3-yl%252529-1%25252C2%25252C4-Triazoles%25252C%252BTetrazoles%25252C%252Band%252B-1%25252C3%25252C4-Oxadiazoles%25253A%252BSynthesis%25252C%252BPalladium%252BComplexes%25252C%252Band%252BCatalytic%252BApplications%26aulast%3DBumagin%26aufirst%3DN.%2BA.%26date%3D2014%26date%3D2014%26volume%3D49%26issue%3D10%26spage%3D1515%26epage%3D1529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peter M.  Colman</span>. </span><span class="cited-content_cbyCitation_article-title">Crystallography and New Medicines: Examples from Influenza and Cell Death. </span><span class="cited-content_cbyCitation_journal-name">Australian Journal of Chemistry</span><span> <strong>2014,</strong> <em>67 </em>
                                    (12)
                                     , 1720. <a href="https://doi.org/10.1071/CH14318" title="DOI URL">https://doi.org/10.1071/CH14318</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1071/CH14318&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1071%2FCH14318%26sid%3Dliteratum%253Aachs%26jtitle%3DAustralian%2520Journal%2520of%2520Chemistry%26atitle%3DCrystallography%252Band%252BNew%252BMedicines%25253A%252BExamples%252Bfrom%252BInfluenza%252Band%252BCell%252BDeath%26aulast%3DColman%26aufirst%3DPeter%2BM.%26date%3D2014%26volume%3D67%26issue%3D12%26spage%3D1720" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jonathan B.  Baell</span>, <span class="hlFld-ContribAuthor ">Lori  Ferrins</span>, <span class="hlFld-ContribAuthor ">Hendrik  Falk</span>, <span class="hlFld-ContribAuthor ">George  Nikolakopoulos</span>. </span><span class="cited-content_cbyCitation_article-title">PAINS: Relevance to Tool Compound Discovery and Fragment-Based Screening. </span><span class="cited-content_cbyCitation_journal-name">Australian Journal of Chemistry</span><span> <strong>2013,</strong> <em>66 </em>
                                    (12)
                                     , 1483. <a href="https://doi.org/10.1071/CH13551" title="DOI URL">https://doi.org/10.1071/CH13551</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1071/CH13551&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1071%2FCH13551%26sid%3Dliteratum%253Aachs%26jtitle%3DAustralian%2520Journal%2520of%2520Chemistry%26atitle%3DPAINS%25253A%252BRelevance%252Bto%252BTool%252BCompound%252BDiscovery%252Band%252BFragment-Based%252BScreening%26aulast%3DBaell%26aufirst%3DJonathan%2BB.%26date%3D2013%26volume%3D66%26issue%3D12%26spage%3D1483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_null" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-13/jm400556w/production/images/medium/jm-2013-00556w_0027.gif" alt="" id="_i1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-13/jm400556w/production/images/large/jm-2013-00556w_0027.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400556w&amp;id=f_null"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-13/jm400556w/production/images/medium/jm-2013-00556w_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-13/jm400556w/production/images/large/jm-2013-00556w_0002.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Structure of Previously Reported BH3-Mimetics Acylsulfonamide Derivatives <b>1</b>, <b>2</b>, and <b>3</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-13/jm400556w/production/images/large/jm-2013-00556w_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400556w&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-13/jm400556w/production/images/medium/jm-2013-00556w_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-13/jm400556w/production/images/large/jm-2013-00556w_0003.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Identification of compound <b>6</b>. The final set of 46 reordered compounds was tested against Bcl-w, Bcl-X<sub>L</sub>, and Mcl-1 using the luminescence proximity assay (LPA) and fluorescence polarization (FP) assays together with a counter-screen assay. Hits were compounds showing IC<sub>50</sub> values below 60 μM against any of the three targets.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-13/jm400556w/production/images/large/jm-2013-00556w_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400556w&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-13/jm400556w/production/images/medium/jm-2013-00556w_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-13/jm400556w/production/images/large/jm-2013-00556w_0008.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Furyl-benzothiazole Hydrazone Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-13/jm400556w/production/images/large/jm-2013-00556w_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400556w&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(i) NaNO<sub>2</sub>, HCl, H<sub>2</sub>O, 0 °C; (ii) CuCl<sub>2</sub>, acetone; (iii) ammonium formate, Pd/C, MeOH; (iv) 2-hydrazino-benzothiazole, EtOH or AcOH, 60–80 °C; (v) H<sub>2</sub>SO<sub>4</sub>, MeOH.</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-13/jm400556w/production/images/medium/jm-2013-00556w_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-13/jm400556w/production/images/large/jm-2013-00556w_0009.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Analogues with Various Replacements of the Benzothiazole Group<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-13/jm400556w/production/images/large/jm-2013-00556w_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400556w&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(i) NH<sub>2</sub>NH<sub>2</sub>, EtOH, 70 °C; (ii) NH<sub>2</sub>NH<sub>2</sub>.H<sub>2</sub>O, NH<sub>2</sub>NH<sub>2</sub>·HCl, ethylene glycol, 140 °C; (iii) Various R-NH-NH<sub>2</sub>, EtOH or AcOH, 60–80 °C.</p></p></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-13/jm400556w/production/images/medium/jm-2013-00556w_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-13/jm400556w/production/images/large/jm-2013-00556w_0010.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Analogues with Various Biarylic Moieties Using the Meerwein Reaction<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-13/jm400556w/production/images/large/jm-2013-00556w_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400556w&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(i) NaNO<sub>2</sub>, HCl, H<sub>2</sub>O, 0 °C; (ii) CuCl<sub>2</sub>, acetone; (iii) 2-hydrazino-benzothiazole, EtOH or AcOH, 60–80 °C.</p></p></figure><figure data-id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-13/jm400556w/production/images/medium/jm-2013-00556w_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-13/jm400556w/production/images/large/jm-2013-00556w_0011.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Analogues with Various Biarylic Moieties Using a Suzuki–Miyaura Coupling Reaction<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-13/jm400556w/production/images/large/jm-2013-00556w_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400556w&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(i) TBAB, K<sub>2</sub>CO<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, dioxane/H<sub>2</sub>O, 70 °C, μW; (ii) NaOH, MeOH/THF then HCl; (iii) 2-hydrazino-benzothiazole, EtOH or AcOH, 60–80 °C.</p></p></figure><figure data-id="sch5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-13/jm400556w/production/images/medium/jm-2013-00556w_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-13/jm400556w/production/images/large/jm-2013-00556w_0012.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of Simple Conformationally Constrained Analogues<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-13/jm400556w/production/images/large/jm-2013-00556w_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400556w&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(i) Bispinacoldiboron, Pd(dppf)Cl<sub>2</sub>, KOAc, toluene, 150 °C, μW; (ii) 6-Bromopicolinic acid, TBAB, K<sub>2</sub>CO<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, dioxane/H<sub>2</sub>O, 70 °C, μW; (iii) 2-hydrazino-benzothiazole, EtOH or AcOH, 60–80 °C.</p></p></figure><figure data-id="sch6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-13/jm400556w/production/images/medium/jm-2013-00556w_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-13/jm400556w/production/images/large/jm-2013-00556w_0013.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of Constrained Hydrazone Analogues<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-13/jm400556w/production/images/large/jm-2013-00556w_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400556w&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(i) Bispinacoldiboron, Pd(dppf)Cl<sub>2</sub>, KOAc, toluene, 150 °C, μM; (ii) 6-bromopicolinic acid, TBAB, K<sub>2</sub>CO<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, dioxane/H<sub>2</sub>O, 70 °C, μW; (iii) 6-bromopicolinic acid, Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, Na<sub>2</sub>CO<sub>3</sub>, EtOH/DME/H<sub>2</sub>O; (iv) 2-hydrazino-benzothiazole, EtOH or AcOH, 60–80 °C; (v) <i>t</i>-butyl 6-bromo-picolinate, TBAB, K<sub>2</sub>CO<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, dioxane/H<sub>2</sub>O, 70 °C, μW; (vi) <i>n</i> = 1: <i>m</i>-CPBA, CHCl<sub>3</sub>; (vii) <i>n</i> = 2: <i>m</i>-CPBA, CH<sub>2</sub>Cl<sub>2</sub>; (viii) formic acid.</p></p></figure><figure data-id="sch7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-13/jm400556w/production/images/medium/jm-2013-00556w_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-13/jm400556w/production/images/large/jm-2013-00556w_0014.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Synthesis of Analogues of <b>59b</b> with Alternative Terminal Aryl Rings<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-13/jm400556w/production/images/large/jm-2013-00556w_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400556w&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(i) TBAB, K<sub>2</sub>CO<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, dioxane/H<sub>2</sub>O, 70 °C, μW; (ii) Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, Na<sub>2</sub>CO<sub>3</sub>, EtOH/DME/H<sub>2</sub>O; (iii) LiOH or NaOH, THF/MeOH; (iv) 2-hydrazino-benzothiazole, EtOH or AcOH, 60–80 °C.</p></p></figure><figure data-id="fig2" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-13/jm400556w/production/images/medium/jm-2013-00556w_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-13/jm400556w/production/images/large/jm-2013-00556w_0004.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Binding affinities of compound <b>6</b> and its close analogues for Bcl-X<sub>L</sub>. IC<sub>50</sub> values shown with standard deviation if two separate experiments were performed, with standard error indicated with * if three or more.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-13/jm400556w/production/images/large/jm-2013-00556w_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400556w&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-13/jm400556w/production/images/medium/jm-2013-00556w_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-13/jm400556w/production/images/large/jm-2013-00556w_0005.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Introduction of constraints to the hydrazone core. IC<sub>50</sub> values shown with standard deviation if two separate experiments were performed, with standard error indicated with * if three or more.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-13/jm400556w/production/images/large/jm-2013-00556w_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400556w&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-13/jm400556w/production/images/medium/jm-2013-00556w_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-13/jm400556w/production/images/large/jm-2013-00556w_0006.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Kinetic analysis of three key benzothiazole analogues, two molecules from the acylsulfonamide series, and wt-Bim26mer peptide. (A) Sensorgrams for compound <b>59b</b> (concentrations: 100, 50, 25, 12.5, 6.25, 3.13 nM). (B) Sensorgrams for compound <b>1</b> (concentrations: 270, 90, 30, 10, 3.3 nM). (C) Kinetic plot for compounds <b>1</b>, <b>4</b>, <b>12a</b>, <b>38</b>, <b>59b</b>, and wt-Bim26mer.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-13/jm400556w/production/images/large/jm-2013-00556w_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400556w&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-13/jm400556w/production/images/medium/jm-2013-00556w_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-13/jm400556w/production/images/large/jm-2013-00556w_0007.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (A) Cytochrome <i>c</i> release experiments on <i>mcl-1</i><sup>–/–</sup> MEF cells. In red: IC<sub>50</sub> for each compound. Cells treated with compounds at a concentration of 10 μM. Abscissa: compounds. Left ordinate: cytochrome <i>c</i> release as % of that released by Bim 26-mer BH3 peptide. Right ordinate: binding IC<sub>50</sub> in μM (LPA). Error bars: standard error. (B) Cytochrome <i>c</i> release experiments on <i>mcl-1</i><sup>–/–</sup> MEF cells and bax<sup>–/–</sup>/bak<sup>–/–</sup> MEF cells. Left ordinate: cytochrome <i>c</i> release as % of Bim 26-mer BH3 peptide. Abscissa: compounds. Error bars: Standard Error.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-13/jm400556w/production/images/large/jm-2013-00556w_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm400556w&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i165">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51526" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51526" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 64 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Cory, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, J. M.</span><span> </span><span class="NLM_article-title">Killing cancer cells by flipping the Bcl-2/Bax switch</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">5</span><span class="NLM_x">–</span> <span class="NLM_lpage">6</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2005&pages=5-6&author=S.+Coryauthor=J.+M.+Adams&title=Killing+cancer+cells+by+flipping+the+Bcl-2%2FBax+switch"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCory%26aufirst%3DS.%26aulast%3DAdams%26aufirst%3DJ.%2BM.%26atitle%3DKilling%2520cancer%2520cells%2520by%2520flipping%2520the%2520Bcl-2%252FBax%2520switch%26jtitle%3DCancer%2520Cell%26date%3D2005%26volume%3D8%26spage%3D5%26epage%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Strasser, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cory, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, J. M.</span><span> </span><span class="NLM_article-title">Deciphering the rules of programmed cell death to improve therapy of cancer and other diseases</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">3667</span><span class="NLM_x">–</span> <span class="NLM_lpage">3683</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2011&pages=3667-3683&author=A.+Strasserauthor=S.+Coryauthor=J.+M.+Adams&title=Deciphering+the+rules+of+programmed+cell+death+to+improve+therapy+of+cancer+and+other+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStrasser%26aufirst%3DA.%26aulast%3DCory%26aufirst%3DS.%26aulast%3DAdams%26aufirst%3DJ.%2BM.%26atitle%3DDeciphering%2520the%2520rules%2520of%2520programmed%2520cell%2520death%2520to%2520improve%2520therapy%2520of%2520cancer%2520and%2520other%2520diseases%26jtitle%3DEMBO%2520J.%26date%3D2011%26volume%3D30%26spage%3D3667%26epage%3D3683" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Hanahan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinberg, R. A.</span><span> </span><span class="NLM_article-title">The hallmarks of cancer</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">57</span><span class="NLM_x">–</span> <span class="NLM_lpage">70</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm400556w&amp;key=10.1016%2FS0092-8674%2800%2981683-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm400556w&amp;key=10647931" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm400556w&amp;key=1%3ACAS%3A528%3ADC%252BD3cXks1CktA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2000&pages=57-70&author=D.+Hanahanauthor=R.+A.+Weinberg&title=The+hallmarks+of+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The hallmarks of cancer</span></div><div class="casAuthors">Hanahan, Douglas; Weinberg, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">57-70</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review is given with many refs. on principles governing the transformation of normal human cells into malignant cancers.  The authors suggest that research over the past decades has revealed a small no. of mol., biochem., and cellular traits (acquired capabilities) shared by most and perhaps all types of cancer.  Topics included are the acquired capabilities self-sufficiency in growth signals, insensitivity to antigrowth signals, evading apoptosis, limitless replicative potential, sustained angiogenesis, and tissue invasion and metastasis followed by genome instability as an enabling characteristic and alternative pathways to cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooXmGqKjM1C7Vg90H21EOLACvtfcHk0liJnItgWfwA9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXks1CktA%253D%253D&md5=1d23c4400dad34c7f32d4a0c41890349</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2800%2981683-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252800%252981683-9%26sid%3Dliteratum%253Aachs%26aulast%3DHanahan%26aufirst%3DD.%26aulast%3DWeinberg%26aufirst%3DR.%2BA.%26atitle%3DThe%2520hallmarks%2520of%2520cancer%26jtitle%3DCell%26date%3D2000%26volume%3D100%26spage%3D57%26epage%3D70" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Labi, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erlacher, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiessling, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villunger, A.</span><span> </span><span class="NLM_article-title">BH3-only proteins in cell death initiation, malignant disease and anticancer therapy</span> <span class="citation_source-journal">Cell Death Differ.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1325</span><span class="NLM_x">–</span> <span class="NLM_lpage">1338</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm400556w&amp;key=10.1038%2Fsj.cdd.4401940" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm400556w&amp;key=16645634" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm400556w&amp;key=1%3ACAS%3A528%3ADC%252BD28XmvFaitr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2006&pages=1325-1338&author=V.+Labiauthor=M.+Erlacherauthor=S.+Kiesslingauthor=A.+Villunger&title=BH3-only+proteins+in+cell+death+initiation%2C+malignant+disease+and+anticancer+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">BH3-only proteins in cell death initiation, malignant disease and anticancer therapy</span></div><div class="casAuthors">Labi, V.; Erlacher, M.; Kiessling, S.; Villunger, A.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death and Differentiation</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1325-1338</span>CODEN:
                <span class="NLM_cas:coden">CDDIEK</span>;
        ISSN:<span class="NLM_cas:issn">1350-9047</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Induction of apoptosis in tumor cells, either by direct activation of the death receptor pathway using agonistic antibodies or recombinant ligands, or direct triggering of the Bcl-2-regulated intrinsic apoptosis pathway by small mol. drugs, carries high hopes to overcome the shortcomings of current anticancer therapies.  The latter therapy concept builds on a more detailed understanding of how Bcl-2-like mols. maintain mitochondrial integrity and how BH3-only proteins and Bax/Bak-like mols. can undermine it.  Means to unleash the apoptotic potential of BH3-only proteins in tumor cells, or bypass the need for BH3-only proteins by blocking possible interactions of Bcl-2-like prosurvival mols. with Bax and/or Bak allowing their direct activation, constitute interesting options for the design of novel anticancer therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofpeJbnadPqLVg90H21EOLACvtfcHk0liJnItgWfwA9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmvFaitr4%253D&md5=c714f82592b1c8fe9df9d385c104414d</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fsj.cdd.4401940&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.cdd.4401940%26sid%3Dliteratum%253Aachs%26aulast%3DLabi%26aufirst%3DV.%26aulast%3DErlacher%26aufirst%3DM.%26aulast%3DKiessling%26aufirst%3DS.%26aulast%3DVillunger%26aufirst%3DA.%26atitle%3DBH3-only%2520proteins%2520in%2520cell%2520death%2520initiation%252C%2520malignant%2520disease%2520and%2520anticancer%2520therapy%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2006%26volume%3D13%26spage%3D1325%26epage%3D1338" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Villunger, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labi, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouillet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strasser, A.</span><span> </span><span class="NLM_article-title">Can the analysis of BH3-only protein knockout mice clarify the issue of ‘direct versus indirect’ activation of Bax and Bak?</span> <span class="citation_source-journal">Cell Death Differ.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1545</span><span class="NLM_x">–</span> <span class="NLM_lpage">1546</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm400556w&amp;key=10.1038%2Fcdd.2011.100" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm400556w&amp;key=21909118" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm400556w&amp;key=1%3ACAS%3A280%3ADC%252BC3MfivValtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=1545-1546&author=A.+Villungerauthor=V.+Labiauthor=P.+Bouilletauthor=J.+Adamsauthor=A.+Strasser&title=Can+the+analysis+of+BH3-only+protein+knockout+mice+clarify+the+issue+of+%E2%80%98direct+versus+indirect%E2%80%99+activation+of+Bax+and+Bak%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Can the analysis of BH3-only protein knockout mice clarify the issue of 'direct versus indirect' activation of Bax and Bak?</span></div><div class="casAuthors">Villunger A; Labi V; Bouillet P; Adams J; Strasser A</div><div class="citationInfo"><span class="NLM_cas:title">Cell death and differentiation</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1545-6</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTtkSGMVo1DgTdblLE_E9PWfW6udTcc2eanMgg_naIgA7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3MfivValtw%253D%253D&md5=4e52b5b315a799e7a504e4383f42660f</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fcdd.2011.100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcdd.2011.100%26sid%3Dliteratum%253Aachs%26aulast%3DVillunger%26aufirst%3DA.%26aulast%3DLabi%26aufirst%3DV.%26aulast%3DBouillet%26aufirst%3DP.%26aulast%3DAdams%26aufirst%3DJ.%26aulast%3DStrasser%26aufirst%3DA.%26atitle%3DCan%2520the%2520analysis%2520of%2520BH3-only%2520protein%2520knockout%2520mice%2520clarify%2520the%2520issue%2520of%2520%25E2%2580%2598direct%2520versus%2520indirect%25E2%2580%2599%2520activation%2520of%2520Bax%2520and%2520Bak%253F%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2011%26volume%3D18%26spage%3D1545%26epage%3D1546" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Leber, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, D. W.</span><span> </span><span class="NLM_article-title">Embedded together: the life and death consequences of interaction of the Bcl-2 family with membranes</span> <span class="citation_source-journal">Apoptosis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">897</span><span class="NLM_x">–</span> <span class="NLM_lpage">911</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2007&pages=897-911&author=B.+Leberauthor=J.+Linauthor=D.+W.+Andrews&title=Embedded+together%3A+the+life+and+death+consequences+of+interaction+of+the+Bcl-2+family+with+membranes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLeber%26aufirst%3DB.%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DAndrews%26aufirst%3DD.%2BW.%26atitle%3DEmbedded%2520together%253A%2520the%2520life%2520and%2520death%2520consequences%2520of%2520interaction%2520of%2520the%2520Bcl-2%2520family%2520with%2520membranes%26jtitle%3DApoptosis%26date%3D2007%26volume%3D12%26spage%3D897%26epage%3D911" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Leber, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, D. W.</span><span> </span><span class="NLM_article-title">Still embedded together binding to membranes regulates Bcl-2 protein interactions</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">5221</span><span class="NLM_x">–</span> <span class="NLM_lpage">5230</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2010&pages=5221-5230&author=B.+Leberauthor=J.+Linauthor=D.+W.+Andrews&title=Still+embedded+together+binding+to+membranes+regulates+Bcl-2+protein+interactions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLeber%26aufirst%3DB.%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DAndrews%26aufirst%3DD.%2BW.%26atitle%3DStill%2520embedded%2520together%2520binding%2520to%2520membranes%2520regulates%2520Bcl-2%2520protein%2520interactions%26jtitle%3DOncogene%26date%3D2010%26volume%3D29%26spage%3D5221%26epage%3D5230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Lindsten, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zong, W. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rathmell, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiels, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ulrich, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waymire, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahar, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frauwirth, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eng, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adelman, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simon, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golden, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korsmeyer, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacGregor, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, C. B.</span><span> </span><span class="NLM_article-title">The combined functions of proapoptotic Bcl-2 family members bak and bax are essential for normal development of multiple tissues</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1389</span><span class="NLM_x">–</span> <span class="NLM_lpage">1399</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2000&pages=1389-1399&author=T.+Lindstenauthor=A.+J.+Rossauthor=A.+Kingauthor=W.+X.+Zongauthor=J.+C.+Rathmellauthor=H.+A.+Shielsauthor=E.+Ulrichauthor=K.+G.+Waymireauthor=P.+Maharauthor=K.+Frauwirthauthor=Y.+Chenauthor=M.+Weiauthor=V.+M.+Engauthor=D.+M.+Adelmanauthor=M.+C.+Simonauthor=A.+Maauthor=J.+A.+Goldenauthor=G.+Evanauthor=S.+J.+Korsmeyerauthor=G.+R.+MacGregorauthor=C.+B.+Thompson&title=The+combined+functions+of+proapoptotic+Bcl-2+family+members+bak+and+bax+are+essential+for+normal+development+of+multiple+tissues"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLindsten%26aufirst%3DT.%26aulast%3DRoss%26aufirst%3DA.%2BJ.%26aulast%3DKing%26aufirst%3DA.%26aulast%3DZong%26aufirst%3DW.%2BX.%26aulast%3DRathmell%26aufirst%3DJ.%2BC.%26aulast%3DShiels%26aufirst%3DH.%2BA.%26aulast%3DUlrich%26aufirst%3DE.%26aulast%3DWaymire%26aufirst%3DK.%2BG.%26aulast%3DMahar%26aufirst%3DP.%26aulast%3DFrauwirth%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DWei%26aufirst%3DM.%26aulast%3DEng%26aufirst%3DV.%2BM.%26aulast%3DAdelman%26aufirst%3DD.%2BM.%26aulast%3DSimon%26aufirst%3DM.%2BC.%26aulast%3DMa%26aufirst%3DA.%26aulast%3DGolden%26aufirst%3DJ.%2BA.%26aulast%3DEvan%26aufirst%3DG.%26aulast%3DKorsmeyer%26aufirst%3DS.%2BJ.%26aulast%3DMacGregor%26aufirst%3DG.%2BR.%26aulast%3DThompson%26aufirst%3DC.%2BB.%26atitle%3DThe%2520combined%2520functions%2520of%2520proapoptotic%2520Bcl-2%2520family%2520members%2520bak%2520and%2520bax%2520are%2520essential%2520for%2520normal%2520development%2520of%2520multiple%2520tissues%26jtitle%3DMol.%2520Cell%26date%3D2000%26volume%3D6%26spage%3D1389%26epage%3D1399" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Wei, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zong, W. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsten, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panoutsakopoulou, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ross, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacGregor, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korsmeyer, S. J.</span><span> </span><span class="NLM_article-title">Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">292</span><span class="NLM_x">, </span> <span class="NLM_fpage">727</span><span class="NLM_x">–</span> <span class="NLM_lpage">730</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm400556w&amp;key=10.1126%2Fscience.1059108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm400556w&amp;key=11326099" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm400556w&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjt1eltr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=292&publication_year=2001&pages=727-730&author=M.+C.+Weiauthor=W.+X.+Zongauthor=E.+H.+Chengauthor=T.+Lindstenauthor=V.+Panoutsakopoulouauthor=A.+J.+Rossauthor=K.+A.+Rothauthor=G.+R.+MacGregorauthor=C.+B.+Thompsonauthor=S.+J.+Korsmeyer&title=Proapoptotic+BAX+and+BAK%3A+a+requisite+gateway+to+mitochondrial+dysfunction+and+death"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Proapoptotic BAX and BAK: A requisite gateway to mitochondrial dysfunction and death</span></div><div class="casAuthors">Wei, Michael C.; Zong, Wei-Xing; Cheng, Emily H. -Y.; Lindsten, Tullia; Panoutsakopoulou, Vily; Ross, Andrea J.; Roth, Kevin A.; MacGregor, Grant R.; Thompson, Craig B.; Korsmeyer, Stanley J.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">292</span>
        (<span class="NLM_cas:issue">5517</span>),
    <span class="NLM_cas:pages">727-730</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Multiple death signals influence mitochondria during apoptosis, yet the crit. initiating event for mitochondrial dysfunction in vivo has been unclear.  TBID, the caspase-activated form of a "BH3-domain-only" BCL-2 family member, triggers the homooligomerization of "multidomain" conserved proapoptotic family members BAK or BAX, resulting in the release of cytochrome c from mitochondria.  The authors find that cells lacking both Bax and Bak, but not cells lacking only one of these components, are completely resistant to tBID-induced cytochrome c release and apoptosis.  Moreover, doubly deficient cells are resistant to multiple apoptotic stimuli that act through disruption of mitochondrial function: staurosporine, UV radiation, growth factor deprivation, etoposide, and the endoplasmic reticulum stress stimuli thapsigargin and tunicamycin.  Thus, activation of a "multidomain" proapoptotic member, BAX or BAK, appears to be an essential gateway to mitochondrial dysfunction required for cell death in response to diverse stimuli.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUXoRFmyvptbVg90H21EOLACvtfcHk0lgboK5QjhHdYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjt1eltr0%253D&md5=2eae779df72480afc9e9378217ec1a9b</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1126%2Fscience.1059108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1059108%26sid%3Dliteratum%253Aachs%26aulast%3DWei%26aufirst%3DM.%2BC.%26aulast%3DZong%26aufirst%3DW.%2BX.%26aulast%3DCheng%26aufirst%3DE.%2BH.%26aulast%3DLindsten%26aufirst%3DT.%26aulast%3DPanoutsakopoulou%26aufirst%3DV.%26aulast%3DRoss%26aufirst%3DA.%2BJ.%26aulast%3DRoth%26aufirst%3DK.%2BA.%26aulast%3DMacGregor%26aufirst%3DG.%2BR.%26aulast%3DThompson%26aufirst%3DC.%2BB.%26aulast%3DKorsmeyer%26aufirst%3DS.%2BJ.%26atitle%3DProapoptotic%2520BAX%2520and%2520BAK%253A%2520a%2520requisite%2520gateway%2520to%2520mitochondrial%2520dysfunction%2520and%2520death%26jtitle%3DScience%26date%3D2001%26volume%3D292%26spage%3D727%26epage%3D730" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Lessene, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czabotar, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colman, P. M.</span><span> </span><span class="NLM_article-title">BCL-2 family antagonists for cancer therapy</span> <span class="citation_source-journal">Nature Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">989</span><span class="NLM_x">–</span> <span class="NLM_lpage">1000</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=989-1000&author=G.+Lesseneauthor=P.+E.+Czabotarauthor=P.+M.+Colman&title=BCL-2+family+antagonists+for+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLessene%26aufirst%3DG.%26aulast%3DCzabotar%26aufirst%3DP.%2BE.%26aulast%3DColman%26aufirst%3DP.%2BM.%26atitle%3DBCL-2%2520family%2520antagonists%2520for%2520cancer%2520therapy%26jtitle%3DNature%2520Rev.%2520Drug%2520Discovery%26date%3D2008%26volume%3D7%26spage%3D989%26epage%3D1000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Czabotar, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lessene, G.</span><span> </span><span class="NLM_article-title">Bcl-2 Family Proteins as Therapeutic Targets</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">3132</span><span class="NLM_x">–</span> <span class="NLM_lpage">3148</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm400556w&amp;key=10.2174%2F138161210793292429" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm400556w&amp;key=20687882" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm400556w&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVKlurrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2010&pages=3132-3148&author=P.+E.+Czabotarauthor=G.+Lessene&title=Bcl-2+Family+Proteins+as+Therapeutic+Targets"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Bcl-2 family proteins as therapeutic targets</span></div><div class="casAuthors">Czabotar, Peter E.; Lessene, Guillaume</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">3132-3148</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The mitochondrion provides the stage for the interplay of mol. interactions that regulate apoptosis via the intrinsic pathway.  The release of apoptogenic factors from this compartment constitutes a crit. juncture in this apoptotic pathway.  Regulation of the integrity of the outer mitochondrial membrane (OMM) is the task of the Bcl-2 family of proteins.  A network of interactions between the various subgroups of the family decides the apoptotic fate of a cell and, as such, an imbalance within this network can lead to a variety of disease states.  In particular, over-expression of pro-survival Bcl-2 family proteins is a hallmark of many cancers.  Here we discuss recent advances in targeting the Bcl-2 family with both peptides and small mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpoBLy-8vLMRbVg90H21EOLACvtfcHk0lgboK5QjhHdYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVKlurrL&md5=42a0f634b9bc21d2c93b5696914e56be</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.2174%2F138161210793292429&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161210793292429%26sid%3Dliteratum%253Aachs%26aulast%3DCzabotar%26aufirst%3DP.%2BE.%26aulast%3DLessene%26aufirst%3DG.%26atitle%3DBcl-2%2520Family%2520Proteins%2520as%2520Therapeutic%2520Targets%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2010%26volume%3D16%26spage%3D3132%26epage%3D3148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Souers, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leverson, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boghaert, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ackler, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catron, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dayton, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Enschede, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fairbrother, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hymowitz, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khaw, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kovar, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maecker, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsh, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitten, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nimmer, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oleksijew, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sampath, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seymour, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sullivan, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tahir, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tse, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wendt, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xue, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humerickhouse, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenberg, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elmore, S. W.</span><span> </span><span class="NLM_article-title">ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets</span> <span class="citation_source-journal">Nature Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">202</span><span class="NLM_x">–</span> <span class="NLM_lpage">208</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=202-208&author=A.+J.+Souersauthor=J.+D.+Leversonauthor=E.+R.+Boghaertauthor=S.+L.+Acklerauthor=N.+D.+Catronauthor=J.+Chenauthor=B.+D.+Daytonauthor=H.+Dingauthor=S.+H.+Enschedeauthor=W.+J.+Fairbrotherauthor=D.+C.+Huangauthor=S.+G.+Hymowitzauthor=S.+Jinauthor=S.+L.+Khawauthor=P.+J.+Kovarauthor=L.+T.+Lamauthor=J.+Leeauthor=H.+L.+Maeckerauthor=K.+C.+Marshauthor=K.+D.+Masonauthor=M.+J.+Mittenauthor=P.+M.+Nimmerauthor=A.+Oleksijewauthor=C.+H.+Parkauthor=C.+M.+Parkauthor=D.+C.+Phillipsauthor=A.+W.+Robertsauthor=D.+Sampathauthor=J.+F.+Seymourauthor=M.+L.+Smithauthor=G.+M.+Sullivanauthor=S.+K.+Tahirauthor=C.+Tseauthor=M.+D.+Wendtauthor=Y.+Xiaoauthor=J.+C.+Xueauthor=H.+Zhangauthor=R.+A.+Humerickhouseauthor=S.+H.+Rosenbergauthor=S.+W.+Elmore&title=ABT-199%2C+a+potent+and+selective+BCL-2+inhibitor%2C+achieves+antitumor+activity+while+sparing+platelets"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSouers%26aufirst%3DA.%2BJ.%26aulast%3DLeverson%26aufirst%3DJ.%2BD.%26aulast%3DBoghaert%26aufirst%3DE.%2BR.%26aulast%3DAckler%26aufirst%3DS.%2BL.%26aulast%3DCatron%26aufirst%3DN.%2BD.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DDayton%26aufirst%3DB.%2BD.%26aulast%3DDing%26aufirst%3DH.%26aulast%3DEnschede%26aufirst%3DS.%2BH.%26aulast%3DFairbrother%26aufirst%3DW.%2BJ.%26aulast%3DHuang%26aufirst%3DD.%2BC.%26aulast%3DHymowitz%26aufirst%3DS.%2BG.%26aulast%3DJin%26aufirst%3DS.%26aulast%3DKhaw%26aufirst%3DS.%2BL.%26aulast%3DKovar%26aufirst%3DP.%2BJ.%26aulast%3DLam%26aufirst%3DL.%2BT.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DMaecker%26aufirst%3DH.%2BL.%26aulast%3DMarsh%26aufirst%3DK.%2BC.%26aulast%3DMason%26aufirst%3DK.%2BD.%26aulast%3DMitten%26aufirst%3DM.%2BJ.%26aulast%3DNimmer%26aufirst%3DP.%2BM.%26aulast%3DOleksijew%26aufirst%3DA.%26aulast%3DPark%26aufirst%3DC.%2BH.%26aulast%3DPark%26aufirst%3DC.%2BM.%26aulast%3DPhillips%26aufirst%3DD.%2BC.%26aulast%3DRoberts%26aufirst%3DA.%2BW.%26aulast%3DSampath%26aufirst%3DD.%26aulast%3DSeymour%26aufirst%3DJ.%2BF.%26aulast%3DSmith%26aufirst%3DM.%2BL.%26aulast%3DSullivan%26aufirst%3DG.%2BM.%26aulast%3DTahir%26aufirst%3DS.%2BK.%26aulast%3DTse%26aufirst%3DC.%26aulast%3DWendt%26aufirst%3DM.%2BD.%26aulast%3DXiao%26aufirst%3DY.%26aulast%3DXue%26aufirst%3DJ.%2BC.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DHumerickhouse%26aufirst%3DR.%2BA.%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26aulast%3DElmore%26aufirst%3DS.%2BW.%26atitle%3DABT-199%252C%2520a%2520potent%2520and%2520selective%2520BCL-2%2520inhibitor%252C%2520achieves%2520antitumor%2520activity%2520while%2520sparing%2520platelets%26jtitle%3DNature%2520Med.%26date%3D2013%26volume%3D19%26spage%3D202%26epage%3D208" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Oltersdorf, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elmore, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoemaker, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armstrong, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Augeri, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belli, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruncko, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deckwerth, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinges, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajduk, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joseph, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitada, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korsmeyer, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kunzer, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Letai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitten, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nettesheim, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ng, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nimmer, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connor, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oleksijew, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petros, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tahir, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomaselli, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wendt, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fesik, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenberg, S. H.</span><span> </span><span class="NLM_article-title">An inhibitor of Bcl-2 family proteins induces regression of solid tumours</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">435</span><span class="NLM_x">, </span> <span class="NLM_fpage">677</span><span class="NLM_x">–</span> <span class="NLM_lpage">681</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm400556w&amp;key=10.1038%2Fnature03579" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm400556w&amp;key=15902208" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm400556w&amp;key=1%3ACAS%3A528%3ADC%252BD2MXks1Ogtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=435&publication_year=2005&pages=677-681&author=T.+Oltersdorfauthor=S.+W.+Elmoreauthor=A.+R.+Shoemakerauthor=R.+C.+Armstrongauthor=D.+J.+Augeriauthor=B.+A.+Belliauthor=M.+Brunckoauthor=T.+L.+Deckwerthauthor=J.+Dingesauthor=P.+J.+Hajdukauthor=M.+K.+Josephauthor=S.+Kitadaauthor=S.+J.+Korsmeyerauthor=A.+R.+Kunzerauthor=A.+Letaiauthor=C.+Liauthor=M.+J.+Mittenauthor=D.+G.+Nettesheimauthor=S.+Ngauthor=P.+M.+Nimmerauthor=J.+M.+O%E2%80%99Connorauthor=A.+Oleksijewauthor=A.+M.+Petrosauthor=J.+C.+Reedauthor=W.+Shenauthor=S.+K.+Tahirauthor=C.+B.+Thompsonauthor=K.+J.+Tomaselliauthor=B.+L.+Wangauthor=M.+D.+Wendtauthor=H.+C.+Zhangauthor=S.+W.+Fesikauthor=S.+H.+Rosenberg&title=An+inhibitor+of+Bcl-2+family+proteins+induces+regression+of+solid+tumours"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">An inhibitor of Bcl-2 family proteins induces regression of solid tumours</span></div><div class="casAuthors">Oltersdorf, Tilman; Elmore, Steven W.; Shoemaker, Alexander R.; Armstrong, Robert C.; Augeri, David J.; Belli, Barbara A.; Bruncko, Milan; Deckwerth, Thomas L.; Dinges, Jurgen; Hajduk, Philip J.; Joseph, Mary K.; Kitada, Shinichi; Korsmeyer, Stanley J.; Kunzer, Aaron R.; Letai, Anthony; Li, Chi; Mitten, Michael J.; Nettesheim, David G.; Ng, Shi Chung; Nimmer, Paul M.; O'Connor, Jacqueline M.; Oleksijew, Anatol; Petros, Andrew M.; Reed, John C.; Shen, Wang; Tahir, Stephen K.; Thompson, Craig B.; Tomaselli, Kevin J.; Wang, Baole; Wendt, Michael D.; Zhang, Haichao; Fesik, Stephen W.; Rosenberg, Saul H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">435</span>
        (<span class="NLM_cas:issue">7042</span>),
    <span class="NLM_cas:pages">677-681</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Proteins in the Bcl-2 family are central regulators of programmed cell death, and members that inhibit apoptosis, such as Bcl-XL and Bcl-2, are overexpressed in many cancers and contribute to tumor initiation, progression and resistance to therapy.  Bcl-XL expression correlates with chemo-resistance of tumor cell lines, and redns. in Bcl-2 increase sensitivity to anticancer drugs and enhance in vivo survival.  The development of inhibitors of these proteins as potential anticancer therapeutics has been previously explored, but obtaining potent small-mol. inhibitors has proved difficult owing to the necessity of targeting a protein-protein interaction.  Here, using NMR-based screening, parallel synthesis and structure-based design, the authors have discovered ABT-737, a small-mol. inhibitor of the antiapoptotic proteins Bcl-2, Bcl-XL and Bcl-w, with an affinity two to three orders of magnitude more potent than previously reported compds.  Mechanistic studies reveal that ABT-737 does not directly initiate the apoptotic process, but enhances the effects of death signals, displaying synergistic cytotoxicity with chemotherapeutics and radiation.  ABT-737 exhibits single-agent-mechanism-based killing of cells from lymphoma and small-cell lung carcinoma lines, as well as primary patient-derived cells, and in animal models, ABT-737 improves survival, causes regression of established tumors, and produces cures in a high percentage of the mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBt7_zVt8HrbVg90H21EOLACvtfcHk0lhNhwcajO_V6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXks1Ogtb0%253D&md5=4940d06838506f181b6310d3458a595f</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fnature03579&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature03579%26sid%3Dliteratum%253Aachs%26aulast%3DOltersdorf%26aufirst%3DT.%26aulast%3DElmore%26aufirst%3DS.%2BW.%26aulast%3DShoemaker%26aufirst%3DA.%2BR.%26aulast%3DArmstrong%26aufirst%3DR.%2BC.%26aulast%3DAugeri%26aufirst%3DD.%2BJ.%26aulast%3DBelli%26aufirst%3DB.%2BA.%26aulast%3DBruncko%26aufirst%3DM.%26aulast%3DDeckwerth%26aufirst%3DT.%2BL.%26aulast%3DDinges%26aufirst%3DJ.%26aulast%3DHajduk%26aufirst%3DP.%2BJ.%26aulast%3DJoseph%26aufirst%3DM.%2BK.%26aulast%3DKitada%26aufirst%3DS.%26aulast%3DKorsmeyer%26aufirst%3DS.%2BJ.%26aulast%3DKunzer%26aufirst%3DA.%2BR.%26aulast%3DLetai%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DMitten%26aufirst%3DM.%2BJ.%26aulast%3DNettesheim%26aufirst%3DD.%2BG.%26aulast%3DNg%26aufirst%3DS.%26aulast%3DNimmer%26aufirst%3DP.%2BM.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DJ.%2BM.%26aulast%3DOleksijew%26aufirst%3DA.%26aulast%3DPetros%26aufirst%3DA.%2BM.%26aulast%3DReed%26aufirst%3DJ.%2BC.%26aulast%3DShen%26aufirst%3DW.%26aulast%3DTahir%26aufirst%3DS.%2BK.%26aulast%3DThompson%26aufirst%3DC.%2BB.%26aulast%3DTomaselli%26aufirst%3DK.%2BJ.%26aulast%3DWang%26aufirst%3DB.%2BL.%26aulast%3DWendt%26aufirst%3DM.%2BD.%26aulast%3DZhang%26aufirst%3DH.%2BC.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26atitle%3DAn%2520inhibitor%2520of%2520Bcl-2%2520family%2520proteins%2520induces%2520regression%2520of%2520solid%2520tumours%26jtitle%3DNature%26date%3D2005%26volume%3D435%26spage%3D677%26epage%3D681" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Bruncko, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oost, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belli, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joseph, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kunzer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martineau, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McClellan, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitten, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ng, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nimmer, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oltersdorf, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petros, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoemaker, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, X. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wendt, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fesik, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenberg, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elmore, S. W.</span><span> </span><span class="NLM_article-title">Studies leading to potent, dual inhibitors of Bcl-2 and Bcl-x<sub>L</sub></span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">641</span><span class="NLM_x">–</span> <span class="NLM_lpage">662</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm061152t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm400556w&amp;key=1%3ACAS%3A528%3ADC%252BD2sXptVGmug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=641-662&author=M.+Brunckoauthor=T.+K.+Oostauthor=B.+A.+Belliauthor=H.+Dingauthor=M.+K.+Josephauthor=A.+Kunzerauthor=D.+Martineauauthor=W.+J.+McClellanauthor=M.+Mittenauthor=S.+C.+Ngauthor=P.+M.+Nimmerauthor=T.+Oltersdorfauthor=C.+M.+Parkauthor=A.+M.+Petrosauthor=A.+R.+Shoemakerauthor=X.+H.+Songauthor=X.+L.+Wangauthor=M.+D.+Wendtauthor=H.+C.+Zhangauthor=S.+W.+Fesikauthor=S.+H.+Rosenbergauthor=S.+W.+Elmore&title=Studies+leading+to+potent%2C+dual+inhibitors+of+Bcl-2+and+Bcl-xL"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Studies Leading to Potent, Dual Inhibitors of Bcl-2 and Bcl-xL</span></div><div class="casAuthors">Bruncko, Milan; Oost, Thorsten K.; Belli, Barbara A.; Ding, Hong; Joseph, Mary K.; Kunzer, Aaron; Martineau, Darlene; McClellan, William J.; Mitten, Michael; Ng, Shi-Chung; Nimmer, Paul M.; Oltersdorf, Tilman; Park, Cheol-Min; Petros, Andrew M.; Shoemaker, Alexander R.; Song, Xiaohong; Wang, Xilu; Wendt, Michael D.; Zhang, Haichao; Fesik, Stephen W.; Rosenberg, Saul H.; Elmore, Steven W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">641-662</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Overexpression of the antiapoptotic proteins Bcl-2 and Bcl-xL provides a common mechanism through which cancer cells gain a survival advantage and become resistant to conventional chemotherapy.  Inhibition of these prosurvival proteins is an attractive strategy for cancer therapy.  We recently described the discovery of a selective Bcl-xL antagonist that potentiates the antitumor activity of chemotherapy and radiation.  Here we describe the use of structure-guided design to exploit a deep hydrophobic binding pocket on the surface of these proteins to develop the first dual, subnanomolar inhibitors of Bcl-xL and Bcl-2.  This study culminated in the identification of 2 (I), which exhibited EC50 values of 8 nM and 30 nM in Bcl-2 and Bcl-xL dependent cells, resp.  Compd. 2 demonstrated single agent efficacy against human follicular lymphoma cell lines that overexpress Bcl-2, and efficacy in a murine xenograft model of lymphoma when given both as a single agent and in combination with etoposide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpF2G6VoJIheLVg90H21EOLACvtfcHk0lhNhwcajO_V6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXptVGmug%253D%253D&md5=e7bf502c69c4247c39ce7e070984b3a6</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fjm061152t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm061152t%26sid%3Dliteratum%253Aachs%26aulast%3DBruncko%26aufirst%3DM.%26aulast%3DOost%26aufirst%3DT.%2BK.%26aulast%3DBelli%26aufirst%3DB.%2BA.%26aulast%3DDing%26aufirst%3DH.%26aulast%3DJoseph%26aufirst%3DM.%2BK.%26aulast%3DKunzer%26aufirst%3DA.%26aulast%3DMartineau%26aufirst%3DD.%26aulast%3DMcClellan%26aufirst%3DW.%2BJ.%26aulast%3DMitten%26aufirst%3DM.%26aulast%3DNg%26aufirst%3DS.%2BC.%26aulast%3DNimmer%26aufirst%3DP.%2BM.%26aulast%3DOltersdorf%26aufirst%3DT.%26aulast%3DPark%26aufirst%3DC.%2BM.%26aulast%3DPetros%26aufirst%3DA.%2BM.%26aulast%3DShoemaker%26aufirst%3DA.%2BR.%26aulast%3DSong%26aufirst%3DX.%2BH.%26aulast%3DWang%26aufirst%3DX.%2BL.%26aulast%3DWendt%26aufirst%3DM.%2BD.%26aulast%3DZhang%26aufirst%3DH.%2BC.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26aulast%3DElmore%26aufirst%3DS.%2BW.%26atitle%3DStudies%2520leading%2520to%2520potent%252C%2520dual%2520inhibitors%2520of%2520Bcl-2%2520and%2520Bcl-xL%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D641%26epage%3D662" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Tse, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoemaker, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adickes, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsh, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitten, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nimmer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tahir, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fesik, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenberg, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elmore, S. W.</span><span> </span><span class="NLM_article-title">ABT-263: a potent and orally bioavailable Bcl-2 family inhibitor</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">3421</span><span class="NLM_x">–</span> <span class="NLM_lpage">3428</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm400556w&amp;key=10.1158%2F0008-5472.CAN-07-5836" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm400556w&amp;key=18451170" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm400556w&amp;key=1%3ACAS%3A528%3ADC%252BD1cXltlSltrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2008&pages=3421-3428&author=C.+Tseauthor=A.+R.+Shoemakerauthor=J.+Adickesauthor=M.+G.+Andersonauthor=J.+Chenauthor=S.+Jinauthor=E.+F.+Johnsonauthor=K.+C.+Marshauthor=M.+J.+Mittenauthor=P.+Nimmerauthor=L.+Robertsauthor=S.+K.+Tahirauthor=Y.+Xiaoauthor=X.+Yangauthor=H.+Zhangauthor=S.+Fesikauthor=S.+H.+Rosenbergauthor=S.+W.+Elmore&title=ABT-263%3A+a+potent+and+orally+bioavailable+Bcl-2+family+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">ABT-263: A Potent and Orally Bioavailable Bcl-2 Family Inhibitor</span></div><div class="casAuthors">Tse, Christin; Shoemaker, Alexander R.; Adickes, Jessica; Anderson, Mark G.; Chen, Jun; Jin, Sha; Johnson, Eric F.; Marsh, Kennan C.; Mitten, Michael J.; Nimmer, Paul; Roberts, Lisa; Tahir, Stephen K.; Xiao, Yu; Yang, Xiufen; Zhang, Haichao; Fesik, Stephen; Rosenberg, Saul H.; Elmore, Steven W.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3421-3428</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Overexpression of the prosurvival Bcl-2 family members (Bcl-2, Bcl-xL, and Mcl-1) is commonly assocd. with tumor maintenance, progression, and chemoresistance.  We previously reported the discovery of ABT-737, a potent, small-mol. Bcl-2 family protein inhibitor.  A major limitation of ABT-737 is that it is not orally bioavailable, which would limit chronic single agent therapy and flexibility to dose in combination regimens.  Here we report the biol. properties of ABT-263, a potent, orally bioavailable Bad-like BH3 mimetic (Ki's of <1 nmol/L for Bcl-2, Bcl-xL, and Bcl-w).  The oral bioavailability of ABT-263 in preclin. animal models is 20% to 50%, depending on formulation.  ABT-263 disrupts Bcl-2/Bcl-xL interactions with pro-death proteins (e.g., Bim), leading to the initiation of apoptosis within 2 h posttreatment.  In human tumor cells, ABT-263 induces Bax translocation, cytochrome c release, and subsequent apoptosis.  Oral administration of ABT-263 alone induces complete tumor regressions in xenograft models of small-cell lung cancer and acute lymphoblastic leukemia.  In xenograft models of aggressive B-cell lymphoma and multiple myeloma where ABT-263 exhibits modest or no single agent activity, it significantly enhances the efficacy of clin. relevant therapeutic regimens.  These data provide the rationale for clin. trials evaluating ABT-263 in small-cell lung cancer and B-cell malignancies.  The oral efficacy of ABT-263 should provide dosing flexibility to maximize clin. utility both as a single agent and in combination regimens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojLK8zIgyDWbVg90H21EOLACvtfcHk0lhozF642RwMJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXltlSltrs%253D&md5=a43029cc218d25d4e1fb6dd1186475c4</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-07-5836&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-07-5836%26sid%3Dliteratum%253Aachs%26aulast%3DTse%26aufirst%3DC.%26aulast%3DShoemaker%26aufirst%3DA.%2BR.%26aulast%3DAdickes%26aufirst%3DJ.%26aulast%3DAnderson%26aufirst%3DM.%2BG.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DJin%26aufirst%3DS.%26aulast%3DJohnson%26aufirst%3DE.%2BF.%26aulast%3DMarsh%26aufirst%3DK.%2BC.%26aulast%3DMitten%26aufirst%3DM.%2BJ.%26aulast%3DNimmer%26aufirst%3DP.%26aulast%3DRoberts%26aufirst%3DL.%26aulast%3DTahir%26aufirst%3DS.%2BK.%26aulast%3DXiao%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DFesik%26aufirst%3DS.%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26aulast%3DElmore%26aufirst%3DS.%2BW.%26atitle%3DABT-263%253A%2520a%2520potent%2520and%2520orally%2520bioavailable%2520Bcl-2%2520family%2520inhibitor%26jtitle%3DCancer%2520Res.%26date%3D2008%26volume%3D68%26spage%3D3421%26epage%3D3428" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Park, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruncko, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adickes, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauch, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kunzer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsh, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nimmer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoemaker, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tahir, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tse, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wendt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fesik, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenberg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elmore, S.</span><span> </span><span class="NLM_article-title">Discovery of an orally bioavailable small molecule inhibitor of prosurvival B-cell lymphoma 2 proteins</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">6902</span><span class="NLM_x">–</span> <span class="NLM_lpage">6915</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800669s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm400556w&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1WlsbvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=6902-6915&author=C.+M.+Parkauthor=M.+Brunckoauthor=J.+Adickesauthor=J.+Bauchauthor=H.+Dingauthor=A.+Kunzerauthor=K.+C.+Marshauthor=P.+Nimmerauthor=A.+Shoemakerauthor=X.+Songauthor=S.+Tahirauthor=C.+Tseauthor=X.+Wangauthor=M.+Wendtauthor=X.+Yangauthor=H.+Zhangauthor=S.+Fesikauthor=S.+Rosenbergauthor=S.+Elmore&title=Discovery+of+an+orally+bioavailable+small+molecule+inhibitor+of+prosurvival+B-cell+lymphoma+2+proteins"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of an Orally Bioavailable Small Molecule Inhibitor of Prosurvival B-Cell Lymphoma 2 Proteins</span></div><div class="casAuthors">Park, Cheol-Min; Bruncko, Milan; Adickes, Jessica; Bauch, Joy; Ding, Hong; Kunzer, Aaron; Marsh, Kennan C.; Nimmer, Paul; Shoemaker, Alexander R.; Song, Xiaohong; Tahir, Stephen K.; Tse, Christin; Wang, Xilu; Wendt, Michael D.; Yang, Xiufen; Zhang, Haichao; Fesik, Stephen W.; Rosenberg, Saul H.; Elmore, Steven W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6902-6915</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Overexpression of prosurvival proteins such as Bcl-2 and Bcl-XL has been correlated with tumorigenesis and resistance to chemotherapy, and thus, the development of antagonists of these proteins may provide a novel means for the treatment of cancer.  We recently described the discovery of 1 (ABT-737), which binds Bcl-2, Bcl-XL, and Bcl-w with high affinity, shows robust antitumor activity in murine tumor xenograft models, but is not orally bioavailable.  Herein, we report that targeted modifications at three key positions of 1 resulted in a 20-fold improvement in the pharmacokinetic/pharmacodynamic relationship (PK/PD) between oral exposure (AUC) and in vitro efficacy in human tumor cell lines (EC50).  The resulting compd., 2 (ABT-263), is orally efficacious in an established xenograft model of human small cell lung cancer, inducing complete tumor regressions in all animals.  Compd. 2 is currently in multiple phase 1 clin. trials in patients with small cell lung cancer and hematol. malignancies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrF1JFNLCqAULVg90H21EOLACvtfcHk0lhozF642RwMJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1WlsbvE&md5=83975ec5e8f642abc3507d35d00c9e14</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm800669s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800669s%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DC.%2BM.%26aulast%3DBruncko%26aufirst%3DM.%26aulast%3DAdickes%26aufirst%3DJ.%26aulast%3DBauch%26aufirst%3DJ.%26aulast%3DDing%26aufirst%3DH.%26aulast%3DKunzer%26aufirst%3DA.%26aulast%3DMarsh%26aufirst%3DK.%2BC.%26aulast%3DNimmer%26aufirst%3DP.%26aulast%3DShoemaker%26aufirst%3DA.%26aulast%3DSong%26aufirst%3DX.%26aulast%3DTahir%26aufirst%3DS.%26aulast%3DTse%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DWendt%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DFesik%26aufirst%3DS.%26aulast%3DRosenberg%26aufirst%3DS.%26aulast%3DElmore%26aufirst%3DS.%26atitle%3DDiscovery%2520of%2520an%2520orally%2520bioavailable%2520small%2520molecule%2520inhibitor%2520of%2520prosurvival%2520B-cell%2520lymphoma%25202%2520proteins%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D6902%26epage%3D6915" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Chen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willis, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fletcher, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hinds, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colman, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Day, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, D. C.</span><span> </span><span class="NLM_article-title">Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">393</span><span class="NLM_x">–</span> <span class="NLM_lpage">403</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm400556w&amp;key=10.1016%2Fj.molcel.2004.12.030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm400556w&amp;key=15694340" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm400556w&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhs1Oit78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2005&pages=393-403&author=L.+Chenauthor=S.+N.+Willisauthor=A.+Weiauthor=B.+J.+Smithauthor=J.+I.+Fletcherauthor=M.+G.+Hindsauthor=P.+M.+Colmanauthor=C.+L.+Dayauthor=J.+M.+Adamsauthor=D.+C.+Huang&title=Differential+targeting+of+prosurvival+Bcl-2+proteins+by+their+BH3-only+ligands+allows+complementary+apoptotic+function"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function</span></div><div class="casAuthors">Chen, Lin; Willis, Simon N.; Wei, Andrew; Smith, Brian J.; Fletcher, Jamie I.; Hinds, Mark G.; Colman, Peter M.; Day, Catherine L.; Adams, Jerry M.; Huang, David C. S.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">393-403</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Apoptosis is initiated when Bcl-2 and its prosurvival relatives are engaged by proapoptotic BH3-only proteins via interaction of its BH3 domain with a groove on the Bcl-2-like proteins.  These interactions have been considered promiscuous, but our anal. of the affinity of eight BH3 peptides for five Bcl-2-like proteins has revealed that the interactions vary over 10,000-fold in affinity, and accordingly, only certain protein pairs assoc. inside cells.  Bim and Puma potently engaged all the prosurvival proteins comparably.  Bad, however, bound tightly to Bcl-2, Bcl-xL, and Bcl-w but only weakly to A1 and not to Mcl-1.  Strikingly, Noxa bound only Mcl-1 and A1.  In accord with their complementary binding, Bad and Noxa cooperated to induce potent killing.  The results suggest that apoptosis relies on selective interactions between particular subsets of these proteins and that it should be feasible to discover BH3-mimetic drugs that inactivate specific prosurvival targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHzR4DFj95LbVg90H21EOLACvtfcHk0lh37PVkuadjjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhs1Oit78%253D&md5=702d041ad86552b3581fed5198a96d7b</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.molcel.2004.12.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molcel.2004.12.030%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DL.%26aulast%3DWillis%26aufirst%3DS.%2BN.%26aulast%3DWei%26aufirst%3DA.%26aulast%3DSmith%26aufirst%3DB.%2BJ.%26aulast%3DFletcher%26aufirst%3DJ.%2BI.%26aulast%3DHinds%26aufirst%3DM.%2BG.%26aulast%3DColman%26aufirst%3DP.%2BM.%26aulast%3DDay%26aufirst%3DC.%2BL.%26aulast%3DAdams%26aufirst%3DJ.%2BM.%26aulast%3DHuang%26aufirst%3DD.%2BC.%26atitle%3DDifferential%2520targeting%2520of%2520prosurvival%2520Bcl-2%2520proteins%2520by%2520their%2520BH3-only%2520ligands%2520allows%2520complementary%2520apoptotic%2520function%26jtitle%3DMol.%2520Cell%26date%3D2005%26volume%3D17%26spage%3D393%26epage%3D403" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Mason, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vandenberg, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cory, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, D. C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, A. W.</span><span> </span><span class="NLM_article-title">In vivo efficacy of the Bcl-2 antagonist ABT-737 against aggressive Myc-driven lymphomas</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">17961</span><span class="NLM_x">–</span> <span class="NLM_lpage">17966</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=17961-17966&author=K.+D.+Masonauthor=C.+J.+Vandenbergauthor=C.+L.+Scottauthor=A.+H.+Weiauthor=S.+Coryauthor=D.+C.+S.+Huangauthor=A.+W.+Roberts&title=In+vivo+efficacy+of+the+Bcl-2+antagonist+ABT-737+against+aggressive+Myc-driven+lymphomas"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMason%26aufirst%3DK.%2BD.%26aulast%3DVandenberg%26aufirst%3DC.%2BJ.%26aulast%3DScott%26aufirst%3DC.%2BL.%26aulast%3DWei%26aufirst%3DA.%2BH.%26aulast%3DCory%26aufirst%3DS.%26aulast%3DHuang%26aufirst%3DD.%2BC.%2BS.%26aulast%3DRoberts%26aufirst%3DA.%2BW.%26atitle%3DIn%2520vivo%2520efficacy%2520of%2520the%2520Bcl-2%2520antagonist%2520ABT-737%2520against%2520aggressive%2520Myc-driven%2520lymphomas%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2008%26volume%3D105%26spage%3D17961%26epage%3D17966" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">van Delft, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vandenberg, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czabotar, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willis, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Day, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cory, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, D. C. S.</span><span> </span><span class="NLM_article-title">The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">389</span><span class="NLM_x">–</span> <span class="NLM_lpage">399</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm400556w&amp;key=10.1016%2Fj.ccr.2006.08.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm400556w&amp;key=17097561" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm400556w&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1Glu7nK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2006&pages=389-399&author=M.+F.+van+Delftauthor=A.+H.+Weiauthor=K.+D.+Masonauthor=C.+J.+Vandenbergauthor=L.+Chenauthor=P.+E.+Czabotarauthor=S.+N.+Willisauthor=C.+L.+Scottauthor=C.+L.+Dayauthor=S.+Coryauthor=J.+M.+Adamsauthor=A.+W.+Robertsauthor=D.+C.+S.+Huang&title=The+BH3+mimetic+ABT-737+targets+selective+Bcl-2+proteins+and+efficiently+induces+apoptosis+via+Bak%2FBax+if+Mcl-1+is+neutralized"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized</span></div><div class="casAuthors">van Delft, Mark F.; Wei, Andrew H.; Mason, Kylie D.; Vandenberg, Cassandra J.; Chen, Lin; Czabotar, Peter E.; Willis, Simon N.; Scott, Clare L.; Day, Catherine L.; Cory, Suzanne; Adams, Jerry M.; Roberts, Andrew W.; Huang, David C. S.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">389-399</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Since apoptosis is impaired in malignant cells overexpressing prosurvival Bcl-2 proteins, drugs mimicking their natural antagonists, BH3-only proteins, might overcome chemoresistance.  Of seven putative BH3 mimetics tested, only ABT-737 triggered Bax/Bak-mediated apoptosis.  Despite its high affinity for Bcl-2, Bcl-xL, and Bcl-w, many cell types proved refractory to ABT-737.  We show that this resistance reflects ABT-737's inability to target another prosurvival relative, Mcl-1.  Downregulation of Mcl-1 by several strategies conferred sensitivity to ABT-737.  Furthermore, enforced Mcl-1 expression in a mouse lymphoma model conferred resistance.  In contrast, cells overexpressing Bcl-2 remained highly sensitive to ABT-737.  Hence, ABT-737 should prove efficacious in tumors with low Mcl-1 levels, or when combined with agents that inactivate Mcl-1, even to treat those tumors that overexpress Bcl-2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWAmMTX4bzgbVg90H21EOLACvtfcHk0li4Chj9sqCMIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1Glu7nK&md5=6c1de734427cb187fbb9002fd9269ca8</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2006.08.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2006.08.027%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BDelft%26aufirst%3DM.%2BF.%26aulast%3DWei%26aufirst%3DA.%2BH.%26aulast%3DMason%26aufirst%3DK.%2BD.%26aulast%3DVandenberg%26aufirst%3DC.%2BJ.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DCzabotar%26aufirst%3DP.%2BE.%26aulast%3DWillis%26aufirst%3DS.%2BN.%26aulast%3DScott%26aufirst%3DC.%2BL.%26aulast%3DDay%26aufirst%3DC.%2BL.%26aulast%3DCory%26aufirst%3DS.%26aulast%3DAdams%26aufirst%3DJ.%2BM.%26aulast%3DRoberts%26aufirst%3DA.%2BW.%26aulast%3DHuang%26aufirst%3DD.%2BC.%2BS.%26atitle%3DThe%2520BH3%2520mimetic%2520ABT-737%2520targets%2520selective%2520Bcl-2%2520proteins%2520and%2520efficiently%2520induces%2520apoptosis%2520via%2520Bak%252FBax%2520if%2520Mcl-1%2520is%2520neutralized%26jtitle%3DCancer%2520Cell%26date%3D2006%26volume%3D10%26spage%3D389%26epage%3D399" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nimmer, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tahir, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fryer, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hahn, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iciek, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgan, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nasarre, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Preusser, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinhart, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenberg, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elmore, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tse, C.</span><span> </span><span class="NLM_article-title">Bcl-2 family proteins are essential for platelet survival</span> <span class="citation_source-journal">Cell Death Differ.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">943</span><span class="NLM_x">–</span> <span class="NLM_lpage">951</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm400556w&amp;key=10.1038%2Fsj.cdd.4402072" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm400556w&amp;key=17205078" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm400556w&amp;key=1%3ACAS%3A528%3ADC%252BD2sXktlOitro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2007&pages=943-951&author=H.+Zhangauthor=P.+M.+Nimmerauthor=S.+K.+Tahirauthor=J.+Chenauthor=R.+M.+Fryerauthor=K.+R.+Hahnauthor=L.+A.+Iciekauthor=S.+J.+Morganauthor=M.+C.+Nasarreauthor=R.+Nelsonauthor=L.+C.+Preusserauthor=G.+A.+Reinhartauthor=M.+L.+Smithauthor=S.+H.+Rosenbergauthor=S.+W.+Elmoreauthor=C.+Tse&title=Bcl-2+family+proteins+are+essential+for+platelet+survival"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Bcl-2 family proteins are essential for platelet survival</span></div><div class="casAuthors">Zhang, H.; Nimmer, P. M.; Tahir, S. K.; Chen, J.; Fryer, R. M.; Hahn, K. R.; Iciek, L. A.; Morgan, S. J.; Nasarre, M. C.; Nelson, R.; Preusser, L. C.; Reinhart, G. A.; Smith, M. L.; Rosenberg, S. H.; Elmore, S. W.; Tse, C.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death and Differentiation</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">943-951</span>CODEN:
                <span class="NLM_cas:coden">CDDIEK</span>;
        ISSN:<span class="NLM_cas:issn">1350-9047</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Platelets are relatively short-lived, anucleated cells that are essential for proper hemostasis.  The regulation of platelet survival in the circulation remains poorly understood.  The process of platelet activation and senescence in vivo is assocd. with processes similar to those obsd. during apoptosis in nucleated cells, including loss of mitochondrial membrane potential, caspase activation, phosphatidylserine (PS) externalization, and cell shrinkage.  ABT-737, a potent antagonist of Bcl-2, Bcl-XL, and Bcl-w, induces apoptosis in nucleated cells dependent on these proteins for survival.  In vivo, ABT-737 induces a redn. of circulating platelets that is maintained during drug therapy, followed by recovery to normal levels within several days after treatment cessation.  Whole body scintog. utilizing [111]Indium-labeled platelets in dogs shows that ABT-737-induced platelet clearance is primarily mediated by the liver.  In vitro, ABT-737 treatment leads to activation of key apoptotic processes including cytochrome c release, caspase-3 activation, and PS externalization in isolated platelets.  Despite these changes, ABT-737 is ineffective in promoting platelet activation as measured by granule release markers and platelet aggregation.  Taken together, these data suggest that ABT-737 induces an apoptosis-like response in platelets that is distinct from platelet activation and results in enhanced clearance in vivo by the reticuloendothelial system.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpG1nWthgLjMrVg90H21EOLACvtfcHk0li4Chj9sqCMIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXktlOitro%253D&md5=4ffa5dced24a6e58b7a3dd39d1ddf09f</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1038%2Fsj.cdd.4402072&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.cdd.4402072%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DNimmer%26aufirst%3DP.%2BM.%26aulast%3DTahir%26aufirst%3DS.%2BK.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DFryer%26aufirst%3DR.%2BM.%26aulast%3DHahn%26aufirst%3DK.%2BR.%26aulast%3DIciek%26aufirst%3DL.%2BA.%26aulast%3DMorgan%26aufirst%3DS.%2BJ.%26aulast%3DNasarre%26aufirst%3DM.%2BC.%26aulast%3DNelson%26aufirst%3DR.%26aulast%3DPreusser%26aufirst%3DL.%2BC.%26aulast%3DReinhart%26aufirst%3DG.%2BA.%26aulast%3DSmith%26aufirst%3DM.%2BL.%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26aulast%3DElmore%26aufirst%3DS.%2BW.%26aulast%3DTse%26aufirst%3DC.%26atitle%3DBcl-2%2520family%2520proteins%2520are%2520essential%2520for%2520platelet%2520survival%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2007%26volume%3D14%26spage%3D943%26epage%3D951" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Mason, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carpinelli, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fletcher, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collinge, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hilton, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellis, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ekert, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metcalf, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kile, B. T.</span><span> </span><span class="NLM_article-title">Programmed anuclear cell death delimits platelet life span</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">128</span><span class="NLM_x">, </span> <span class="NLM_fpage">1173</span><span class="NLM_x">–</span> <span class="NLM_lpage">1186</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm400556w&amp;key=10.1016%2Fj.cell.2007.01.037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm400556w&amp;key=17382885" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm400556w&amp;key=1%3ACAS%3A528%3ADC%252BD2sXkslGms7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2007&pages=1173-1186&author=K.+D.+Masonauthor=M.+R.+Carpinelliauthor=J.+I.+Fletcherauthor=J.+E.+Collingeauthor=A.+A.+Hiltonauthor=S.+Ellisauthor=P.+N.+Kellyauthor=P.+G.+Ekertauthor=D.+Metcalfauthor=A.+W.+Robertsauthor=D.+C.+Huangauthor=B.+T.+Kile&title=Programmed+anuclear+cell+death+delimits+platelet+life+span"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Programmed anuclear cell death delimits platelet life span</span></div><div class="casAuthors">Mason, Kylie D.; Carpinelli, Marina R.; Fletcher, Jamie I.; Collinge, Janelle E.; Hilton, Adrienne A.; Ellis, Sarah; Kelly, Priscilla N.; Ekert, Paul G.; Metcalf, Donald; Roberts, Andrew W.; Huang, David C. S.; Kile, Benjamin T.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">128</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1173-1186</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Platelets are anuclear cytoplasmic fragments essential for blood clotting and wound healing.  Despite much speculation, the factors detg. their life span in the circulation are unknown.  We show here that an intrinsic program for apoptosis controls platelet survival and dictates their life span.  Pro-survival Bcl-xL constrains the pro-apoptotic activity of Bak to maintain platelet survival, but as Bcl-xL degrades, aged platelets are primed for cell death.  Genetic ablation or pharmacol. inactivation of Bcl-xL reduces platelet half-life and causes thrombocytopenia in a dose-dependent manner.  Deletion of Bak corrects these defects, and platelets from Bak-deficient mice live longer than normal.  Thus, platelets are, by default, genetically programmed to die by apoptosis.  The antagonistic balance between Bcl-xL and Bak constitutes a mol. clock that dets. platelet life span: this represents an important paradigm for cellular homeostasis, and has profound implications for the diagnosis and treatment of disorders that affect platelet no. and function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOmRufdMqb1rVg90H21EOLACvtfcHk0lhsT-eCgRIdLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXkslGms7Y%253D&md5=c8fa8d967cf22317d15802cd25ceb365</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2007.01.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2007.01.037%26sid%3Dliteratum%253Aachs%26aulast%3DMason%26aufirst%3DK.%2BD.%26aulast%3DCarpinelli%26aufirst%3DM.%2BR.%26aulast%3DFletcher%26aufirst%3DJ.%2BI.%26aulast%3DCollinge%26aufirst%3DJ.%2BE.%26aulast%3DHilton%26aufirst%3DA.%2BA.%26aulast%3DEllis%26aufirst%3DS.%26aulast%3DKelly%26aufirst%3DP.%2BN.%26aulast%3DEkert%26aufirst%3DP.%2BG.%26aulast%3DMetcalf%26aufirst%3DD.%26aulast%3DRoberts%26aufirst%3DA.%2BW.%26aulast%3DHuang%26aufirst%3DD.%2BC.%26aulast%3DKile%26aufirst%3DB.%2BT.%26atitle%3DProgrammed%2520anuclear%2520cell%2520death%2520delimits%2520platelet%2520life%2520span%26jtitle%3DCell%26date%3D2007%26volume%3D128%26spage%3D1173%26epage%3D1186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Tahir, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, X. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgan-Lappe, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarthy, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warner, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ng, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fesik, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elmore, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenberg, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tse, C.</span><span> </span><span class="NLM_article-title">Influence of Bcl-2 family members on the cellular response of small-cell lung cancer cell lines to ABT-737</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">1176</span><span class="NLM_x">–</span> <span class="NLM_lpage">1183</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2007&pages=1176-1183&author=S.+K.+Tahirauthor=X.+F.+Yangauthor=M.+G.+Andersonauthor=S.+E.+Morgan-Lappeauthor=A.+V.+Sarthyauthor=J.+Chenauthor=R.+B.+Warnerauthor=S.+C.+Ngauthor=S.+W.+Fesikauthor=S.+W.+Elmoreauthor=S.+H.+Rosenbergauthor=C.+Tse&title=Influence+of+Bcl-2+family+members+on+the+cellular+response+of+small-cell+lung+cancer+cell+lines+to+ABT-737"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTahir%26aufirst%3DS.%2BK.%26aulast%3DYang%26aufirst%3DX.%2BF.%26aulast%3DAnderson%26aufirst%3DM.%2BG.%26aulast%3DMorgan-Lappe%26aufirst%3DS.%2BE.%26aulast%3DSarthy%26aufirst%3DA.%2BV.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DWarner%26aufirst%3DR.%2BB.%26aulast%3DNg%26aufirst%3DS.%2BC.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26aulast%3DElmore%26aufirst%3DS.%2BW.%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26aulast%3DTse%26aufirst%3DC.%26atitle%3DInfluence%2520of%2520Bcl-2%2520family%2520members%2520on%2520the%2520cellular%2520response%2520of%2520small-cell%2520lung%2520cancer%2520cell%2520lines%2520to%2520ABT-737%26jtitle%3DCancer%2520Res.%26date%3D2007%26volume%3D67%26spage%3D1176%26epage%3D1183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Beroukhim, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mermel, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porter, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raychaudhuri, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donovan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barretina, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boehm, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dobson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urashima, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henry, K. T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinchback, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ligon, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haery, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greulich, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reich, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winckler, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrence, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weir, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiang, D. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bass, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prensner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liefeld, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yecies, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Signoretti, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maher, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaye, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tepper, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fletcher, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tabernero, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baselga, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsao, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demichelis, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubin, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janne, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daly, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nucera, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levine, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ebert, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabriel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rustgi, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antonescu, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ladanyi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Letai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garraway, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beer, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">True, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamoto, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pomeroy, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golub, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lander, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Getz, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sellers, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyerson, M.</span><span> </span><span class="NLM_article-title">The landscape of somatic copy-number alteration across human cancers</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">463</span><span class="NLM_x">, </span> <span class="NLM_fpage">899</span><span class="NLM_x">–</span> <span class="NLM_lpage">905</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm400556w&amp;key=10.1038%2Fnature08822" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm400556w&amp;key=20164920" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm400556w&amp;key=1%3ACAS%3A528%3ADC%252BC3cXitFemsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=463&publication_year=2010&pages=899-905&author=R.+Beroukhimauthor=C.+H.+Mermelauthor=D.+Porterauthor=G.+Weiauthor=S.+Raychaudhuriauthor=J.+Donovanauthor=J.+Barretinaauthor=J.+S.+Boehmauthor=J.+Dobsonauthor=M.+Urashimaauthor=K.+T.+M.+Henryauthor=R.+M.+Pinchbackauthor=A.+H.+Ligonauthor=Y.+Choauthor=L.+Haeryauthor=H.+Greulichauthor=M.+Reichauthor=W.+Wincklerauthor=M.+S.+Lawrenceauthor=B.+A.+Weirauthor=K.+E.+Tanakaauthor=D.+Y.+Chiangauthor=A.+J.+Bassauthor=A.+Looauthor=C.+Hoffmanauthor=J.+Prensnerauthor=T.+Liefeldauthor=Q.+Gaoauthor=D.+Yeciesauthor=S.+Signorettiauthor=E.+Maherauthor=F.+J.+Kayeauthor=H.+Sasakiauthor=J.+E.+Tepperauthor=J.+A.+Fletcherauthor=J.+Taberneroauthor=J.+Baselgaauthor=M.+Tsaoauthor=F.+Demichelisauthor=M.+A.+Rubinauthor=P.+A.+Janneauthor=M.+J.+Dalyauthor=C.+Nuceraauthor=R.+L.+Levineauthor=B.+L.+Ebertauthor=S.+Gabrielauthor=A.+K.+Rustgiauthor=C.+R.+Antonescuauthor=M.+Ladanyiauthor=A.+Letaiauthor=L.+A.+Garrawayauthor=M.+Lodaauthor=D.+G.+Beerauthor=L.+D.+Trueauthor=A.+Okamotoauthor=S.+L.+Pomeroyauthor=S.+Singerauthor=T.+Golubauthor=E.+S.+Landerauthor=G.+Getzauthor=W.+R.+Sellersauthor=M.+Meyerson&title=The+landscape+of+somatic+copy-number+alteration+across+human+cancers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">The landscape of somatic copy-number alteration across human cancers</span></div><div class="casAuthors">Beroukhim, Rameen; Mermel, Craig H.; Porter, Dale; Wei, Guo; Raychaudhuri, Soumya; Donovan, Jerry; Barretina, Jordi; Boehm, Jesse S.; Dobson, Jennifer; Urashima, Mitsuyoshi; Mc Henry, Kevin T.; Pinchback, Reid M.; Ligon, Azra H.; Cho, Yoon-Jae; Haery, Leila; Greulich, Heidi; Reich, Michael; Winckler, Wendy; Lawrence, Michael S.; Weir, Barbara A.; Tanaka, Kumiko E.; Chiang, Derek Y.; Bass, Adam J.; Loo, Alice; Hoffman, Carter; Prensner, John; Liefeld, Ted; Gao, Qing; Yecies, Derek; Signoretti, Sabina; Maher, Elizabeth; Kaye, Frederic J.; Sasaki, Hidefumi; Tepper, Joel E.; Fletcher, Jonathan A.; Tabernero, Josep; Baselga, Jose; Tsao, Ming-Sound; Demichelis, Francesca; Rubin, Mark A.; Janne, Pasi A.; Daly, Mark J.; Nucera, Carmelo; Levine, Ross L.; Ebert, Benjamin L.; Gabriel, Stacey; Rustgi, Anil K.; Antonescu, Cristina R.; Ladanyi, Marc; Letai, Anthony; Garraway, Levi A.; Loda, Massimo; Beer, David G.; True, Lawrence D.; Okamoto, Aikou; Pomeroy, Scott L.; Singer, Samuel; Golub, Todd R.; Lander, Eric S.; Getz, Gad; Sellers, William R.; Meyerson, Matthew</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">463</span>
        (<span class="NLM_cas:issue">7283</span>),
    <span class="NLM_cas:pages">899-905</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A powerful way to discover key genes with causal roles in oncogenesis is to identify genomic regions that undergo frequent alteration in human cancers.  Here we present high-resoln. analyses of somatic copy-no. alterations (SCNAs) from 3131 cancer specimens, belonging largely to 26 histol. types.  We identify 158 regions of focal SCNA that are altered at significant frequency across several cancer types, of which 122 cannot be explained by the presence of a known cancer target gene located within these regions.  Several gene families are enriched among these regions of focal SCNA, including the BCL2 family of apoptosis regulators and the NF-κB pathway.  We show that cancer cells contg. amplifications surrounding the MCL1 and BCL2L1 anti-apoptotic genes depend on the expression of these genes for survival.  Finally, we demonstrate that a large majority of SCNAs identified in individual cancer types are present in several cancer types.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCxYRlqR0wXLVg90H21EOLACvtfcHk0lgC5bsLgrHo-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXitFemsr0%253D&md5=be6d81f5449cba96dfb4659106f706b0</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1038%2Fnature08822&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature08822%26sid%3Dliteratum%253Aachs%26aulast%3DBeroukhim%26aufirst%3DR.%26aulast%3DMermel%26aufirst%3DC.%2BH.%26aulast%3DPorter%26aufirst%3DD.%26aulast%3DWei%26aufirst%3DG.%26aulast%3DRaychaudhuri%26aufirst%3DS.%26aulast%3DDonovan%26aufirst%3DJ.%26aulast%3DBarretina%26aufirst%3DJ.%26aulast%3DBoehm%26aufirst%3DJ.%2BS.%26aulast%3DDobson%26aufirst%3DJ.%26aulast%3DUrashima%26aufirst%3DM.%26aulast%3DHenry%26aufirst%3DK.%2BT.%2BM.%26aulast%3DPinchback%26aufirst%3DR.%2BM.%26aulast%3DLigon%26aufirst%3DA.%2BH.%26aulast%3DCho%26aufirst%3DY.%26aulast%3DHaery%26aufirst%3DL.%26aulast%3DGreulich%26aufirst%3DH.%26aulast%3DReich%26aufirst%3DM.%26aulast%3DWinckler%26aufirst%3DW.%26aulast%3DLawrence%26aufirst%3DM.%2BS.%26aulast%3DWeir%26aufirst%3DB.%2BA.%26aulast%3DTanaka%26aufirst%3DK.%2BE.%26aulast%3DChiang%26aufirst%3DD.%2BY.%26aulast%3DBass%26aufirst%3DA.%2BJ.%26aulast%3DLoo%26aufirst%3DA.%26aulast%3DHoffman%26aufirst%3DC.%26aulast%3DPrensner%26aufirst%3DJ.%26aulast%3DLiefeld%26aufirst%3DT.%26aulast%3DGao%26aufirst%3DQ.%26aulast%3DYecies%26aufirst%3DD.%26aulast%3DSignoretti%26aufirst%3DS.%26aulast%3DMaher%26aufirst%3DE.%26aulast%3DKaye%26aufirst%3DF.%2BJ.%26aulast%3DSasaki%26aufirst%3DH.%26aulast%3DTepper%26aufirst%3DJ.%2BE.%26aulast%3DFletcher%26aufirst%3DJ.%2BA.%26aulast%3DTabernero%26aufirst%3DJ.%26aulast%3DBaselga%26aufirst%3DJ.%26aulast%3DTsao%26aufirst%3DM.%26aulast%3DDemichelis%26aufirst%3DF.%26aulast%3DRubin%26aufirst%3DM.%2BA.%26aulast%3DJanne%26aufirst%3DP.%2BA.%26aulast%3DDaly%26aufirst%3DM.%2BJ.%26aulast%3DNucera%26aufirst%3DC.%26aulast%3DLevine%26aufirst%3DR.%2BL.%26aulast%3DEbert%26aufirst%3DB.%2BL.%26aulast%3DGabriel%26aufirst%3DS.%26aulast%3DRustgi%26aufirst%3DA.%2BK.%26aulast%3DAntonescu%26aufirst%3DC.%2BR.%26aulast%3DLadanyi%26aufirst%3DM.%26aulast%3DLetai%26aufirst%3DA.%26aulast%3DGarraway%26aufirst%3DL.%2BA.%26aulast%3DLoda%26aufirst%3DM.%26aulast%3DBeer%26aufirst%3DD.%2BG.%26aulast%3DTrue%26aufirst%3DL.%2BD.%26aulast%3DOkamoto%26aufirst%3DA.%26aulast%3DPomeroy%26aufirst%3DS.%2BL.%26aulast%3DSinger%26aufirst%3DS.%26aulast%3DGolub%26aufirst%3DT.%26aulast%3DLander%26aufirst%3DE.%2BS.%26aulast%3DGetz%26aufirst%3DG.%26aulast%3DSellers%26aufirst%3DW.%2BR.%26aulast%3DMeyerson%26aufirst%3DM.%26atitle%3DThe%2520landscape%2520of%2520somatic%2520copy-number%2520alteration%2520across%2520human%2520cancers%26jtitle%3DNature%26date%3D2010%26volume%3D463%26spage%3D899%26epage%3D905" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Amundson, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myers, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scudiero, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitada, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fornace, A. J.,  Jr.</span><span> </span><span class="NLM_article-title">An informatics approach identifying markers of chemosensitivity in human cancer cell lines</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">6101</span><span class="NLM_x">–</span> <span class="NLM_lpage">6110</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm400556w&amp;key=11085534" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm400556w&amp;key=1%3ACAS%3A528%3ADC%252BD3cXotV2lsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2000&pages=6101-6110&author=S.+A.+Amundsonauthor=T.+G.+Myersauthor=D.+Scudieroauthor=S.+Kitadaauthor=J.+C.+Reedauthor=A.+J.+Fornace&title=An+informatics+approach+identifying+markers+of+chemosensitivity+in+human+cancer+cell+lines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">An informatics approach identifying markers of chemosensitivity in human cancer cell lines</span></div><div class="casAuthors">Amundson, Sally A.; Myers, Timothy G.; Scudiero, Dominic; Kitada, Shinichi; Reed, John C.; Fornace, Albert J., Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6101-6110</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">We have used a sensitive and reproducible method of measuring mRNA expression to compare basal levels of 10 transcripts in the 60 cell lines of the National Cancer Institute's in vitro anticancer drug screen (NCI-ACDS) under conditions of exponential growth.  The strongest correlation among these target genes was between levels of CIP1/WAF1 and BAX.  Levels of the three major growth arrest and DNA damage-inducible gene transcripts, (GADD34, GADD45, and GADD153), which are coordinately regulated in response to many stresses, were also correlated across the 60 cell lines.  Although the stress induction of several of the transcripts studied here has been shown to be dependent on wild-type p53 status, basal levels of only CIP1/WAF1 and BAX were found to correlate with p53 status.  As expected, basal expression of O6 alkyl guanine alkyl-transferase correlated well with resistance to O6-alkylating agents (r = -0.44) but not with resistance to alkylators with different mechanisms of action (r = -0.04).  When basal expression levels of the 10 genes across the NCI-ACDS panel were compared with sensitivities to a panel of 122 std. chemotherapy agents, the most striking relationship was a strong neg. correlation (r = -0.3) between basal BCL-X levels and sensitivity to drugs in all of the mechanistic classes except one class of antimetabolites.  Sensitivities to a maximally diverse sample of 1200 from 70,000 compds. tested in the NCI-ACDS of agents were also neg. correlated with BCL-X levels.  A novel application of factor anal. revealed that the newly discovered assocns. were independent of previously demonstrated sensitivity factors such as p53 mutation status and native population doubling time.  A similar pattern of correlation was seen for Bcl-XL protein levels.  Conversely, BAX and BCL2, two other genes assocd. with regulation of apoptosis, showed no overall correlation with drug sensitivities.  This suggests that BCL-X may play a unique role in general resistance to cytotoxic agents, with the cell lines demonstrating relative resistance to 70,000 cytotoxic agents in the NCI-ACDS being characterized by high BCL-X expression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGDcpza2WFJbVg90H21EOLACvtfcHk0lgC5bsLgrHo-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXotV2lsb4%253D&md5=0da385ff6e48e7351d16036c1a8fcf2e</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAmundson%26aufirst%3DS.%2BA.%26aulast%3DMyers%26aufirst%3DT.%2BG.%26aulast%3DScudiero%26aufirst%3DD.%26aulast%3DKitada%26aufirst%3DS.%26aulast%3DReed%26aufirst%3DJ.%2BC.%26aulast%3DFornace%26aufirst%3DA.%2BJ.%26atitle%3DAn%2520informatics%2520approach%2520identifying%2520markers%2520of%2520chemosensitivity%2520in%2520human%2520cancer%2520cell%2520lines%26jtitle%3DCancer%2520Res.%26date%3D2000%26volume%3D60%26spage%3D6101%26epage%3D6110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Lessene, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czabotar, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sleebs, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zobel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowes, K. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baell, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colman, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deshayes, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fairbrother, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flygare, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbons, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kersten, W. J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kulasegaram, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moss, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parisot, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Street, I. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, D. C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, K. G.</span><span> </span><span class="NLM_article-title">Structure-guided design of a selective BCL-X<sub>L</sub> inhibitor</span> <span class="citation_source-journal">Nature Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">390</span><span class="NLM_x">–</span> <span class="NLM_lpage">397</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm400556w&amp;key=10.1038%2Fnchembio.1246" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm400556w&amp;key=23603658" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm400556w&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmt1Whsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=390-397&author=G.+Lesseneauthor=P.+E.+Czabotarauthor=B.+E.+Sleebsauthor=K.+Zobelauthor=K.+N.+Lowesauthor=J.+M.+Adamsauthor=J.+B.+Baellauthor=P.+M.+Colmanauthor=K.+Deshayesauthor=W.+J.+Fairbrotherauthor=J.+A.+Flygareauthor=P.+Gibbonsauthor=W.+J.+A.+Kerstenauthor=S.+Kulasegaramauthor=R.+M.+Mossauthor=J.+P.+Parisotauthor=B.+J.+Smithauthor=I.+P.+Streetauthor=H.+Yangauthor=D.+C.+S.+Huangauthor=K.+G.+Watson&title=Structure-guided+design+of+a+selective+BCL-XL+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-guided design of a selective BCL-XL inhibitor</span></div><div class="casAuthors">Lessene, Guillaume; Czabotar, Peter E.; Sleebs, Brad E.; Zobel, Kerry; Lowes, Kym N.; Adams, Jerry M.; Baell, Jonathan B.; Colman, Peter M.; Deshayes, Kurt; Fairbrother, Wayne J.; Flygare, John A.; Gibbons, Paul; Kersten, Wilhelmus J. A.; Kulasegaram, Sanji; Moss, Rebecca M.; Parisot, John P.; Smith, Brian J.; Street, Ian P.; Yang, Hong; Huang, David C. S.; Watson, Keith G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">390-397</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The prosurvival BCL-2 family protein BCL-XL is often overexpressed in solid tumors and renders malignant tumor cells resistant to anticancer therapeutics.  Enhancing apoptotic responses by inhibiting BCL-XL will most likely have widespread utility in cancer treatment and, instead of inhibiting multiple prosurvival BCL-2 family members, a BCL-XL-selective inhibitor would be expected to minimize the toxicity to normal tissues.  We describe the use of a high-throughput screen to discover a new series of small mols. targeting BCL-XL and their structure-guided development by medicinal chem.  The optimized compd., WEHI-539 (7), has high affinity (subnanomolar) and selectivity for BCL-XL and potently kills cells by selectively antagonizing its prosurvival activity.  WEHI-539 will be an invaluable tool for distinguishing the roles of BCL-XL from those of its prosurvival relatives, both in normal cells and notably in malignant tumor cells, many of which may prove to rely upon BCL-XL for their sustained growth.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGph9LM-ZVEscrVg90H21EOLACvtfcHk0lgC5bsLgrHo-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmt1Whsb0%253D&md5=c9179ea71db5b72968b0b0e9f8a03eeb</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1246&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1246%26sid%3Dliteratum%253Aachs%26aulast%3DLessene%26aufirst%3DG.%26aulast%3DCzabotar%26aufirst%3DP.%2BE.%26aulast%3DSleebs%26aufirst%3DB.%2BE.%26aulast%3DZobel%26aufirst%3DK.%26aulast%3DLowes%26aufirst%3DK.%2BN.%26aulast%3DAdams%26aufirst%3DJ.%2BM.%26aulast%3DBaell%26aufirst%3DJ.%2BB.%26aulast%3DColman%26aufirst%3DP.%2BM.%26aulast%3DDeshayes%26aufirst%3DK.%26aulast%3DFairbrother%26aufirst%3DW.%2BJ.%26aulast%3DFlygare%26aufirst%3DJ.%2BA.%26aulast%3DGibbons%26aufirst%3DP.%26aulast%3DKersten%26aufirst%3DW.%2BJ.%2BA.%26aulast%3DKulasegaram%26aufirst%3DS.%26aulast%3DMoss%26aufirst%3DR.%2BM.%26aulast%3DParisot%26aufirst%3DJ.%2BP.%26aulast%3DSmith%26aufirst%3DB.%2BJ.%26aulast%3DStreet%26aufirst%3DI.%2BP.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DHuang%26aufirst%3DD.%2BC.%2BS.%26aulast%3DWatson%26aufirst%3DK.%2BG.%26atitle%3DStructure-guided%2520design%2520of%2520a%2520selective%2520BCL-XL%2520inhibitor%26jtitle%3DNature%2520Chem.%2520Biol.%26date%3D2013%26volume%3D9%26spage%3D390%26epage%3D397" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="note"><p class="first last">The LPA technology proved to be a reliable technology compared to others. In particular, it allowed us to screen at high starting concentrations and obtain reproducible and meaningful results. In addition, the conditions used in the screen removed misleading SAR patterns due to nonselective hydrophobic interactions.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Petros, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinges, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Augeri, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baumeister, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Betebenner, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bures, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elmore, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajduk, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joseph, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landis, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nettesheim, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenberg, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zanze, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fesik, S. W.</span><span> </span><span class="NLM_article-title">Discovery of a potent inhibitor of the antiapoptotic protein Bcl-x<sub>L</sub> from NMR and parallel synthesis</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">656</span><span class="NLM_x">–</span> <span class="NLM_lpage">663</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0507532" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm400556w&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlant73J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=656-663&author=A.+M.+Petrosauthor=J.+Dingesauthor=D.+J.+Augeriauthor=S.+A.+Baumeisterauthor=D.+A.+Betebennerauthor=M.+G.+Buresauthor=S.+W.+Elmoreauthor=P.+J.+Hajdukauthor=M.+K.+Josephauthor=S.+K.+Landisauthor=D.+G.+Nettesheimauthor=S.+H.+Rosenbergauthor=W.+Shenauthor=S.+Thomasauthor=X.+Wangauthor=I.+Zanzeauthor=H.+Zhangauthor=S.+W.+Fesik&title=Discovery+of+a+potent+inhibitor+of+the+antiapoptotic+protein+Bcl-xL+from+NMR+and+parallel+synthesis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Potent Inhibitor of the Antiapoptotic Protein Bcl-xL from NMR and Parallel Synthesis</span></div><div class="casAuthors">Petros, Andrew M.; Dinges, Jurgen; Augeri, David J.; Baumeister, Steven A.; Betebenner, David A.; Bures, Mark G.; Elmore, Steven W.; Hajduk, Philip J.; Joseph, Mary K.; Landis, Shelley K.; Nettesheim, David G.; Rosenberg, Saul H.; Shen, Wang; Thomas, Sheela; Wang, Xilu; Zanze, Irini; Zhang, Haichao; Fesik, Stephen W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">656-663</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The antiapoptotic proteins Bcl-xL and Bcl-2 play key roles in the maintenance of normal cellular homeostasis.  However, their overexpression can lead to oncogenic transformation and is responsible for drug resistance in certain types of cancer.  This makes Bcl-xL and Bcl-2 attractive targets for the development of potential anticancer agents.  Here we describe the structure-based discovery of a potent Bcl-xL inhibitor directed at a hydrophobic groove on the surface of the protein.  This groove represents the binding site for BH3 peptides from proapoptotic Bcl-2 family members such as Bak and Bad.  Application of NMR-based screening yielded an initial biaryl acid with an affinity (Kd) of ∼300 μM for the protein.  Following the classical "SAR by NMR" approach, a second-site ligand was identified that bound proximal to the first-site ligand in the hydrophobic groove.  From NMR-based structural studies and parallel synthesis, a potent ligand was obtained, which binds to Bcl-xL with an inhibition const. (Ki) of 36 ± 2 nM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYP_kg1BoLW7Vg90H21EOLACvtfcHk0ljipjkX6yk4mg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlant73J&md5=ef6d8989682f6eaadeda9d7b6eae09e4</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm0507532&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0507532%26sid%3Dliteratum%253Aachs%26aulast%3DPetros%26aufirst%3DA.%2BM.%26aulast%3DDinges%26aufirst%3DJ.%26aulast%3DAugeri%26aufirst%3DD.%2BJ.%26aulast%3DBaumeister%26aufirst%3DS.%2BA.%26aulast%3DBetebenner%26aufirst%3DD.%2BA.%26aulast%3DBures%26aufirst%3DM.%2BG.%26aulast%3DElmore%26aufirst%3DS.%2BW.%26aulast%3DHajduk%26aufirst%3DP.%2BJ.%26aulast%3DJoseph%26aufirst%3DM.%2BK.%26aulast%3DLandis%26aufirst%3DS.%2BK.%26aulast%3DNettesheim%26aufirst%3DD.%2BG.%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26aulast%3DShen%26aufirst%3DW.%26aulast%3DThomas%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DZanze%26aufirst%3DI.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26atitle%3DDiscovery%2520of%2520a%2520potent%2520inhibitor%2520of%2520the%2520antiapoptotic%2520protein%2520Bcl-xL%2520from%2520NMR%2520and%2520parallel%2520synthesis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D656%26epage%3D663" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="note"><p class="first last">Both technologies are solution competition assays. We believe that the discrepancy between the two sets of values may originate from the way the data is presented. In ref <a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">27</a>, <i>K</i><sub>i</sub> values are derived from IC<sub>50</sub> values using a formula, which was not disclosed in the original publication. We note that, in our studies, the IC<sub>50</sub> values obtained with the AlphaScreen assay correlate closely with the direct binding <i>K</i><sub>D</sub>s obtained with surface plasmon resonance.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="note"><p class="first last">Our experience in targeting Bcl-2 family of proteins has led us to value consistency across multiple assay platforms rather than an absolute value of the binding affinity. For reasons inherent to these targets, e.g., hydrophobic nature of the groove with hydrogen bond donors at specific points, hydrophobic acidic molecules tend to appear often as nonselective hits. These proteins have led to a large number of “frequent hitters”, see ref <a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">31</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="note"><p class="first last">There was no other hit against either of the three proteins that showed consistent activity in both LPA and fluorescence polarization assays.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Baell, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holloway, G. A.</span><span> </span><span class="NLM_article-title">New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">2719</span><span class="NLM_x">–</span> <span class="NLM_lpage">2740</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901137j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm400556w&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsF2qsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2719-2740&author=J.+B.+Baellauthor=G.+A.+Holloway&title=New+substructure+filters+for+removal+of+pan+assay+interference+compounds+%28PAINS%29+from+screening+libraries+and+for+their+exclusion+in+bioassays"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays</span></div><div class="casAuthors">Baell, Jonathan B.; Holloway, Georgina A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2719-2740</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This report describes a no. of substructural features which can help to identify compds. that appear as frequent hitters (promiscuous compds.) in many biochem. high throughput screens.  The compds. identified by such substructural features are not recognized by filters commonly used to identify reactive compds.  Even though these substructural features were identified using only one assay detection technol., such compds. have been reported to be active from many different assays.  In fact, these compds. are increasingly prevalent in the literature as potential starting points for further exploration, whereas they may not be.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro_JARcceWjLVg90H21EOLACvtfcHk0ljipjkX6yk4mg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsF2qsLw%253D&md5=fbf397aa4910753c550425708c866fd2</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjm901137j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901137j%26sid%3Dliteratum%253Aachs%26aulast%3DBaell%26aufirst%3DJ.%2BB.%26aulast%3DHolloway%26aufirst%3DG.%2BA.%26atitle%3DNew%2520substructure%2520filters%2520for%2520removal%2520of%2520pan%2520assay%2520interference%2520compounds%2520%2528PAINS%2529%2520from%2520screening%2520libraries%2520and%2520for%2520their%2520exclusion%2520in%2520bioassays%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2719%26epage%3D2740" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><div class="note"><p class="first last">It is worrying to note that rhodanine-like structures are still published as Bcl-X<sub>L</sub> inhibitors in the recent literature. See for example</p></div><span class="NLM_contrib-group">Feng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, D.</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">3465</span><span class="NLM_x">–</span> <span class="NLM_lpage">3479</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901004c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=It+is+worrying+to+note+that+rhodanine-like+structures+are+still+published+as+Bcl-XL+inhibitors+in+the+recent+literature.+See+for+exampleFeng%2C+Y.%3B+Ding%2C+X.%3B+Chen%2C+T.%3B+Chen%2C+L.%3B+Liu%2C+F.%3B+Jia%2C+X.%3B+Luo%2C+X.%3B+Shen%2C+X.%3B+Chen%2C+K.%3B+Jiang%2C+H.%3B+Wang%2C+H.%3B+Liu%2C+H.%3B+Liu%2C+D.J.+Med.+Chem.+2010%2C+53%2C+3465%E2%80%933479"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjm901004c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901004c%26sid%3Dliteratum%253Aachs%26aulast%3DFeng%26aufirst%3DY.%26aulast%3DDing%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DT.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DF.%26aulast%3DJia%26aufirst%3DX.%26aulast%3DLuo%26aufirst%3DX.%26aulast%3DShen%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DJiang%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DD.%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D3465%26epage%3D3479" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Meerwein, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchner, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Emster, K.</span><span> </span><span class="NLM_article-title">Memorandum from the Chemistry Institute, University of Marburg. The action of aromatic diazo compound on alpha,beta-unsaturated carbonyl bonds</span> <span class="citation_source-journal">J. Prakt. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1939</span><span class="NLM_x">, </span> <span class="NLM_volume">152</span><span class="NLM_x">, </span> <span class="NLM_fpage">237</span><span class="NLM_x">–</span> <span class="NLM_lpage">266</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm400556w&amp;key=10.1002%2Fprac.19391520705" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm400556w&amp;key=1%3ACAS%3A528%3ADyaA1MXksVahtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=152&publication_year=1939&pages=237-266&author=H.+Meerweinauthor=E.+Buchnerauthor=K.+van+Emster&title=Memorandum+from+the+Chemistry+Institute%2C+University+of+Marburg.+The+action+of+aromatic+diazo+compound+on+alpha%2Cbeta-unsaturated+carbonyl+bonds"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Reaction of aromatic diazo compounds upon α,β-unsaturated carbonyl compounds</span></div><div class="casAuthors">Meerwein, Hans; Buchner, Eberhard; van Emster, Konrad</div><div class="citationInfo"><span class="NLM_cas:title">Journal fuer Praktische Chemie (Leipzig)</span>
        (<span class="NLM_cas:date">1939</span>),
    <span class="NLM_cas:volume">152</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">237-66</span>CODEN:
                <span class="NLM_cas:coden">JPCEAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-8383</span>.
    </div><div class="casAbstract">The following work shows that α,β-unsatd. CO compds., i. e., aldehydes, ketones and carboxylic acids and their derivs., react under suitable conditions with arom. diazo compds., during which N is split off and in most cases the aryl group of the diazo compd. replaces the H of the α-C atom.  In some cases the halogen of RMgX adds to the β-C atom and since this can be split off easily, it affords a method of prepg. unsatd. compds. with a substituent on the α-C atom adjoining the CO group.  A further modification of the reaction is obsd. in the case of RCH:CHCO2H, in which CO2 is split off to give RCH:CHAr.  C2H2 compds. behave similarly to those contg. a double bond.  The reaction of the diazo compds. with unsatd. CO compds. takes place in dil. acid soln. with addn. of salts of weak acids; an equal vol. of Me2CO is used to facilitate soln. but it also appears to have a sp. effect in the reaction.  Cupric (but not cuprous) salts act as catalysts.  An interesting side reaction is the formation of AcCH2X, the yield varying with the acidity of the soln. and with the nature of the diazo soln.  With 0.25 mol CuCl2, and 1.6 mol AcONa the following yields (%) of AcCH2Cl were obsd.: PhN2Cl 28.4, p-Cl deriv. 44.6, p-NO2 deriv. 41.5, o,p-di-Cl deriv. 64.8, p-MeO deriv. 18.5.  3-Arylcoumarins were prepd. as follows: p-ClC6H4N2Cl (from 15.9 g. p-ClC6H4NH2, 50 g. of 25% HCl and 9 g. NaNO2 in 18 cc. H2O), mixed with a soln. of 18.25 g. coumarin in 100 cc. Me2CO contg. 40 g. AcONa in suspension and 5 g. CuCl2 in 10 cc. H2O, gives 45.9% of 3-p-chlorophenyl deriv.; with MeCN in place of Me2CO the yield is 57%; 3-Ph deriv., 25.9%; 3-β-naphthyl deriv., m. 170°, 17.6%; 3-p-nitrophenyl deriv., 49.9%; o-isomer, S-yellow, m. 172-3°, 11%; 3-p-methoxyphenyl deriv., m. 136.5-8.5°, 35.3%; 3-p-acetaminophenyl deriv., m. 249.5°, 27.8%. p-HO3SC6H4N2Cl gives 43% of Na 3-phenylcoumarin-p-sulfonate, microneedles. p-HO2CC6H4N2Cl gives 46-52% of 3-phenylcoumarin-p-carboxylic acid, m. 288-90°.  Umbelliferone (I) and p-ClC6H4N2Cl give 48% of the 3-p-chlorophenyl deriv., m. 280-2°; if an excess of Na2CO3 is added to the Na deriv. of I, there results a chocolate-brown azo dye, C15H19O3N2Cl.  The prepn. of stilbene is carried out as follows: p-O2NC6H4N2Cl (from 17.25 g. base), 18.5 g. PhCH:CHCO2H (II) in 150 cc. Me2CO, 27.5 g. of AcONa and 5.3 g. of CuCl2 at 14-17° for 1.25 h. give AcCH2Cl, small quantities of p-O2NC6H4Cl and PhNO2, 3.4 g. of recovered II, 0.8 g. of α-p-nitrophenylcinnamic acid and 48% of nitrostilbene; the following yields (%) of stilbenes (base used given) are calcd. on the II entering into reaction: PhNH2 36.5, p-MeC6H4NH2 48.8, p-ClC6H4NH2 68.8, o,p-Cl2C6H3NH2 34.4, p-O2NC6H4NH2 58.4, o-isomer 43.9, p-MeOC6H4NH2 49.2, p-HO3SC6H4NH2 77.5.  Because of the difficulties of isolation of the stilbenes, the yields are probably much higher.  Na stilbene-p-sulfonate, needles, decomp. above 259°. p-HOC6H4CH:CHCO2H and p-ClC6H4N2Cl give 56.5% of p-chloro-p'-hydroxystilbene, m. 185.5-6°; p-MeOC6H4CH:CHCO2H gives 61.2% of p-ClC6H4CH:CHC6H4OMe-p and p-ClC6H4CH:CHCO2H gives 8% of (4-ClC6H4CH)2.  PhCH:CHCN and p-ClC6H4N2Cl give 76.5% of PhCH:C(C6H4Cl-p)CN.  PhCH:CHCO2Me in C5H5N-AcOH gives 30% of Me α-p-chlorophenyl-β-chlorohydrocinnamic acid (III), m. 124-4.5°; heating with AcONa in AcOH for 3 h. at 140° gives the Me ester, m. 85.5°, of α-p-chlorophenylcinnamic acid, m. 181.5°; p-ClC6H4N2Br gives the β-Br analog of III, m. 123°. p-O2NC6H4N2Cl and crotonic acid give 68% of p-nitrophenylcrotonic acid, pale yellow, m. 173.5-4.5°; the neutral fraction gives p,p'-dinitroazobenzene.  Me crotonate and o,p-Cl2C6H3N2Cl give the Me ester, b0.1 130-40°, of α-o,p-dichlorophenyl-β-chlorobutyric acid, m. 124.5-5° (22.4%). p-ClC6H4N2Cl and phenylpropiolic acid yield Me α-p-chlorophenyl-β-chlorocinnamate, b0.1 160-5°, m. 63°; Me fumarate gives 42.8% of Me α-p-chlorophenyl-β-chlorosuccinate (IV), m. 79°; boiling with 2 N EtOH-KOH gives a quant. yield of p-chlorophenylfumaric acid (V), m. 222°; the mother liquor from IV with EtOH-KOH gives 26.8% of V.  Distg. 10 g. V with 10 mg. chlorocymenesulfonic acid gives 5.8 g. of p-chlorophenylmaleic anhydride (VI), m. 146°.  VI with boiling H2O gives p-chlorophenylmaleic acid, m. 141-3°, whereas heating 10 g. VI with 4.5 N NaOH for 20 h. gives 4.3 g.V.  Me maleate and p-ClC6H4N2Cl give 7.5 g. IV and 9.3 g. V; if the reaction product is heated 2 h. with 2 N NaOH the products are 28% IV and 19.1% VI.  PhCH:CHO and p-ClC6H4N2Cl give 1-(p-chlorophenyl)cinnamaldehyde, m. 85-6°; the yellow concd. H2SO4 soln. turns emerald-green on standing; there also results a small quantity of an isomer, m. 128°.  Many diazo salts are sol. in liq. SO2; heating p-ClC6H4N2Cl in SO2 in the presence of CuCl2 gives 80% of 4-ClC6H4SO2Cl; with AcONa and CuCl2 there is formed an azo sulfone, 4-ClC6H4N:NSO2C6H4Cl-4.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXCjtxQL98tLVg90H21EOLACvtfcHk0liBstfLnkEM9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaA1MXksVahtQ%253D%253D&md5=19d0174c2e62aa3106d3cee27a05f5ed</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1002%2Fprac.19391520705&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fprac.19391520705%26sid%3Dliteratum%253Aachs%26aulast%3DMeerwein%26aufirst%3DH.%26aulast%3DBuchner%26aufirst%3DE.%26aulast%3Dvan%2BEmster%26aufirst%3DK.%26atitle%3DMemorandum%2520from%2520the%2520Chemistry%2520Institute%252C%2520University%2520of%2520Marburg.%2520The%2520action%2520of%2520aromatic%2520diazo%2520compound%2520on%2520alpha%252Cbeta-unsaturated%2520carbonyl%2520bonds%26jtitle%3DJ.%2520Prakt.%2520Chem.%26date%3D1939%26volume%3D152%26spage%3D237%26epage%3D266" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Racane, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tralic-Kulenovic, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boykin, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karminski-Zamola, G.</span><span> </span><span class="NLM_article-title">Synthesis of new cyano-substituted bis-benzothiazolyl arylfurans and arylthiophenes</span> <span class="citation_source-journal">Molecules</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">342</span><span class="NLM_x">–</span> <span class="NLM_lpage">348</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2003&pages=342-348&author=L.+Racaneauthor=V.+Tralic-Kulenovicauthor=D.+W.+Boykinauthor=G.+Karminski-Zamola&title=Synthesis+of+new+cyano-substituted+bis-benzothiazolyl+arylfurans+and+arylthiophenes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRacane%26aufirst%3DL.%26aulast%3DTralic-Kulenovic%26aufirst%3DV.%26aulast%3DBoykin%26aufirst%3DD.%2BW.%26aulast%3DKarminski-Zamola%26aufirst%3DG.%26atitle%3DSynthesis%2520of%2520new%2520cyano-substituted%2520bis-benzothiazolyl%2520arylfurans%2520and%2520arylthiophenes%26jtitle%3DMolecules%26date%3D2003%26volume%3D8%26spage%3D342%26epage%3D348" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Han, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castro, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgess, K.</span><span> </span><span class="NLM_article-title">Microwave-assisted functionalization of bromo-fluorescein and bromorhodamine derivatives</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">9359</span><span class="NLM_x">–</span> <span class="NLM_lpage">9362</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2003&pages=9359-9362&author=J.+W.+Hanauthor=J.+C.+Castroauthor=K.+Burgess&title=Microwave-assisted+functionalization+of+bromo-fluorescein+and+bromorhodamine+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DJ.%2BW.%26aulast%3DCastro%26aufirst%3DJ.%2BC.%26aulast%3DBurgess%26aufirst%3DK.%26atitle%3DMicrowave-assisted%2520functionalization%2520of%2520bromo-fluorescein%2520and%2520bromorhodamine%2520derivatives%26jtitle%3DTetrahedron%2520Lett.%26date%3D2003%26volume%3D44%26spage%3D9359%26epage%3D9362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="note"><p class="first last">The synthetic methodology for the preparation of the substrates not previously described in the literature is presented in detail in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="note"><p class="first last">The binding efficiency calculations presented herein are obtained from the following formula: (−1.4 × log(IC<sub>50</sub>))/(nb heavy atoms).</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="note"><p class="first last">A large number of analogues were prepared during the course of this study. This account describes only the most salient and representative findings of our work, see:</p></div><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Adams, J. M.; Baell, J. B.; Colman, P. M.; Czabotar, P. E.; Huang, D. C. S.; Lessene, G. L.; Sleebs, B. E.; Smith, B. J.; Street, I. P.; Watson, K. G.</span><span> </span><span class="NLM_article-title">Benzothiazole compounds</span>. PCT WO2009039553 A1,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=J.+M.+Adams&author=J.+B.+Baell&author=P.+M.+Colman&author=P.+E.+Czabotar&author=D.+C.+S.+Huang&author=G.+L.+Lessene&author=B.+E.+Sleebs&author=B.+J.+Smith&author=I.+P.+Street&author=K.+G.+Watson&title=Benzothiazole+compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DJ.%2BM.%26atitle%3DBenzothiazole%2520compounds%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="note"><p class="first last">In our laboratory, compounds are routinely tested against both Bcl-X<sub>L</sub> and Mcl-1 using the LPA assay.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Myszka, D. G.</span><span> </span><span class="NLM_article-title">Analysis of small-molecule interactions using Biacore S51 technology</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">329</span><span class="NLM_x">, </span> <span class="NLM_fpage">316</span><span class="NLM_x">–</span> <span class="NLM_lpage">323</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Fjm400556w&amp;key=10.1016%2Fj.ab.2004.03.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Fjm400556w&amp;key=15158493" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm400556w&amp;key=1%3ACAS%3A528%3ADC%252BD2cXkt1Wqsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=329&publication_year=2004&pages=316-323&author=D.+G.+Myszka&title=Analysis+of+small-molecule+interactions+using+Biacore+S51+technology"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Analysis of small-molecule interactions using Biacore S51 technology</span></div><div class="casAuthors">Myszka, David G.</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Biochemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">329</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">316-323</span>CODEN:
                <span class="NLM_cas:coden">ANBCA2</span>;
        ISSN:<span class="NLM_cas:issn">0003-2697</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science</span>)
        </div><div class="casAbstract">Biacore S51 is a new surface plasmon resonance-based biosensor developed by Biacore AB (Uppsala, Sweden).  The instrument was engineered specifically to support small-mol. drug discovery and development.  The platform includes increased sensitivity, larger sample handling capabilities, and automated data processing to improve throughput.  Compared to previously released Biacore instruments, the most significant design change relates to the introduction of the hydrodynamic-addressing flow cell.  This design allows two reaction surfaces and a ref. surface to be placed within the same flow cell, thereby improving data quality and extending the kinetic range of the instrument.  Using a set of small-mol. inhibitors of the enzyme carbonic anhydrase II, we tested the reproducibility, sensitivity, and dynamic range of the biosensor.  Given the S51's performance capabilities, it should play an active role in secondary screening by providing high-resoln. information for small-mol./target interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNguzVHOfT67Vg90H21EOLACvtfcHk0liPzg-ShwSYgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXkt1Wqsrg%253D&md5=8e17fa2377f43c6eee2dcd51c00acfe6</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.ab.2004.03.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ab.2004.03.028%26sid%3Dliteratum%253Aachs%26aulast%3DMyszka%26aufirst%3DD.%2BG.%26atitle%3DAnalysis%2520of%2520small-molecule%2520interactions%2520using%2520Biacore%2520S51%2520technology%26jtitle%3DAnal.%2520Biochem.%26date%3D2004%26volume%3D329%26spage%3D316%26epage%3D323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Lee, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colman, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fairlie, W. D.</span><span> </span><span class="NLM_article-title">EGL-1 BH3 mutants reveal the importance of protein levels and target affinity for cell-killing potency</span> <span class="citation_source-journal">Cell Death Differ.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1609</span><span class="NLM_x">–</span> <span class="NLM_lpage">1618</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Fjm400556w&amp;key=10.1038%2Fcdd.2008.86" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Fjm400556w&amp;key=18566606" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm400556w&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFWht7jF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2008&pages=1609-1618&author=E.+F.+Leeauthor=L.+Chenauthor=H.+Yangauthor=P.+M.+Colmanauthor=D.+C.+Huangauthor=W.+D.+Fairlie&title=EGL-1+BH3+mutants+reveal+the+importance+of+protein+levels+and+target+affinity+for+cell-killing+potency"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">EGL-1 BH3 mutants reveal the importance of protein levels and target affinity for cell-killing potency</span></div><div class="casAuthors">Lee, E. F.; Chen, L.; Yang, H.; Colman, P. M.; Huang, D. C. S.; Fairlie, W. D.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death and Differentiation</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1609-1618</span>CODEN:
                <span class="NLM_cas:coden">CDDIEK</span>;
        ISSN:<span class="NLM_cas:issn">1350-9047</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Studies of the cell death pathway in the nematode Caenorhabditis elegans provided the first evidence of the evolutionary conservation of apoptosis signalling.  Here we show that the worm Bcl-2 homol. domain-3 (BH3)-only protein EGL-1 binds mammalian pro-survival proteins very poorly, but can be converted into a high-affinity ligand for Bcl-2 and Bcl-xL by subtle mutation of the cysteine residue at position 62 within the BH3 domain.  A 100-fold increase in affinity was obsd. following a single atom change (cysteine to serine substitution), and a further 10-fold increase by replacement with glycine.  The low affinity of wild-type EGL-1 for mammalian pro-survival proteins and its poor expression correlates with its weak killing activity in mammalian cells whereas the high-affinity C62G mutant is a very potent killer of cells lacking Mcl-1.  Cell killing by the C62S mutant with intermediate affinity only occurs when this EGL-1 BH3 domain is placed in a more stable context, namely that of BimS, which allows higher expression, though the kinetics of cell death now vary depending on whether Mcl-1 is neutralized by Noxa or genetically deleted.  These results demonstrate how levels of BH3-only proteins, target affinity and the spectrum of neutralization of pro-survival proteins all contribute to killing activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrh-TkkLAD7LbVg90H21EOLACvtfcHk0liPzg-ShwSYgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFWht7jF&md5=ff2ddd1fb404d6a1f4131d343b885e21</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1038%2Fcdd.2008.86&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcdd.2008.86%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DE.%2BF.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DColman%26aufirst%3DP.%2BM.%26aulast%3DHuang%26aufirst%3DD.%2BC.%26aulast%3DFairlie%26aufirst%3DW.%2BD.%26atitle%3DEGL-1%2520BH3%2520mutants%2520reveal%2520the%2520importance%2520of%2520protein%2520levels%2520and%2520target%2520affinity%2520for%2520cell-killing%2520potency%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2008%26volume%3D15%26spage%3D1609%26epage%3D1618" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="note"><p class="first last">See detailed description in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Willis, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dewson, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naik, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fletcher, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, D. C.</span><span> </span><span class="NLM_article-title">Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins</span> <span class="citation_source-journal">Genes Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1294</span><span class="NLM_x">–</span> <span class="NLM_lpage">1305</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2005&pages=1294-1305&author=S.+N.+Willisauthor=L.+Chenauthor=G.+Dewsonauthor=A.+Weiauthor=E.+Naikauthor=J.+I.+Fletcherauthor=J.+M.+Adamsauthor=D.+C.+Huang&title=Proapoptotic+Bak+is+sequestered+by+Mcl-1+and+Bcl-xL%2C+but+not+Bcl-2%2C+until+displaced+by+BH3-only+proteins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWillis%26aufirst%3DS.%2BN.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DDewson%26aufirst%3DG.%26aulast%3DWei%26aufirst%3DA.%26aulast%3DNaik%26aufirst%3DE.%26aulast%3DFletcher%26aufirst%3DJ.%2BI.%26aulast%3DAdams%26aufirst%3DJ.%2BM.%26aulast%3DHuang%26aufirst%3DD.%2BC.%26atitle%3DProapoptotic%2520Bak%2520is%2520sequestered%2520by%2520Mcl-1%2520and%2520Bcl-xL%252C%2520but%2520not%2520Bcl-2%252C%2520until%2520displaced%2520by%2520BH3-only%2520proteins%26jtitle%3DGenes%2520Dev.%26date%3D2005%26volume%3D19%26spage%3D1294%26epage%3D1305" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="note"><p class="first last">The mechanism of action of potent analogues of this series is thoroughly investigated in ref <a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">25</a>. These compounds induce apoptosis by selectively and potently directly interacting with Bcl-x<sub>L</sub></p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="note"><p class="first last">Full titration would be required to thoroughly correlate the binding affinities of the compounds with their ability to induce cytochrome <i>c</i> release.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Wendt, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kunzer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McClellan, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruncko, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oost, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joseph, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nimmer, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ng, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoemaker, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petros, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oleksijew, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsh, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauch, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oltersdorf, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belli, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martineau, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fesik, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenberg, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elmore, S. W.</span><span> </span><span class="NLM_article-title">Discovery and structure–activity relationship of antagonists of B-cell lymphoma 2 family proteins with chemopotentiation activity in vitro and in vivo</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">1165</span><span class="NLM_x">–</span> <span class="NLM_lpage">1181</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050754u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Fjm400556w&amp;key=1%3ACAS%3A528%3ADC%252BD28XjsFemtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=1165-1181&author=M.+D.+Wendtauthor=W.+Shenauthor=A.+Kunzerauthor=W.+J.+McClellanauthor=M.+Brunckoauthor=T.+K.+Oostauthor=H.+Dingauthor=M.+K.+Josephauthor=H.+C.+Zhangauthor=P.+M.+Nimmerauthor=S.+C.+Ngauthor=A.+R.+Shoemakerauthor=A.+M.+Petrosauthor=A.+Oleksijewauthor=K.+Marshauthor=J.+Bauchauthor=T.+Oltersdorfauthor=B.+A.+Belliauthor=D.+Martineauauthor=S.+W.+Fesikauthor=S.+H.+Rosenbergauthor=S.+W.+Elmore&title=Discovery+and+structure%E2%80%93activity+relationship+of+antagonists+of+B-cell+lymphoma+2+family+proteins+with+chemopotentiation+activity+in+vitro+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Structure-Activity Relationship of Antagonists of B-Cell Lymphoma 2 Family Proteins with Chemopotentiation Activity in Vitro and in Vivo</span></div><div class="casAuthors">Wendt, Michael D.; Shen, Wang; Kunzer, Aaron; McClellan, William J.; Bruncko, Milan; Oost, Thorsten K.; Ding, Hong; Joseph, Mary K.; Zhang, Haichao; Nimmer, Paul M.; Ng, Shi-Chung; Shoemaker, Alexander R.; Petros, Andrew M.; Oleksijew, Anatol; Marsh, Kennan; Bauch, Joy; Oltersdorf, Tilman; Belli, Barbara A.; Martineau, Darlene; Fesik, Stephen W.; Rosenberg, Saul H.; Elmore, Steven W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1165-1181</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Development of a rationally designed potentiator of cancer chemotherapy, via inhibition of Bcl-XL function, is described.  Lead compds. generated by NMR screening and directed parallel synthesis displayed sub-μM binding but were strongly deactivated in the presence of serum.  The dominant component of serum deactivation was identified as domain III of human serum albumin (HSA); NMR soln. structures of inhibitors bound to both Bcl-XL and HSA domain III indicated two potential optimization sites for sepn. of affinities.  Modifications at both sites resulted in compds. with improved Bcl-XL binding and greatly increased activity in the presence of human serum, culminating in 73R, which bound to Bcl-XL with a Ki of 0.8 nM.  In a cellular assay 73R reversed the protection afforded by Bcl-XL overexpression against cytokine deprivation in FL5.12 cells with an EC50 of 0.47 μM.  73R showed little effect on the viability of the human non small cell lung cancer cell line A549.  However, consistent with the proposed mechanism, 73R potentiated the activity of paclitaxel and UV irradn. in vitro and potentiated the antitumor efficacy of paclitaxel in a mouse xenograft model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNcJMZIao1pbVg90H21EOLACvtfcHk0ljDwki_DrBFqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjsFemtw%253D%253D&md5=a0311af587e06f1adf0f87d356137435</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fjm050754u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050754u%26sid%3Dliteratum%253Aachs%26aulast%3DWendt%26aufirst%3DM.%2BD.%26aulast%3DShen%26aufirst%3DW.%26aulast%3DKunzer%26aufirst%3DA.%26aulast%3DMcClellan%26aufirst%3DW.%2BJ.%26aulast%3DBruncko%26aufirst%3DM.%26aulast%3DOost%26aufirst%3DT.%2BK.%26aulast%3DDing%26aufirst%3DH.%26aulast%3DJoseph%26aufirst%3DM.%2BK.%26aulast%3DZhang%26aufirst%3DH.%2BC.%26aulast%3DNimmer%26aufirst%3DP.%2BM.%26aulast%3DNg%26aufirst%3DS.%2BC.%26aulast%3DShoemaker%26aufirst%3DA.%2BR.%26aulast%3DPetros%26aufirst%3DA.%2BM.%26aulast%3DOleksijew%26aufirst%3DA.%26aulast%3DMarsh%26aufirst%3DK.%26aulast%3DBauch%26aufirst%3DJ.%26aulast%3DOltersdorf%26aufirst%3DT.%26aulast%3DBelli%26aufirst%3DB.%2BA.%26aulast%3DMartineau%26aufirst%3DD.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26aulast%3DElmore%26aufirst%3DS.%2BW.%26atitle%3DDiscovery%2520and%2520structure%25E2%2580%2593activity%2520relationship%2520of%2520antagonists%2520of%2520B-cell%2520lymphoma%25202%2520family%2520proteins%2520with%2520chemopotentiation%2520activity%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D1165%26epage%3D1181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Mao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajduk, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craig, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bell, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borre, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fesik, S. W.</span><span> </span><span class="NLM_article-title">Rational design of diflunisal analogues with reduced affinity for human serum albumin</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">123</span><span class="NLM_x">, </span> <span class="NLM_fpage">10429</span><span class="NLM_x">–</span> <span class="NLM_lpage">10435</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja015955b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2001&pages=10429-10435&author=H.+Maoauthor=P.+J.+Hajdukauthor=R.+Craigauthor=R.+Bellauthor=T.+Borreauthor=S.+W.+Fesik&title=Rational+design+of+diflunisal+analogues+with+reduced+affinity+for+human+serum+albumin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fja015955b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja015955b%26sid%3Dliteratum%253Aachs%26aulast%3DMao%26aufirst%3DH.%26aulast%3DHajduk%26aufirst%3DP.%2BJ.%26aulast%3DCraig%26aufirst%3DR.%26aulast%3DBell%26aufirst%3DR.%26aulast%3DBorre%26aufirst%3DT.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26atitle%3DRational%2520design%2520of%2520diflunisal%2520analogues%2520with%2520reduced%2520affinity%2520for%2520human%2520serum%2520albumin%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2001%26volume%3D123%26spage%3D10429%26epage%3D10435" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Copeland, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pompliano, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meek, T. D.</span><span> </span><span class="NLM_article-title">Drug-target residence time and its implications for lead optimization</span> <span class="citation_source-journal">Nature Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">730</span><span class="NLM_x">–</span> <span class="NLM_lpage">739</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=730-739&author=R.+A.+Copelandauthor=D.+L.+Pomplianoauthor=T.+D.+Meek&title=Drug-target+residence+time+and+its+implications+for+lead+optimization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCopeland%26aufirst%3DR.%2BA.%26aulast%3DPompliano%26aufirst%3DD.%2BL.%26aulast%3DMeek%26aufirst%3DT.%2BD.%26atitle%3DDrug-target%2520residence%2520time%2520and%2520its%2520implications%2520for%2520lead%2520optimization%26jtitle%3DNature%2520Rev.%2520Drug%2520Discovery%26date%3D2006%26volume%3D5%26spage%3D730%26epage%3D739" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Tummino, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Copeland, R. A.</span><span> </span><span class="NLM_article-title">Residence time of receptor–ligand complexes and its effect on biological function</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">5481</span><span class="NLM_x">–</span> <span class="NLM_lpage">5492</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi8002023" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2008&pages=5481-5492&author=P.+J.+Tumminoauthor=R.+A.+Copeland&title=Residence+time+of+receptor%E2%80%93ligand+complexes+and+its+effect+on+biological+function"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Fbi8002023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi8002023%26sid%3Dliteratum%253Aachs%26aulast%3DTummino%26aufirst%3DP.%2BJ.%26aulast%3DCopeland%26aufirst%3DR.%2BA.%26atitle%3DResidence%2520time%2520of%2520receptor%25E2%2580%2593ligand%2520complexes%2520and%2520its%2520effect%2520on%2520biological%2520function%26jtitle%3DBiochemistry%26date%3D2008%26volume%3D47%26spage%3D5481%26epage%3D5492" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Verdine, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walensky, L. D.</span><span> </span><span class="NLM_article-title">The challenge of drugging undruggable targets in cancer: lessons learned from targeting BCL-2 family members</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">7264</span><span class="NLM_x">–</span> <span class="NLM_lpage">7270</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Fjm400556w&amp;key=10.1158%2F1078-0432.CCR-07-2184" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Fjm400556w&amp;key=18094406" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Fjm400556w&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVCktr%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=7264-7270&author=G.+L.+Verdineauthor=L.+D.+Walensky&title=The+challenge+of+drugging+undruggable+targets+in+cancer%3A+lessons+learned+from+targeting+BCL-2+family+members"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">The Challenge of Drugging Undruggable Targets in Cancer: Lessons Learned from Targeting BCL-2 Family Members</span></div><div class="casAuthors">Verdine, Gregory L.; Walensky, Loren D.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">7264-7270</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  The genomic and proteomic revolutions have provided us with an ever-increasing no. of mechanistic insights into cancer pathogenesis.  Mutated genes and pathol. protein products have emerged as the basis for modern anticancer drug development.  With the increasing realization of the importance of disrupting oncogenic protein-protein interaction, new challenges have emerged for classical small mol. and protein-based drug modalities, i.e., the crit. need to target flat and extended protein surfaces.  Here, we highlight two distinct technologies that are being used to bridge the pharmacol. gap between small mols. and protein therapeutics.  With the BCL-2 family of survival proteins as their substrate for intracellular targeting, we conclude that peptide stapling and fragment-based drug discovery show promise to traverse the crit. surface features of proteins that drive human cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgYQX3c_4_qLVg90H21EOLACvtfcHk0li3bLxgKmJ8sg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVCktr%252FK&md5=1b7fcbe41063e04470f7c34b50410a42</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-07-2184&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-07-2184%26sid%3Dliteratum%253Aachs%26aulast%3DVerdine%26aufirst%3DG.%2BL.%26aulast%3DWalensky%26aufirst%3DL.%2BD.%26atitle%3DThe%2520challenge%2520of%2520drugging%2520undruggable%2520targets%2520in%2520cancer%253A%2520lessons%2520learned%2520from%2520targeting%2520BCL-2%2520family%2520members%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2007%26volume%3D13%26spage%3D7264%26epage%3D7270" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Berg, T.</span><span> </span><span class="NLM_article-title">Small-molecule inhibitors of protein–protein interactions</span> <span class="citation_source-journal">Curr. Opin. Drug Discovery Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">666</span><span class="NLM_x">–</span> <span class="NLM_lpage">674</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2008&pages=666-674&author=T.+Berg&title=Small-molecule+inhibitors+of+protein%E2%80%93protein+interactions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBerg%26aufirst%3DT.%26atitle%3DSmall-molecule%2520inhibitors%2520of%2520protein%25E2%2580%2593protein%2520interactions%26jtitle%3DCurr.%2520Opin.%2520Drug%2520Discovery%2520Dev.%26date%3D2008%26volume%3D11%26spage%3D666%26epage%3D674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Shoemaker, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oleksijew, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauch, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belli, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borre, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruncko, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deckwirth, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frost, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarvis, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joseph, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marsh, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McClellan, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nellans, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ng, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nimmer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connor, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oltersdorf, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qing, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stavropoulos, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tahir, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warner, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fesik, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenberg, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elmore, S. W.</span><span> </span><span class="NLM_article-title">A small-molecule inhibitor of Bcl-X<sub>L</sub> potentiates the activity of cytotoxic drugs in vitro and in vivo</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">8731</span><span class="NLM_x">–</span> <span class="NLM_lpage">8739</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2006&pages=8731-8739&author=A.+R.+Shoemakerauthor=A.+Oleksijewauthor=J.+Bauchauthor=B.+A.+Belliauthor=T.+Borreauthor=M.+Brunckoauthor=T.+Deckwirthauthor=D.+J.+Frostauthor=K.+Jarvisauthor=M.+K.+Josephauthor=K.+Marshauthor=W.+McClellanauthor=H.+Nellansauthor=S.+Ngauthor=P.+Nimmerauthor=J.+M.+O%E2%80%99Connorauthor=T.+Oltersdorfauthor=W.+Qingauthor=W.+Shenauthor=J.+Stavropoulosauthor=S.+K.+Tahirauthor=B.+L.+Wangauthor=R.+Warnerauthor=H.+C.+Zhangauthor=S.+W.+Fesikauthor=S.+H.+Rosenbergauthor=S.+W.+Elmore&title=A+small-molecule+inhibitor+of+Bcl-XL+potentiates+the+activity+of+cytotoxic+drugs+in+vitro+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShoemaker%26aufirst%3DA.%2BR.%26aulast%3DOleksijew%26aufirst%3DA.%26aulast%3DBauch%26aufirst%3DJ.%26aulast%3DBelli%26aufirst%3DB.%2BA.%26aulast%3DBorre%26aufirst%3DT.%26aulast%3DBruncko%26aufirst%3DM.%26aulast%3DDeckwirth%26aufirst%3DT.%26aulast%3DFrost%26aufirst%3DD.%2BJ.%26aulast%3DJarvis%26aufirst%3DK.%26aulast%3DJoseph%26aufirst%3DM.%2BK.%26aulast%3DMarsh%26aufirst%3DK.%26aulast%3DMcClellan%26aufirst%3DW.%26aulast%3DNellans%26aufirst%3DH.%26aulast%3DNg%26aufirst%3DS.%26aulast%3DNimmer%26aufirst%3DP.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DJ.%2BM.%26aulast%3DOltersdorf%26aufirst%3DT.%26aulast%3DQing%26aufirst%3DW.%26aulast%3DShen%26aufirst%3DW.%26aulast%3DStavropoulos%26aufirst%3DJ.%26aulast%3DTahir%26aufirst%3DS.%2BK.%26aulast%3DWang%26aufirst%3DB.%2BL.%26aulast%3DWarner%26aufirst%3DR.%26aulast%3DZhang%26aufirst%3DH.%2BC.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26aulast%3DElmore%26aufirst%3DS.%2BW.%26atitle%3DA%2520small-molecule%2520inhibitor%2520of%2520Bcl-XL%2520potentiates%2520the%2520activity%2520of%2520cytotoxic%2520drugs%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DCancer%2520Res.%26date%3D2006%26volume%3D66%26spage%3D8731%26epage%3D8739" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Lee, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czabotar, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sleebs, B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lessene, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colman, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fairlie, W. D.</span><span> </span><span class="NLM_article-title">Conformational changes in Bcl-2 pro-survival proteins determine their capacity to bind ligands</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">284</span><span class="NLM_x">, </span> <span class="NLM_fpage">30508</span><span class="NLM_x">–</span> <span class="NLM_lpage">30517</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Fjm400556w&amp;key=10.1074%2Fjbc.M109.040725" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Fjm400556w&amp;key=19726685" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Fjm400556w&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlSru7rM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=30508-30517&author=E.+F.+Leeauthor=P.+E.+Czabotarauthor=H.+Yangauthor=B.+E.+Sleebsauthor=G.+Lesseneauthor=P.+M.+Colmanauthor=B.+J.+Smithauthor=W.+D.+Fairlie&title=Conformational+changes+in+Bcl-2+pro-survival+proteins+determine+their+capacity+to+bind+ligands"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Conformational Changes in Bcl-2 Pro-survival Proteins Determine their Capacity to Bind Ligands</span></div><div class="casAuthors">Lee, Erinna F.; Czabotar, Peter E.; Yang, Hong; Sleebs, Brad E.; Lessene, Guillaume; Colman, Peter M.; Smith, Brian J.; Fairlie, W. Douglas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">284</span>
        (<span class="NLM_cas:issue">44</span>),
    <span class="NLM_cas:pages">30508-30517</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Antagonists of anti-apoptotic Bcl-2 family members hold promise as cancer therapeutics.  Apoptosis is triggered when a peptide contg. a BH3 motif or a small mol. BH3 peptidomimetic, such as ABT 737, binds to the relevant Bcl-2 family members.  ABT-737 is an antagonist of Bcl-2, Bcl-xL, and Bcl-w but not of Mcl-1.  Here we describe new structures of mutant BH3 peptides bound to Bcl-xL and Mcl-1.  These structures suggested a rationale for the failure of ABT-737 to bind Mcl-1, but a designed variant of ABT-737 failed to acquire binding affinity for Mcl-1.  Rather, it was selective for Bcl-xL, a result attributable in part to significant backbone refolding and movements of helical segments in its ligand binding site.  To date there are few reported crystal structures of org. ligands in complex with their pro-survival protein targets.  Our structure of this new org. ligand provided insights into the structural transitions that occur within the BH3 binding groove, highlighting significant differences in the structural properties of members of the Bcl-2 pro-survival protein family.  Such differences are likely to influence and be important in the quest for compds. capable of selectively antagonizing the different family members.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrR0Yq3r-UYlrVg90H21EOLACvtfcHk0likSlRvxPsWPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlSru7rM&md5=8be86f3bd7c1cdf1e7ba9b289baf248a</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M109.040725&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M109.040725%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DE.%2BF.%26aulast%3DCzabotar%26aufirst%3DP.%2BE.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DSleebs%26aufirst%3DB.%2BE.%26aulast%3DLessene%26aufirst%3DG.%26aulast%3DColman%26aufirst%3DP.%2BM.%26aulast%3DSmith%26aufirst%3DB.%2BJ.%26aulast%3DFairlie%26aufirst%3DW.%2BD.%26atitle%3DConformational%2520changes%2520in%2520Bcl-2%2520pro-survival%2520proteins%2520determine%2520their%2520capacity%2520to%2520bind%2520ligands%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26spage%3D30508%26epage%3D30517" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="note"><p class="first last">For a more detailed discussion, see refs <a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">10</a> and <a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">11</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Porter, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Payne, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Candole, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ford, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutchinson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trevitt, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watkins, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitcombe, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stubberfield, C.</span><span> </span><span class="NLM_article-title">Tetrahydroisoquinoline amide substituted phenyl pyrazoles as selective Bcl-2 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">230</span><span class="NLM_x">–</span> <span class="NLM_lpage">233</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=230-233&author=J.+Porterauthor=A.+Payneauthor=B.+De+Candoleauthor=D.+Fordauthor=B.+Hutchinsonauthor=G.+Trevittauthor=J.+Turnerauthor=C.+Edwardsauthor=C.+Watkinsauthor=I.+Whitcombeauthor=J.+Davisauthor=C.+Stubberfield&title=Tetrahydroisoquinoline+amide+substituted+phenyl+pyrazoles+as+selective+Bcl-2+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPorter%26aufirst%3DJ.%26aulast%3DPayne%26aufirst%3DA.%26aulast%3DDe%2BCandole%26aufirst%3DB.%26aulast%3DFord%26aufirst%3DD.%26aulast%3DHutchinson%26aufirst%3DB.%26aulast%3DTrevitt%26aufirst%3DG.%26aulast%3DTurner%26aufirst%3DJ.%26aulast%3DEdwards%26aufirst%3DC.%26aulast%3DWatkins%26aufirst%3DC.%26aulast%3DWhitcombe%26aufirst%3DI.%26aulast%3DDavis%26aufirst%3DJ.%26aulast%3DStubberfield%26aufirst%3DC.%26atitle%3DTetrahydroisoquinoline%2520amide%2520substituted%2520phenyl%2520pyrazoles%2520as%2520selective%2520Bcl-2%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D230%26epage%3D233" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Lipinski, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombardo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dominy, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feeney, P. J.</span><span> </span><span class="NLM_article-title">Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings</span> <span class="citation_source-journal">Adv. Drug Delivery Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">25</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Fjm400556w&amp;key=10.1016%2FS0169-409X%2896%2900423-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Fjm400556w&amp;key=1%3ACAS%3A528%3ADyaK2sXktlKlsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1997&pages=3-25&author=C.+A.+Lipinskiauthor=F.+Lombardoauthor=B.+W.+Dominyauthor=P.+J.+Feeney&title=Experimental+and+computational+approaches+to+estimate+solubility+and+permeability+in+drug+discovery+and+development+settings"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings</span></div><div class="casAuthors">Lipinski, Christopher A.; Lombardo, Franco; Dominy, Beryl W.; Feeney, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">3-25</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review with 50 refs.  Exptl. and computational approaches to est. soly. and permeability in discovery and development settings are described.  In the discovery setting 'the rule of 5' predicts that poor absorption or permeation is more likely when there are more than 5 H-bond donors, 10 H-bond acceptors, the mol. wt. (MWT) is >500 and the calcd. Log P (CLogP) is >5.  Computational methodol. for the rule-based Moriguchi Log P (MLogP) calcn. is described.  Turbidimetric soly. measurement is described and applied to known drugs.  High throughput screening (HTS) leads tend to have higher MWT and Log P and lower turbidimetric soly. than leads in the pre-HTS era.  In the development setting, soly. calcns. focus on exact value prediction and are difficult because of polymorphism.  Recent work on linear free energy relationships and Log P approaches are critically reviewed.  Useful predictions are possible in closely related analog series when coupled with exptl. thermodn. soly. measurements.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGon9gEeZ7cboLVg90H21EOLACvtfcHk0ljf5nv0dZjdvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXktlKlsQ%253D%253D&md5=405f70b0594d428f1275e1d56642cd3a</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1016%2FS0169-409X%2896%2900423-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0169-409X%252896%252900423-1%26sid%3Dliteratum%253Aachs%26aulast%3DLipinski%26aufirst%3DC.%2BA.%26aulast%3DLombardo%26aufirst%3DF.%26aulast%3DDominy%26aufirst%3DB.%2BW.%26aulast%3DFeeney%26aufirst%3DP.%2BJ.%26atitle%3DExperimental%2520and%2520computational%2520approaches%2520to%2520estimate%2520solubility%2520and%2520permeability%2520in%2520drug%2520discovery%2520and%2520development%2520settings%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D1997%26volume%3D23%26spage%3D3%26epage%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Veber, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopple, K. D.</span><span> </span><span class="NLM_article-title">Molecular properties that influence the oral bioavailability of drug candidates</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">2615</span><span class="NLM_x">–</span> <span class="NLM_lpage">2623</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm020017n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Fjm400556w&amp;key=1%3ACAS%3A528%3ADC%252BD38XjsFCmt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=2615-2623&author=D.+F.+Veberauthor=S.+R.+Johnsonauthor=H.+Y.+Chengauthor=B.+R.+Smithauthor=K.+W.+Wardauthor=K.+D.+Kopple&title=Molecular+properties+that+influence+the+oral+bioavailability+of+drug+candidates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Properties That Influence the Oral Bioavailability of Drug Candidates</span></div><div class="casAuthors">Veber, Daniel F.; Johnson, Stephen R.; Cheng, Hung-Yuan; Smith, Brian R.; Ward, Keith W.; Kopple, Kenneth D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2615-2623</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Oral bioavailability measurements in rats for over 1100 drug candidates studied at Smith-Kline Beecham Pharmaceuticals (now Glaxo Smith-Kline) have allowed us to analyze the relative importance of mol. properties considered to influence that drug property.  Reduced mol. flexibility, as measured by the no. of rotatable bonds, and low polar surface area or total hydrogen bond count (sum of donors and acceptors) are found to be important predictors of good oral bioavailability, independent of mol. wt.  That on av. both the no. of rotatable bonds and polar surface area or hydrogen bond count tend to increase with mol. wt. may in part explain the success of the mol. wt. parameter in predicting oral bioavailability.  The commonly applied mol. wt. cutoff at 500 does not itself significantly sep. compds. with poor oral bioavailability from those with acceptable values in this extensive data set.  Our observations suggest that compds. which meet only the 2 criteria of (1) 10 or fewer rotatable bonds and (2) polar surface area ≤140 Å2 (or 12 or fewer H-bond donors and acceptors) will have a high probability of good oral bioavailability in the rat.  Data sets for the artificial membrane permeation rate and for clearance in the rat were also examd.  Reduced polar surface area correlates better with increased permeation rate than does lipophilicity (C log P), and increased rotatable bond count has a neg. effect on the permeation rate.  A threshold permeation rate is a prerequisite of oral bioavailability.  The rotatable bond count does not correlate with the data examd. here for the in vivo clearance rate in the rat.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3JtJEkO7yVLVg90H21EOLACvtfcHk0ljf5nv0dZjdvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjsFCmt7g%253D&md5=eaad26ed6a259de82ad65a8834fc397d</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1021%2Fjm020017n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020017n%26sid%3Dliteratum%253Aachs%26aulast%3DVeber%26aufirst%3DD.%2BF.%26aulast%3DJohnson%26aufirst%3DS.%2BR.%26aulast%3DCheng%26aufirst%3DH.%2BY.%26aulast%3DSmith%26aufirst%3DB.%2BR.%26aulast%3DWard%26aufirst%3DK.%2BW.%26aulast%3DKopple%26aufirst%3DK.%2BD.%26atitle%3DMolecular%2520properties%2520that%2520influence%2520the%2520oral%2520bioavailability%2520of%2520drug%2520candidates%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D2615%26epage%3D2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="note"><p class="first last">Some researchers use screening hit binding efficiency as a criterion for go/no go progression. Our approach to lead generation assumes that any screening hit with molecular weight around 300 or more and displaying low micromolar target affinity is unlikely to also coincidentally be an optimum fit. Therefore, we use medicinal chemistry to seek out suboptimal substructures and improve them. Groups using fragment-based lead generation have adopted a parallel philosophy. See for example</p></div><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Hadjuk, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bures, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Praestgaard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fesik, S. W.</span><span> </span><span class="NLM_article-title">Privileged Molecules for Protein Binding Identified from NMR-Based Screening</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">3443</span><span class="NLM_x">–</span> <span class="NLM_lpage">3447</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=3443-3447&author=P.+J.+Hadjukauthor=M.+Buresauthor=J.+Praestgaardauthor=S.+W.+Fesik&title=Privileged+Molecules+for+Protein+Binding+Identified+from+NMR-Based+Screening"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHadjuk%26aufirst%3DP.%2BJ.%26aulast%3DBures%26aufirst%3DM.%26aulast%3DPraestgaard%26aufirst%3DJ.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26atitle%3DPrivileged%2520Molecules%2520for%2520Protein%2520Binding%2520Identified%2520from%2520NMR-Based%2520Screening%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D3443%26epage%3D3447" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="note"><p class="first last">We suggest that this strategy is relevant to any type of target, not just that described herein.</p></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Katz, L.</span><span> </span><span class="NLM_article-title">Antituberculous Compounds. 111. Benzothiazole and Benzoxazole Derivatives</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1952</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x">, </span> <span class="NLM_fpage">712</span><span class="NLM_x">–</span> <span class="NLM_lpage">714</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=1952&pages=712-714&author=L.+Katz&title=Antituberculous+Compounds.+111.+Benzothiazole+and+Benzoxazole+Derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKatz%26aufirst%3DL.%26atitle%3DAntituberculous%2520Compounds.%2520111.%2520Benzothiazole%2520and%2520Benzoxazole%2520Derivatives%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1952%26volume%3D75%26spage%3D712%26epage%3D714" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Iemura, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawashima, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukuda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsukamoto, G.</span><span> </span><span class="NLM_article-title">Synthesis of 2-(4-substituted-1-piperazinyl)benzimidazoles as H1-antihistaminic agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">1178</span><span class="NLM_x">–</span> <span class="NLM_lpage">1183</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00157a010" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=1986&pages=1178-1183&author=R.+Iemuraauthor=T.+Kawashimaauthor=T.+Fukudaauthor=K.+Itoauthor=G.+Tsukamoto&title=Synthesis+of+2-%284-substituted-1-piperazinyl%29benzimidazoles+as+H1-antihistaminic+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1021%2Fjm00157a010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00157a010%26sid%3Dliteratum%253Aachs%26aulast%3DIemura%26aufirst%3DR.%26aulast%3DKawashima%26aufirst%3DT.%26aulast%3DFukuda%26aufirst%3DT.%26aulast%3DIto%26aufirst%3DK.%26aulast%3DTsukamoto%26aufirst%3DG.%26atitle%3DSynthesis%2520of%25202-%25284-substituted-1-piperazinyl%2529benzimidazoles%2520as%2520H1-antihistaminic%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1986%26volume%3D29%26spage%3D1178%26epage%3D1183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">Czabotar, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Delft, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Day, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fairlie, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hinds, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colman, P. M.</span><span> </span><span class="NLM_article-title">Structural insights into the degradation of Mcl-1 induced by BH3 domains</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">6217</span><span class="NLM_x">–</span> <span class="NLM_lpage">6222</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Fjm400556w&amp;key=10.1073%2Fpnas.0701297104" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Fjm400556w&amp;key=17389404" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Fjm400556w&amp;key=1%3ACAS%3A528%3ADC%252BD2sXks1arurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2007&pages=6217-6222&author=P.+E.+Czabotarauthor=E.+F.+Leeauthor=M.+F.+van+Delftauthor=C.+L.+Dayauthor=B.+J.+Smithauthor=D.+C.+Huangauthor=W.+D.+Fairlieauthor=M.+G.+Hindsauthor=P.+M.+Colman&title=Structural+insights+into+the+degradation+of+Mcl-1+induced+by+BH3+domains"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Structural insights into the degradation of MCl-1 induced by BH3 domains</span></div><div class="casAuthors">Czabotar, Peter E.; Lee, Erinna F.; van Delft, Mark F.; Day, Catherine L.; Smith, Brian J.; Huang, David C. S.; Fairlie, W. Douglas; Hinds, Mark G.; Colman, Peter M.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">6217-6222</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Apoptosis is held in check by prosurvival proteins of the Bcl-2 family.  The distantly related BH3-only proteins bind to and antagonize Bcl-2 proteins, thereby promoting apoptosis.  Whereas binding of the BH3-only protein Noxa to prosurvival Mcl-1 induces Mcl-1 degrdn. by the proteasome, binding of another BH3-only ligand, Bim, elevates Mcl-1 protein levels.  We compared the three- dimensional structures of the complexes formed between BH3 peptides of both Bim and Noxa, and we show that a discrete C-terminal sequence of the Noxa BH3 is necessary to instigate Mcl-1 degrdn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprkT9u8IpxRLVg90H21EOLACvtfcHk0lhV1GDhMkqZdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXks1arurw%253D&md5=f91d0194ce195855706f69364b7e6fb6</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0701297104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0701297104%26sid%3Dliteratum%253Aachs%26aulast%3DCzabotar%26aufirst%3DP.%2BE.%26aulast%3DLee%26aufirst%3DE.%2BF.%26aulast%3Dvan%2BDelft%26aufirst%3DM.%2BF.%26aulast%3DDay%26aufirst%3DC.%2BL.%26aulast%3DSmith%26aufirst%3DB.%2BJ.%26aulast%3DHuang%26aufirst%3DD.%2BC.%26aulast%3DFairlie%26aufirst%3DW.%2BD.%26aulast%3DHinds%26aufirst%3DM.%2BG.%26aulast%3DColman%26aufirst%3DP.%2BM.%26atitle%3DStructural%2520insights%2520into%2520the%2520degradation%2520of%2520Mcl-1%2520induced%2520by%2520BH3%2520domains%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2007%26volume%3D104%26spage%3D6217%26epage%3D6222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group">Lee, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czabotar, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Delft, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michalak, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyle, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willis, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puthalakath, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouillet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colman, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fairlie, W. D.</span><span> </span><span class="NLM_article-title">A novel BH3 ligand that selectively targets Mcl-1 reveals that apoptosis can proceed without Mcl-1 degradation</span> <span class="citation_source-journal">J. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">180</span><span class="NLM_x">, </span> <span class="NLM_fpage">341</span><span class="NLM_x">–</span> <span class="NLM_lpage">355</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=180&publication_year=2008&pages=341-355&author=E.+F.+Leeauthor=P.+E.+Czabotarauthor=M.+F.+van+Delftauthor=E.+M.+Michalakauthor=M.+J.+Boyleauthor=S.+N.+Willisauthor=H.+Puthalakathauthor=P.+Bouilletauthor=P.+M.+Colmanauthor=D.+C.+Huangauthor=W.+D.+Fairlie&title=A+novel+BH3+ligand+that+selectively+targets+Mcl-1+reveals+that+apoptosis+can+proceed+without+Mcl-1+degradation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DE.%2BF.%26aulast%3DCzabotar%26aufirst%3DP.%2BE.%26aulast%3Dvan%2BDelft%26aufirst%3DM.%2BF.%26aulast%3DMichalak%26aufirst%3DE.%2BM.%26aulast%3DBoyle%26aufirst%3DM.%2BJ.%26aulast%3DWillis%26aufirst%3DS.%2BN.%26aulast%3DPuthalakath%26aufirst%3DH.%26aulast%3DBouillet%26aufirst%3DP.%26aulast%3DColman%26aufirst%3DP.%2BM.%26aulast%3DHuang%26aufirst%3DD.%2BC.%26aulast%3DFairlie%26aufirst%3DW.%2BD.%26atitle%3DA%2520novel%2520BH3%2520ligand%2520that%2520selectively%2520targets%2520Mcl-1%2520reveals%2520that%2520apoptosis%2520can%2520proceed%2520without%2520Mcl-1%2520degradation%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2008%26volume%3D180%26spage%3D341%26epage%3D355" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group">Lee, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedorova, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zobel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyle, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perugini, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colman, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deshayes, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fairlie, W. D.</span><span> </span><span class="NLM_article-title">Novel Bcl-2 homology-3 domain-like sequences identified from screening randomized peptide libraries for inhibitors of the pro-survival Bcl-2 proteins</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">284</span><span class="NLM_x">, </span> <span class="NLM_fpage">31315</span><span class="NLM_x">–</span> <span class="NLM_lpage">31326</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=31315-31326&author=E.+F.+Leeauthor=A.+Fedorovaauthor=K.+Zobelauthor=M.+J.+Boyleauthor=H.+Yangauthor=M.+A.+Peruginiauthor=P.+M.+Colmanauthor=D.+C.+Huangauthor=K.+Deshayesauthor=W.+D.+Fairlie&title=Novel+Bcl-2+homology-3+domain-like+sequences+identified+from+screening+randomized+peptide+libraries+for+inhibitors+of+the+pro-survival+Bcl-2+proteins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DE.%2BF.%26aulast%3DFedorova%26aufirst%3DA.%26aulast%3DZobel%26aufirst%3DK.%26aulast%3DBoyle%26aufirst%3DM.%2BJ.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DPerugini%26aufirst%3DM.%2BA.%26aulast%3DColman%26aufirst%3DP.%2BM.%26aulast%3DHuang%26aufirst%3DD.%2BC.%26aulast%3DDeshayes%26aufirst%3DK.%26aulast%3DFairlie%26aufirst%3DW.%2BD.%26atitle%3DNovel%2520Bcl-2%2520homology-3%2520domain-like%2520sequences%2520identified%2520from%2520screening%2520randomized%2520peptide%2520libraries%2520for%2520inhibitors%2520of%2520the%2520pro-survival%2520Bcl-2%2520proteins%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26spage%3D31315%26epage%3D31326" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group">Zhang, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, T. D. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oldenburg, K. R.</span><span> </span><span class="NLM_article-title">A simple statistical parameter for use in evaluation and validation of high throughput screening assays</span> <span class="citation_source-journal">J. Biomol. Screening</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">67</span><span class="NLM_x">–</span> <span class="NLM_lpage">73</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Fjm400556w&amp;key=10.1177%2F108705719900400206" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Fjm400556w&amp;key=10838414" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Fjm400556w&amp;key=1%3ACAS%3A280%3ADC%252BC2sbit12juw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1999&pages=67-73&author=J.+H.+Zhangauthor=T.+D.+Y.+Chungauthor=K.+R.+Oldenburg&title=A+simple+statistical+parameter+for+use+in+evaluation+and+validation+of+high+throughput+screening+assays"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays</span></div><div class="casAuthors">Zhang; Chung; Oldenburg</div><div class="citationInfo"><span class="NLM_cas:title">Journal of biomolecular screening</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">67-73</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The ability to identify active compounds (3hits2) from large chemical libraries accurately and rapidly has been the ultimate goal in developing high-throughput screening (HTS) assays.  The ability to identify hits from a particular HTS assay depends largely on the suitability or quality of the assay used in the screening.  The criteria or parameters for evaluating the 3suitability2 of an HTS assay for hit identification are not well defined and hence it still remains difficult to compare the quality of assays directly.  In this report, a screening window coefficient, called 3Z-factor,2 is defined.  This coefficient is reflective of both the assay signal dynamic range and the data variation associated with the signal measurements, and therefore is suitable for assay quality assessment.  The Z-factor is a dimensionless, simple statistical characteristic for each HTS assay.  The Z-factor provides a useful tool for comparison and evaluation of the quality of assays, and can be utilized in assay optimization and validation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRkwW5JDdXnbsNIRw0GKUoEfW6udTcc2eYyXu6zbevAK7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2sbit12juw%253D%253D&md5=0ec4ed2ccdd3b4a16521567a0975d31f</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1177%2F108705719900400206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F108705719900400206%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%2BH.%26aulast%3DChung%26aufirst%3DT.%2BD.%2BY.%26aulast%3DOldenburg%26aufirst%3DK.%2BR.%26atitle%3DA%2520simple%2520statistical%2520parameter%2520for%2520use%2520in%2520evaluation%2520and%2520validation%2520of%2520high%2520throughput%2520screening%2520assays%26jtitle%3DJ.%2520Biomol.%2520Screening%26date%3D1999%26volume%3D4%26spage%3D67%26epage%3D73" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i157"><a href="/doi/suppl/10.1021/jm400556w">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_27462"></div></div></div></div></div><hr /></hr><p class="last">Screening cascade, the synthesis of <b>60a</b>–<b>d</b>, all steady state curves, sensorgrams and parameters from SPR experiments for compounds <b>1</b>, <b>4</b>, <b>12a</b>, <b>38</b>, <b>59b</b>, and wtBim-26mer, Biacore 3000 competition assay details.  This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm400556w/suppl_file/jm400556w_si_001.pdf">jm400556w_si_001.pdf (3.47 MB)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm400556w&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2013.56.issue-13%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Fjm400556w%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm400556w" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679a33f0eafc3cca","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
